
<html lang="en"     class="pb-page"  data-request-id="35086b18-c230-4454-af81-5119177c8d60"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2018.61.issue-16;wgroup:string:ACHS website Group;website:website:acspubs;article:article:10.1021/acs.jmedchem.7b01686;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Prolyl Hydroxylase Inhibitors: A Breakthrough in the Therapy of Anemia Associated with Chronic Diseases" /></meta><meta name="dc.Creator" content="Amit A.  Joharapurkar" /></meta><meta name="dc.Creator" content="Vrajesh B.  Pandya" /></meta><meta name="dc.Creator" content="Vishal J.  Patel" /></meta><meta name="dc.Creator" content="Ranjit C.  Desai" /></meta><meta name="dc.Creator" content="Mukul R.  Jain" /></meta><meta name="dc.Description" content="Chronic kidney disease, cancer, chronic inflammatory disorders, nutritional, and genetic deficiency can cause anemia. Hypoxia causes induction of hypoxia-inducible factor (HIF), which stimulates er..." /></meta><meta name="Description" content="Chronic kidney disease, cancer, chronic inflammatory disorders, nutritional, and genetic deficiency can cause anemia. Hypoxia causes induction of hypoxia-inducible factor (HIF), which stimulates er..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="May 1, 2018" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b01686" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01686" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b01686" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01686" /></link>
        
    
    

<title>Prolyl Hydroxylase Inhibitors: A Breakthrough in the Therapy of Anemia Associated with Chronic Diseases | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b01686" /></meta><meta property="og:title" content="Prolyl Hydroxylase Inhibitors: A Breakthrough in the Therapy of Anemia Associated with Chronic Diseases" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01686/20180816/images/large/jm-2017-01686a_0012.jpeg" /></meta><meta property="og:description" content="Chronic kidney disease, cancer, chronic inflammatory disorders, nutritional, and genetic deficiency can cause anemia. Hypoxia causes induction of hypoxia-inducible factor (HIF), which stimulates erythropoietin (EPO) synthesis. Prolyl hydroxylase domain (PHD) enzyme inhibition can stabilize hypoxia-inducible factor (HIF). HIF stabilization also decreases hepcidin, a hormone of hepatic origin, which regulates iron homeostasis. PHD inhibitors represent a novel pharmacological treatment of anemia associated with chronic diseases. Many orally active PHD inhibitors like roxadustat, molidustat, vadadustat, and desidustat are in late phase clinical trials. This review discusses the role of PHD inhibitors in the treatment of anemia associated with chronic diseases." /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta><meta name="twitter:description" content="Chronic kidney disease, cancer, chronic inflammatory disorders, nutritional, and genetic deficiency can cause anemia. Hypoxia causes induction of hypoxia-inducible factor (HIF), which stimulates erythropoietin (EPO) synthesis. Prolyl hydroxylase domain (PHD) enzyme inhibition can stabilize hypoxia-inducible factor (HIF). HIF stabilization also decreases hepcidin, a hormone of hepatic origin, which regulates iron homeostasis. PHD inhibitors represent a novel pharmacological treatment of anemia associated with chronic diseases. Many orally active PHD inhibitors like roxadustat, molidustat, vadadustat, and desidustat are in late phase clinical trials. This review discusses the role of PHD inhibitors in the treatment of anemia associated with chronic diseases." /></meta><meta name="twitter:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01686/20180816/images/large/jm-2017-01686a_0012.jpeg" /></meta><meta name="twitter:title" content="Prolyl Hydroxylase Inhibitors: A Breakthrough in the Therapy of Anemia Associated with Chronic Diseases" /></meta>
        
            <meta property="og:type" content="Article" /></meta>
        

        
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b01686"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/ke1q~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-6ee29527b3d8ff00a106.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b01686">
            
        





































    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-12/achre4.2021.54.issue-12/20210615/achre4.2021.54.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-6/amrcda.2021.2.issue-6/20210625/amrcda.2021.2.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-6/aabmcb.2021.4.issue-6/20210621/aabmcb.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-6/aaembp.2021.3.issue-6/20210622/aaembp.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-6/aaemcq.2021.4.issue-6/20210628/aaemcq.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-25/aamick.2021.13.issue-25/20210630/aamick.2021.13.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-6/aanmf6.2021.4.issue-6/20210625/aanmf6.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-6/aapmcd.2021.3.issue-6/20210611/aapmcd.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-6/abseba.2021.7.issue-6/20210614/abseba.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-12/accacs.2021.11.issue-12/20210618/accacs.2021.11.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-6/acscii.2021.7.issue-6/20210623/acscii.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-6/acbcct.2021.16.issue-6/20210618/acbcct.2021.16.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-3/achsc5.2021.28.issue-3/20210524/achsc5.2021.28.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-12/acncdm.2021.12.issue-12/20210616/acncdm.2021.12.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-6/aesccq.2021.5.issue-6/20210617/aesccq.2021.5.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-6/aelccp.2021.6.issue-6/20210611/aelccp.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-6/aeecco.2021.1.issue-6/20210611/aeecco.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-6/aewcaa.2021.1.issue-6/20210611/aewcaa.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-5/afsthl.2021.1.issue-5/20210618/afsthl.2021.1.issue-5.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-6/aidcbc.2021.7.issue-6/20210611/aidcbc.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-6/amlccd.2021.10.issue-6/20210615/amlccd.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-6/amlcef.2021.3.issue-6/20210607/amlcef.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-6/amclct.2021.12.issue-6/20210610/amclct.2021.12.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-6/ancac3.2021.15.issue-6/20210622/ancac3.2021.15.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-25/acsodf.2021.6.issue-25/20210629/acsodf.2021.6.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-6/apchd5.2021.8.issue-6/20210616/apchd5.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-6/ascefj.2021.6.issue-6/20210625/ascefj.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-25/ascecg.2021.9.issue-25/20210628/ascecg.2021.9.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-6/asbcd6.2021.10.issue-6/20210618/asbcd6.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-25/ancham.2021.93.issue-25/20210629/ancham.2021.93.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-25/bichaw.2021.60.issue-25/20210629/bichaw.2021.60.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-6/bcches.2021.32.issue-6/20210616/bcches.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-6/bomaf6.2021.22.issue-6/20210614/bomaf6.2021.22.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-24/cgeabj.2021.99.issue-24/20210628-01/cgeabj.2021.99.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-6/crtoec.2021.34.issue-6/20210621/crtoec.2021.34.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-12/chreay.2021.121.issue-12/20210623/chreay.2021.121.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-12/cmatex.2021.33.issue-12/20210622/cmatex.2021.33.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-6/cgdefu.2021.21.issue-6/20210602/cgdefu.2021.21.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-12/enfuem.2021.35.issue-12/20210617/enfuem.2021.35.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-12/esthag.2021.55.issue-12/20210615/esthag.2021.55.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-6/estlcu.2021.8.issue-6/20210608/estlcu.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-25/iecred.2021.60.issue-25/20210630/iecred.2021.60.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-12/inocaj.2021.60.issue-12/20210621/inocaj.2021.60.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-6/jaaucr.2021.1.issue-6/20210628/jaaucr.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-25/jafcau.2021.69.issue-25/20210630/jafcau.2021.69.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-6/jceaax.2021.66.issue-6/20210610/jceaax.2021.66.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-6/jceda8.2021.98.issue-6/20210608/jceda8.2021.98.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-6/jcisd8.2021.61.issue-6/20210628/jcisd8.2021.61.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-6/jctcce.2021.17.issue-6/20210608/jctcce.2021.17.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-12/jmcmar.2021.64.issue-12/20210624/jmcmar.2021.64.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-6/jnprdf.2021.84.issue-6/20210625/jnprdf.2021.84.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-12/joceah.2021.86.issue-12/20210618/joceah.2021.86.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-24/jpcafh.2021.125.issue-24/20210624/jpcafh.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-24/jpcbfk.2021.125.issue-24/20210624/jpcbfk.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-24/jpccck.2021.125.issue-24/20210624/jpccck.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-24/jpclcd.2021.12.issue-24/20210624/jpclcd.2021.12.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-6/jprobs.2021.20.issue-6/20210604/jprobs.2021.20.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-25/jacsat.2021.143.issue-25/20210630/jacsat.2021.143.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-6/jamsef.2021.32.issue-6/20210602/jamsef.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-25/langd5.2021.37.issue-25/20210629/langd5.2021.37.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-12/mamobx.2021.54.issue-12/20210622/mamobx.2021.54.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-6/mpohbp.2021.18.issue-6/20210607/mpohbp.2021.18.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-12/nalefd.2021.21.issue-12/20210623/nalefd.2021.21.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-12/orlef7.2021.23.issue-12/20210618/orlef7.2021.23.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-6/oprdfk.2021.25.issue-6/20210618/oprdfk.2021.25.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-12/orgnd7.2021.40.issue-12/20210628/orgnd7.2021.40.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b01686&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b01686&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b01686&amp;href=/doi/10.1021/acs.jmedchem.7b01686" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 16</span><span class="cit-fg-pageRange">, 6964-6982</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/16" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b01561" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/acs.jmedchem.8b00124" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Prolyl Hydroxylase Inhibitors: A Breakthrough in the Therapy of Anemia Associated with Chronic Diseases</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Amit A. Joharapurkar</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Amit A. Joharapurkar</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Zydus Research Centre, Cadila Healthcare Limited, Sarkhej Bavla NH8A, Moraiya, Ahmedabad 382210, India</div></div><span class="conrtib-corresp"><strong>*</strong>Phone: +91-2717-665555. Fax: +91-2717-665551. E-mail: <a href="/cdn-cgi/l/email-protection#ccada1a5b8a6a3a4adbeadbcb9bea7adbe8cb6b5a8b9bfafada8a5a0ade2afa3a1"><span class="__cf_email__" data-cfemail="9ffef2f6ebf5f0f7feedfeefeaedf4feeddfe5e6fbeaecfcfefbf6f3feb1fcf0f2">[email protected]</span></a></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Amit+A.++Joharapurkar">Amit A. Joharapurkar</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath1">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-0723-4371" title="Orcid link">http://orcid.org/0000-0003-0723-4371</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Vrajesh B. Pandya</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Vrajesh B. Pandya</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Zydus Research Centre, Cadila Healthcare Limited, Sarkhej Bavla NH8A, Moraiya, Ahmedabad 382210, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Vrajesh+B.++Pandya">Vrajesh B. Pandya</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath2">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9004-4514" title="Orcid link">http://orcid.org/0000-0001-9004-4514</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Vishal J. Patel</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Vishal J. Patel</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Zydus Research Centre, Cadila Healthcare Limited, Sarkhej Bavla NH8A, Moraiya, Ahmedabad 382210, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Vishal+J.++Patel">Vishal J. Patel</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath3">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ranjit C. Desai</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ranjit C. Desai</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Zydus Research Centre, Cadila Healthcare Limited, Sarkhej Bavla NH8A, Moraiya, Ahmedabad 382210, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ranjit+C.++Desai">Ranjit C. Desai</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath4">View Biography</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Mukul R. Jain</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Mukul R. Jain</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Zydus Research Centre, Cadila Healthcare Limited, Sarkhej Bavla NH8A, Moraiya, Ahmedabad 382210, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mukul+R.++Jain">Mukul R. Jain</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath5">View Biography</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01686&amp;href=/doi/10.1021%2Facs.jmedchem.7b01686" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 16</span><span class="cit-pageRange">, 6964–6982</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">May 1, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>15 November 2017</li><li><span class="item_label"><b>Published</b> online</span>1 May 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 23 August 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b01686" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01686</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D6964%26pageCount%3D19%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DAmit%2BA.%2BJoharapurkar%252C%2BVrajesh%2BB.%2BPandya%252C%2BVishal%2BJ.%2BPatel%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D61%26issueNum%3D16%26contentID%3Dacs.jmedchem.7b01686%26title%3DProlyl%2BHydroxylase%2BInhibitors%253A%2BA%2BBreakthrough%2Bin%2Bthe%2BTherapy%2Bof%2BAnemia%2BAssociated%2Bwith%2BChronic%2BDiseases%26numPages%3D19%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D6982%26publicationDate%3DAugust%2B2018">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b01686"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">4965</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">52</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b01686" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Prolyl Hydroxylase Inhibitors: A Breakthrough in the Therapy of Anemia Associated with Chronic Diseases&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Amit&quot;,&quot;last_name&quot;:&quot;A. Joharapurkar&quot;},{&quot;first_name&quot;:&quot;Vrajesh&quot;,&quot;last_name&quot;:&quot;B. Pandya&quot;},{&quot;first_name&quot;:&quot;Vishal&quot;,&quot;last_name&quot;:&quot;J. Patel&quot;},{&quot;first_name&quot;:&quot;Ranjit&quot;,&quot;last_name&quot;:&quot;C. Desai&quot;},{&quot;first_name&quot;:&quot;Mukul&quot;,&quot;last_name&quot;:&quot;R. Jain&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;05&quot;,&quot;day&quot;:&quot;01&quot;,&quot;issue&quot;:&quot;16&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;6964-6982&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b01686&quot;},&quot;abstract&quot;:&quot;Chronic kidney disease, cancer, chronic inflammatory disorders, nutritional, and genetic deficiency can cause anemia. Hypoxia causes induction of hypoxia-inducible factor (HIF), which stimulates erythropoietin (EPO) synthesis. Prolyl hydroxylase domain (PHD) enzyme inhibition can stabilize hypoxia-inducible factor (HIF). HIF stabilization also decreases hepcidin, a hormone of hepatic origin, which regulates iron homeostasis. PHD inhibitors represent a novel pharmacological treatment of anemia associated with chronic diseases. Many orally active PHD inhibitors like roxadustat, molidustat, vadadustat, and desidustat are in late phase clinical trials. This review discusses the role of PHD inhibitors in the treatment of anemia associated with chronic diseases.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01686&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01686" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01686&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01686" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01686&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01686" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01686&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01686&amp;href=/doi/10.1021/acs.jmedchem.7b01686" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b01686" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b01686" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01686&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b01686%26sid%3Dliteratum%253Aachs%26pmid%3D29712435%26genre%3Darticle%26aulast%3DJoharapurkar%26date%3D2018%26atitle%3DProlyl%2BHydroxylase%2BInhibitors%253A%2BA%2BBreakthrough%2Bin%2Bthe%2BTherapy%2Bof%2BAnemia%2BAssociated%2Bwith%2BChronic%2BDiseases%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D16%26spage%3D6964%26epage%3D6982%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290758" title="Anatomy">Anatomy</a>,</li><li><a href="/action/doSearch?ConceptID=292263" title="Iron">Iron</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/16" title="Go to Volume 61, Issue 16"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/jmcmar.2018.61.issue-16/20180823/jmcmar.2018.61.issue-16.largecover.jpg" alt="Go to Volume 61, Issue 16"/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01686/20180816/images/medium/jm-2017-01686a_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01686/20180816/images/large/jm-2017-01686a_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01686&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Chronic kidney disease, cancer, chronic inflammatory disorders, nutritional, and genetic deficiency can cause anemia. Hypoxia causes induction of hypoxia-inducible factor (HIF), which stimulates erythropoietin (EPO) synthesis. Prolyl hydroxylase domain (PHD) enzyme inhibition can stabilize hypoxia-inducible factor (HIF). HIF stabilization also decreases hepcidin, a hormone of hepatic origin, which regulates iron homeostasis. PHD inhibitors represent a novel pharmacological treatment of anemia associated with chronic diseases. Many orally active PHD inhibitors like roxadustat, molidustat, vadadustat, and desidustat are in late phase clinical trials. This review discusses the role of PHD inhibitors in the treatment of anemia associated with chronic diseases.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75271" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75271" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Anemia is a disorder of blood involving a decreased amount of red blood cells (RBC) or hemoglobin in circulation.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Chronic kidney disease (CKD), cancer, inflammatory disorders, nutritional deficiencies, genetic disorders, and some drugs can cause anemia. Nutritional deficiency anemia is frequent in women, children, and elderly. Iron and vitamin supplementation is used to treat nutritional deficiency anemia.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Thalassemia is a most common genetic disorder causing anemia.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Chronic kidney disease, chemotherapy, and inflammatory diseases can reduce erythropoietin (EPO) synthesis and inefficient iron homeostasis.<a onclick="showRef(event, 'ref1 ref4'); return false;" href="javascript:void(0);" class="ref ref1 ref4">(1,4)</a> Treatment of anemia associated with CKD is done using EPO analogues or erythropoiesis-stimulating agents (ESA).<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5,6)</a> However, they are associated with cardiovascular side effects and may increase the progression of malignancy in cancer patients.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> CKD patients also demonstrate iron deficiency which requires iron supplementation.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Functional iron deficiency is a significant problem that limits the use of ESAs in most of the patients.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a></div><div class="NLM_p last">Stabilization of hypoxia-inducible factor (HIF) represents a novel approach for the treatment of CKD. Under normal conditions, HIF undergoes oxidative degradation by prolyl hydroxylase domain (PHD) enzymes. Hypoxia is the major inhibitory factor for PHD activity, which stabilizes HIF and stimulates EPO synthesis. PHD inhibition also decreases hepcidin production, which improves iron utilization.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> An increase in EPO and a decrease in hepcidin, caused by pharmacological inhibition of PHDs, can efficiently cure anemia associated with chronic diseases.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Mechanism of Erythropoiesis</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32087" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32087" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Erythropoiesis occurs in the bone marrow. In the bone marrow, hematopoietic stem cells (HSCs) differentiate into colony forming units-erythroid (CFU-Es) and then to erythroblasts, which enucleate to form reticulocytes.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> In the bone marrow, CFU-Es and proerythroblasts are stimulated by EPO for further differentiation (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). Formation of erythrocytes from reticulocytes occurs within 24–48 h, and the mature erythrocytes circulate in the blood for 120 days, before phagocytosis in the spleen, liver, and bone marrow degrades them.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01686/20180816/images/medium/jm-2017-01686a_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01686/20180816/images/large/jm-2017-01686a_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Stages of erythropoiesis. The process of erythropoiesis occurs in the bone marrow. Erythropoiesis is the process of proliferation and differentiation of erythroid progenitors into reticulocytes and erythrocytes (RBC). The common myeloid progenitors, also known as stem cells, form RBC, white blood cells, and platelets. Stem cells are differentiated into early stage burst-forming unit–erythroid (BFU-E) and then later stage colony-forming unit–erythroid (CFU-E) progenitors. CFU-Es differentiate into proerythroblasts, which then undergo mitosis to form erythroblasts. The erythroblast is basophilic, polychromatic, and orthochromatic. The erythroblast denucleates to become a reticulocyte, which enters the bloodstream. Reticulocytes mature to become RBCs after shedding cellular organelles such as mitochondria, Golgi apparatus, and endoplasmic reticulum. A stage of erythropoiesis from BFU-E to erythroblast differentiation requires EPO. Maturation of RBCs from erythroblasts requires iron.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01686/20180816/images/large/jm-2017-01686a_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01686&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">EPO-mediated signaling is necessary for the survival and differentiation of erythroid progenitors. EPO binds to specific EPO receptors (EPORs) and signals through Janus tyrosine kinase-2 (JAK2).<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> JAK2 stimulates signal transduction and activator of transcription-5 (STAT-5), RAS–RAF–MAP kinase, and phosphoinositide-3 kinase/AKT kinase (protein kinase B).<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13,14)</a> On the other hand, erythroid progenitors undergo apoptosis by the cluster of differentiation 95 (CD95), a membrane protein of the tumor necrosis factor (TNF) receptor family, which triggers apoptosis after binding to the CD95 ligand, which is produced by mature erythroblasts. Thus, the negative feedback cycle controls the production of mature erythrocytes in blood.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a></div><div class="NLM_p last">Iron is vital for hemoglobin synthesis and reticulocytes maturation. Hepcidin is a hepatic hormone that regulates iron metabolism.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Ferroportin (FPN) is the ferrous exporter present in macrophages (reticuloendothelial cells), enterocytes, and hepatocytes. Hepcidin binds to ferroportin and causes its degradation by internalization and lysosomal digestion. This action of hepcidin causes iron entrapment in macrophages or enterocytes, creating a functional iron deficiency in the body. Erythropoiesis and hypoxia also regulate hepcidin levels.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Increased iron levels (as in iron loading with iron supplementation) increases hepcidin production via bone morphogenetic protein/SMAD (BMP/SMAD) signaling. On the other hand, increased inflammation stimulates hepcidin production via IL-6/STAT signaling.<a onclick="showRef(event, 'ref8 ref16'); return false;" href="javascript:void(0);" class="ref ref8 ref16">(8,16)</a></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Stimulation of Erythropoiesis by HIF-Prolyl Hydroxylases</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45107" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45107" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">High altitude or hypoxia enhances RBC synthesis by stimulating EPO production. Hypoxia-inducible factor (HIF) is the regulator for hypoxic induction of erythropoiesis.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> There are three isoforms of HIF (HIF-1, -2, and -3), of which HIF-1 and HIF-2 regulate the vascular response to hypoxia. Specifically HIF-1 regulates the metabolic response, while HIF-2 stimulates erythropoiesis in response to hypoxia. HIF-3 is less closely related to HIF-1 and HIF-2, and its role is not yet fully understood. HIF-1 and HIF-2 consist of two subunits, namely α and β. HIF-α is hydroxylated at two proline residues (Pro402 and Pro564 for HIF-1α, and Pro405 and Pro531 for HIF-2α) by prolyl hydroxylase (PHD). Once hydroxylated, HIF-α is recognized by Hippel–Lindau tumor suppressor protein (pVHL), which facilitates its proteasomal degradation by E3 ubiquitin ligase. Thus, E3 ubiquitin ligase does not cause degradation of HIF but rather ligates HIF, thereby tagging it with a signal to carry it to proteasomes for degradation. PHD enzymes require oxygen, iron, ascorbate, and 2-oxoglutarate (2-OG) for their activity (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). Oxygen deficiency (hypoxia) causes PHD inhibition and activates HIF-α, while HIF-β is constitutively expressed.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01686/20180816/images/medium/jm-2017-01686a_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01686/20180816/images/large/jm-2017-01686a_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. PHD-HIF mechanism of enzyme action. At normal oxygen concentration (normoxia), prolyl hydroxylase domain-containing (PHD) enzymes (PHD1, PHD2, or PHD3) are active. Active PHDs hydroxylate HIF-α residues. Once hydroxylated, HIF-α is recognized by Hippel–Lindau tumor suppressor protein (pVHL), which facilitates its proteasomal degradation by E3 ubiquitin ligase. Thus, E3 ubiquitin ligase does not cause degradation of HIF but rather ligates HIF, thereby tagging it with a signal to carry it to proteasome for degradation. For this reaction, PHDs require 2-oxoglutarate (2-OG) as a substrate and iron (Fe) as a cofactor. On the other hand, in hypoxic conditions, or by pharmacological inhibition of PHDs, HIF-α is protected from degradation and heterodimerizes with HIF-β. The HIF complex is then translocated to the nucleus and stimulates EPO gene expression. Stimulation of EPO gene expression under hypoxia or PHD inhibition translates into efficient erythropoiesis. HIF complex is also involved in the regulation of angiogenesis, glucose metabolism, lipid metabolism, and vasodilation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01686/20180816/images/large/jm-2017-01686a_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01686&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">There are three isoforms of PHD, namely, PHD1, PHD2, and PHD3.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> The hypoxic stabilization of PHDs also follows a negative regulatory mechanism. In prolonged hypoxia, PHD3, and frequently PHD2 mRNA, is increased to accelerate degradation of HIF upon reoxygenation after long-term hypoxia.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> The active sites of all isoforms of PHDs share a high-sequence homology. PHD1 shows more affinity toward HIF-2α than HIF-1α and hydroxylates it under normoxic condition. Deletion of the PHD1 gene induces hypoxia tolerance by shifting the tricarboxylic acid cycle to the glycolytic pathway.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Tolerance to hypoxia is due to reduced oxidative stress and may not be due to angiogenesis, erythropoiesis, or vasodilation.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> PHD2 gene deletion accelerated RBC synthesis without a significant increase in EPO levels.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Inactivation of PHD1 and PHD3 leads to erythrocytosis by activating the hepatic HIF-2α, whereas only PHD2 deficiency leads to erythrocytosis by activating the renal EPO pathway.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a></div><div class="NLM_p">Interstitial fibroblasts of kidneys express PHD enzymes. PHD2 inhibition causes HIF-2α stabilization and generates EPO.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Fibrosis decreases the capacity of the renal tissue to generate EPO, sequentially causing anemia.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> HIF stabilization can also cause EPO synthesis in the liver. In the kidneys and liver, HIF-2 stimulates EPO gene transcription by binding to hypoxia-responsive regulatory elements.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Erythropoiesis requires EPO as well as iron for successful maturation of RBCs. HIF-2 induces efficient absorption as well as utilization of iron by stimulation of genes required for iron transport and metabolism (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). HIF-2 stimulates divalent metal transporter 1 (DMT1) and duodenal cytochrome <i>b</i> reductase 1 (Dcytb).<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Dcytb converts the ferric iron to the ferrous form (Fe<sup>2+</sup>) in the intestine. This conversion is vital because the gut lumen cannot absorb the ferric form of iron. Once the iron is converted to the ferrous form, it is taken up into enterocytes by DMT1. Ceruloplasmin is the enzyme in the enterocyte that oxidizes ferrous iron back to the ferric form.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Transferrin transports iron (in the ferric form) in plasma using the transferrin receptor.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Heme-oxygenase-1 required for the release of iron from the reticuloendothelial system and ferroportin is the membrane iron exporter present in all major iron depots in the body.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Although HIF has a direct role in modulation of all of these proteins involved in iron metabolism, the primary mechanism by which it indirectly stimulates efficient iron utilization is through regulation of hepcidin. Stabilization of HIF-α by oxygen deficiency or genetic changes or pharmacological inhibition leads to suppression of hepcidin.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a></div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01686/20180816/images/medium/jm-2017-01686a_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01686/20180816/images/large/jm-2017-01686a_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Iron metabolism and the role of hepcidin. Absorption of iron mainly occurs in the intestine. The nonheme iron in the ferric form is converted in the ferrous form by duodenal cytochrome <i>b</i> (Dcytb). Divalent metal transporter 1 (DMT1) facilitates the transfer of iron into enterocytes. Hepcidin is a regulator of iron homeostasis that downregulates DMT1 and limits iron absorption. Ferritin is the soluble and nontoxic form of iron in plasma. Ferritin is the form of stored iron. Iron in the ferrous state enters into blood circulation with the help of the transport protein ferroportin. Hephastin converts ferrous iron to ferric iron, which then binds to transferrin (TRF) and circulates as TRF bound ferric iron. It is taken up into the metabolic tissues such as macrophage or the liver by transferrin receptor (TRFR). TRF-bound ferric iron is then released free into the cell. Inside the cell, DMT1 converts ferric iron into ferrous iron, after which it is stored as ferritin or released from the cell by ferroportin. Hepcidin inhibits ferroportin, by which it can block iron uptake into cellular stores and decreases iron in circulation. Like hephastin, ceruloplasmin present in blood converts ferrous iron into the ferric form. The ferric form binds to TRF and circulates in the blood. TRF-bound ferric iron is taken up by reticulocytes for hemoglobin synthesis, which then mature into RBCs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01686/20180816/images/large/jm-2017-01686a_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01686&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Apart from liver and kidney, the PHD-HIF system has an important role in the bone marrow. HIF activation stimulates expression of the EPO receptor and also modulates hemoglobin synthesis. Also, it modulates the differentiation and maturation of erythroid cells.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></div><div class="NLM_p">Peritubular interstitial cells generate EPO in the kidneys.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> With increasing hypoxia, the density of the EPO producing cells increases substantially, as a result of the increased density of EPO producing cells, which results in increased EPO gene expression and enhanced release of EPO into the bloodstream.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Differentiation of renal fibroblast-like cells under inflammatory stimulus results in fibrosis and, hence, decreased ability of the cells to generate and release EPO into plasma, which results in anemia.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> In the liver, GATA-4 is the major modulator for EPO production.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> It has been observed that the induction of erythropoiesis in the liver causes normalization of hemoglobin in rodents, in which anemia was induced by nephrectomy or inflammation.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> It has been observed that inactivation of all the three PHD isoforms is needed for a significant EPO synthesis from liver.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> CKD is associated with pathologies like enhanced levels of creatinine and urea in the circulation. These pathologies can modulate the HIF system, ultimately adding to the burden of anemia.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Positive changes in renal physiology can also add to renal EPO production, as observed with diuretic treatment.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a></div><div class="NLM_p">A major population of CKD patients suffers from severe anemia. The degree of anemia in these patients is dependent on the severity of renal failure.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> However, even the fibrotic kidneys have the potential to generate EPO under a positive stimulus, which can correct anemia.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> A substantial population of CKD patients does not respond to ESA therapy due to an underlying inflammatory state. Inflammation-induced functional iron deficiency is a common reason for the unresponsiveness or resistance of CKD patients to EPO therapy.<a onclick="showRef(event, 'ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref36 ref37">(36,37)</a> The release of inflammatory cytokines decreases not only renal EPO production but also suppresses efficient differentiation and maturation of erythropoietic progenitors in the bone marrow.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> Inflammation upregulates hepcidin through the STAT-3 pathway or the BMP/SMAD1/5/8 pathway.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> As already discussed, increased hepcidin causes degradation of ferroportin and causes entrapment of iron in tissue stores, resulting in a functional iron deficiency, which cannot be corrected using oral iron supplementation. As the iron deficiency gets severe, iron regulatory proteins bind to HIF-2α and further decrease erythropoiesis.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> This feedback mechanism makes the anemia in CKD patients difficult to treat using erythropoietin analogues or iron supplementations.</div><div class="NLM_p">Activation of HIF signaling using PHD inhibition demonstrates a unique and rational approach to correct anemia associated with chronic diseases. Because of the pharmacological inhibition of HIF-PHD, there occurs a transient induction of HIF-regulated genes. Plasma EPO generated due to this inhibition is much lower than that observed in patients after injection of recombinant erythropioetins,<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> suggesting that PHD inhibitors may not have the risk for cardiovascular side effects that occur due to high levels of plasma EPO. Prolyl hydroxylase inhibitors decrease hepcidin and thus reduce the functional iron deficiency in CKD patients.<a onclick="showRef(event, 'ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref39 ref40">(39,40)</a></div><div class="NLM_p last">Currently, six PHD inhibitors are in various phases of clinical trials for the treatment of anemia associated with CKD.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> FG-2216, the first clinically tested small molecule PHD inhibitor, has shown enhanced erythropoiesis in patients with end-stage renal disease (ESRD).<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">Evolution of Medicinal Chemistry Strategies for PHD Inhibition</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63400" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63400" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Under normoxic conditions, PHDs catalyze the hydroxylation of two conserved proline residues in HIF-α. The hydroxylation of HIF-α directs it toward degradation. Because metal ions are required for the 2-OG-dependent hydroxylation, targeting or chelating metal ions was the first approach exercised for the design of PHD inhibitors. Salts of Co<sup>2+</sup>, Cu<sup>2+</sup>, and Ni<sup>2+</sup> were used to antagonize Fe<sup>2+</sup>, a cofactor for PHD enzyme action.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> Additionally, iron chelators such as deferoxamine,<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> 3,4-dihydroxybenzoic acid,<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> 1,10-phenanthrolines,<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> and quercetin<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> have been shown to inhibit PHD. However, these compounds are not specific PHD inhibitors. They also inhibit iron-dependent pathways other than PHDs and may cause undue toxicities.</div><div class="NLM_p">Synthesis of 2-OG (<b>1</b>) analogues was the first specific approach used for the design of PHD inhibitors. Most of the clinically advanced molecules are 2-OG derivatives. PHD enzymatic activity requires 2-OG as the substrate. A cocrystal structure of 2-OG bound to the PHD2 catalytic domain (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3OUJ">3OUJ</a>) has shown bidentate chelation of the Fe center by the C1 and C2 sp2 oxygen atoms and a salt bridge between the C5 carboxylate and Arg383. The wall of the 2-OG pocket is lined with hydrophobic residues including tyrosine-310, -303, and -329, isoleucine-327 and -256, methionine-299, leucine-343, tryptophan-389, alanine-301 and -365, and valine-376. <i>N</i>-Oxalylglycine (<b>2</b>, NOG) was the first reported 2-OG mimetic molecule.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> Compound <b>2</b> shows a stronger interaction with PHD2 (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3HQR">3HQR</a>) and has an N–H group in place of the C3 methylene group in <b>1</b>. This modification reduced the susceptibility of the 2-carbonyl group to nucleophilic attack by oxygen. Dimethyloxalylglycine (<b>3</b>, DMOG)<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> is a cell-permeable precursor of NOG used extensively as a tool compound to study the in vivo pharmacology of PHD inhibitors. Several active site targeted inhibitors identified in this class have strong binding interactions with hydrophobic residues in the 2-OG pocket.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> Hydrophobic heterocycles used in the place of ferrous ion coordination fragment of <b>2</b> caused a stronger binding with PHD.</div><div class="NLM_p">A crystal structure (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2HBT">2HBT</a>, <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>) of isoquinoline derivative <b>15</b> (R<sub>1</sub> = Cl, R<sub>2</sub> = R<sub>3</sub> = R<sub>4</sub> = R<sub>5</sub> = H in <b>4</b>, <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>) bound with PHD was reported by a group at Procter and Gamble.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> Groups at Oxford University and Amgen have disclosed the crystal structure (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2G1M">2G1M</a>) of another isoquinoline derivative (R<sub>1</sub> = R<sub>2</sub> = R<sub>3</sub> = R<sub>4</sub> = H, R<sub>5</sub> = I in <b>4</b>, <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>).<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> Three conserved iron-binding triad residues (His313, Asp315, His374) occupy half of the ligand sphere of the bound Fe (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). The other three metal coordination sites of the octahedral complex involve the bidentate binding of the isoquinoline nitrogen atom and the exocyclic carbonyl oxygen atom of the ligand and a water molecule. The terminal carboxylate group interacts with Arg383 by making a salt bridge and with Tyr329 in the back of the 2-OG binding pocket by a H bond interaction. A π-stacking hydrophobic interaction with Tyr310 and a H-bonding interaction of the phenolic hydroxyl group with Tyr303 are other key interactions observed for this molecule.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01686/20180816/images/medium/jm-2017-01686a_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01686/20180816/images/large/jm-2017-01686a_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Structure of a 247-residue C-terminal catalytic domain of PHD2 bound to <b>15</b> (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2HBT">2HBT</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01686/20180816/images/large/jm-2017-01686a_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01686&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01686/20180816/images/medium/jm-2017-01686a_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01686/20180816/images/large/jm-2017-01686a_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Chemotypes derived from 2-OG.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01686/20180816/images/large/jm-2017-01686a_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01686&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The newer 2-OG analogues caused a specific PHD inhibition owing to a differentiated mechanism. 2-OG mimetics like <b>2</b> allowed HIF binding with PHD enzymes but blocked the formation of the Fe(IV)═O complex (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3HQR">3HQR</a>). On the other hand, larger heterocyclic inhibitors such as <b>15</b> stabilized a closed conformational structure, preventing HIF substrate binding (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3HQU">3HQU</a>).<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a></div><div class="NLM_p">Most of the PHD inhibitors consists of three structural features based on the ligand–protein interactions. The first characteristic is a bidentate coordination site to an iron atom. The second important feature is a carboxylic acid forming a salt bridge with the Arg383 side chain. The third attribute is a hydrogen bond acceptor for the phenolic hydroxyl of Tyr303. <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a> demonstrates these features. However, several potent PHD inhibitors identified through high throughput screening (HTS) do not possess a carboxylic acid group that can form a salt bridge with Arg residue.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> Chan et al. described their efforts to identify PHD inhibitors that do not contain the carboxylic acid group.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> Stroke was the primary indication of these PHD inhibitors. The lack of a carboxylic acid group helps in better CNS penetration, and hence these inhibitors were considered useful in the treatment of neurological disorders. A comprehensive review has compiled the assay procedures used to screen PHD inhibitors.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> A separate review has covered significant 2-OG derived PHD inhibitors.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a></div><div class="NLM_p">An isoquinoline scaffold (<b>4</b>, <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>)<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> is widely used in the design of PHD inhibitors, especially in two clinical candidates, <b>15</b> (FG-2216, <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>) and <b>16</b> (FG-4592, roxadustat, <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>), discovered by FibroGen, Inc. (San Francisco, CA, U.S.). Several research groups modified the phenyl ring of the isoquinoline core with 5,6-membered bicyclic, tricyclic, and heterocyclic rings.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> Monocyclic pyridine derivatives (represented by general structure <b>5</b>) were developed by Akebia Therapeutics.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a></div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01686/20180816/images/medium/jm-2017-01686a_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01686/20180816/images/large/jm-2017-01686a_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Carboxylic acid-based PHD inhibitors (part 1).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01686/20180816/images/large/jm-2017-01686a_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01686&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The oxygen atom from carbonyl group of the quinolone (e.g., <b>6</b>) and monocyclic pyridone (e.g., <b>7</b>) derivatives was useful for Fe chelation.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> The phenyl ring of the quinolone core underwent modification in these compounds for optimizing the activity.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a></div><div class="NLM_p last">The compounds discussed above contain a glycinamide side chain attached to the ring containing the heteroatom that chelates iron. Modifications where the iron chelating heteroatom is present in another ring fused with a central core were also reported. GSK has reported some such compounds like quinolines (X = CH in <b>8</b>),<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> quinoxalines (X = N in <b>8</b>)<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> with 6-membered ring fusion, and benzimidazole derivatives (e.g., <b>9</b> and <b>10</b>)<a onclick="showRef(event, 'ref60 ref61'); return false;" href="javascript:void(0);" class="ref ref60 ref61">(60,61)</a> with a 5-membered ring fusion. In compounds denoted by <b>10</b>, an additional cyclic ring fused with the central core has replaced the phenolic OH. It has the potential to produce symmetrical analogues which offer two chelation binding modes. Janssen Pharmaceuticals reported benzimidazole derivatives represented by <b>11</b>.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> An X-ray cocrystal structure with one of the compounds (R<sub>1</sub> = R<sub>4</sub> = H, R<sub>2</sub> = R<sub>3</sub> = Cl) with PHD2 (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3OUI">3OUI</a>) has shown that the NH group from the imidazole ring interacts with Tyr303. In earlier compounds, this purpose was served by the key phenolic OH. The other nitrogen of the imidazole ring is involved in Fe chelation with carbonyl group from the glycinamide side chain. Cyclic modification of the amide group in pyrazole derivatives caused strong iron chelation (<b>12</b>). JNJ-42041935 (R<sub>1</sub> = R<sub>4</sub> = H, R<sub>2</sub> = OCF<sub>3</sub>, R<sub>3</sub> = Cl in <b>12</b>, <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>) is a pan-PHD inhibitor whose pharmacological profile has been reported.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> Expansion of the benzimidazole core in <b>12</b> by insertion of the “C═O” group into the C–N bond allowed a H-bond interaction with Tyr303 as in a series of quinazolinones (<b>13</b>).<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> JNJ-42905343 (R<sub>1</sub> = R<sub>4</sub> = H, R<sub>2</sub> = 2,6-dimethylphenoxy, R<sub>3</sub> = F in <b>13</b>) increased serum iron and erythropoietin in rats.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> In PGPS (peptidoglycan-polysaccharide)-treated rats, administration of JNJ-42905343 for 28 days corrected functional iron deficiency (FID) and anemia, an effect attributed to the increased expression of iron reductase Dcytb and iron transporter protein DMT1 in the duodenum. Human recombinant EPO (rhEPO) did not affect Dcytb and DMT1 and was not effective in correcting anemia in the PGPS model.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> The aminoquinoxaline derivatives <b>14</b> demonstrate a significant modification in which a substituted amino group replaced the carbonyl group that forms a H bond with Tyr303.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> As discussed above, inhibitors derived from 2-OG possess a carboxylic acid group as a critical pharmacophore, while noncarboxylic acid-based PHD inhibitors are also reported (mainly identified through HTS). In this review, we have classified them as carboxylic acid-based PHD inhibitors, noncarboxylic acid PHD inhibitors, and even in the third category where they have demonstrated a nonconventional binding mode especially with iron.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">Carboxylic Acid-Based PHD Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27570" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27570" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The first optimized structural modification of 2-OG derived chemotypes resulted in <b>15</b> (FG-2216, <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>). FibroGen advanced this molecule to phase II trials in 2005.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> Compound <b>15</b> caused enhanced erythropoiesis in preclinical studies as well as in patients. The erythropoiesis was higher in nephric dialysis patients than in anephric patients, implying that <b>15</b> induced EPO production in malfunctioning kidneys. However, following the death of one subject due to fulminant hepatitis in the trial, clinical development of <b>15</b> was suspended.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> Another clinical candidate is <b>16</b> (roxadustat, FG-4592), an analogue of FG-2216 with an additional 7-phenoxy substituent and methyl group in place of the chloro in <b>15</b>.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> Compound <b>16</b> is currently in phase III clinical trials. Zhejiang Beta Pharma Inc. also reported the polymorphic forms of <b>16</b>.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a></div><div class="NLM_p">Fibrogen reported PHD1 selective isoquinoline derivatives for therapeutic indications such as muscle degeneration, colitis, and inflammatory bowel disease (IBD) exemplified by <b>17</b>–<b>20</b>.<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> This patent application describes data for 184 compounds that show selective inhibition of PHD1 over PHD2. The prototype compound <b>17</b> was nonselective, and selectivity was enhanced by chain elongation, e.g., <b>18</b>, which was 5-fold selective for PHD1, although further elongation did not improve the selectivity. Branching the alkyl chain by introducing a methyl group in <b>19</b> made it 40-fold selective for PHD1 over PHD2. New branching with alkyl, aryl, and aralkyl groups at both the amino and carboxylic acid terminals did not improve selectivity. Compound <b>20</b>, with dimethyl branching and methoxy substituent on phenyl ring, has shown excellent activity and 40-fold selectivity (half-maximal inhibitory concentration IC<sub>50</sub> PHD1 = 0.24 μM, PHD2 = 9.4 μM). Shenyang Sunshine Pharmaceuticals in two separate publications reported 5-hydroxy-1,7 naphthyridine derivatives exemplified by <b>21</b> and <b>22</b>. Compounds <b>21</b> and <b>22</b> are aza analogues of isoquinoline derivatives of fibrogen (e.g., <b>16</b>) substituted with aryl/heteroaryl and aryloxy/heteroaryloxy groups, respectively.<a onclick="showRef(event, 'ref72 ref73'); return false;" href="javascript:void(0);" class="ref ref72 ref73">(72,73)</a> These compounds were evaluated for EPO induction and PHD2 inhibitory activity in preclinical assays and compared with <b>16</b>, where compounds <b>21</b> and <b>22</b> have shown superior activity in of reticulocyte production.</div><div class="NLM_p">Procter and Gamble invented monocyclic pyridines exemplified by <b>23</b> and <b>24</b> and later licensed to Akebia therapeutics.<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> Compound <b>23</b> (also known as vadadustat) is now undergoing late phase clinical trials for the treatment of anemia associated with CKD. A fluoro analogue <b>24</b> (AKB6899) has the potential to treat cancer.<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> It was shown to be a stabilizer of HIF-2α via inhibition of PHD3, which enhances the production of suppressor of vascular endothelial growth factor receptor-1 (sVEGFR-1) but not vascular endothelial growth factor (VEGF) from granulocyte-macrophage-colony-stimulating factor (GM-CSF)-stimulated monocytes and macrophages. Compound <b>24</b> suppresses angiogenesis and provides a potential method for treating cancer. Compound <b>24</b> caused selective up-regulation of HIF-2α but did not affect VEGF. An increase in HIF-2α also enhanced sVEGFR-1 production in human peripheral blood monocytes when stimulated with GM-CSF in the presence of <b>24</b>. Recent reports indicate the polymorphic forms of <b>23</b> and a process for the preparation of <b>23</b>, <b>24</b>, and analogues.<a onclick="showRef(event, 'ref76 ref77'); return false;" href="javascript:void(0);" class="ref ref76 ref77">(76,77)</a> Recently, both of these compounds were shown to be useful for the treatment of ocular diseases,<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> followed by two disclosures studying formulation and dosing regimens for both the compounds<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> and the synthesis of deuterium-enriched analogues.<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a></div><div class="NLM_p">In the same monocyclic pyridine class, China Pharmaceutical University reported alkynylpyridines as PHD inhibitors (e.g., <b>25</b>).<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a> Compounds in this series possess a substituted alkynyl group on the pyridine ring of <b>23</b> and <b>24</b>. Compound <b>25</b> inhibited PHD2 with an IC<sub>50</sub> of 13.7 nM. Another modification of the pyridine class was reported by Shenyang Sunshine Pharmaceuticals in the form of diaryl ether analogues of compounds <b>23</b> and <b>24</b>, in which a phenoxy group replaced the aryl substituent (e.g., <b>26</b>, PHD2 IC<sub>50</sub> = 15 μM).</div><div class="NLM_p">Mitsubishi Tanabe reported pyrazolopyrimidine derivatives exemplified by <b>27</b>–<b>29</b>.<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> These compounds are the heterocyclic modification of phenyl ring of <b>13</b> (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>) described earlier by Janssen. In this disclosure, PHD2 and PHD3 enzymatic inhibition data of more than 500 compounds are reported, along with EPO production measured in a cell-based assay. The structure–activity modifications involved the use of branched alkyl, cycloalkyl, and aralkyl groups on the pyrazole ring. Compound <b>27</b>, with a bulky bis(4-chlorophenyl) methane group, inhibited PHD2 with an IC<sub>50</sub> value of 0.02 μM and PHD3 with 2.6 μM, demonstrating 130-fold selectivity for PHD2. The inhibition of PHDs correlated with a 40-fold increase in EPO, whereas compound <b>28</b> with a naphthyl substituent (PHD2 IC<sub>50</sub> = 0.012 μM, PHD3 IC<sub>50</sub> = 0.18 μM) has been shown to increase EPO induction by more than 100-fold. Compounds with substituents on the other nitrogen, as described in <b>29</b>, have usually been found to have a negligible effect on EPO induction despite higher potency for PHD inhibition.</div><div class="NLM_p">Merck has reported bis-carboxamide derivatives exemplified by <b>30</b>, <b>31</b>, <b>32</b>, and <b>33</b>.<a onclick="showRef(event, 'ref83 ref84'); return false;" href="javascript:void(0);" class="ref ref83 ref84">(83,84)</a> Compound <b>30</b> was a potent PHD2 inhibitor (IC<sub>50</sub> < 20 nM). In a separate publication, bis-carboxamide derivatives with a pyridine central core were reported (e.g., <b>31</b>, IC<sub>50</sub> = 0.62 nM).<a onclick="showRef(event, 'ref85 ref86'); return false;" href="javascript:void(0);" class="ref ref85 ref86">(85,86)</a> Compound <b>32</b> was designed to increase the half-life of the pyrimidine class of compound by inserting a cyclopropyl group (e.g., <b>30</b>, half-life of 0.28 h, and <b>32</b>, half-life of 4.78 h).<a onclick="showRef(event, 'ref87 ref88'); return false;" href="javascript:void(0);" class="ref ref87 ref88">(87,88)</a> A prodrug approach is also useful for the improvement in oral bioavailability.<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a> An ester prodrug <b>33</b> was found to have 3-fold increased bioavailability compared to that of the parent acid <b>32</b> in Wistar rats when administered orally at 2 mg/kg dose.</div><div class="NLM_p">GSK has reported the pyrimidine-trione class of inhibitors.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> A clinical candidate, <b>34</b> (daprodustat, <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>), from this class is in late phase clinical evaluation.<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a> It is a potent inhibitor of all PHD isoforms (IC<sub>50</sub>s (nM) for PHD1:3.5 ± 0.6, PHD2:22.2 ± 13.4, PHD3:5.5 ± 5.1) with at least 1000-fold selectivity against collagen prolyl hydroxylase (CP4H) and factor inhibiting HIF (FIH) in enzyme inhibition assays. When dosed intravenously, <b>34</b> showed low blood clearance in the mouse, rat, dog, and monkey and good oral bioavailability across all of these species. Compound <b>34</b> was dosed at 60 mg/kg in B6D2F1 mice to see its effect on EPO. Following treatment for a week with <b>34</b>, EPO protein levels peaked at 12 h postdose by 11.2-fold with negligible change in VEGF. Compound <b>34</b> was able to increase reticulocytes and hemoglobin in B6D2F1 mice in a dose-related manner within a week’s treatment. Compound <b>34</b> was found to be safe in 14-day oral toxicity studies in Sprague–Dawley rats. Taisho Pharmaceuticals report a series of partially saturated pyridone derivatives exemplified by <b>35</b>.<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a> This compilation reports the IC<sub>50</sub> values of selected compounds and the percentage inhibition of PHD2 at 1 μM for nearly 500 compounds. Lead optimization involved various alkyl, aryl, and heteroaryl substituents at the nitrogen atom of the pyridone ring. Alkyl groups are connected to both saturated carbons of the central core. Spirocyclic modification of the central core was done using 3–6-membered carbocyclic or heterocyclic ring systems. Compound <b>35</b> show the most potent inhibition of PHD2 with an IC<sub>50</sub> of 14 nM.</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01686/20180816/images/medium/jm-2017-01686a_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01686/20180816/images/large/jm-2017-01686a_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Carboxylic acid-based PHD inhibitors (part 2).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01686/20180816/images/large/jm-2017-01686a_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01686&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p"><i>N</i>-Alkoxyquinolones exemplified by <b>36</b> were disclosed by Cadila Healthcare.<a onclick="showRef(event, 'ref41 ref92'); return false;" href="javascript:void(0);" class="ref ref41 ref92">(41,92)</a> Compounds in this invention increased EPO and hemoglobin levels after oral administration to mice. Pyridine, pyrimidine, and thiophene groups were used to replace the phenyl ring. An optimized molecule <b>36</b> (ZYAN1, desidustat) is now in phase 2 clinical trials.<a onclick="showRef(event, 'ref92 ref93'); return false;" href="javascript:void(0);" class="ref ref92 ref93">(92,93)</a> Merck reported a series of bicyclic pyridones exemplified by <b>37</b>–<b>40</b>.<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a> The fused ring was either a fully saturated cyclohexyl ring or a saturated ring with additional N and O heteroatoms. Eighty-five compounds in this report are potent PHD2 inhibitors. Structure–activity relationships (SAR) were evaluated by exploring various aryl, aralkyl, or heteroaralkyl groups at the N atom of the pyridone ring. Tetrahydropyran derivative <b>37</b> is the most potent PHD2 inhibitor (IC<sub>50</sub> = 5.4 nM) in this group. Shifting the oxygen atom to its adjacent carbon did not change the potency for PHD2 inhibition. Another modification with fused cyclohexyl ring as in <b>38</b> inhibited PHD2 with an IC<sub>50</sub> of 66 nM. Introduction of NH as in <b>39</b> has improved the potency for inhibition of PHD2 (IC<sub>50</sub> = 22.9 nM). The lactam derivative <b>40</b> demonstrated improved potency (IC<sub>50</sub> = 7.3 nM). Varying the substitution pattern of groups attached to the N atom of pyridone ring was responsible for the change in PHD2 inhibitory activity. Merck has reported a set of compounds in the quinolone class exemplified by <b>41</b>–<b>46</b>.<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a> Piperidine, morpholine, thiomorpholine, and piperazine rings were fused to the quinolone to generate a tricyclic central core. The phenyl ring of the quinolone was substituted with alkyl, aryl, halogen, −CN and – SO<sub>2</sub>CH<sub>3</sub> groups, with maximum activity observed with polar groups −CN and – SO<sub>2</sub>CH<sub>3</sub> at almost all positions in the majority of compounds. Aryl, aralkyl, and heteroalkyl groups are connected to both carbons. Morpholine-fused tricyclic derivative <b>41</b> inhibited PHD2 with an IC<sub>50</sub> of 21 nM. The introduction of a CN group, as shown in <b>42</b>, improved PHD2 IC<sub>50</sub> to 1.8 nM. Compound <b>43</b> with a 4-trifluoromethylphenyl group inhibited PHD2 with IC<sub>50</sub> values of 0.9 and 1.3 nM for the separated enantiomers. Its corresponding thiomorpholine <b>44</b>, piperazine <b>45</b>, and piperidine <b>46</b> derivatives inhibited PHD2 with IC<sub>50</sub> values 1.5, 1, and 1.9 nM, respectively, in racemic form.</div><div class="NLM_p">Merck developed dihydrothienopyridone and dihydrofuropyridone series of PHD inhibitors, exemplified by <b>47</b> and <b>48</b>.<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a> Compounds in these series contain aryl or heterocyclic groups directly attached to N atom of pyridone ring unlike previously reported compounds where the alkyl group is attached to it. Compound <b>47</b>, with an IC<sub>50</sub> value of 5.8 nM, and compound <b>48</b>, with an IC<sub>50</sub> value of 4.1 nM, are the optimized compounds.</div><div class="NLM_p">Additional work in a dihydrofuropyridone class of inhibitors was reported focused on modulating the pharmacokinetic (PK) profile. This report disclosed PHD2 inhibitory activity and PK data of 60 compounds in preclinical models.<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a> Compound <b>49</b> and <b>50</b> have been shown to possess significantly higher hepatic availability with liver/plasma ratio of drug concentration of 35.65 and 257.5, respectively.</div><div class="NLM_p last">In a recent publication, a group at Japan Tobacco disclosed a series of triazolopyridine derivatives (e.g., <b>51</b>–<b>55</b>) and the subsequent discovery of their clinical candidate <b>54</b> (JTZ-951).<a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a> Although <b>51</b> inhibited PHD (IC<sub>50</sub> = 0.82 μM), it failed to stimulate EPO release from Hep3B cells. It was claimed to be due to poor cell permeability of this compound. An improvement in cell permeability was achieved by incorporation of lipophilic substituents on the phenyl ring of the central core. The optimized compound was <b>52</b>, which has an <i>n</i>-pentyl substituent (IC<sub>50</sub> PHD2 = 0.85 μM, EC<sub>50</sub> Hep3B = 4.2 μM). Inhibitory potency was reduced when the <i>n</i>-pentyl group was attached next to the phenolic carbon (e.g., <b>53</b>, IC<sub>50</sub> PHD2 = 2.5 μM, EC<sub>50</sub> Hep3B = 9.3 μM). suggesting a possible loss of a H-bonding interaction with the OH with Tyr303. Compound <b>54</b>, with a 2-phenylethyl side chain, displayed much better activity (IC<sub>50</sub> PHD2 = 0.22 μM, EC<sub>50</sub> Hep3B = 5.7 μM) and exhibited a significant increase in EPO levels in mice (plasma EPO = 6500 pg/mL) and rat (plasma EPO = 17000 pg/mL) at 8 h when administered orally at a dose of 10 mg/kg. This compound had good solubility and did not affect CYP enzymes. In rats, it was shown to have a short <i>t</i><sub>1/2</sub> and claimed to exhibit good oral bioavailability (<i>F</i>(%) = 75). Oral dosing of compound <b>54</b> at 1 and 3 mg/kg showed a dose-dependent increase in hemoglobin following a month-long treatment in rats. Compound <b>55</b>, with a methyl substituent in the 5-membered ring, showed a reduction in activity compared to <b>54</b>, suggesting possible interference with the adjacent N atom involved in the iron chelation (IC<sub>50</sub> PHD2 = 1.6 μM, EC<sub>50</sub> Hep3B = 15 μM).</div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i7">Non-Carboxylic Acid PHD Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30776" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30776" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">HTS efforts by GSK led to the discovery of quinazoline-2,4-diones and 4-oxo-2-thioxo-7-quinazolines exemplified by <b>56</b>, <b>57</b>, <b>58</b>, and <b>59</b> (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>). All compounds in these series had either a pyrimidinedione or ketopyrimidinethione core attached to an <i>N</i>3-azaheterocycle.<a onclick="showRef(event, 'ref99 ref100'); return false;" href="javascript:void(0);" class="ref ref99 ref100">(99,100)</a> These compounds bind to the active site iron by chelation of the N atom of the heterocycle and either the keto or thiono group of the core. The phenyl ring was modified to a pyridine ring as in <b>57</b><a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(101)</a> and a thiophene ring as in <b>58</b> and <b>59</b>.<a onclick="showRef(event, 'ref102 ref103'); return false;" href="javascript:void(0);" class="ref ref102 ref103">(102,103)</a> PHD3 inhibitory activity (IC<sub>50</sub> value) for all exemplified compounds was in the range of 1–100 nM.</div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01686/20180816/images/medium/jm-2017-01686a_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01686/20180816/images/large/jm-2017-01686a_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Non-carboxylic acid PHD inhibitors (part 1).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01686/20180816/images/large/jm-2017-01686a_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01686&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Akebia has reported hydroxypyridone derivatives <b>60</b> and <b>61</b> derived from a known iron-chelator <span class="smallcaps smallerCapital">l</span>-mimosine.<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a> Compound <b>60</b> has been reported to inhibit PHD2 with an IC<sub>50</sub> of 14 μM. These compounds were claimed to promote wound healing, increase innate defense, and treat ulcerative colitis.<a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">(105)</a></div><div class="NLM_p">Merck reported 5-aminocarbonyl-4-hydroxypyrimidine derivatives <b>62</b> and <b>64</b> identified by HTS.<a onclick="showRef(event, 'ref106 ref107'); return false;" href="javascript:void(0);" class="ref ref106 ref107">(106,107)</a> Most of the reported compounds are potent (IC<sub>50</sub> of <10 nM in homogeneous time-resolved fluorescence (HTRF) assay for PHD inhibition), with <b>62</b> (IC<sub>50</sub> = 0.7 nM) as an optimized lead. The nitrogen-containing heterocycle at the C2 position of the central pyrimidine ring and analogues containing 1-pyrazolyl or 3-pyridazyl groups at this position were found to be optimum for inhibition of HIF-PHD. The presence of an OH group on the inner pyrimidine ring and appropriately located N atom in both of the rings are responsible for hydrogen bonding to Tyr303 and iron chelation. Structure optimization of this series led to the discovery of the optimized lead <b>63</b> (MK8617).<a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(108)</a> The presence of a benzhydryl group has shown an improved affinity for PHD2. Docking models favor the use of one aryl ring stacked over Arg322 attributed to cation−π interactions. During lead optimization, compounds have been shown to be exceptionally long <i>t</i><sub>1/2</sub> (>60 h) in dogs and monkeys. To achieve a once daily dosing paradigm in humans, strategies to increase phase I metabolism and hence lower the residence time was adopted. The introduction of two methoxy groups resulted in compound <b>63</b> with a significantly lowered <i>t</i><sub>1/2</sub> observed in the dog (19 h) and monkey (10 h). The reduced half-life of <b>63</b> was due to <i>O</i>-demethylation. A pyridazine ring provided an iron chelation site and was found useful to remove human ether-a-go-go-related gene (hERG) inhibitory activity. A pyrazole ring caused hERG activity inhibition (hERG inhibition IC<sub>50</sub> = 0.9 μM). Compound <b>63</b> inhibited PHD2 with an IC<sub>50</sub> of 1 nM and was found not to be a substrate, inhibitor, or inducer of cytochromes P450. It was found to be selective against an array of enzymes and receptors and possessed good oral bioavailability and a longer half-life in all of the preclinical models, including rhesus monkeys. Despite the increase in EPO levels, VEGF did not change after treatment with <b>63</b> in mice. In Sprague–Dawley rats, this compound caused an increase in EPO and hemoglobin after repeated dosing, at 1.5, 5, and 15 mg/kg, by the oral route. The 5-aminocarbonyl-4-hydroxypyrimidine class contained compounds bearing phosphinic acid, phosphonic acid, and phosphonate ester groups, exemplified by <b>64</b>.<a onclick="showRef(event, 'ref109 ref110'); return false;" href="javascript:void(0);" class="ref ref109 ref110">(109,110)</a> Compound <b>64</b> inhibited PHD2 with an IC<sub>50</sub> in the low nanomolar range. Phosphorus-containing groups are attached to one of the phenyl rings of the benzhydryl moiety, while a few derivatives also replaced one of the phenyl rings with aliphatic phosphonic acid derivatives.</div><div class="NLM_p">A novel spiroindolone series exemplified by <b>65</b>, with one more report of spiroazaindoles, was reported by Merck.<a onclick="showRef(event, 'ref111 ref112'); return false;" href="javascript:void(0);" class="ref ref111 ref112">(111,112)</a> A major effort using mass spectrometry-based high throughput screening methodology assessed more than 500000 compounds.<a onclick="showRef(event, 'ref113'); return false;" href="javascript:void(0);" class="ref ref113">(113)</a> Optimization of early hits led to the identification of compound <b>65</b> (PHD2 IC<sub>50</sub> = 0.7 nM), in which a 2-pyridylmethyl group was found to be essential for the desired potency, although it was not bioavailable. Efforts to reduce the lipophilicity of the central core resulted in a spirohydantoin class of compounds, exemplified by <b>66</b>. It showed high potency (IC<sub>50</sub> PHD1 = 0.2 nM, PHD2 = 0.2 nM, PHD3 = 1.6 nM), improved PK (<i>F</i>(%) = 47%, <i>t</i><sub>1/2</sub> = 1.1 h in rat), and minimal hERG inhibition (IC<sub>50</sub> = 22 μM).<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a></div><div class="NLM_p">Compound <b>66</b> is a short-acting PHD inhibitor, which was based on the rationale that only a very short-time inhibition of the PHDs is sufficient for HIF stabilization and further downstream EPO upregulation. A shorter duration of action offered by the shorter half-life of the compound may lead to an improved safety profile in the clinic. The concept of having a short half-life of PHD inhibitors was also discussed by researchers at Janssen by defining duodenal uptake of iron as a target to treat FID and inflammation-induced anemia.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> Oral administration of a low dose of a PHD inhibitor is an effective treatment for FID without the requirement for systemic exposure to the compound. The local concentration of the PHD inhibitor that surrounds the enterocyte of the duodenum is higher after oral administration than that achieved after systemic absorption. In this context, a PHD inhibitor that has limited systemic absorption and one with a short half-life might be advantageous for the treatment of FID and anemia associated with chronic disease.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a></div><div class="NLM_p">A spirocyclic class of PHD inhibitor was also explored by GSK, which resulted in the identification of 2,8-diazaspiro[4.5]decan-1-one derivatives, exemplified by <b>67</b> (pIC<sub>50</sub> = 8.3).<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a> This series of compounds lacks the phenyl ring fusion as seen in <b>65</b>. A crystal structure between a close analogue of <b>67</b> and PHD2 revealed several novel interactions, including a H-bond between the lactam carbonyl and Arg322, a π–cation interaction with Arg322, a π–π stacking interaction with Trp389, and a π–π stacking interaction with His313. In an oral absorption study in mice, <b>67</b> demonstrated good oral bioavailability with high peripheral exposure (dose-normalized area under curve (DNAUC): 634 ng h/mL). The high oral bioavailability of <b>67</b> was due to low hepatic clearance.</div><div class="NLM_p">Compounds <b>68</b>–<b>70</b> possessing a pyrazolone central core (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>) were earlier disclosed by Bayer.<a onclick="showRef(event, 'ref116 ref117'); return false;" href="javascript:void(0);" class="ref ref116 ref117">(116,117)</a> Compounds from this series chelate iron through the nitrogen from the pyridine or pyrimidine ring attached via the nitrogen atom of the central core and N1 of the pyrazolone ring in its enol tautomeric form. The enolic OH may engage Tyr303 as observed with phenolic PHD inhibitors. The nitrogen of the 3-pyridyl ring in <b>68</b>–<b>69</b> was essential for high potency. Compound <b>68</b> inhibited PHD activity in a FRET assay with an IC<sub>50</sub> value of 0.43 μM and the EC<sub>50</sub> value in a luciferase reporter assay in A549 cells was found to be 4.9 μM.<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a> The IC<sub>50</sub> value of amide analogue <b>69</b> was found to be 0.91 μM. Bayer has also described molecules similar to <b>68</b>–<b>69</b> with a dihydropyrazolethione (not shown) as a central core with similar activity.<a onclick="showRef(event, 'ref118 ref119'); return false;" href="javascript:void(0);" class="ref ref118 ref119">(118,119)</a> Bayer has disclosed a pyrazolone series replacing the 3-pyridyl with 5-membered nitrogen-containing heterocycles, as exemplified by <b>70</b>.<a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a> A recent publication disclosed the discovery efforts for the clinical candidate <b>70</b> (molidustat, BAY 85-3934).<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a> A brief SAR was drawn around the triazole ring, pyrazole central core, and pyrimidine ring. Replacement of the triazole ring with other heterocycles such as imidazole, thiadiazole, and isooxazole with an N atom always present at the third position suggested the importance of a heteroatom for optimum potency. Docking of the pyrazolol tautomer of <b>70</b> into the active site of PHD2 (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2G19">2G19</a>) suggested bidentate iron binding via the ring nitrogen atoms of the pyrazolol core and the adjacent pyrimidine ring. The triazole moiety was proposed to engage in an electrostatic interaction with Arg 383. It was shown to have excellent oral bioavailability across the species (<i>F</i> (%): 34 (rat), 71 (dog), and 61 (monkey)). The metabolism of <b>70</b> was found to occur via <i>N</i>-glucuronidation. Urinary excretion is the primary route of elimination of <b>70</b>.<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a> It was reported to be a reversible, 2-OG-competitive, pan-PHD inhibitor with IC<sub>50</sub> values of 480, 280, and 450 nM for PHD 1, 2 and 3, respectively. Following a single oral administration of <b>70</b>, EPO was significantly induced at doses of 1.25 mg/kg and above in male Wistar rats. In a 26-day, repeat-dose study, treatment with <b>70</b> at 1.25 and 5 mg/kg doses increased PCV (packed cell volume) by 3% and 17%, respectively, from baseline. The efficacy of <b>70</b> was compared to rhEPO in cynomolgus monkeys.</div><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01686/20180816/images/medium/jm-2017-01686a_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01686/20180816/images/large/jm-2017-01686a_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Noncarboxylic acid PHD inhibitors (part 2).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01686/20180816/images/large/jm-2017-01686a_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01686&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">A single dose of rhEPO (100 IU/kg, subcutaneous) or <b>70</b> (1.5 mg/kg, oral) increased hemoglobin and RBC to a similar extent in a two week study. Treatment with <b>70</b> showed an erythropoietic effect in different models of anemia in the rat. In a disease model of subtotal nephrectomy in rats, treatment with <b>70</b> led to a sustained reduction in mean systolic blood pressure. Thus, <b>70</b> demonstrated a better cardiovascular safety profile over rhEPO for the treatment of anemia associated with CKD.</div><div class="NLM_p">Compounds with a pyrazole central core (similar to Bayer compounds) described by Takeda are exemplified by <b>71</b>–<b>72</b>.<a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(122)</a> The essential rings such as 3-pyridyl and triazolyl with an N atom at the third position are absent in these molecules. The profiles of 434 compounds disclosed in this patent suggested the 4-pyridyl and 4-cyanophenyl rings as possible substitutes. The 2-pyridyl ring attached to the central core is attached to various secondary and tertiary amides. The compounds showed PHD inhibition in the range of pIC<sub>50</sub> values spanning a range of 5.43–8.67, with most of the modulation achieved by exploring amines at the amide group. A cell-based HIF-stabilization assay was used to assess the PHD inhibitory activity of compounds. pIC<sub>50</sub> values for <b>71</b> and <b>72</b> in the enzyme inhibition assay were found to be 8.4 and 8.0, respectively, while pEC<sub>50</sub> values in the cell-based test were found to be 6.45 and 6.25, respectively. Compound <b>72</b> was also evaluated in the in vivo cardioprotection assay, at 5 mg/kg, 10 mg/kg, and 30 mg/kg in preclinical models. Compound <b>72</b> reduced the area of infarct in mice by 59% at 30 mg/kg and by 50% at 10 mg/kg compared to vehicle. Compound <b>72</b> also decreased markers of cardiac injury; the corresponding reduction of lactate dehydrogenase (LDH) released to the coronary effluent was 56% and 51% at 30 and 10 mg/kg, respectively. In mice, <b>72</b> at 60 mg/kg in C57BL/6 mice increased VEGF mRNA by 2-fold, when compared to <b>72</b>, which could be responsible for protection against cardiac injury.<a onclick="showRef(event, 'ref122 ref123'); return false;" href="javascript:void(0);" class="ref ref122 ref123">(122,123)</a> Daiichi also reported another modification of the pyrazole class of compounds in the form of a novel series of EPO secretagogues exemplified by <b>73</b>.<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a> The triazole and pyridine rings reported in <b>93</b>–<b>95</b> were replaced with an acetylamino group, as shown in <b>73</b>. EPO induction activity of 27 examples was evaluated using Hep3b cell line. Compound <b>73</b> caused a 40-fold increase in EPO in this assay.</div><div class="NLM_p">Taisho has reported a series of triazole substituted heteroaryl amides exemplified by <b>74</b>.<a onclick="showRef(event, 'ref125'); return false;" href="javascript:void(0);" class="ref ref125">(125)</a> The report of these molecules contains more than 200 examples with the data for PHD2 inhibition at 1 μM. One may postulate that the N atom from the triazole ring could form an iron chelating moiety with the adjacent 2-pyridyl ring. The free NH group may be involved in a H-bond interaction with Tyr303 similar to that reported for benzimidazole-based inhibitors <b>11</b> and <b>12</b>. The IC<sub>50</sub> value for <b>74</b> was 61 nM. The presence of an amide or reverse amide was preferred for high potency. However, any change such as an alkyl ether or an amide with an alkyl spacer at that position was found to be detrimental to activity. Compounds with an electron-releasing methoxy group para to the nitrogen atom of the pyridine ring have been found to be potent and effective.</div><div class="NLM_p last">CrystalGenomics, Inc. has disclosed a series of phenolic compounds (e.g., <b>75</b> and <b>76</b>).<a onclick="showRef(event, 'ref126'); return false;" href="javascript:void(0);" class="ref ref126">(126)</a> This group has also published the SAR and binding mode for a series of thiazole derivatives targeted at the 2-OG binding site.<a onclick="showRef(event, 'ref127'); return false;" href="javascript:void(0);" class="ref ref127">(127)</a> The presence of a cyano group was found to be the key to achieve PHD2 inhibitory potency during SAR evaluation of their initial hit. Compound <b>75</b> has shown the highest PHD2 inhibitory activity with an IC<sub>50</sub> value of 0.4 μM in an enzymatic assay. However, it did not show significant EPO release even at 100 μM in Hep3B cells due to its poor permeability in a parallel artificial membrane permeability assay (PAMPA). Compound <b>76</b> inhibited PHD2 with an IC<sub>50</sub> of 2.1 μM, but it has shown around 40-fold EPO secretion at 50 μM concentration, which correlates with improved cell permeability. The cocrystal structure of an analogue related to <b>76</b> (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4KBZ">4KBZ</a>) suggests that it binds to Fe through the nitrogen atoms in the hydroxylpyridine and thiazole rings. This binding mode also enables the formation of an H-bond between the hydroxyl moiety and the conserved Tyr303. These compounds were potent due to an interaction of the cyano group with Tyr329 and Arg383, which is similar to the one shown by the carboxylic group-containing PHD inhibitors.</div></div><div id="sec7" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">PHD Inhibitors with Nonconventional Binding Mode</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76288" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76288" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Takeda has published a report on the bicyclic heteroaryl derivatives exemplified by <b>77</b>–<b>79</b> (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>), which contains IC<sub>50</sub> values of PHD1 inhibition for 262 examples.<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a> A recent publication also described SAR of compounds in this class.<a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a> Modification of a lead identified from fragment screening campaign resulted in the identification of compound <b>77</b> (IC<sub>50</sub> value of 0.034 μM). Both nonbridgehead nitrogen atoms of the 5-membered rings were found to be essential for PHD inhibition. More precisely, the nitrogen atom distant from the bridgehead nitrogen was found to be more important than the nitrogen atom next to it. The SAR showed a preference for electron withdrawing substituents in the 4-position of the phenyl ring with 4-CN group showing the best activity. Replacement of the phenyl ring with 5,6-membered heterocycles did not help to improve potency further. An X-ray cocrystal structure of compound <b>77</b> with PHD1 (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5V1B">5V1B</a>) showed new monodentate coordination of the triazolopyridine N atom (away from the bridgehead nitrogen) with the active site Fe<sup>2+</sup> ion, unlike the bidentate chelation interaction observed for almost all previously reported PHD inhibitors. The nitrile group showed a hydrogen bond interaction with the side chain of Asn315. The phenyl ring is positioned appropriately to make a π-stacking interaction with Tyr287, and the triazolopyridine N3 atom is potentially making a water-mediated interaction with Tyr313. Compound <b>77</b>, when evaluated for its PK profile in C57BL6 mice at 3 mg/kg, showed modest oral exposure (176 ng.h/mL) and high clearance (108 mL/min/kg). Brain drug levels were comparable to the plasma exposure (brain/plasma ratio 0.95), indicating the utility of the compound for the treatment of brain (CNS) related disorders. Compound <b>78</b> (IC<sub>50</sub> = 0.074 μM) with a <i>meta</i>-methyl group in the top phenyl ring of <b>77</b> improved oral exposure (1869 ng·h/mL) while maintaining good CNS penetration (brain/plasma ratio 0.88). Compound <b>79</b> (IC<sub>50</sub> = 0.09 μM), with an amino group introduced into the central core of <b>78</b>, exhibited excellent peripheral exposure (40038 ng.h/mL) but poor CNS penetration (brain/plasma ratio 0.21). Compound <b>78</b> showed high protein binding, low solubility, and poor permeability, which are responsible for the poor penetration of the brain. Compound <b>78</b> was found to be a substrate for multidrug resistance protein (MDR)-1 in an in vitro MDCK-MDR-1 assay (efflux ratio 12).</div><figure id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01686/20180816/images/medium/jm-2017-01686a_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01686/20180816/images/large/jm-2017-01686a_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. PHD inhibitors with the nonconventional binding mode.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01686/20180816/images/large/jm-2017-01686a_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01686&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">A multicentered team from the University of Oxford and the BioNanotechnology Research Centre from the Republic of Korea has published a series of diacylhydrazines as dual-action inhibitors of PHD. These PHD inhibitors bind to the active site iron. Also, these compounds bind with the cellular iron in a nonspecific way. Because diacylhydrazines possess considerable metal ion chelating ability and vulnerability to undergo oxidation to diacylazo-Michael acceptors, they can be toxic to the mammalian system.<a onclick="showRef(event, 'ref130'); return false;" href="javascript:void(0);" class="ref ref130">(130)</a> A broad profiling approach utilizing ESI-MS analysis of mixtures of the catalytic domain of PHD2, ferrous sulfate, and diacyl hydrazines (derived from various pyridine, quinolone, and isoquinoline carboxylic acids, hydrazine, and aliphatic diacids) enabled the identification of several analogues that bind this additional iron atom. Compound <b>80</b> inhibited PHD2 with an IC<sub>50</sub> of 18.4 μM and showed increased HIF-1α levels in Hep3B cells.</div><div class="NLM_p last">The Korea Institute of Science and Technology reported pyrithione Zn (<b>81</b>) as a highly selective PHD3 inhibitor by screening 1040 FDA-approved drugs and bioactive compounds.<a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(131)</a> Pyrithione Zn is accepted worldwide as a microbicidal agent. It has shown IC<sub>50</sub> value for PHD3 0.98 μM, while for PHD2 it was >1 mM. The contribution of Zn<sup>2+</sup> to PHD3 inhibition was found to be nonsignificant. A mechanistic investigation led to the understanding that it is an allosteric inhibitor of PHD3.</div></div><div id="sec8" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Learnings from the Clinical Trials of Prolyl Hydroxylase Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_03763" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_03763" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The first rationally designed PHD inhibitor that reached clinical trials in ESRD patients for the treatment of anemia was <b>15</b>. A modified analogue <b>16</b> (roxadustat) is currently in the late stage of phase III clinical trials. Earlier trials of <b>16</b> were carried out on patients with nondialysis dependent chronic kidney disease (ND-CKD) and dialysis-dependent CKD. In these trials, <b>16</b> improved anemia (defined as hemoglobin increase ≥1 g/dL) and maintained hemoglobin levels (defined as hemoglobin not falling more than 0.5 g/dL).<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> It has also improved EPO release and decreased hepcidin in clinical trials, which can be considered the first proof of principle for PHD inhibitors in late-stage clinical trials without a significant safety concern. Compound <b>16</b> could be the first molecule in the PHD class to reach the clinic for the treatment of anemia associated with chronic kidney disease patients. It has a half-life of 12 h after oral dosing. When <b>16</b> was administered in doses of either 1.0 or 2.0 mg/kg twice weekly (BIW) or three times weekly (TIW), endogenous EPO release started within 4 h, which reached a peak at 10 h after dosing. The increase in EPO was reversible because endogenous EPO levels returned to baseline a day after administration. Maximum serum EPO levels after administration of 1 mg/kg roxadustat were 115 mU/mL, which was significantly lower than those achieved by intravenous injection of recombinant erythropoietin. After 6 weeks of treatment, <b>16</b> has shown a significant decrease in hepcidin levels, which has translated into reducing functional iron deficiency. After these initial trials, <b>16</b> has undergone clinical trials in more than 1000 patients.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> Apart from EPO, HIF activation causes VEGF stimulation that can lead to angiogenesis and induce tumor progression. However, despite the induction of erythropoiesis, <b>16</b> does not promote tumor initiation, progression, or metastasis in a VEGF-sensitive model of spontaneous breast cancer.<a onclick="showRef(event, 'ref132'); return false;" href="javascript:void(0);" class="ref ref132">(132)</a> Compound <b>16</b> is a pan-PHD inhibitor (which inhibits all the three PHD isoforms), and the dosing frequency was mostly biweekly or triweekly doses, ranging from 1 to 2 mg/kg. It is expected to enter the clinical use in late 2018.</div><div class="NLM_p">Compound <b>34</b> or daprodustat (GSK1278863) is currently undergoing phase III clinical trials.<a onclick="showRef(event, 'ref133'); return false;" href="javascript:void(0);" class="ref ref133">(133)</a> In a double-blind, placebo-controlled trial in anemia patients on hemodialysis (HD), <b>34</b> increased hemoglobin in a dose-related manner after 4 weeks of treatment. A dose-dependent increase in plasma EPO concentration was observed up to 8 mg dose, where the response was saturated. Serum EPO levels increased beyond 500 mIU/mL in the patients treated with 10 mg of <b>34</b>, although VEGF did not change. However, daprodustat affects cardiac repolarization. Statistically significant decreases in the Δ<i>Q</i>Tc were observed by daprodustat treatment, along with higher incidences of gastrointestinal adverse events.<a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a></div><div class="NLM_p">Compound <b>23</b> (vadadustat/AKB-6548) is currently in phase III clinical trials. In phase I trials, <b>23</b> (900 mg) increased the peak serum concentration of EPO to 32.4 mU/mL at 18 h after treatment in healthy adults.<a onclick="showRef(event, 'ref135'); return false;" href="javascript:void(0);" class="ref ref135">(135)</a> In a phase II study, <b>23</b> treatment for 6 weeks has significantly increased hemoglobin in a dose-dependent manner and also increased iron-binding capacity in the blood. It was associated with a decrease in ferritin and hepcidin concentration, indicating a significant improvement in iron homeostasis for efficient erythropoiesis. There were no changes in blood pressure, VEGF, C-reactive protein, or total cholesterol.<a onclick="showRef(event, 'ref135'); return false;" href="javascript:void(0);" class="ref ref135">(135)</a> A transient decrease in mean arterial blood pressure and a mild transient increase in serum uric acid level was observed in a 4-week dose escalation study.<a onclick="showRef(event, 'ref136'); return false;" href="javascript:void(0);" class="ref ref136">(136)</a></div><div class="NLM_p">Compound <b>70</b> (molidustat/BAY 85-3934) is a pan-PHD inhibitor, which is currently in phase II clinical trials. The dose of 5–50 mg of <b>95</b> has resulted in a dose-dependent increase in serum EPO levels, with a peak of 39.8 mU/mL, at 12 h after a single dose of 50 mg in healthy humans, when compared to 14.8 mU/mL for placebo.<a onclick="showRef(event, 'ref137'); return false;" href="javascript:void(0);" class="ref ref137">(137)</a></div><div class="NLM_p last">Compound <b>36</b> (desidustat/ZYAN1), is a pan-PHD inhibitor in phase II clinical trials. Preclinical profile of <b>36</b> indicates that it has a potential to treat anemia associated with CKD and chemotherapy-induced anemia at equivalent doses. It has demonstrated hematinic potential by combined effects on EPO release and efficient iron utilization owing to hepcidin suppression.<a onclick="showRef(event, 'ref138'); return false;" href="javascript:void(0);" class="ref ref138">(138)</a> Its pharmacokinetics is minimally affected in patients with CKD.<a onclick="showRef(event, 'ref139'); return false;" href="javascript:void(0);" class="ref ref139">(139)</a> In phase I clinical trials conducted in Australia and India, single (10–300 mg) and multiple doses (100–300 mg) of <b>36</b> in healthy subjects was found to be safe and well-tolerated. Administration of <b>36</b> was associated with a dose-related increase in <i>C</i><sub>max</sub> and AUC. Serum EPO concentrations showed a trend of dose–response as well.<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> On the basis of the <i>t</i><sub>1/2</sub>, pharmacodynamic activity, and lack of drug accumulation, this compound is suitable for alternate day dosing in the clinic, which is currently in phase II clinical trials. There are a few other compounds like <b>54</b> (JTZ-951), JNJ-42905343, and DS-1093. However, no significant development activities have been published for these compounds.</div></div><div id="sec9" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51673" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51673" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The discovery of prolyl hydroxylase enzyme inhibitors introduced new therapeutic options in the field of anemia associated with chronic diseases. More than a decade after the development of the first molecule that reached clinical trials, the understanding of prolyl hydroxylase inhibitors has increased extensively, with the conclusive evidence that inhibition of PHD could provide an exciting approach for the treatment of anemia associated with CKD. Many safe and effective PHD inhibitors followed the discovery of <b>15</b>. These PHD inhibitors consist of a 2-oxoglutarate scaffold. These compounds blocked the interaction between 2-OG and prolyl hydroxylase and also stabilized the closed conformation of the PHD–inhibitor complex, which inhibited the substrate binding for degradation of HIF. Thus, carboxylic acid-based PHD inhibitors were discovered that incorporated an isoquinoline ring and which were optimized to the most advanced clinical candidate <b>16</b>. Akebia Therapeutics has developed monocyclic pyridine derivative <b>23</b>, GSK developed pyrimidine-trione derivative <b>34</b>, and Cadila Healthcare developed <i>N</i>-alkoxyquinolone derivative <b>36</b>, which maintains the carboxylic acid chain intact. Bayer took a different approach to the development of a noncarboxylic acid-based moiety, <b>70</b>. Compound <b>70</b> achieved 2-fold iron chelation using the ring nitrogen atoms of the pyrazole core and the adjacent pyrimidine ring, with an added interaction of the triazole moiety with the 2-OG binding residue Arg-383. These compounds have been developed for a once daily or an alternate day (thrice a week) dosing regimen. The alternative day dosing regimen was designed to address the compliance issue in dialysis patients, where the drug administration needs to be in synchrony with a dialysis routine. On the other hand, an overly long half-life may invites safety issues due to prolonged stabilization of HIF. The Merck group’s optimization of <b>63</b> highlighted the importance of a structure–activity approach balancing potency, reducing side effects, and achieving the desired half-life owing to increased metabolism of the compound.</div><div class="NLM_p">PHD inhibitors stimulate renal and hepatic erythropoiesis, along with the promotion of efficient iron utilization. They induce a transient increase in the expression of HIF-regulated genes, including renal and hepatic EPO, and maintain a physiological concentration of EPO in blood. The peak EPO concentration after a clinically useful dose of <b>16</b>, <b>23</b>, <b>34</b>, <b>36</b>, and <b>70</b> have resulted in EPO levels of 32.4–500 mU/mL in circulation, which is many-fold lower than those achieved by recombinant erythropoietin administration. Thus, PHD inhibitors are a safer therapeutic option for the treatment of anemia associated with CKD. An underestimated advantage of PHD inhibitors lies in their positive modulation of iron homeostasis under anemic conditions. CKD and other inflammatory disorders are associated with increased hepcidin. By suppression of hepcidin, PHD inhibitors improve functional iron deficiency, which may reduce the need for iron supplementation (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>).</div><figure id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01686/20180816/images/medium/jm-2017-01686a_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01686/20180816/images/large/jm-2017-01686a_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Mechanism of action of HIF-PHD inhibitors. The chronic inflammatory condition or kidney disease increases the release of inflammatory cytokines and decreases erythropoietin release. Inflammatory cytokines stimulate hepcidin synthesis. Increased levels of hepcidin downregulate DMT1, Dcytb, and block ferroportin and inhibit iron absorption. Hepcidin degrades ferroportin in macrophages and the liver, which leads to reduced iron availability in the blood and increases intracellular iron. The decrease in EPO and increased hepcidin inhibit hemoglobin synthesis and the maturation of RBCs, resulting in anemia. PHD inhibitors stabilize HIF and stimulate EPO release and decrease hepcidin levels and thus stimulate efficient erythropoiesis.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01686/20180816/images/large/jm-2017-01686a_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01686&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Loss of function mutations in humans and PHD gene knockout data in mice have indicated that inhibition of PHDs can be useful in some indications related to hypoxia and vascular responses, although diseases other than anemia associated with CKD have yet to establish clinical proof of concept. Studies in PHD knockout mice suggest that the effect of PHD inhibitors is dependent on the extent of activation of the different isoforms of PHDs (PHD1, 2, and 3). It also depends on how the erythropoiesis in the kidney and the liver are differentially affected. On the other hand, PHD2 inhibition alone is enough to deliver a clinically relevant erythropoiesis response from the kidneys. However, to achieve a significant erythropoiesis response from the liver (as in anephric patients), simultaneous inhibition of PHD1, PHD2, and PHD3 are necessary. On the other hand, HIF activation has a widespread effect on the body, which causes angiogenesis and oncogenesis due to vascular responses to hypoxia. Hence, PHD inhibitors may arouse a safety concern in situations like diabetic nephropathy or malignancies. However, the induction of erythropoiesis by PHD inhibition has been reported not to increase tumor progression in VEGF-sensitive models of cancer. If translated to humans, this phenomenon may be useful to position PHD inhibitors for the treatment of chemotherapy-induced anemia in cancer patients.</div><div class="NLM_p last">The majority of the PHD inhibitors were designed based on a 2-OG mimetic approach using in vitro and in vivo screening, although some have been discovered by an HTS approach. The in vitro assays used for the testing of compounds are not uniform across the laboratories, mostly due to the use of different active fragment proteins of HIF and PHD. On the other hand, the in vivo screening using hematocrit as the marker of erythropoiesis has successfully translated to the clinic for most of the clinically advanced compounds. HIF signaling is a complicated process which affects many vital pathways including glucose and lipid metabolism, angiogenesis, and vascular metabolism. The role of specific PHD isoforms or HIF-α isoforms in the regulation of these different pathways is not yet adequately delineated. Hence, it is difficult to distinguish the toxicities of PHD inhibitors that are related to the mechanism and those which are off-target. Still, PHD inhibitors are safe in CKD patients. However, the effect in long-term clinical studies using the markers of tumor progression, angiogenesis, and cardio-metabolic abnormalities are necessary in order to expand the therapeutic use of PHD inhibitors to condition like chemotherapy-induced anemia and anemia associated with aging.</div></div><div class="NLM_back"><div class="NLM_notes" id="notes-1"><p class="first last">The authors declare the following competing financial interest(s): All the authors are employee(s) or consultant(s) of Zydus Research Centre, a unit of Cadila Healthcare Limited, which develops PHD inhibitors. The authors have no other conflicts of interest to report.</p></div><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/acs.jmedchem.7b01686" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86141" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86141" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Amit A. Joharapurkar</span> - <span class="hlFld-Affiliation affiliation">Zydus Research Centre, Cadila Healthcare Limited, Sarkhej Bavla NH8A, Moraiya, Ahmedabad 382210, India</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-0723-4371" title="Orcid link">http://orcid.org/0000-0003-0723-4371</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#ef8e82869b8580878e9d8e9f9a9d848e9daf95968b9a9c8c8e8b86838ec18c8082"><span class="__cf_email__" data-cfemail="fc9d9195889693949d8e9d8c898e979d8ebc868598898f9f9d9895909dd29f9391">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vrajesh B. Pandya</span> - <span class="hlFld-Affiliation affiliation">Zydus Research Centre, Cadila Healthcare Limited, Sarkhej Bavla NH8A, Moraiya, Ahmedabad 382210, India</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9004-4514" title="Orcid link">http://orcid.org/0000-0001-9004-4514</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vishal J. Patel</span> - <span class="hlFld-Affiliation affiliation">Zydus Research Centre, Cadila Healthcare Limited, Sarkhej Bavla NH8A, Moraiya, Ahmedabad 382210, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ranjit C. Desai</span> - <span class="hlFld-Affiliation affiliation">Zydus Research Centre, Cadila Healthcare Limited, Sarkhej Bavla NH8A, Moraiya, Ahmedabad 382210, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mukul R. Jain</span> - <span class="hlFld-Affiliation affiliation">Zydus Research Centre, Cadila Healthcare Limited, Sarkhej Bavla NH8A, Moraiya, Ahmedabad 382210, India</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><p>The authors declare the following competing financial interest(s): All the authors are employee(s) or consultant(s) of Zydus Research Centre, a unit of Cadila Healthcare Limited, which develops PHD inhibitors. The authors have no other conflicts of interest to report.<br /></br></p></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51776" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51776" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Amit A. Joharapurkar</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01686&amp;id=BIO-d251e1986-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Amit A. Joharapurkar</b> received his Ph.D. in 2005, after which he followed a career in research at the Zydus Research Centre, Ahmedabad, India, where he has led pharmacology efforts for several programs in the metabolic disorders therapeutic area, including the discovery of PHD inhibitors. He is the recipient of the CDRI Award for Excellence in Drug Research 2018. His scientific interests include obesity, diabetes, dyslipidemia, and anemia.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Vrajesh B. Pandya</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01686&amp;id=BIO-d251e1991-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Vrajesh B. Pandya</b> is a medicinal chemist at Zydus Research Centre, Cadila Healthcare Limited, Ahmedabad, India. He obtained his Ph.D. degree from The Maharaja Sayajirao University of Baroda, Vadodara, India. His work in medicinal chemistry focused on novel compounds for the treatment of thrombotic and related disorders. He has contributed to the discovery and development of PHD inhibitors at Zydus Research Centre.</p></figure></div><div class="bio" rid="ath3"><figure id="ath3" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Vishal J. Patel</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01686&amp;id=BIO-d251e1996-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Vishal J. Patel</b> received his Ph.D. in Pharmacology from Kadi Sarva Vishwavidyalaya, India. His Ph.D. project focused on the development of coagonist of glucagon-derived peptide hormones as useful tools in the treatment of metabolic disorders. He has worked as a pharmacologist in Torrent Research Centre, India, and joined Zydus Research Centre in 2007. In Zydus Research Centre, he is involved in screening and development of new chemical entities for obesity, dyslipidemia, and anemia programs. He is the recipient of Wiley-Journal of Diabetes Young Investigator Award in 2013, and Keystone Symposia Future of Science Fund scholarship in 2016,</p></figure></div><div class="bio" rid="ath4"><figure id="ath4" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Ranjit C. Desai</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01686&amp;id=BIO-d251e2001-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Ranjit C. Desai</b> was a Senior Vice President and Head of Chemistry (July 2012–Dec 2017) at Zydus Research Centre, Cadila Healthcare Ltd, Ahmedabad, India. He is the inventor of desidustat, a PHD inhibitor currently in phase 2 clinical trials. Dr. Desai received his Ph.D. from the MS University of Baroda, India, working with Dr. Sukh Dev at the Malti-Chem Research Centre. After working as a postdoctoral associate at Clemson University, Purdue University, and the University of Montreal, he worked at Sanofi-Winthrop, Hoechst Celanese, and Merck Research Laboratories. Currently, he is a Senior Consultant at Zydus Research Centre and runs projects in the metabolic diseases and antibacterial area.</p></figure></div><div class="bio" rid="ath5"><figure id="ath5" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Mukul R. Jain</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01686&amp;id=BIO-d251e2006-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Mukul R. Jain</b> is President at Zydus Research Centre, Cadila Healthcare Ltd., Ahmedabad, India. His team is involved in discovery and development of new drugs. Dr. Jain obtained his M.Pharm. and Ph.D. from Nagpur University, India. After completing Ph.D., he worked at Wockhardt and Ranbaxy Research Centers before moving to the University of Florida at Gainesville as a Postdoc Associate. He then worked as Assistant Professor in the National Institute of Pharmaceutical Education and Research, Mohali, India, before joining Zydus Research Centre in 2000. His group at Zydus Research Centre has developed several NCEs including Saroglitazar and Desidustat and also contributed to the development of several biologics & vaccines of Cadila Healthcare Ltd.</p></figure></div><div class="ack" id="ACK-d251e2011-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25311" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25311" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors are grateful to Mr. Pankaj R. Patel, Chairman of Cadila Healthcare Ltd., India for his guidance & support.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">AUC</td><td class="NLM_def"><p class="first last">area under the curve</p></td></tr><tr><td class="NLM_term">EPO</td><td class="NLM_def"><p class="first last">erythropoietin</p></td></tr><tr><td class="NLM_term">ESA</td><td class="NLM_def"><p class="first last">erythrocyte-stimulating agents</p></td></tr><tr><td class="NLM_term">PHD</td><td class="NLM_def"><p class="first last">prolyl hydroxylase domain</p></td></tr><tr><td class="NLM_term">HIF</td><td class="NLM_def"><p class="first last">hypoxia-inducible transcription factor</p></td></tr><tr><td class="NLM_term">RBC</td><td class="NLM_def"><p class="first last">red blood cells</p></td></tr><tr><td class="NLM_term">CKD</td><td class="NLM_def"><p class="first last">chronic kidney disease</p></td></tr><tr><td class="NLM_term">HSC</td><td class="NLM_def"><p class="first last">hematopoietic stem cells</p></td></tr><tr><td class="NLM_term">CFU-E</td><td class="NLM_def"><p class="first last">colony forming units, erythroid</p></td></tr><tr><td class="NLM_term">EPOR</td><td class="NLM_def"><p class="first last">EPO receptors</p></td></tr><tr><td class="NLM_term">rhEPO</td><td class="NLM_def"><p class="first last">human recombinant EPO</p></td></tr><tr><td class="NLM_term">JAK2</td><td class="NLM_def"><p class="first last">Janus tyrosine kinase-2</p></td></tr><tr><td class="NLM_term">STAT</td><td class="NLM_def"><p class="first last">signal transduction and activator of transcription</p></td></tr><tr><td class="NLM_term">AKT kinase</td><td class="NLM_def"><p class="first last">protein kinase B</p></td></tr><tr><td class="NLM_term">CD95</td><td class="NLM_def"><p class="first last">cluster of differentiation 95</p></td></tr><tr><td class="NLM_term">TNF</td><td class="NLM_def"><p class="first last">tumor necrosis factor</p></td></tr><tr><td class="NLM_term">FPN</td><td class="NLM_def"><p class="first last">ferroportin</p></td></tr><tr><td class="NLM_term">BMP/SMAD</td><td class="NLM_def"><p class="first last">bone morphogenetic protein/SMAD</p></td></tr><tr><td class="NLM_term">IL-6</td><td class="NLM_def"><p class="first last">interleukin 6</p></td></tr><tr><td class="NLM_term">ERFE</td><td class="NLM_def"><p class="first last">erythroferrone</p></td></tr><tr><td class="NLM_term">pVHL</td><td class="NLM_def"><p class="first last">Hippel–Lindau tumor suppressor protein</p></td></tr><tr><td class="NLM_term">2-OG</td><td class="NLM_def"><p class="first last">2-oxoglutarate</p></td></tr><tr><td class="NLM_term">TRF</td><td class="NLM_def"><p class="first last">transferrin</p></td></tr><tr><td class="NLM_term">DMT1</td><td class="NLM_def"><p class="first last">divalent metal transporter 1</p></td></tr><tr><td class="NLM_term">Dcytb</td><td class="NLM_def"><p class="first last">duodenal cytochrome <i>b</i></p></td></tr><tr><td class="NLM_term">TRFR</td><td class="NLM_def"><p class="first last">transferrin receptor</p></td></tr><tr><td class="NLM_term">VEGF</td><td class="NLM_def"><p class="first last">vascular endothelial growth factor</p></td></tr><tr><td class="NLM_term">NOG</td><td class="NLM_def"><p class="first last"><i>N</i>-oxalylglycine</p></td></tr><tr><td class="NLM_term">DMOG</td><td class="NLM_def"><p class="first last">dimethyloxalylglycine</p></td></tr><tr><td class="NLM_term">IBD</td><td class="NLM_def"><p class="first last">inflammatory bowel disease</p></td></tr><tr><td class="NLM_term">GM-CSF</td><td class="NLM_def"><p class="first last">granulocyte-macrophage colony-stimulating factor</p></td></tr><tr><td class="NLM_term">VEGFR-1</td><td class="NLM_def"><p class="first last">vascular endothelial growth factor receptor-1</p></td></tr><tr><td class="NLM_term">sVEGFR-1</td><td class="NLM_def"><p class="first last">suppressor of vascular endothelial growth factor receptor-1</p></td></tr><tr><td class="NLM_term">IC<sub>50</sub></td><td class="NLM_def"><p class="first last">half-maximal inhibitory concentration</p></td></tr><tr><td class="NLM_term">EC<sub>50</sub></td><td class="NLM_def"><p class="first last">half-maximal effective concentration</p></td></tr><tr><td class="NLM_term">CP4H</td><td class="NLM_def"><p class="first last">collagen prolyl hydroxylase</p></td></tr><tr><td class="NLM_term">FIH</td><td class="NLM_def"><p class="first last">factor inhibiting HIF</p></td></tr><tr><td class="NLM_term">HTS</td><td class="NLM_def"><p class="first last">high throughput screening</p></td></tr><tr><td class="NLM_term">HTRF</td><td class="NLM_def"><p class="first last">homogeneous time resolved fluorescence</p></td></tr><tr><td class="NLM_term">hERG</td><td class="NLM_def"><p class="first last">human ether-a-go-go-related gene</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetic</p></td></tr><tr><td class="NLM_term">PCV</td><td class="NLM_def"><p class="first last">packed cell volume</p></td></tr><tr><td class="NLM_term">rhEPO</td><td class="NLM_def"><p class="first last">human recombinant erythropoietin</p></td></tr><tr><td class="NLM_term">LDH</td><td class="NLM_def"><p class="first last">lactate dehydrogenase</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">PAMPA</td><td class="NLM_def"><p class="first last">parallel artificial membrane permeability assay</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">MDR</td><td class="NLM_def"><p class="first last">multidrug resistance protein</p></td></tr><tr><td class="NLM_term">FDA</td><td class="NLM_def"><p class="first last">U.S. Food and Drug Administration</p></td></tr><tr><td class="NLM_term">BIW</td><td class="NLM_def"><p class="first last">twice weekly</p></td></tr><tr><td class="NLM_term">TIW</td><td class="NLM_def"><p class="first last">three times weekly</p></td></tr><tr><td class="NLM_term">ESRD</td><td class="NLM_def"><p class="first last">end stage renal disease</p></td></tr><tr><td class="NLM_term">ND-CKD</td><td class="NLM_def"><p class="first last">nondialysis dependent chronic kidney disease</p></td></tr><tr><td class="NLM_term">HD</td><td class="NLM_def"><p class="first last">hemodialysis</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53405" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53405" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 139 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smith, R. E.,  Jr.</span></span> <span> </span><span class="NLM_article-title">The clinical and economic burden of anemia</span>. <i>Am. J. Manag. Care</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">S59</span>– <span class="NLM_lpage">S66</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=20297873" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2010&pages=S59-S66&author=R.+E.+Smith&title=The+clinical+and+economic+burden+of+anemia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DR.%2BE.%26atitle%3DThe%2520clinical%2520and%2520economic%2520burden%2520of%2520anemia%26jtitle%3DAm.%2520J.%2520Manag.%2520Care%26date%3D2010%26volume%3D16%26spage%3DS59%26epage%3DS66" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">West, C. E.</span></span> <span> </span><span class="NLM_article-title">Strategies to control nutritional anemia</span>. <i>Am. J. Clin. Nutr.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">789</span>– <span class="NLM_lpage">790</span>, <span class="refDoi"> DOI: 10.1093/ajcn/64.5.789</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1093%2Fajcn%2F64.5.789" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=8901803" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=1%3ACAS%3A280%3ADyaK2s%252FlslCltg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=1996&pages=789-790&author=C.+E.+West&title=Strategies+to+control+nutritional+anemia&doi=10.1093%2Fajcn%2F64.5.789"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Strategies to control nutritional anemia</span></div><div class="casAuthors">West C E</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of clinical nutrition</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">789-90</span>
        ISSN:<span class="NLM_cas:issn">0002-9165</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQTTaj7VO7kTpHZzFRCXxVKfW6udTcc2eZeOik7q6cnWLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2s%252FlslCltg%253D%253D&md5=c222ed1160937e62c4b1d70f86b838d0</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1093%2Fajcn%2F64.5.789&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fajcn%252F64.5.789%26sid%3Dliteratum%253Aachs%26aulast%3DWest%26aufirst%3DC.%2BE.%26atitle%3DStrategies%2520to%2520control%2520nutritional%2520anemia%26jtitle%3DAm.%2520J.%2520Clin.%2520Nutr.%26date%3D1996%26volume%3D64%26spage%3D789%26epage%3D790%26doi%3D10.1093%2Fajcn%2F64.5.789" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haines, D.</span></span> <span> </span><span class="NLM_article-title">Clinical management of patients with thalassemia syndromes</span>. <i>Clin. J. Oncol. Nurs.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">310</span>– <span class="NLM_lpage">317</span>, <span class="refDoi"> DOI: 10.1188/16.CJON.310-317</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1188%2F16.CJON.310-317" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=27206298" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=1%3ACAS%3A280%3ADC%252BC2s%252FitVersA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2016&pages=310-317&author=M.+Martinauthor=D.+Haines&title=Clinical+management+of+patients+with+thalassemia+syndromes&doi=10.1188%2F16.CJON.310-317"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical Management of Patients With Thalassemia Syndromes</span></div><div class="casAuthors">Martin Marie; Haines Drucilla</div><div class="citationInfo"><span class="NLM_cas:title">Clinical journal of oncology nursing</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">310-7</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Thalassemia is a chronic inherited blood disorder that reduces hemoglobin production, causing chronic hemolytic anemia.  Patients often are diagnosed via newborn screening programs.  Patients diagnosed with the most severe form of thalassemia often require chronic red blood cell transfusions to control their anemia.  The side effect of chronic transfusions is cumulative iron overload for which chelation therapy is required.  The incidence of thalassemia is low; therefore, care is best delivered at specialized treatment centers that offer multidisciplinary coordination.  OBJECTIVES:  This article reviews the diagnosis, management, and curative options for thalassemia.  METHODS:  This review follows a hypothetical patient with thalassemia and his family through the major stages of the disease.  FINDINGS:  Increasing knowledge about thalassemia and its management among healthcare providers can improve patient outcomes and quality of life.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQGyO0rO3dB09yzdcP07UmufW6udTcc2ebaSkq5IZye2Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s%252FitVersA%253D%253D&md5=e2150496666740757f9cb805e4f5e058</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1188%2F16.CJON.310-317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1188%252F16.CJON.310-317%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DM.%26aulast%3DHaines%26aufirst%3DD.%26atitle%3DClinical%2520management%2520of%2520patients%2520with%2520thalassemia%2520syndromes%26jtitle%3DClin.%2520J.%2520Oncol.%2520Nurs.%26date%3D2016%26volume%3D20%26spage%3D310%26epage%3D317%26doi%3D10.1188%2F16.CJON.310-317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Babitt, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, H. Y.</span></span> <span> </span><span class="NLM_article-title">Mechanisms of anemia in CKD</span>. <i>J. Am. Soc. Nephrol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">1631</span>– <span class="NLM_lpage">1634</span>, <span class="refDoi"> DOI: 10.1681/ASN.2011111078</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1681%2FASN.2011111078" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=22935483" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1SqtrbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2012&pages=1631-1634&author=J.+L.+Babittauthor=H.+Y.+Lin&title=Mechanisms+of+anemia+in+CKD&doi=10.1681%2FASN.2011111078"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of anemia in CKD</span></div><div class="casAuthors">Babitt, Jodie L.; Lin, Herbert Y.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Society of Nephrology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1631-1634</span>CODEN:
                <span class="NLM_cas:coden">JASNEU</span>;
        ISSN:<span class="NLM_cas:issn">1046-6673</span>.
    
            (<span class="NLM_cas:orgname">American Society of Nephrology</span>)
        </div><div class="casAbstract">A review.  Anemia is a common feature of CKD assocd. with poor outcomes.  The current management of patients with anemia in CKD is controversial, with recent clin. trials demonstrating increased morbidity and mortality related to erythropoiesis stimulating agents.  Here, we examine recent insights into the mol. mechanisms underlying anemia of CKD.  These insights hold promise for the development of new diagnostic tests and therapies that directly target the pathophysiol. processes underlying this form of anemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHLv6v984Sy7Vg90H21EOLACvtfcHk0lg8u9-t9Oj0Sw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1SqtrbI&md5=61eb06e56feaca437b459809fb007ed3</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1681%2FASN.2011111078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1681%252FASN.2011111078%26sid%3Dliteratum%253Aachs%26aulast%3DBabitt%26aufirst%3DJ.%2BL.%26aulast%3DLin%26aufirst%3DH.%2BY.%26atitle%3DMechanisms%2520of%2520anemia%2520in%2520CKD%26jtitle%3DJ.%2520Am.%2520Soc.%2520Nephrol.%26date%3D2012%26volume%3D23%26spage%3D1631%26epage%3D1634%26doi%3D10.1681%2FASN.2011111078" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eschbach, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egrie, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Downing, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Browne, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adamson, J. W.</span></span> <span> </span><span class="NLM_article-title">Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>316</i></span>,  <span class="NLM_fpage">73</span>– <span class="NLM_lpage">78</span>, <span class="refDoi"> DOI: 10.1056/NEJM198701083160203</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1056%2FNEJM198701083160203" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=3537801" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=1%3ACAS%3A280%3ADyaL2s%252FmsFSjsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=316&publication_year=1987&pages=73-78&author=J.+W.+Eschbachauthor=J.+C.+Egrieauthor=M.+R.+Downingauthor=J.+K.+Browneauthor=J.+W.+Adamson&title=Correction+of+the+anemia+of+end-stage+renal+disease+with+recombinant+human+erythropoietin.+Results+of+a+combined+phase+I+and+II+clinical+trial&doi=10.1056%2FNEJM198701083160203"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial</span></div><div class="casAuthors">Eschbach J W; Egrie J C; Downing M R; Browne J K; Adamson J W</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">316</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">73-8</span>
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    </div><div class="casAbstract">We administered recombinant human erythropoietin to 25 anemic patients with end-stage renal disease who were undergoing hemodialysis.  The recombinant human erythropoietin was given intravenously three times weekly after dialysis, and transfusion requirements, hematocrit, ferrokinetics, and reticulocyte responses were monitored.  Over a range of doses between 15 and 500 units per kilogram of body weight, dose-dependent increases in effective erythropoiesis were noted.  At 500 units per kilogram, changes in the hematocrit of as much as 10 percentage points were seen within three weeks, and increases in ferrokinetics of three to four times basal values, as measured by erythron transferrin uptake, were observed.  Of 18 patients receiving effective doses of recombinant human erythropoietin, 12 who had required transfusions no longer needed them, and in 11 the hematocrit increased to 35 percent or more.  Along with the rise in hematocrit, four patients had an increase in blood pressure, and a majority had increases in serum creatinine and potassium levels.  No organ dysfunction or other toxic effects were observed, and no antibodies to the recombinant hormone were formed.  These results demonstrate that recombinant human erythropoietin is effective, can eliminate the need for transfusions with their risks of immunologic sensitization, infection, and iron overload, and can restore the hematocrit to normal in many patients with the anemia of end-stage renal disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTXnooNhxprRmmbXvSEQle5fW6udTcc2ebaSkq5IZye2Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL2s%252FmsFSjsw%253D%253D&md5=0133a0923268a2aa5d3fcf0e1305c4e3</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1056%2FNEJM198701083160203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM198701083160203%26sid%3Dliteratum%253Aachs%26aulast%3DEschbach%26aufirst%3DJ.%2BW.%26aulast%3DEgrie%26aufirst%3DJ.%2BC.%26aulast%3DDowning%26aufirst%3DM.%2BR.%26aulast%3DBrowne%26aufirst%3DJ.%2BK.%26aulast%3DAdamson%26aufirst%3DJ.%2BW.%26atitle%3DCorrection%2520of%2520the%2520anemia%2520of%2520end-stage%2520renal%2520disease%2520with%2520recombinant%2520human%2520erythropoietin.%2520Results%2520of%2520a%2520combined%2520phase%2520I%2520and%2520II%2520clinical%2520trial%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1987%26volume%3D316%26spage%3D73%26epage%3D78%26doi%3D10.1056%2FNEJM198701083160203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Skali, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parving, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parfrey, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burdmann, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ivanovich, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keithi-Reddy, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGill, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMurray, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solomon, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uno, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfeffer, M. A.</span></span> <span> </span><span class="NLM_article-title">Stroke in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia treated with Darbepoetin Alfa: the trial to reduce cardiovascular events with Aranesp therapy (TREAT) experience</span>. <i>Circulation</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>124</i></span>,  <span class="NLM_fpage">2903</span>– <span class="NLM_lpage">2908</span>, <span class="refDoi"> DOI: 10.1161/CIRCULATIONAHA.111.030411</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1161%2FCIRCULATIONAHA.111.030411" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2011&pages=2903-2908&author=H.+Skaliauthor=H.+H.+Parvingauthor=P.+S.+Parfreyauthor=E.+A.+Burdmannauthor=E.+F.+Lewisauthor=P.+Ivanovichauthor=S.+R.+Keithi-Reddyauthor=J.+B.+McGillauthor=J.+J.+McMurrayauthor=A.+K.+Singhauthor=S.+D.+Solomonauthor=H.+Unoauthor=M.+A.+Pfeffer&title=Stroke+in+patients+with+type+2+diabetes+mellitus%2C+chronic+kidney+disease%2C+and+anemia+treated+with+Darbepoetin+Alfa%3A+the+trial+to+reduce+cardiovascular+events+with+Aranesp+therapy+%28TREAT%29+experience&doi=10.1161%2FCIRCULATIONAHA.111.030411"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1161%2FCIRCULATIONAHA.111.030411&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIRCULATIONAHA.111.030411%26sid%3Dliteratum%253Aachs%26aulast%3DSkali%26aufirst%3DH.%26aulast%3DParving%26aufirst%3DH.%2BH.%26aulast%3DParfrey%26aufirst%3DP.%2BS.%26aulast%3DBurdmann%26aufirst%3DE.%2BA.%26aulast%3DLewis%26aufirst%3DE.%2BF.%26aulast%3DIvanovich%26aufirst%3DP.%26aulast%3DKeithi-Reddy%26aufirst%3DS.%2BR.%26aulast%3DMcGill%26aufirst%3DJ.%2BB.%26aulast%3DMcMurray%26aufirst%3DJ.%2BJ.%26aulast%3DSingh%26aufirst%3DA.%2BK.%26aulast%3DSolomon%26aufirst%3DS.%2BD.%26aulast%3DUno%26aufirst%3DH.%26aulast%3DPfeffer%26aufirst%3DM.%2BA.%26atitle%3DStroke%2520in%2520patients%2520with%2520type%25202%2520diabetes%2520mellitus%252C%2520chronic%2520kidney%2520disease%252C%2520and%2520anemia%2520treated%2520with%2520Darbepoetin%2520Alfa%253A%2520the%2520trial%2520to%2520reduce%2520cardiovascular%2520events%2520with%2520Aranesp%2520therapy%2520%2528TREAT%2529%2520experience%26jtitle%3DCirculation%26date%3D2011%26volume%3D124%26spage%3D2903%26epage%3D2908%26doi%3D10.1161%2FCIRCULATIONAHA.111.030411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraut, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samaras, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">West, D. P.</span></span> <span> </span><span class="NLM_article-title">Intersecting guidelines: administering erythropoiesis-stimulating agents to chronic kidney disease patients with cancer</span>. <i>Semin. Dial.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">4</span>, <span class="refDoi"> DOI: 10.1111/j.1525-139X.2008.00524.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1111%2Fj.1525-139X.2008.00524.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=19175532" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=1%3ACAS%3A280%3ADC%252BD1M7ntl2ltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2009&pages=1-4&author=C.+L.+Bennettauthor=P.+S.+Beckerauthor=E.+H.+Krautauthor=A.+T.+Samarasauthor=D.+P.+West&title=Intersecting+guidelines%3A+administering+erythropoiesis-stimulating+agents+to+chronic+kidney+disease+patients+with+cancer&doi=10.1111%2Fj.1525-139X.2008.00524.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Intersecting guidelines: administering erythropoiesis-stimulating agents to chronic kidney disease patients with cancer</span></div><div class="casAuthors">Bennett Charles L; Becker Pamela S; Kraut Eric H; Samaras Athena T; West Dennis P</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in dialysis</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-4</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">There has been a dramatic sea change in the use of erythropoiesis-stimulating agents (ESAs) for anemic persons with chronic kidney disease (CKD) or cancer patients undergoing chemotherapy.  An important area that has not been addressed previously is a CKD patient who also has a malignancy.  Clinical guidelines exist that outline recommended treatments for each disease, but the intersection of the two disease processes presents difficult decisions for patients and physicians.  Herein, we review the background underlying recent revisions in clinical alerts and guidelines for ESAs, and provide guidance for treating anemia among CKD patients who are receiving no therapy, chemotherapy with curative intent, or chemotherapy with palliative intent.  The guiding principle is that comprehensive assessment of risks and benefits in the relevant clinical setting is imperative.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRmLOr97pz6HBJ5E29YNGvQfW6udTcc2eYigYbRLtOJ8Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M7ntl2ltw%253D%253D&md5=bdb7646c345f63999ff2a3c1673874c7</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1111%2Fj.1525-139X.2008.00524.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1525-139X.2008.00524.x%26sid%3Dliteratum%253Aachs%26aulast%3DBennett%26aufirst%3DC.%2BL.%26aulast%3DBecker%26aufirst%3DP.%2BS.%26aulast%3DKraut%26aufirst%3DE.%2BH.%26aulast%3DSamaras%26aufirst%3DA.%2BT.%26aulast%3DWest%26aufirst%3DD.%2BP.%26atitle%3DIntersecting%2520guidelines%253A%2520administering%2520erythropoiesis-stimulating%2520agents%2520to%2520chronic%2520kidney%2520disease%2520patients%2520with%2520cancer%26jtitle%3DSemin.%2520Dial.%26date%3D2009%26volume%3D22%26spage%3D1%26epage%3D4%26doi%3D10.1111%2Fj.1525-139X.2008.00524.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zaritsky, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westerman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olbina, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nemeth, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivera, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nissenson, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salusky, I. B.</span></span> <span> </span><span class="NLM_article-title">Hepcidin--a potential novel biomarker for iron status in chronic kidney disease</span>. <i>Clin. J. Am. Soc. Nephrol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">1051</span>– <span class="NLM_lpage">1056</span>, <span class="refDoi"> DOI: 10.2215/CJN.05931108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.2215%2FCJN.05931108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=19406957" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnsF2rtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=1051-1056&author=J.+Zaritskyauthor=B.+Youngauthor=H.+J.+Wangauthor=M.+Westermanauthor=G.+Olbinaauthor=E.+Nemethauthor=T.+Ganzauthor=S.+Riveraauthor=A.+R.+Nissensonauthor=I.+B.+Salusky&title=Hepcidin%2D%2Da+potential+novel+biomarker+for+iron+status+in+chronic+kidney+disease&doi=10.2215%2FCJN.05931108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Hepcidin-A potential novel biomarker for iron status in chronic kidney disease</span></div><div class="casAuthors">Zaritsky, Joshua; Young, Brian; Wang, He-Jing; Westerman, Mark; Olbina, Gordana; Nemeth, Elizabeta; Ganz, Tomas; Rivera, Seth; Nissenson, Allen R.; Salusky, Isidro B.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Journal of the American Society of Nephrology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1051-1056</span>CODEN:
                <span class="NLM_cas:coden">CJASC7</span>;
        ISSN:<span class="NLM_cas:issn">1555-9041</span>.
    
            (<span class="NLM_cas:orgname">American Society of Nephrology</span>)
        </div><div class="casAbstract">Hepcidin is a key regulator of iron homeostasis, but its study in the setting of chronic kidney disease (CKD) has been hampered by the lack of validated serum assays.  This study reports the first measurements of bioactive serum hepcidin using a novel competitive ELISA in 48 pediatric (PCKD2-4) and 32 adult (ACKD2-4) patients with stages 2 to 4 CKD along with 26 pediatric patients with stage 5 CKD (PCKD5D) on peritoneal dialysis.  When compared with their resp. controls (pediatric median = 25.3 ng/mL, adult = 72.9 ng/mL), hepcidin was significantly increased in PCKD2-4 (127.3 ng/mL), ACKD2-4 (269.9 ng/mL), and PCKD5D (652.4 ng/mL).  Multivariate regression anal. was used to assess the relationship between hepcidin and indicators of anemia, iron status, inflammation, and renal function.  In PCKD2-4 (R2 = 0.57), only ferritin correlated with hepcidin.  In ACKD2-4 (R2 = 0.78), ferritin and sol. transferrin receptor were assocd. with hepcidin, whereas GFR was inversely correlated.  In PCKD5D (R2 = 0.52), percent iron satn. and ferritin were predictors of hepcidin.  In a multivariate anal. that incorporated all three groups (R2 = 0.6), hepcidin was predicted by ferritin, C-reactive protein, and whether the patient had stage 5D vs. stages 2 to 4 CKD.  These findings suggest that increased hepcidin across the spectrum of CKD may contribute to abnormal iron regulation and erythropoiesis and may be a novel biomarker of iron status and erythropoietin resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrd-xo6YQbyF7Vg90H21EOLACvtfcHk0ljJWm3xJrjtFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnsF2rtbk%253D&md5=70e1413497a5a855c51cebd4e42b8570</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.2215%2FCJN.05931108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2215%252FCJN.05931108%26sid%3Dliteratum%253Aachs%26aulast%3DZaritsky%26aufirst%3DJ.%26aulast%3DYoung%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DH.%2BJ.%26aulast%3DWesterman%26aufirst%3DM.%26aulast%3DOlbina%26aufirst%3DG.%26aulast%3DNemeth%26aufirst%3DE.%26aulast%3DGanz%26aufirst%3DT.%26aulast%3DRivera%26aufirst%3DS.%26aulast%3DNissenson%26aufirst%3DA.%2BR.%26aulast%3DSalusky%26aufirst%3DI.%2BB.%26atitle%3DHepcidin--a%2520potential%2520novel%2520biomarker%2520for%2520iron%2520status%2520in%2520chronic%2520kidney%2520disease%26jtitle%3DClin.%2520J.%2520Am.%2520Soc.%2520Nephrol.%26date%3D2009%26volume%3D4%26spage%3D1051%26epage%3D1056%26doi%3D10.2215%2FCJN.05931108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tarng, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, W. C.</span></span> <span> </span><span class="NLM_article-title">Erythropoietin hyporesponsiveness: from iron deficiency to iron overload</span>. <i>Kidney Int.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">S107</span>– <span class="NLM_lpage">S118</span>, <span class="refDoi"> DOI: 10.1038/sj.ki.4490858</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1038%2Fsj.ki.4490858" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1999&pages=S107-S118&author=D.+C.+Tarngauthor=T.+P.+Huangauthor=T.+W.+Chenauthor=W.+C.+Yang&title=Erythropoietin+hyporesponsiveness%3A+from+iron+deficiency+to+iron+overload&doi=10.1038%2Fsj.ki.4490858"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fsj.ki.4490858&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.ki.4490858%26sid%3Dliteratum%253Aachs%26aulast%3DTarng%26aufirst%3DD.%2BC.%26aulast%3DHuang%26aufirst%3DT.%2BP.%26aulast%3DChen%26aufirst%3DT.%2BW.%26aulast%3DYang%26aufirst%3DW.%2BC.%26atitle%3DErythropoietin%2520hyporesponsiveness%253A%2520from%2520iron%2520deficiency%2520to%2520iron%2520overload%26jtitle%3DKidney%2520Int.%26date%3D1999%26volume%3D55%26spage%3DS107%26epage%3DS118%26doi%3D10.1038%2Fsj.ki.4490858" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Holdstock, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meadowcroft, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maier, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rastogi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeig, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lepore, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cobitz, A. R.</span></span> <span> </span><span class="NLM_article-title">Four-Week Studies of Oral Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor GSK1278863 for Treatment of Anemia</span>. <i>J. Am. Soc. Nephrol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>27</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1234</span>– <span class="NLM_lpage">1244</span>, <span class="refDoi"> DOI: 10.1681/ASN.2014111139</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1681%2FASN.2014111139" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=26494831" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=1%3ACAS%3A528%3ADC%252BC2sXptVeltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2016&pages=1234-1244&issue=4&author=L.+Holdstockauthor=A.+M.+Meadowcroftauthor=R.+Maierauthor=B.+M.+Johnsonauthor=D.+Jonesauthor=A.+Rastogiauthor=S.+Zeigauthor=J.+J.+Leporeauthor=A.+R.+Cobitz&title=Four-Week+Studies+of+Oral+Hypoxia-Inducible+Factor-Prolyl+Hydroxylase+Inhibitor+GSK1278863+for+Treatment+of+Anemia&doi=10.1681%2FASN.2014111139"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Four-week studies of oral hypoxia-inducible factor-prolyl hydroxylase inhibitor GSK1278863 for treatment of anemia</span></div><div class="casAuthors">Holdstock, Louis; Meadowcroft, Amy M.; Maier, Rayma; Johnson, Brendan M.; Jones, Delyth; Rastogi, Anjay; Zeig, Steven; Lepore, John J.; Cobitz, Alexander R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Society of Nephrology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1234-1244</span>CODEN:
                <span class="NLM_cas:coden">JASNEU</span>;
        ISSN:<span class="NLM_cas:issn">1046-6673</span>.
    
            (<span class="NLM_cas:orgname">American Society of Nephrology</span>)
        </div><div class="casAbstract">Hypoxia-inducible factor prolyl hydroxylase inhibitors stabilize levels of hypoxia-inducible factor that upregulate transcription of multiple genes assocd. with the response to hypoxia, including prodn. of erythropoietin.  We conducted two phase 2a studies to explore the relationship between the dose of the hypoxia-inducible factor-prolyl hydroxylase inhibitor GSK1278863 and Hb response in patients with anemia of CKD (baseline Hb 8.5-11.0 g/dL) not undergoing dialysis and not receiving recombinant human erythropoietin (nondialysis study) and in patients with anemia of CKD (baseline Hb 9.5-12.0 g/dL) on hemodialysis and being treated with stable doses of recombinant human erythropoietin (hemodialysis study).  Participants were randomized 1:1:1:1 to a once-daily oral dose of GSK1278863 (0.5 mg, 2 mg, or 5 mg) or control (placebo for the nondialysis study; continuing on recombinant human erythropoietin for the hemodialysis study) for 4 wk, with a 2-wk follow-up.  In the nondialysis study, GSK1278863 produced dose-dependent effects on Hb, with the highest dose resulting in a mean increase of 1 g/dL at week 4.  In the hemodialysis study, treatment with GSK1278863 in the 5-mg arm maintained mean Hb concns. after the switch from recombinant human erythropoietin, whereas mean Hb decreased in the lower-dose arms.  In both studies, the effects on Hb occurred with elevations in endogenous erythropoietin within the range usually obsd. in the resp. populations and markedly lower than those in the recombinant human erythropoietin control arm in the hemodialysis study, and without clin. significant elevations in plasma vascular endothelial growth factor concns.  GSK1278863 was generally safe and well tolerated at the doses and duration studied.  GSK1278863 may prove an effective alternative for managing anemia of CKD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVJzuvw1x6JbVg90H21EOLACvtfcHk0ljJWm3xJrjtFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXptVeltA%253D%253D&md5=e105ac25308286d9b4512285920cc032</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1681%2FASN.2014111139&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1681%252FASN.2014111139%26sid%3Dliteratum%253Aachs%26aulast%3DHoldstock%26aufirst%3DL.%26aulast%3DMeadowcroft%26aufirst%3DA.%2BM.%26aulast%3DMaier%26aufirst%3DR.%26aulast%3DJohnson%26aufirst%3DB.%2BM.%26aulast%3DJones%26aufirst%3DD.%26aulast%3DRastogi%26aufirst%3DA.%26aulast%3DZeig%26aufirst%3DS.%26aulast%3DLepore%26aufirst%3DJ.%2BJ.%26aulast%3DCobitz%26aufirst%3DA.%2BR.%26atitle%3DFour-Week%2520Studies%2520of%2520Oral%2520Hypoxia-Inducible%2520Factor-Prolyl%2520Hydroxylase%2520Inhibitor%2520GSK1278863%2520for%2520Treatment%2520of%2520Anemia%26jtitle%3DJ.%2520Am.%2520Soc.%2520Nephrol.%26date%3D2016%26volume%3D27%26issue%3D4%26spage%3D1234%26epage%3D1244%26doi%3D10.1681%2FASN.2014111139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Koury, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bondurant, M. C.</span></span> <span> </span><span class="NLM_article-title">The mechanism of erythropoietin action</span>. <i>Am. J. Kidney Dis.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">4 Suppl 1</span>),  <span class="NLM_fpage">20</span>– <span class="NLM_lpage">23</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=1656733" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=1%3ACAS%3A528%3ADyaK38XhsFymsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1991&pages=20-23&issue=4+Suppl+1&author=M.+J.+Kouryauthor=M.+C.+Bondurant&title=The+mechanism+of+erythropoietin+action"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">The mechanism of erythropoietin action</span></div><div class="casAuthors">Koury, Mark J.; Bondurant, Maurice C.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Kidney Diseases</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">4, Suppl. 1</span>),
    <span class="NLM_cas:pages">20-3</span>CODEN:
                <span class="NLM_cas:coden">AJKDDP</span>;
        ISSN:<span class="NLM_cas:issn">0272-6386</span>.
    </div><div class="casAbstract">A review, with 24 refs., on the mechanism of erythropoietin action with emphasis on its effects on target cells (committed erythroid progenitor cells), and its control of red blood cell prodn. (mainly by preventing programmed cell death).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoK3AHSyqD5X7Vg90H21EOLACvtfcHk0lh-RvGymMv3lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XhsFymsw%253D%253D&md5=964b05daee82342aca6c36099ee7b4a5</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKoury%26aufirst%3DM.%2BJ.%26aulast%3DBondurant%26aufirst%3DM.%2BC.%26atitle%3DThe%2520mechanism%2520of%2520erythropoietin%2520action%26jtitle%3DAm.%2520J.%2520Kidney%2520Dis.%26date%3D1991%26volume%3D18%26issue%3D4%2520Suppl%25201%26spage%3D20%26epage%3D23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Willekens, F. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Werre, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groenen-Döpp, Y.
A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roerdinkholder-Stoelwinder, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Pauw, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bosman, G. J.</span></span> <span> </span><span class="NLM_article-title">Erythrocyte vesiculation: a self-protective mechanism?</span>. <i>Br. J. Haematol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>141</i></span>,  <span class="NLM_fpage">549</span>– <span class="NLM_lpage">556</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2141.2008.07055.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1111%2Fj.1365-2141.2008.07055.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=18419623" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnt1eisbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=141&publication_year=2008&pages=549-556&author=F.+L.+Willekensauthor=J.+M.+Werreauthor=Y.%0AA.+Groenen-D%C3%B6ppauthor=B.+Roerdinkholder-Stoelwinderauthor=B.+De+Pauwauthor=G.+J.+Bosman&title=Erythrocyte+vesiculation%3A+a+self-protective+mechanism%3F&doi=10.1111%2Fj.1365-2141.2008.07055.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Erythrocyte vesiculation: a self-protective mechanism?</span></div><div class="casAuthors">Willekens, Frans L. A.; Werre, Jan M.; Groenen-Doepp, Yvonne A. M.; Roerdinkholder-Stoelwinder, Bregt; de Pauw, Ben; Bosman, Giel J. C. G. M.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Haematology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">141</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">549-556</span>CODEN:
                <span class="NLM_cas:coden">BJHEAL</span>;
        ISSN:<span class="NLM_cas:issn">0007-1048</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Previous studies demonstrated that 20% of Hb is lost from circulating erythrocytes during their total lifespan by vesiculation.  To study whether removal mols. other than membrane-bound Hb were present in erythrocyte-derived vesicles, flow cytometry and immunoblot anal. were employed to examine the presence of phosphatidylserine (PS) and IgG, and senescent cell antigens resp.  It was demonstrated that 67% of glycophorin A-pos. vesicles exposed PS, and that half of these vesicles also contained IgG.  Immunoblot anal. revealed the presence of a breakdown product of band 3 that reacted with antibodies directed against senescent erythrocyte antigen-assocd. band 3 sequences.  In contrast, only the oldest erythrocytes contained senescent cell antigens and IgG, and only 0.1% of erythrocytes, of all ages, exposed PS.  It was concluded that vesiculation constitutes a mechanism for the removal of erythrocyte membrane patches contg. removal mols., thereby postponing the untimely elimination of otherwise healthy erythrocytes.  Consequently, these same removal mols. mediate the rapid removal of erythrocyte-derived vesicles from the circulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpai9cuG9I_7bVg90H21EOLACvtfcHk0lh-RvGymMv3lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnt1eisbs%253D&md5=6b2c58d6179a4ddd0cb2f0c78aa371ca</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2141.2008.07055.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2141.2008.07055.x%26sid%3Dliteratum%253Aachs%26aulast%3DWillekens%26aufirst%3DF.%2BL.%26aulast%3DWerre%26aufirst%3DJ.%2BM.%26aulast%3DGroenen-D%25C3%25B6pp%26aufirst%3DY.%2BA.%26aulast%3DRoerdinkholder-Stoelwinder%26aufirst%3DB.%26aulast%3DDe%2BPauw%26aufirst%3DB.%26aulast%3DBosman%26aufirst%3DG.%2BJ.%26atitle%3DErythrocyte%2520vesiculation%253A%2520a%2520self-protective%2520mechanism%253F%26jtitle%3DBr.%2520J.%2520Haematol.%26date%3D2008%26volume%3D141%26spage%3D549%26epage%3D556%26doi%3D10.1111%2Fj.1365-2141.2008.07055.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Constantinescu, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lodish, H. F.</span></span> <span> </span><span class="NLM_article-title">The N-terminal domain of janus kinase 2 is required for golgi processing and cell surface expression of erythropoietin receptor</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1327</span>– <span class="NLM_lpage">1338</span>, <span class="refDoi"> DOI: 10.1016/S1097-2765(01)00401-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1016%2FS1097-2765%2801%2900401-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2001&pages=1327-1338&author=L.+J.+Huangauthor=S.+N.+Constantinescuauthor=H.+F.+Lodish&title=The+N-terminal+domain+of+janus+kinase+2+is+required+for+golgi+processing+and+cell+surface+expression+of+erythropoietin+receptor&doi=10.1016%2FS1097-2765%2801%2900401-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2FS1097-2765%2801%2900401-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1097-2765%252801%252900401-4%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DL.%2BJ.%26aulast%3DConstantinescu%26aufirst%3DS.%2BN.%26aulast%3DLodish%26aufirst%3DH.%2BF.%26atitle%3DThe%2520N-terminal%2520domain%2520of%2520janus%2520kinase%25202%2520is%2520required%2520for%2520golgi%2520processing%2520and%2520cell%2520surface%2520expression%2520of%2520erythropoietin%2520receptor%26jtitle%3DMol.%2520Cell%26date%3D2001%26volume%3D8%26spage%3D1327%26epage%3D1338%26doi%3D10.1016%2FS1097-2765%2801%2900401-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Richmond, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chohan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barber, D. L.</span></span> <span> </span><span class="NLM_article-title">Turning cells red: signal transduction mediated by erythropoietin</span>. <i>Trends Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">146</span>– <span class="NLM_lpage">155</span>, <span class="refDoi"> DOI: 10.1016/j.tcb.2005.01.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1016%2Fj.tcb.2005.01.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=15752978" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitVeit78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=146-155&author=T.+D.+Richmondauthor=M.+Chohanauthor=D.+L.+Barber&title=Turning+cells+red%3A+signal+transduction+mediated+by+erythropoietin&doi=10.1016%2Fj.tcb.2005.01.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Turning cells red: signal transduction mediated by erythropoietin</span></div><div class="casAuthors">Richmond, Terri D.; Chohan, Manprit; Barber, Dwayne L.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Cell Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">146-155</span>CODEN:
                <span class="NLM_cas:coden">TCBIEK</span>;
        ISSN:<span class="NLM_cas:issn">0962-8924</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Erythropoietin (EPO) is the crucial cytokine regulator of red blood-cell prodn.  Since the discovery of EPO in 1985 and the isolation of its cognate receptor four years later, there has been significant interest in understanding the unique ability of this ligand-receptor pair to promote erythroid mitogenesis, survival and differentiation.  The development of knockout mice has elucidated the precise role of the ligand, receptor and downstream players in murine erythroid development.  In this review, we summarize EPO-mediated signaling pathways and examine their significance in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqC0ZGqvvOp9bVg90H21EOLACvtfcHk0lh-RvGymMv3lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitVeit78%253D&md5=e2dc801d032c6f080da38e83507cb265</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.tcb.2005.01.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tcb.2005.01.007%26sid%3Dliteratum%253Aachs%26aulast%3DRichmond%26aufirst%3DT.%2BD.%26aulast%3DChohan%26aufirst%3DM.%26aulast%3DBarber%26aufirst%3DD.%2BL.%26atitle%3DTurning%2520cells%2520red%253A%2520signal%2520transduction%2520mediated%2520by%2520erythropoietin%26jtitle%3DTrends%2520Cell%2520Biol.%26date%3D2005%26volume%3D15%26spage%3D146%26epage%3D155%26doi%3D10.1016%2Fj.tcb.2005.01.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De
Maria, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Testa, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luchetti, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeuner, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stassi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelosi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riccioni, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felli, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samoggia, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peschle, C.</span></span> <span> </span><span class="NLM_article-title">Apoptotic role of Fas/Fas ligand system in the regulation of erythropoiesis</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>93</i></span>,  <span class="NLM_fpage">796</span>– <span class="NLM_lpage">803</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1999&pages=796-803&author=R.+De%0AMariaauthor=U.+Testaauthor=L.+Luchettiauthor=A.+Zeunerauthor=G.+Stassiauthor=E.+Pelosiauthor=R.+Riccioniauthor=N.+Felliauthor=P.+Samoggiaauthor=C.+Peschle&title=Apoptotic+role+of+Fas%2FFas+ligand+system+in+the+regulation+of+erythropoiesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BMaria%26aufirst%3DR.%26aulast%3DTesta%26aufirst%3DU.%26aulast%3DLuchetti%26aufirst%3DL.%26aulast%3DZeuner%26aufirst%3DA.%26aulast%3DStassi%26aufirst%3DG.%26aulast%3DPelosi%26aufirst%3DE.%26aulast%3DRiccioni%26aufirst%3DR.%26aulast%3DFelli%26aufirst%3DN.%26aulast%3DSamoggia%26aufirst%3DP.%26aulast%3DPeschle%26aufirst%3DC.%26atitle%3DApoptotic%2520role%2520of%2520Fas%252FFas%2520ligand%2520system%2520in%2520the%2520regulation%2520of%2520erythropoiesis%26jtitle%3DBlood%26date%3D1999%26volume%3D93%26spage%3D796%26epage%3D803" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sebastiani, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pantopoulos, K.</span></span> <span> </span><span class="NLM_article-title">Pharmacological targeting of the hepcidin/ferroportin axis</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">160</span>, <span class="refDoi"> DOI: 10.3389/fphar.2016.00160</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.3389%2Ffphar.2016.00160" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=27445804" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsV2gtLbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=160&author=G.+Sebastianiauthor=N.+Wilkinsonauthor=K.+Pantopoulos&title=Pharmacological+targeting+of+the+hepcidin%2Fferroportin+axis&doi=10.3389%2Ffphar.2016.00160"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological targeting of the hepcidin/ferroportin axis</span></div><div class="casAuthors">Sebastiani, Giada; Wilkinson, Nicole; Pantopoulos, Kostas</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Pharmacology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">160/1-160/11</span>CODEN:
                <span class="NLM_cas:coden">FPRHAU</span>;
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">The iron regulatory hormone hepcidin limits iron fluxes to the bloodstream by promoting degrdn. of the iron exporter ferroportin in target cells.  Hepcidin insufficiency causes hyperabsorption of dietary iron, hyperferremia and tissue iron overload, which are hallmarks of hereditary hemochromatosis.  Similar responses are also obsd. in iron-loading anemias due to ineffective erythropoiesis (such as thalassemias, dyserythropoietic anemias and myelodysplastic syndromes) and in chronic liver diseases.  On the other hand, excessive hepcidin expression inhibits dietary iron absorption and leads to hypoferremia and iron retention within tissue macrophages.  This reduces iron availability for erythroblasts and contributes to the development of anemias with iron-restricted erythropoiesis (such as anemia of chronic disease and iron-refractory iron-deficiency anemia).  Pharmacol. targeting of the hepcidin/ferroportin axis may offer considerable therapeutic benefits by correcting iron traffic.  This review summarizes the principles underlying the development of hepcidin-based therapies for the treatment of iron-related disorders, and discusses the emerging strategies for manipulating hepcidin pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpovZjDSpbqLLVg90H21EOLACvtfcHk0ljvSKzage2WHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsV2gtLbJ&md5=da5e0178edf870b1ec304a7203e5ef96</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2016.00160&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2016.00160%26sid%3Dliteratum%253Aachs%26aulast%3DSebastiani%26aufirst%3DG.%26aulast%3DWilkinson%26aufirst%3DN.%26aulast%3DPantopoulos%26aufirst%3DK.%26atitle%3DPharmacological%2520targeting%2520of%2520the%2520hepcidin%252Fferroportin%2520axis%26jtitle%3DFront.%2520Pharmacol.%26date%3D2016%26volume%3D7%26spage%3D160%26doi%3D10.3389%2Ffphar.2016.00160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Semenza, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G. L.</span></span> <span> </span><span class="NLM_article-title">A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">5447</span>– <span class="NLM_lpage">5454</span>, <span class="refDoi"> DOI: 10.1128/MCB.12.12.5447</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1128%2FMCB.12.12.5447" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=1448077" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=1%3ACAS%3A528%3ADyaK3sXltFShsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1992&pages=5447-5454&author=G.+L.+Semenzaauthor=G.+L.+Wang&title=A+nuclear+factor+induced+by+hypoxia+via+de+novo+protein+synthesis+binds+to+the+human+erythropoietin+gene+enhancer+at+a+site+required+for+transcriptional+activation&doi=10.1128%2FMCB.12.12.5447"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation</span></div><div class="casAuthors">Semenza, Gregg L.; Wang, Guang L.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5447-54</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    </div><div class="casAbstract">A 50-nucleotide enhancer from the human erythropoietin gene 3'-flanking sequence was identified which can mediate a 7-fold transcriptional induction in response to hypoxia when cloned 3' to a simian virus 40 promoter-chloramphenicol acetyltransferase reporter gene and transiently expressed in Hep3B cells.  Nucleotides (nt) 1 to 33 of this sequence mediate 7-fold induction of reporter gene expression when present in 2 tandem copies compared with 3-fold induction when present in a single copy, suggesting that nt 34 to 50 bind a factor which amplifies the induction signal.  DNase I footprinting demonstrated binding of a constitutive nuclear factor to nt 26 to 48.  Mutagenesis studies revealed that nt 4 to 12 and 19 to 23 are essential for induction, as substitutions at either site eliminated hypoxia-induced expression.  Electrophoretic mobility shift assays identified a nuclear factor which bound to a probe spanning nt 1 to 18 but not to a probe contg. a mutation which eliminated enhancer function.  Factor binding was induced by hypoxia, and its induction was sensitive to cycloheximide treatment.  Thus, this is a functionally tripartite, 50-nt hypoxia-inducible enhancer which binds several nuclear factors, one of which is induced by hypoxia via de novo protein synthesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEJEpkpLpOV7Vg90H21EOLACvtfcHk0ljvSKzage2WHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXltFShsr0%253D&md5=672c5097c32e993177fd89f02223a20a</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1128%2FMCB.12.12.5447&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.12.12.5447%26sid%3Dliteratum%253Aachs%26aulast%3DSemenza%26aufirst%3DG.%2BL.%26aulast%3DWang%26aufirst%3DG.%2BL.%26atitle%3DA%2520nuclear%2520factor%2520induced%2520by%2520hypoxia%2520via%2520de%2520novo%2520protein%2520synthesis%2520binds%2520to%2520the%2520human%2520erythropoietin%2520gene%2520enhancer%2520at%2520a%2520site%2520required%2520for%2520transcriptional%2520activation%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D1992%26volume%3D12%26spage%3D5447%26epage%3D5454%26doi%3D10.1128%2FMCB.12.12.5447" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marxsen, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stengel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doege, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heikkinen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jokilehto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jelkmann, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaakkola, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metzen, E.</span></span> <span> </span><span class="NLM_article-title">Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by induction of HIF-α-prolyl-4-hydroxylases</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>381</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">761</span>– <span class="NLM_lpage">767</span>, <span class="refDoi"> DOI: 10.1042/BJ20040620</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1042%2FBJ20040620" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=381&publication_year=2004&pages=761-767&issue=3&author=J.+H.+Marxsenauthor=P.+Stengelauthor=K.+Doegeauthor=P.+Heikkinenauthor=T.+Jokilehtoauthor=T.+Wagnerauthor=W.+Jelkmannauthor=P.+Jaakkolaauthor=E.+Metzen&title=Hypoxia-inducible+factor-1+%28HIF-1%29+promotes+its+degradation+by+induction+of+HIF-%CE%B1-prolyl-4-hydroxylases&doi=10.1042%2FBJ20040620"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1042%2FBJ20040620&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20040620%26sid%3Dliteratum%253Aachs%26aulast%3DMarxsen%26aufirst%3DJ.%2BH.%26aulast%3DStengel%26aufirst%3DP.%26aulast%3DDoege%26aufirst%3DK.%26aulast%3DHeikkinen%26aufirst%3DP.%26aulast%3DJokilehto%26aufirst%3DT.%26aulast%3DWagner%26aufirst%3DT.%26aulast%3DJelkmann%26aufirst%3DW.%26aulast%3DJaakkola%26aufirst%3DP.%26aulast%3DMetzen%26aufirst%3DE.%26atitle%3DHypoxia-inducible%2520factor-1%2520%2528HIF-1%2529%2520promotes%2520its%2520degradation%2520by%2520induction%2520of%2520HIF-%25CE%25B1-prolyl-4-hydroxylases%26jtitle%3DBiochem.%2520J.%26date%3D2004%26volume%3D381%26issue%3D3%26spage%3D761%26epage%3D767%26doi%3D10.1042%2FBJ20040620" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Geyte, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fraisl, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiss, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aragonés, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzone, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mairbäurl, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Bock, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeoung, N. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mollenhauer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Georgiadou, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bishop, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roncal, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutherland, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jordan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallez, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weitz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maxwell, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ratcliffe, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carmeliet, P.</span></span> <span> </span><span class="NLM_article-title">Loss or silencing of the PHD1 prolyl hydroxylase protects livers of mice against ischemia/reperfusion injury</span>. <i>Gastroenterology</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>138</i></span>,  <span class="NLM_fpage">1143</span>– <span class="NLM_lpage">1154</span>, <span class="refDoi"> DOI: 10.1053/j.gastro.2009.09.057</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1053%2Fj.gastro.2009.09.057" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2010&pages=1143-1154&author=M.+Schneiderauthor=K.+Van+Geyteauthor=P.+Fraislauthor=J.+Kissauthor=J.+Aragon%C3%A9sauthor=M.+Mazzoneauthor=H.+Mairb%C3%A4urlauthor=K.+De+Bockauthor=N.+H.+Jeoungauthor=M.+Mollenhauerauthor=M.+Georgiadouauthor=T.+Bishopauthor=C.+Roncalauthor=A.+Sutherlandauthor=B.+Jordanauthor=B.+Gallezauthor=J.+Weitzauthor=R.+A.+Harrisauthor=P.+Maxwellauthor=M.+Baesauthor=P.+Ratcliffeauthor=P.+Carmeliet&title=Loss+or+silencing+of+the+PHD1+prolyl+hydroxylase+protects+livers+of+mice+against+ischemia%2Freperfusion+injury&doi=10.1053%2Fj.gastro.2009.09.057"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1053%2Fj.gastro.2009.09.057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1053%252Fj.gastro.2009.09.057%26sid%3Dliteratum%253Aachs%26aulast%3DSchneider%26aufirst%3DM.%26aulast%3DVan%2BGeyte%26aufirst%3DK.%26aulast%3DFraisl%26aufirst%3DP.%26aulast%3DKiss%26aufirst%3DJ.%26aulast%3DAragon%25C3%25A9s%26aufirst%3DJ.%26aulast%3DMazzone%26aufirst%3DM.%26aulast%3DMairb%25C3%25A4url%26aufirst%3DH.%26aulast%3DDe%2BBock%26aufirst%3DK.%26aulast%3DJeoung%26aufirst%3DN.%2BH.%26aulast%3DMollenhauer%26aufirst%3DM.%26aulast%3DGeorgiadou%26aufirst%3DM.%26aulast%3DBishop%26aufirst%3DT.%26aulast%3DRoncal%26aufirst%3DC.%26aulast%3DSutherland%26aufirst%3DA.%26aulast%3DJordan%26aufirst%3DB.%26aulast%3DGallez%26aufirst%3DB.%26aulast%3DWeitz%26aufirst%3DJ.%26aulast%3DHarris%26aufirst%3DR.%2BA.%26aulast%3DMaxwell%26aufirst%3DP.%26aulast%3DBaes%26aufirst%3DM.%26aulast%3DRatcliffe%26aufirst%3DP.%26aulast%3DCarmeliet%26aufirst%3DP.%26atitle%3DLoss%2520or%2520silencing%2520of%2520the%2520PHD1%2520prolyl%2520hydroxylase%2520protects%2520livers%2520of%2520mice%2520against%2520ischemia%252Freperfusion%2520injury%26jtitle%3DGastroenterology%26date%3D2010%26volume%3D138%26spage%3D1143%26epage%3D1154%26doi%3D10.1053%2Fj.gastro.2009.09.057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aragonés, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Geyte, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fraisl, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dresselaers, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzone, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dirkx, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zacchigna, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemieux, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeoung, N. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambrechts, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bishop, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lafuste, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diez-Juan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harten, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Noten, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Bock, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willam, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tjwa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosfeld, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Navet, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moons, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandendriessche, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deroose, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wijeyekoon, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nuyts, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jordan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silasi-Mansat, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lupu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dewerchin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pugh, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salmon, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mortelmans, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallez, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorus, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buyse, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sluse, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gnaiger, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hespel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Hecke, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuit, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Veldhoven, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ratcliffe, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maxwell, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carmeliet, P.</span></span> <span> </span><span class="NLM_article-title">Deficiency or inhibition of oxygen sensor Phd1 induces hypoxia tolerance by reprogramming basal metabolism</span>. <i>Nat. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">170</span>– <span class="NLM_lpage">180</span>, <span class="refDoi"> DOI: 10.1038/ng.2007.62</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1038%2Fng.2007.62" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=18176562" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtl2rt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2008&pages=170-180&author=J.+Aragon%C3%A9sauthor=M.+Schneiderauthor=K.+Van+Geyteauthor=P.+Fraislauthor=T.+Dresselaersauthor=M.+Mazzoneauthor=R.+Dirkxauthor=S.+Zacchignaauthor=H.+Lemieuxauthor=N.+H.+Jeoungauthor=D.+Lambrechtsauthor=T.+Bishopauthor=P.+Lafusteauthor=A.+Diez-Juanauthor=S.+K.+Hartenauthor=P.+Van+Notenauthor=K.+De+Bockauthor=C.+Willamauthor=M.+Tjwaauthor=A.+Grosfeldauthor=R.+Navetauthor=L.+Moonsauthor=T.+Vandendriesscheauthor=C.+Derooseauthor=B.+Wijeyekoonauthor=J.+Nuytsauthor=B.+Jordanauthor=R.+Silasi-Mansatauthor=F.+Lupuauthor=M.+Dewerchinauthor=C.+Pughauthor=P.+Salmonauthor=L.+Mortelmansauthor=B.+Gallezauthor=F.+Gorusauthor=J.+Buyseauthor=F.+Sluseauthor=R.+A.+Harrisauthor=E.+Gnaigerauthor=P.+Hespelauthor=P.+Van+Heckeauthor=F.+Schuitauthor=P.+Van+Veldhovenauthor=P.+Ratcliffeauthor=M.+Baesauthor=P.+Maxwellauthor=P.+Carmeliet&title=Deficiency+or+inhibition+of+oxygen+sensor+Phd1+induces+hypoxia+tolerance+by+reprogramming+basal+metabolism&doi=10.1038%2Fng.2007.62"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Deficiency or inhibition of oxygen sensor Phd1 induces hypoxia tolerance by reprogramming basal metabolism</span></div><div class="casAuthors">Aragones, Julian; Schneider, Martin; Van Geyte, Katie; Fraisl, Peter; Dresselaers, Tom; Mazzone, Massimiliano; Dirkx, Ruud; Zacchigna, Serena; Lemieux, Helene; Jeoung, Nam Ho; Lambrechts, Diether; Bishop, Tammie; Lafuste, Peggy; Diez-Juan, Antonio; Harten, Sarah K.; Van Noten, Pieter; De Bock, Katrien; William, Carsten; Tjwa, Marc; Grosfeld, Alexandra; Navet, Rachel; Moons, Lieve; Vandendriessche, Thierry; Deroose, Christophe; Wijeyekoon, Bhathiya; Nuyts, Johan; Jordan, Benedicte; Silasi-Mansat, Robert; Lupu, Florea; Dewerchin, Mieke; Pugh, Chris; Salmon, Phil; Mortelmans, Luc; Gallez, Bernard; Gorus, Frans; Buyse, Johan; Sluse, Francis; Harris, Robert A.; Gnaiger, Erich; Hespel, Peter; Van Hecke, Paul; Schuit, Frans; Van Veldhoven, Paul; Ratcliffe, Peter; Baes, Myriam; Maxwell, Patrick; Carmeliet, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">170-180</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">HIF prolyl hydroxylases (PHD1-3) are oxygen sensors that regulate the stability of the hypoxia-inducible factors (HIFs) in an oxygen-dependent manner.  Here, we show that loss of Pdh1 lowers oxygen consumption in skeletal muscle by reprogramming glucose metab. from oxidative to more anaerobic ATP prodn. through activation of a Pparα pathway.  This metabolic adaptation to oxygen conservation impairs oxidative muscle performance in healthy conditions, but it provides acute protection of myofibers against lethal ischemia.  Hypoxia tolerance is not due to HIF-dependent angiogenesis, erythropoiesis or vasodilation, but rather to reduced generation of oxidative stress, which allows Pdh1-deficient myofibers to preserve mitochondrial respiration.  Hypoxia tolerance relies primarily on Hif-2α and was not obsd. in heterozygous Phd2-deficient or homozygous Phd3-deficient mice.  Of medical importance, conditional knockdown of Pdh1 also rapidly induces hypoxia tolerance.  These findings delineate a new role of Pdh1 in hypoxia tolerance and offer new treatment perspectives for disorders characterized by oxidative stress.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqarAfjz9dFZrVg90H21EOLACvtfcHk0lgqagxDFzYjeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtl2rt7w%253D&md5=b69ff5cabf19da183639bb2bc79e054a</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fng.2007.62&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng.2007.62%26sid%3Dliteratum%253Aachs%26aulast%3DAragon%25C3%25A9s%26aufirst%3DJ.%26aulast%3DSchneider%26aufirst%3DM.%26aulast%3DVan%2BGeyte%26aufirst%3DK.%26aulast%3DFraisl%26aufirst%3DP.%26aulast%3DDresselaers%26aufirst%3DT.%26aulast%3DMazzone%26aufirst%3DM.%26aulast%3DDirkx%26aufirst%3DR.%26aulast%3DZacchigna%26aufirst%3DS.%26aulast%3DLemieux%26aufirst%3DH.%26aulast%3DJeoung%26aufirst%3DN.%2BH.%26aulast%3DLambrechts%26aufirst%3DD.%26aulast%3DBishop%26aufirst%3DT.%26aulast%3DLafuste%26aufirst%3DP.%26aulast%3DDiez-Juan%26aufirst%3DA.%26aulast%3DHarten%26aufirst%3DS.%2BK.%26aulast%3DVan%2BNoten%26aufirst%3DP.%26aulast%3DDe%2BBock%26aufirst%3DK.%26aulast%3DWillam%26aufirst%3DC.%26aulast%3DTjwa%26aufirst%3DM.%26aulast%3DGrosfeld%26aufirst%3DA.%26aulast%3DNavet%26aufirst%3DR.%26aulast%3DMoons%26aufirst%3DL.%26aulast%3DVandendriessche%26aufirst%3DT.%26aulast%3DDeroose%26aufirst%3DC.%26aulast%3DWijeyekoon%26aufirst%3DB.%26aulast%3DNuyts%26aufirst%3DJ.%26aulast%3DJordan%26aufirst%3DB.%26aulast%3DSilasi-Mansat%26aufirst%3DR.%26aulast%3DLupu%26aufirst%3DF.%26aulast%3DDewerchin%26aufirst%3DM.%26aulast%3DPugh%26aufirst%3DC.%26aulast%3DSalmon%26aufirst%3DP.%26aulast%3DMortelmans%26aufirst%3DL.%26aulast%3DGallez%26aufirst%3DB.%26aulast%3DGorus%26aufirst%3DF.%26aulast%3DBuyse%26aufirst%3DJ.%26aulast%3DSluse%26aufirst%3DF.%26aulast%3DHarris%26aufirst%3DR.%2BA.%26aulast%3DGnaiger%26aufirst%3DE.%26aulast%3DHespel%26aufirst%3DP.%26aulast%3DVan%2BHecke%26aufirst%3DP.%26aulast%3DSchuit%26aufirst%3DF.%26aulast%3DVan%2BVeldhoven%26aufirst%3DP.%26aulast%3DRatcliffe%26aufirst%3DP.%26aulast%3DBaes%26aufirst%3DM.%26aulast%3DMaxwell%26aufirst%3DP.%26aulast%3DCarmeliet%26aufirst%3DP.%26atitle%3DDeficiency%2520or%2520inhibition%2520of%2520oxygen%2520sensor%2520Phd1%2520induces%2520hypoxia%2520tolerance%2520by%2520reprogramming%2520basal%2520metabolism%26jtitle%3DNat.%2520Genet.%26date%3D2008%26volume%3D40%26spage%3D170%26epage%3D180%26doi%3D10.1038%2Fng.2007.62" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takeda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fong, G. H.</span></span> <span> </span><span class="NLM_article-title">Essential role for prolyl hydroxylase domain protein 2 in oxygen homeostasis of the adult vascular system</span>. <i>Circulation</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">774</span>– <span class="NLM_lpage">781</span>, <span class="refDoi"> DOI: 10.1161/CIRCULATIONAHA.107.701516</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1161%2FCIRCULATIONAHA.107.701516" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2007&pages=774-781&author=K.+Takedaauthor=A.+Cowanauthor=G.+H.+Fong&title=Essential+role+for+prolyl+hydroxylase+domain+protein+2+in+oxygen+homeostasis+of+the+adult+vascular+system&doi=10.1161%2FCIRCULATIONAHA.107.701516"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1161%2FCIRCULATIONAHA.107.701516&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIRCULATIONAHA.107.701516%26sid%3Dliteratum%253Aachs%26aulast%3DTakeda%26aufirst%3DK.%26aulast%3DCowan%26aufirst%3DA.%26aulast%3DFong%26aufirst%3DG.%2BH.%26atitle%3DEssential%2520role%2520for%2520prolyl%2520hydroxylase%2520domain%2520protein%25202%2520in%2520oxygen%2520homeostasis%2520of%2520the%2520adult%2520vascular%2520system%26jtitle%3DCirculation%26date%3D2007%26volume%3D116%26spage%3D774%26epage%3D781%26doi%3D10.1161%2FCIRCULATIONAHA.107.701516" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takeda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aguila, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parikh, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamothe, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeda, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fong, G. H.</span></span> <span> </span><span class="NLM_article-title">Regulation of adult erythropoiesis by prolyl hydroxylase domain proteins</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">3229</span>– <span class="NLM_lpage">3235</span>, <span class="refDoi"> DOI: 10.1182/blood-2007-09-114561</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1182%2Fblood-2007-09-114561" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2008&pages=3229-3235&author=K.+Takedaauthor=H.+L.+Aguilaauthor=N.+S.+Parikhauthor=X.+Liauthor=K.+Lamotheauthor=L.+J.+Duanauthor=H.+Takedaauthor=F.+S.+Leeauthor=G.+H.+Fong&title=Regulation+of+adult+erythropoiesis+by+prolyl+hydroxylase+domain+proteins&doi=10.1182%2Fblood-2007-09-114561"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1182%2Fblood-2007-09-114561&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2007-09-114561%26sid%3Dliteratum%253Aachs%26aulast%3DTakeda%26aufirst%3DK.%26aulast%3DAguila%26aufirst%3DH.%2BL.%26aulast%3DParikh%26aufirst%3DN.%2BS.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLamothe%26aufirst%3DK.%26aulast%3DDuan%26aufirst%3DL.%2BJ.%26aulast%3DTakeda%26aufirst%3DH.%26aulast%3DLee%26aufirst%3DF.%2BS.%26aulast%3DFong%26aufirst%3DG.%2BH.%26atitle%3DRegulation%2520of%2520adult%2520erythropoiesis%2520by%2520prolyl%2520hydroxylase%2520domain%2520proteins%26jtitle%3DBlood%26date%3D2008%26volume%3D111%26spage%3D3229%26epage%3D3235%26doi%3D10.1182%2Fblood-2007-09-114561" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Binns, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urrutia, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davidoff, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapitsinou, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfaff, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olauson, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wernerson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fogo, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fong, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gross, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haase, V. H.</span></span> <span> </span><span class="NLM_article-title">Distinct subpopulations of FOXD1 stroma-derived cells regulate renal erythropoietin</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>126</i></span>,  <span class="NLM_fpage">1926</span>– <span class="NLM_lpage">1938</span>, <span class="refDoi"> DOI: 10.1172/JCI83551</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1172%2FJCI83551" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2016&pages=1926-1938&author=H.+Kobayashiauthor=Q.+Liuauthor=T.+C.+Binnsauthor=A.+A.+Urrutiaauthor=O.+Davidoffauthor=P.+P.+Kapitsinouauthor=A.+S.+Pfaffauthor=H.+Olausonauthor=A.+Wernersonauthor=A.+B.+Fogoauthor=G.+H.+Fongauthor=K.+W.+Grossauthor=V.+H.+Haase&title=Distinct+subpopulations+of+FOXD1+stroma-derived+cells+regulate+renal+erythropoietin&doi=10.1172%2FJCI83551"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1172%2FJCI83551&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI83551%26sid%3Dliteratum%253Aachs%26aulast%3DKobayashi%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DBinns%26aufirst%3DT.%2BC.%26aulast%3DUrrutia%26aufirst%3DA.%2BA.%26aulast%3DDavidoff%26aufirst%3DO.%26aulast%3DKapitsinou%26aufirst%3DP.%2BP.%26aulast%3DPfaff%26aufirst%3DA.%2BS.%26aulast%3DOlauson%26aufirst%3DH.%26aulast%3DWernerson%26aufirst%3DA.%26aulast%3DFogo%26aufirst%3DA.%2BB.%26aulast%3DFong%26aufirst%3DG.%2BH.%26aulast%3DGross%26aufirst%3DK.%2BW.%26aulast%3DHaase%26aufirst%3DV.%2BH.%26atitle%3DDistinct%2520subpopulations%2520of%2520FOXD1%2520stroma-derived%2520cells%2520regulate%2520renal%2520erythropoietin%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2016%26volume%3D126%26spage%3D1926%26epage%3D1938%26doi%3D10.1172%2FJCI83551" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Souma, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nezu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakano, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamazaki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirano, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sekine, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fong, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishiyama, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyata, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, N.</span></span> <span> </span><span class="NLM_article-title">Erythropoietin synthesis in renal myofibroblasts is restored by activation of hypoxia signaling</span>. <i>J. Am. Soc. Nephrol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">428</span>– <span class="NLM_lpage">438</span>, <span class="refDoi"> DOI: 10.1681/ASN.2014121184</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1681%2FASN.2014121184" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=26054543" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=1%3ACAS%3A528%3ADC%252BC2sXktFGmtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2016&pages=428-438&author=T.+Soumaauthor=M.+Nezuauthor=D.+Nakanoauthor=S.+Yamazakiauthor=I.+Hiranoauthor=H.+Sekineauthor=T.+Danauthor=K.+Takedaauthor=G.+H.+Fongauthor=A.+Nishiyamaauthor=S.+Itoauthor=T.+Miyataauthor=M.+Yamamotoauthor=N.+Suzuki&title=Erythropoietin+synthesis+in+renal+myofibroblasts+is+restored+by+activation+of+hypoxia+signaling&doi=10.1681%2FASN.2014121184"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Erythropoietin synthesis in renal myofibroblasts is restored by activation of hypoxia signaling</span></div><div class="casAuthors">Souma, Tomokazu; Nezu, Masahiro; Nakano, Daisuke; Yamazaki, Shun; Hirano, Ikuo; Sekine, Hiroki; Dan, Takashi; Takeda, Kotaro; Fong, Guo-Hua; Nishiyama, Akira; Ito, Sadayoshi; Miyata, Toshio; Yamamoto, Masayuki; Suzuki, Norio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Society of Nephrology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">428-438</span>CODEN:
                <span class="NLM_cas:coden">JASNEU</span>;
        ISSN:<span class="NLM_cas:issn">1046-6673</span>.
    
            (<span class="NLM_cas:orgname">American Society of Nephrology</span>)
        </div><div class="casAbstract">Erythropoietin (Epo) is produced by renal Epo-producing cells (REPs) in a hypoxia-inducible manner.  The conversion of REPs into myofibroblasts and coincident loss of Epo-producing ability are the major cause of renal fibrosis and anemia.  However, the hypoxic response of these transformed myofibroblasts remains unclear.  Here, we used complementary in vivo transgenic and live imaging approaches to better understand the importance of hypoxia signaling in Epo prodn.  Live imaging of REPs in transgenic mice expressing green fluorescent protein from a modified Epo-gene locus revealed that healthy REPs tightly assocd. with endothelium by wrapping processes around capillaries.  However, this assocn. was hampered in states of renal injury-induced inflammation previously shown to correlate with the transition to myofibroblast-transformed renal Epo-producing cells (MF-REPs).  Furthermore, activation of hypoxia-inducible factors (HIFs) by genetic inactivation of HIF-prolyl hydroxylases (PHD1, PHD2, and PHD3) selectively in Epo-producing cells reactivated Epo prodn. in MF-REPs.  Loss of PHD2 in REPs restored Epo-gene expression in injured kidneys but caused polycythemia.  Notably, combined deletions of PHD1 and PHD3 prevented loss of Epo expression without provoking polycythemia.  Mice with PHD-deficient REPs also showed resistance to LPS-induced Epo repression in kidneys, suggesting that augmented HIF signaling counterbalances inflammatory stimuli in regulation of Epo prodn.  Thus, augmentation of HIF signaling may be an attractive therapeutic strategy for treating renal anemia by reactivating Epo synthesis in MF-REPs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZeN-xtIH0MLVg90H21EOLACvtfcHk0lhDNX30oGR3KQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXktFGmtw%253D%253D&md5=e0776344f30caac64ba73db07436dea6</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1681%2FASN.2014121184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1681%252FASN.2014121184%26sid%3Dliteratum%253Aachs%26aulast%3DSouma%26aufirst%3DT.%26aulast%3DNezu%26aufirst%3DM.%26aulast%3DNakano%26aufirst%3DD.%26aulast%3DYamazaki%26aufirst%3DS.%26aulast%3DHirano%26aufirst%3DI.%26aulast%3DSekine%26aufirst%3DH.%26aulast%3DDan%26aufirst%3DT.%26aulast%3DTakeda%26aufirst%3DK.%26aulast%3DFong%26aufirst%3DG.%2BH.%26aulast%3DNishiyama%26aufirst%3DA.%26aulast%3DIto%26aufirst%3DS.%26aulast%3DMiyata%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DSuzuki%26aufirst%3DN.%26atitle%3DErythropoietin%2520synthesis%2520in%2520renal%2520myofibroblasts%2520is%2520restored%2520by%2520activation%2520of%2520hypoxia%2520signaling%26jtitle%3DJ.%2520Am.%2520Soc.%2520Nephrol.%26date%3D2016%26volume%3D27%26spage%3D428%26epage%3D438%26doi%3D10.1681%2FASN.2014121184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obara, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jishage, K. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minegishi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span> <span> </span><span class="NLM_article-title">Specific contribution of the erythropoietin gene 3′ enhancer to hepatic erythropoiesis after late embryonic stages</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">3896</span>– <span class="NLM_lpage">3905</span>, <span class="refDoi"> DOI: 10.1128/MCB.05463-11</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1128%2FMCB.05463-11" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=21746884" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFGmu7zN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2011&pages=3896-3905&author=N.+Suzukiauthor=N.+Obaraauthor=X.+Panauthor=M.+Watanabeauthor=K.+I.+Jishageauthor=N.+Minegishiauthor=M.+Yamamoto&title=Specific+contribution+of+the+erythropoietin+gene+3%E2%80%B2+enhancer+to+hepatic+erythropoiesis+after+late+embryonic+stages&doi=10.1128%2FMCB.05463-11"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Specific contribution of the erythropoietin gene 3' enhancer to hepatic erythropoiesis after late embryonic stages</span></div><div class="casAuthors">Suzuki, Norio; Obara, Naoshi; Pan, Xiaoqing; Watanabe, Miho; Jishage, Kou-ichi; Minegishi, Naoko; Yamamoto, Masayuki</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">3896-3905</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Erythropoietin (Epo) is secreted from the liver and kidney, where Epo prodn. is strictly regulated at the transcriptional level in a hypoxia- and/or anemia-inducible manner.  Here, we examd. the in vivo function of the enhancer located 3' to the Epo gene (EpoE-3').  Reporter transgenic-mouse analyses revealed that the EpoE-3' enhancer is necessary and sufficient for the liver-specific and hypoxia-responsive expression of the gene after embryonic day 14.5 (E14.5).  However, the enhancer is dispensable for Epo gene expression in the kidney and early-stage embryonic liver.  Genetic removal of EpoE-3' from the endogenous Epo gene resulted in mice with severe anemia at late embryonic and neonatal stages due to defects in hepatic erythropoiesis, but early hepatic and splenic erythropoiesis was not affected.  The mutant mice recover from the anemia in the juvenile period when major Epo prodn. switches from the liver to the kidney.  These results demonstrate that EpoE-3' is necessary for late hepatic erythropoiesis by specifically supporting paracrine prodn. of Epo in the liver.  In contrast, Epo prodn. in the kidney utilizes distinct regulatory machinery and supports erythropoiesis in the bone marrow and spleen in adult animals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpamPXxpc3jrVg90H21EOLACvtfcHk0lhDNX30oGR3KQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFGmu7zN&md5=c9c0df05c96c2748695ce55b5719f5b6</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1128%2FMCB.05463-11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.05463-11%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DN.%26aulast%3DObara%26aufirst%3DN.%26aulast%3DPan%26aufirst%3DX.%26aulast%3DWatanabe%26aufirst%3DM.%26aulast%3DJishage%26aufirst%3DK.%2BI.%26aulast%3DMinegishi%26aufirst%3DN.%26aulast%3DYamamoto%26aufirst%3DM.%26atitle%3DSpecific%2520contribution%2520of%2520the%2520erythropoietin%2520gene%25203%25E2%2580%25B2%2520enhancer%2520to%2520hepatic%2520erythropoiesis%2520after%2520late%2520embryonic%2520stages%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2011%26volume%3D31%26spage%3D3896%26epage%3D3905%26doi%3D10.1128%2FMCB.05463-11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mastrogiannaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matak, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keith, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simon, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaulont, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peyssonnaux, C.</span></span> <span> </span><span class="NLM_article-title">HIF-2α, but not HIF-1α, promotes iron absorption in mice</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>119</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1159</span>– <span class="NLM_lpage">1166</span>, <span class="refDoi"> DOI: 10.1172/JCI38499</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1172%2FJCI38499" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2009&pages=1159-1166&issue=5&author=M.+Mastrogiannakiauthor=P.+Matakauthor=B.+Keithauthor=M.+C.+Simonauthor=S.+Vaulontauthor=C.+Peyssonnaux&title=HIF-2%CE%B1%2C+but+not+HIF-1%CE%B1%2C+promotes+iron+absorption+in+mice&doi=10.1172%2FJCI38499"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1172%2FJCI38499&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI38499%26sid%3Dliteratum%253Aachs%26aulast%3DMastrogiannaki%26aufirst%3DM.%26aulast%3DMatak%26aufirst%3DP.%26aulast%3DKeith%26aufirst%3DB.%26aulast%3DSimon%26aufirst%3DM.%2BC.%26aulast%3DVaulont%26aufirst%3DS.%26aulast%3DPeyssonnaux%26aufirst%3DC.%26atitle%3DHIF-2%25CE%25B1%252C%2520but%2520not%2520HIF-1%25CE%25B1%252C%2520promotes%2520iron%2520absorption%2520in%2520mice%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2009%26volume%3D119%26issue%3D5%26spage%3D1159%26epage%3D1166%26doi%3D10.1172%2FJCI38499" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yamashita, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohneda, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakiyama, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwata, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohneda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujii-Kuriyama, Y.</span></span> <span> </span><span class="NLM_article-title">The microenvironment for erythropoiesis is regulated by HIF-2α through VCAM-1 in endothelial cells</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>112</i></span>,  <span class="NLM_fpage">1482</span>– <span class="NLM_lpage">1492</span>, <span class="refDoi"> DOI: 10.1182/blood-2007-11-122648</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1182%2Fblood-2007-11-122648" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2008&pages=1482-1492&author=T.+Yamashitaauthor=O.+Ohnedaauthor=A.+Sakiyamaauthor=F.+Iwataauthor=K.+Ohnedaauthor=Y.+Fujii-Kuriyama&title=The+microenvironment+for+erythropoiesis+is+regulated+by+HIF-2%CE%B1+through+VCAM-1+in+endothelial+cells&doi=10.1182%2Fblood-2007-11-122648"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1182%2Fblood-2007-11-122648&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2007-11-122648%26sid%3Dliteratum%253Aachs%26aulast%3DYamashita%26aufirst%3DT.%26aulast%3DOhneda%26aufirst%3DO.%26aulast%3DSakiyama%26aufirst%3DA.%26aulast%3DIwata%26aufirst%3DF.%26aulast%3DOhneda%26aufirst%3DK.%26aulast%3DFujii-Kuriyama%26aufirst%3DY.%26atitle%3DThe%2520microenvironment%2520for%2520erythropoiesis%2520is%2520regulated%2520by%2520HIF-2%25CE%25B1%2520through%2520VCAM-1%2520in%2520endothelial%2520cells%26jtitle%3DBlood%26date%3D2008%26volume%3D112%26spage%3D1482%26epage%3D1492%26doi%3D10.1182%2Fblood-2007-11-122648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Paliege, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberger, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bondke, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sciesielski, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shina, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heyman, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flippin, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arend, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klaus, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bachmann, S.</span></span> <span> </span><span class="NLM_article-title">Hypoxia-inducible factor-2α-expressing interstitial fibroblasts are the only renal cells that express erythropoietin under hypoxia-inducible factor stabilization</span>. <i>Kidney Int.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">312</span>– <span class="NLM_lpage">318</span>, <span class="refDoi"> DOI: 10.1038/ki.2009.460</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1038%2Fki.2009.460" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=20016470" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1Kksrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2010&pages=312-318&author=A.+Paliegeauthor=C.+Rosenbergerauthor=A.+Bondkeauthor=L.+Sciesielskiauthor=A.+Shinaauthor=S.+N.+Heymanauthor=L.+A.+Flippinauthor=M.+Arendauthor=S.+J.+Klausauthor=S.+Bachmann&title=Hypoxia-inducible+factor-2%CE%B1-expressing+interstitial+fibroblasts+are+the+only+renal+cells+that+express+erythropoietin+under+hypoxia-inducible+factor+stabilization&doi=10.1038%2Fki.2009.460"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Hypoxia-inducible factor-2α-expressing interstitial fibroblasts are the only renal cells that express erythropoietin under hypoxia-inducible factor stabilization</span></div><div class="casAuthors">Paliege, Alexander; Rosenberger, Christian; Bondke, Anja; Sciesielski, Lina; Shina, Ahuva; Heyman, Samuel N.; Flippin, Lee A.; Arend, Michael; Klaus, Stephen J.; Bachmann, Sebastian</div><div class="citationInfo"><span class="NLM_cas:title">Kidney International</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">312-318</span>CODEN:
                <span class="NLM_cas:coden">KDYIA5</span>;
        ISSN:<span class="NLM_cas:issn">0085-2538</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The adaptation of erythropoietin prodn. to oxygen supply is detd. by the abundance of hypoxia-inducible factor (HIF), a regulation that is induced by a prolyl hydroxylase.  To identify cells that express HIF subunits (HIF-1α and HIF-2α) and erythropoietin, we treated Sprague-Dawley rats with the prolyl hydroxylase inhibitor FG-4497 for 6 h to induce HIF-dependent erythropoietin transcription.  The kidneys were analyzed for colocalization of erythropoietin mRNA with HIF-1α and/or HIF-2α protein along with cell-specific identification markers.  FG-4497 treatment strongly induced erythropoietin mRNA exclusively in cortical interstitial fibroblasts.  Accumulation of HIF-2α was obsd. in these fibroblasts and in endothelial and glomerular cells, whereas HIF-1α was induced only in tubular epithelia.  A large proportion (over 90% in the juxtamedullary cortex) of erythropoietin-expressing cells coexpressed HIF-2α.  No colocalization of erythropoietin and HIF-1α was found.  Hence, we conclude that in the adult kidney, HIF-2α and erythropoietin mRNA colocalize only in cortical interstitial fibroblasts, which makes them the key cell type for renal erythropoietin synthesis as regulated by HIF-2α.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoA0JLj3LtNL7Vg90H21EOLACvtfcHk0lin1VL9pqoKng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1Kksrc%253D&md5=104167e2f6230ad05e5a38f331e5cbcb</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2Fki.2009.460&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fki.2009.460%26sid%3Dliteratum%253Aachs%26aulast%3DPaliege%26aufirst%3DA.%26aulast%3DRosenberger%26aufirst%3DC.%26aulast%3DBondke%26aufirst%3DA.%26aulast%3DSciesielski%26aufirst%3DL.%26aulast%3DShina%26aufirst%3DA.%26aulast%3DHeyman%26aufirst%3DS.%2BN.%26aulast%3DFlippin%26aufirst%3DL.%2BA.%26aulast%3DArend%26aufirst%3DM.%26aulast%3DKlaus%26aufirst%3DS.%2BJ.%26aulast%3DBachmann%26aufirst%3DS.%26atitle%3DHypoxia-inducible%2520factor-2%25CE%25B1-expressing%2520interstitial%2520fibroblasts%2520are%2520the%2520only%2520renal%2520cells%2520that%2520express%2520erythropoietin%2520under%2520hypoxia-inducible%2520factor%2520stabilization%26jtitle%3DKidney%2520Int.%26date%3D2010%26volume%3D77%26spage%3D312%26epage%3D318%26doi%3D10.1038%2Fki.2009.460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sahai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mei, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schrier, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tannen, R. L.</span></span> <span> </span><span class="NLM_article-title">Mechanisms of chronic hypoxia-induced renal cell growth</span>. <i>Kidney Int.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">1277</span>– <span class="NLM_lpage">1281</span>, <span class="refDoi"> DOI: 10.1046/j.1523-1755.1999.00703.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1046%2Fj.1523-1755.1999.00703.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10504474" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=1%3ACAS%3A528%3ADyaK1MXmslGntL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=1999&pages=1277-1281&author=A.+Sahaiauthor=C.+Meiauthor=R.+W.+Schrierauthor=R.+L.+Tannen&title=Mechanisms+of+chronic+hypoxia-induced+renal+cell+growth&doi=10.1046%2Fj.1523-1755.1999.00703.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of chronic hypoxia-induced renal cell growth</span></div><div class="casAuthors">Sahai, Atul; Mei, Changlin; Schrier, Robert W.; Tannen, Richard L.</div><div class="citationInfo"><span class="NLM_cas:title">Kidney International</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1277-1281</span>CODEN:
                <span class="NLM_cas:coden">KDYIA5</span>;
        ISSN:<span class="NLM_cas:issn">0085-2538</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science, Inc.</span>)
        </div><div class="casAbstract">A review with 29 refs.  Chronic local tissue hypoxia appears to play an important role in the initiation and progression of chronic renal disease.  The authors examd. the effect of local hypoxia on cultured renal tubular epithelial and mesangial cell proliferation, dedifferentiation, and extracellular matrix synthesis.  The underlying signaling mechanisms whereby hypoxia induces renal cell growth were evaluated.  The roles of protein kinase C, p38 mitogen-activated protein kinase, TGF-β1, osteopontin, and nitric oxide were detd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjliQ5s4z2yLVg90H21EOLACvtfcHk0lin1VL9pqoKng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmslGntL8%253D&md5=4212fdc0ba3b72e347463c3b609c685b</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1046%2Fj.1523-1755.1999.00703.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1523-1755.1999.00703.x%26sid%3Dliteratum%253Aachs%26aulast%3DSahai%26aufirst%3DA.%26aulast%3DMei%26aufirst%3DC.%26aulast%3DSchrier%26aufirst%3DR.%2BW.%26aulast%3DTannen%26aufirst%3DR.%2BL.%26atitle%3DMechanisms%2520of%2520chronic%2520hypoxia-induced%2520renal%2520cell%2520growth%26jtitle%3DKidney%2520Int.%26date%3D1999%26volume%3D56%26spage%3D1277%26epage%3D1281%26doi%3D10.1046%2Fj.1523-1755.1999.00703.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dame, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sola, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leach, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fandrey, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knöpfle, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engel, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bungert, J.</span></span> <span> </span><span class="NLM_article-title">Hepatic erythropoietin gene regulation by GATA-4</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>279</i></span>,  <span class="NLM_fpage">2955</span>– <span class="NLM_lpage">2961</span>, <span class="refDoi"> DOI: 10.1074/jbc.M310404200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1074%2Fjbc.M310404200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=2955-2961&author=C.+Dameauthor=M.+C.+Solaauthor=K.+C.+Limauthor=K.+M.+Leachauthor=J.+Fandreyauthor=Y.+Maauthor=G.+Kn%C3%B6pfleauthor=J.+D.+Engelauthor=J.+Bungert&title=Hepatic+erythropoietin+gene+regulation+by+GATA-4&doi=10.1074%2Fjbc.M310404200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M310404200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M310404200%26sid%3Dliteratum%253Aachs%26aulast%3DDame%26aufirst%3DC.%26aulast%3DSola%26aufirst%3DM.%2BC.%26aulast%3DLim%26aufirst%3DK.%2BC.%26aulast%3DLeach%26aufirst%3DK.%2BM.%26aulast%3DFandrey%26aufirst%3DJ.%26aulast%3DMa%26aufirst%3DY.%26aulast%3DKn%25C3%25B6pfle%26aufirst%3DG.%26aulast%3DEngel%26aufirst%3DJ.%2BD.%26aulast%3DBungert%26aufirst%3DJ.%26atitle%3DHepatic%2520erythropoietin%2520gene%2520regulation%2520by%2520GATA-4%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D2955%26epage%3D2961%26doi%3D10.1074%2Fjbc.M310404200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Querbes, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogorad, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moslehi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, A. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bulgakova, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuchimanchi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akinc, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fitzgerald, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koteliansky, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaelin, W. G.</span></span> <span> </span><span class="NLM_article-title">Treatment of erythropoietin deficiency in mice with systemically administered siRNA</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>120</i></span>,  <span class="NLM_fpage">1916</span>– <span class="NLM_lpage">1922</span>, <span class="refDoi"> DOI: 10.1182/blood-2012-04-423715</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1182%2Fblood-2012-04-423715" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2012&pages=1916-1922&author=W.+Querbesauthor=R.+L.+Bogoradauthor=J.+Moslehiauthor=J.+Wongauthor=A.+Y.+Chanauthor=E.+Bulgakovaauthor=S.+Kuchimanchiauthor=A.+Akincauthor=K.+Fitzgeraldauthor=V.+Kotelianskyauthor=W.+G.+Kaelin&title=Treatment+of+erythropoietin+deficiency+in+mice+with+systemically+administered+siRNA&doi=10.1182%2Fblood-2012-04-423715"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1182%2Fblood-2012-04-423715&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2012-04-423715%26sid%3Dliteratum%253Aachs%26aulast%3DQuerbes%26aufirst%3DW.%26aulast%3DBogorad%26aufirst%3DR.%2BL.%26aulast%3DMoslehi%26aufirst%3DJ.%26aulast%3DWong%26aufirst%3DJ.%26aulast%3DChan%26aufirst%3DA.%2BY.%26aulast%3DBulgakova%26aufirst%3DE.%26aulast%3DKuchimanchi%26aufirst%3DS.%26aulast%3DAkinc%26aufirst%3DA.%26aulast%3DFitzgerald%26aufirst%3DK.%26aulast%3DKoteliansky%26aufirst%3DV.%26aulast%3DKaelin%26aufirst%3DW.%2BG.%26atitle%3DTreatment%2520of%2520erythropoietin%2520deficiency%2520in%2520mice%2520with%2520systemically%2520administered%2520siRNA%26jtitle%3DBlood%26date%3D2012%26volume%3D120%26spage%3D1916%26epage%3D1922%26doi%3D10.1182%2Fblood-2012-04-423715" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Minamishima, Y. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaelin, W. G.,  Jr.</span></span> <span> </span><span class="NLM_article-title">Reactivation of hepatic EPO synthesis in mice after PHD loss</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>329</i></span>,  <span class="NLM_fpage">407</span>, <span class="refDoi"> DOI: 10.1126/science.1192811</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1126%2Fscience.1192811" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=329&publication_year=2010&pages=407&author=Y.+A.+Minamishimaauthor=W.+G.+Kaelin&title=Reactivation+of+hepatic+EPO+synthesis+in+mice+after+PHD+loss&doi=10.1126%2Fscience.1192811"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1126%2Fscience.1192811&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1192811%26sid%3Dliteratum%253Aachs%26aulast%3DMinamishima%26aufirst%3DY.%2BA.%26aulast%3DKaelin%26aufirst%3DW.%2BG.%26atitle%3DReactivation%2520of%2520hepatic%2520EPO%2520synthesis%2520in%2520mice%2520after%2520PHD%2520loss%26jtitle%3DScience%26date%3D2010%26volume%3D329%26spage%3D407%26doi%3D10.1126%2Fscience.1192811" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chiang, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inagi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujita, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nangaku, M.</span></span> <span> </span><span class="NLM_article-title">Indoxyl sulfate, a representative uremic toxin, suppresses erythropoietin production in a HIF-dependent manner</span>. <i>Lab. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>91</i></span>,  <span class="NLM_fpage">1564</span>– <span class="NLM_lpage">1571</span>, <span class="refDoi"> DOI: 10.1038/labinvest.2011.114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1038%2Flabinvest.2011.114" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2011&pages=1564-1571&author=C.+K.+Chiangauthor=T.+Tanakaauthor=R.+Inagiauthor=T.+Fujitaauthor=M.+Nangaku&title=Indoxyl+sulfate%2C+a+representative+uremic+toxin%2C+suppresses+erythropoietin+production+in+a+HIF-dependent+manner&doi=10.1038%2Flabinvest.2011.114"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1038%2Flabinvest.2011.114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Flabinvest.2011.114%26sid%3Dliteratum%253Aachs%26aulast%3DChiang%26aufirst%3DC.%2BK.%26aulast%3DTanaka%26aufirst%3DT.%26aulast%3DInagi%26aufirst%3DR.%26aulast%3DFujita%26aufirst%3DT.%26aulast%3DNangaku%26aufirst%3DM.%26atitle%3DIndoxyl%2520sulfate%252C%2520a%2520representative%2520uremic%2520toxin%252C%2520suppresses%2520erythropoietin%2520production%2520in%2520a%2520HIF-dependent%2520manner%26jtitle%3DLab.%2520Invest.%26date%3D2011%26volume%3D91%26spage%3D1564%26epage%3D1571%26doi%3D10.1038%2Flabinvest.2011.114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eckardt, K. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurtz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, C.</span></span> <span> </span><span class="NLM_article-title">Regulation of erythropoietin production is related to proximal tubular function</span>. <i>Am. J. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>256</i></span>,  <span class="NLM_fpage">F942</span>– <span class="NLM_lpage">F947</span>, <span class="refDoi"> DOI: 10.1152/ajprenal.1989.256.5.F942</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1152%2Fajprenal.1989.256.5.F942" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=256&publication_year=1989&pages=F942-F947&author=K.+U.+Eckardtauthor=A.+Kurtzauthor=C.+Bauer&title=Regulation+of+erythropoietin+production+is+related+to+proximal+tubular+function&doi=10.1152%2Fajprenal.1989.256.5.F942"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1152%2Fajprenal.1989.256.5.F942&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajprenal.1989.256.5.F942%26sid%3Dliteratum%253Aachs%26aulast%3DEckardt%26aufirst%3DK.%2BU.%26aulast%3DKurtz%26aufirst%3DA.%26aulast%3DBauer%26aufirst%3DC.%26atitle%3DRegulation%2520of%2520erythropoietin%2520production%2520is%2520related%2520to%2520proximal%2520tubular%2520function%26jtitle%3DAm.%2520J.%2520Physiol.%26date%3D1989%26volume%3D256%26spage%3DF942%26epage%3DF947%26doi%3D10.1152%2Fajprenal.1989.256.5.F942" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nangaku, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eckardt, K. U.</span></span> <span> </span><span class="NLM_article-title">Pathogenesis of renal anemia</span>. <i>Semin. Nephrol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">261</span>– <span class="NLM_lpage">268</span>, <span class="refDoi"> DOI: 10.1016/j.semnephrol.2006.06.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1016%2Fj.semnephrol.2006.06.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=16949463" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVyqt7vE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2006&pages=261-268&author=M.+Nangakuauthor=K.+U.+Eckardt&title=Pathogenesis+of+renal+anemia&doi=10.1016%2Fj.semnephrol.2006.06.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Pathogenesis of renal anemia</span></div><div class="casAuthors">Nangaku, Masaomi; Eckardt, Kai-Uwe</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in Nephrology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">261-268</span>CODEN:
                <span class="NLM_cas:coden">SNEPDJ</span>;
        ISSN:<span class="NLM_cas:issn">0270-9295</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Anemia is a common complication of chronic kidney disease.  Although mechanisms involved in the pathogenesis of renal anemia include chronic inflammation, iron deficiency, and shortened half-life of erythrocytes, the primary cause is deficiency of erythropoietin (EPO).  Serum EPO levels in patients with chronic kidney disease are usually within the normal range and thus fail to show an appropriate increase; with decreasing Hb levels, as found in nonrenal anemias.  Studies elucidating the regulation of EPO expression led to the identification of the hypoxia inducible factor-hypoxia responsive element system.  However, despite much progress in understanding the mol. mechanisms through which cells can sense oxygen availability and translate this information into altered gene expression, the reason why EPO prodn. is inappropriately low in diseased kidneys remains incompletely understood.  Both alterations in the function of EPO-producing cells and perturbations of the oxygen-sensing mechanism in the kidney may contribute.  As with other anemias, the consequences of renal anemia are a moderate decrease in tissue oxygen tensions and counterregulatory mechanisms that maintain total oxygen consumption, including a persistent increase in cardiac output.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4KOp5mhHKSrVg90H21EOLACvtfcHk0lg3nLsXZT0ejw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVyqt7vE&md5=fdb43cf481a881151d5da10fdbe9f1df</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.semnephrol.2006.06.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.semnephrol.2006.06.001%26sid%3Dliteratum%253Aachs%26aulast%3DNangaku%26aufirst%3DM.%26aulast%3DEckardt%26aufirst%3DK.%2BU.%26atitle%3DPathogenesis%2520of%2520renal%2520anemia%26jtitle%3DSemin.%2520Nephrol.%26date%3D2006%26volume%3D26%26spage%3D261%26epage%3D268%26doi%3D10.1016%2Fj.semnephrol.2006.06.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baer, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dessypris, E. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldwasser, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krantz, S. B.</span></span> <span> </span><span class="NLM_article-title">Blunted erythropoietin response to anaemia in rheumatoid arthritis</span>. <i>Br. J. Haematol.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">559</span>– <span class="NLM_lpage">564</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2141.1987.tb01344.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1111%2Fj.1365-2141.1987.tb01344.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=3663512" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=1%3ACAS%3A280%3ADyaL1c%252FisVOrsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=1987&pages=559-564&author=A.+N.+Baerauthor=E.+N.+Dessyprisauthor=E.+Goldwasserauthor=S.+B.+Krantz&title=Blunted+erythropoietin+response+to+anaemia+in+rheumatoid+arthritis&doi=10.1111%2Fj.1365-2141.1987.tb01344.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Blunted erythropoietin response to anaemia in rheumatoid arthritis</span></div><div class="casAuthors">Baer A N; Dessypris E N; Goldwasser E; Krantz S B</div><div class="citationInfo"><span class="NLM_cas:title">British journal of haematology</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">559-64</span>
        ISSN:<span class="NLM_cas:issn">0007-1048</span>.
    </div><div class="casAbstract">The relationship of serum immunoreactive erythropoietin to haemoglobin concentration was defined for 54 patients with rheumatoid arthritis (RA) and 41 patients with anaemia of varying aetiology (excluding pregnancy and renal insufficiency), not associated with RA.  Significant inverse correlations between the logarithm of serum immunoreactive erythropoietin and the haemoglobin concentration were noted for the anaemic patients in both groups.  The regression line for the RA patients had a similar slope, but a significantly lower y-intercept as compared to that for the non-RA patients.  Erythropoietin levels were also significantly lower for the group of RA patients than for the group of non-RA patients when matched for comparable haemoglobin concentrations.  These studies suggest that the erythropoietin response to anaemia in RA is intact but blunted relative to that for anaemia of other aetiologies.  Lower levels of serum erythropoietin in anaemic RA patients may contribute to the pathogenesis of their anaemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSh9RcTOZNQYH6oPH0mYWL1fW6udTcc2eamMSmb66mso7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL1c%252FisVOrsQ%253D%253D&md5=4a0958d5574977700738cb4478f1b7cb</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2141.1987.tb01344.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2141.1987.tb01344.x%26sid%3Dliteratum%253Aachs%26aulast%3DBaer%26aufirst%3DA.%2BN.%26aulast%3DDessypris%26aufirst%3DE.%2BN.%26aulast%3DGoldwasser%26aufirst%3DE.%26aulast%3DKrantz%26aufirst%3DS.%2BB.%26atitle%3DBlunted%2520erythropoietin%2520response%2520to%2520anaemia%2520in%2520rheumatoid%2520arthritis%26jtitle%3DBr.%2520J.%2520Haematol.%26date%3D1987%26volume%3D66%26spage%3D559%26epage%3D564%26doi%3D10.1111%2Fj.1365-2141.1987.tb01344.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodnough, L. T.</span></span> <span> </span><span class="NLM_article-title">Anemia of chronic disease</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>352</i></span>,  <span class="NLM_fpage">1011</span>– <span class="NLM_lpage">1023</span>, <span class="refDoi"> DOI: 10.1056/NEJMra041809</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1056%2FNEJMra041809" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=15758012" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=1%3ACAS%3A528%3ADC%252BD2MXit1Wkt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=352&publication_year=2005&pages=1011-1023&author=G.+Weissauthor=L.+T.+Goodnough&title=Anemia+of+chronic+disease&doi=10.1056%2FNEJMra041809"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Anemia of chronic disease</span></div><div class="casAuthors">Weiss, Guenter; Goodnough, Lawrence T.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">352</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1011-1023</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review on pathophysiol. factors of anemia of chronic diseases (dysregulation of the Fe homeostasis, impaired proliferation of erythroid progenitor cells, bluntet erythropoietin response), lab. evaluation (Fe status, erythropoietin), and therapeutic options for the treatment of patients with anemia of chronic disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtoN5biPrYS7Vg90H21EOLACvtfcHk0lg3nLsXZT0ejw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXit1Wkt7Y%253D&md5=bbd706522030bf9e0b333bb442b158e0</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1056%2FNEJMra041809&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra041809%26sid%3Dliteratum%253Aachs%26aulast%3DWeiss%26aufirst%3DG.%26aulast%3DGoodnough%26aufirst%3DL.%2BT.%26atitle%3DAnemia%2520of%2520chronic%2520disease%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2005%26volume%3D352%26spage%3D1011%26epage%3D1023%26doi%3D10.1056%2FNEJMra041809" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pantopoulos, K.</span></span> <span> </span><span class="NLM_article-title">IRP1 regulates erythropoiesis and systemic iron homeostasis by controlling HIF2α mRNA translation</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>122</i></span>,  <span class="NLM_fpage">1658</span>– <span class="NLM_lpage">1668</span>, <span class="refDoi"> DOI: 10.1182/blood-2013-03-492454</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1182%2Fblood-2013-03-492454" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2013&pages=1658-1668&author=N.+Wilkinsonauthor=K.+Pantopoulos&title=IRP1+regulates+erythropoiesis+and+systemic+iron+homeostasis+by+controlling+HIF2%CE%B1+mRNA+translation&doi=10.1182%2Fblood-2013-03-492454"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1182%2Fblood-2013-03-492454&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2013-03-492454%26sid%3Dliteratum%253Aachs%26aulast%3DWilkinson%26aufirst%3DN.%26aulast%3DPantopoulos%26aufirst%3DK.%26atitle%3DIRP1%2520regulates%2520erythropoiesis%2520and%2520systemic%2520iron%2520homeostasis%2520by%2520controlling%2520HIF2%25CE%25B1%2520mRNA%2520translation%26jtitle%3DBlood%26date%3D2013%26volume%3D122%26spage%3D1658%26epage%3D1668%26doi%3D10.1182%2Fblood-2013-03-492454" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Becker, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saad, M.</span></span> <span> </span><span class="NLM_article-title">A new approach to the management of anemia in CKD patients: A review on Roxadustat</span>. <i>Adv. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">848</span>– <span class="NLM_lpage">853</span>, <span class="refDoi"> DOI: 10.1007/s12325-017-0508-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1007%2Fs12325-017-0508-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2017&pages=848-853&author=K.+Beckerauthor=M.+Saad&title=A+new+approach+to+the+management+of+anemia+in+CKD+patients%3A+A+review+on+Roxadustat&doi=10.1007%2Fs12325-017-0508-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1007%2Fs12325-017-0508-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12325-017-0508-9%26sid%3Dliteratum%253Aachs%26aulast%3DBecker%26aufirst%3DK.%26aulast%3DSaad%26aufirst%3DM.%26atitle%3DA%2520new%2520approach%2520to%2520the%2520management%2520of%2520anemia%2520in%2520CKD%2520patients%253A%2520A%2520review%2520on%2520Roxadustat%26jtitle%3DAdv.%2520Ther.%26date%3D2017%26volume%3D34%26spage%3D848%26epage%3D853%26doi%3D10.1007%2Fs12325-017-0508-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Provenzano, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Besarab, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dua, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeig, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poole, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saikali, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saha, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hemmerich, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szczech, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, K. H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neff, T. B.</span></span> <span> </span><span class="NLM_article-title">Roxadustat (FG-4592) versus epoetin alfa for anemia in patients receiving maintenance hemodialysis: a phase 2, randomized, 6-to 19-week, open-label, active-comparator, dose-ranging, safety and exploratory efficacy study</span>. <i>Am. J. Kidney Dis.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">912</span>– <span class="NLM_lpage">924</span>, <span class="refDoi"> DOI: 10.1053/j.ajkd.2015.12.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1053%2Fj.ajkd.2015.12.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=26846333" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFSqu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2016&pages=912-924&author=R.+Provenzanoauthor=A.+Besarabauthor=S.+Wrightauthor=S.+Duaauthor=S.+Zeigauthor=P.+Nguyenauthor=L.+Pooleauthor=K.+G.+Saikaliauthor=G.+Sahaauthor=S.+Hemmerichauthor=L.+Szczechauthor=K.+H.+P.+Yuauthor=T.+B.+Neff&title=Roxadustat+%28FG-4592%29+versus+epoetin+alfa+for+anemia+in+patients+receiving+maintenance+hemodialysis%3A+a+phase+2%2C+randomized%2C+6-to+19-week%2C+open-label%2C+active-comparator%2C+dose-ranging%2C+safety+and+exploratory+efficacy+study&doi=10.1053%2Fj.ajkd.2015.12.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Roxadustat (FG-4592) Versus Epoetin Alfa for Anemia in Patients Receiving Maintenance Hemodialysis: A Phase 2, Randomized, 6- to 19-Week, Open-Label, Active-Comparator, Dose-Ranging, Safety and Exploratory Efficacy Study</span></div><div class="casAuthors">Provenzano, Robert; Besarab, Anatole; Wright, Steven; Dua, Sohan; Zeig, Steven; Nguyen, Peter; Poole, Lona; Saikali, Khalil G.; Saha, Gopal; Hemmerich, Stefan; Szczech, Lynda; Yu, K. H. Peony; Neff, Thomas B.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Kidney Diseases</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">912-924</span>CODEN:
                <span class="NLM_cas:coden">AJKDDP</span>;
        ISSN:<span class="NLM_cas:issn">0272-6386</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Roxadustat (FG-4592) is an oral hypoxia-inducible factor prolyl-hydroxylase inhibitor that promotes erythropoiesis through increasing endogenous erythropoietin, improving iron regulation, and reducing hepcidin.  Phase 2, randomized (3:1), open-label, active-comparator, safety and efficacy study.  Patients with stable end-stage renal disease treated with hemodialysis who previously had Hb (Hb) levels maintained with epoetin alfa.  Part 1: 6-wk dose-ranging study in 54 individuals of thrice-weekly oral roxadustat doses vs. continuation of i.v. epoetin alfa.  Part 2: 19-wk treatment in 90 individuals in 6 cohorts with various starting doses and adjustment rules (1.0-2.0 mg/kg or tiered wt. based) in individuals with a range of epoetin alfa responsiveness.  I.v. iron was prohibited.  Primary end point was Hb level response, defined as end-of-treatment Hb level change (ΔHb) of -0.5 g/dL or greater from baseline (part 1) and as mean Hb level ≥ 11.0 g/dL during the last 4 treatment weeks (part 2).  Hepcidin, iron parameters, cholesterol, and plasma erythropoietin (the latter in a subset).  Baseline epoetin alfa doses were 138.3 ± 51.3 (SD) and 136.3 ± 47.7 U/kg/wk in part 1 and 152.8 ± 80.6 and 173.4 ± 83.7 U/kg/wk in part 2, in individuals randomly assigned to roxadustat and epoetin alfa, resp.  Hb level responder rates in part 1 were 79% in pooled roxadustat 1.5 to 2.0 mg/kg compared to 33% in the epoetin alfa control arm (P = 0.03).  Hepcidin level redn. was greater at roxadustat 2.0 mg/kg vs. epoetin alfa (P < 0.05).  In part 2, the av. roxadustat dose requirement for Hb level maintenance was ∼1.7 mg/kg.  The least-squares-mean ΔHb in roxadustat-treated individuals was comparable to that in epoetin alfa-treated individuals (about -0.5 g/dL) and the least-squares-mean difference in ΔHb between both treatment arms was 0.03 (95% CI, -0.39 to 0.33) g/dL (mixed effect model-repeated measure).  Roxadustat significantly reduced mean total cholesterol levels, not obsd. with epoetin alfa.  No safety concerns were raised.  Short treatment duration and small sample size.  In this phase 2 study of anemia therapy in patients with end-stage renal disease on maintenance hemodialysis therapy, roxadustat was well tolerated and effectively maintained Hb levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3nbuyEB4IJbVg90H21EOLACvtfcHk0lhXzyWnJ7SXCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFSqu70%253D&md5=45cd30b7888f622312a2c13a4a43f610</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1053%2Fj.ajkd.2015.12.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1053%252Fj.ajkd.2015.12.020%26sid%3Dliteratum%253Aachs%26aulast%3DProvenzano%26aufirst%3DR.%26aulast%3DBesarab%26aufirst%3DA.%26aulast%3DWright%26aufirst%3DS.%26aulast%3DDua%26aufirst%3DS.%26aulast%3DZeig%26aufirst%3DS.%26aulast%3DNguyen%26aufirst%3DP.%26aulast%3DPoole%26aufirst%3DL.%26aulast%3DSaikali%26aufirst%3DK.%2BG.%26aulast%3DSaha%26aufirst%3DG.%26aulast%3DHemmerich%26aufirst%3DS.%26aulast%3DSzczech%26aufirst%3DL.%26aulast%3DYu%26aufirst%3DK.%2BH.%2BP.%26aulast%3DNeff%26aufirst%3DT.%2BB.%26atitle%3DRoxadustat%2520%2528FG-4592%2529%2520versus%2520epoetin%2520alfa%2520for%2520anemia%2520in%2520patients%2520receiving%2520maintenance%2520hemodialysis%253A%2520a%2520phase%25202%252C%2520randomized%252C%25206-to%252019-week%252C%2520open-label%252C%2520active-comparator%252C%2520dose-ranging%252C%2520safety%2520and%2520exploratory%2520efficacy%2520study%26jtitle%3DAm.%2520J.%2520Kidney%2520Dis.%26date%3D2016%26volume%3D67%26spage%3D912%26epage%3D924%26doi%3D10.1053%2Fj.ajkd.2015.12.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pandya, V. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joharapurkar, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desai, R. C.</span></span> <span> </span><span class="NLM_article-title">Recent developments in HIF prolyl hydroxylase inhibitors</span>. <i>Med. Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">119</span>– <span class="NLM_lpage">132</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.29200%2Facsmedchemrev-v50.ch5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsVOkur3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2015&pages=119-132&author=V.+B.+Pandyaauthor=A.+A.+Joharapurkarauthor=M.+R.+Jainauthor=R.+C.+Desai&title=Recent+developments+in+HIF+prolyl+hydroxylase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Recent developments in HIF prolyl hydroxylase inhibitors</span></div><div class="casAuthors">Pandya, Vrajesh B.; Joharapurkar, Amit A.; Jain, Mukul R.; Desai, Ranjit C.</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Chemistry Reviews</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">119-133</span>CODEN:
                <span class="NLM_cas:coden">MCREGD</span>;
        ISSN:<span class="NLM_cas:issn">2575-9175</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society, Division of Medicinal Chemistry</span>)
        </div><div class="casAbstract">A review.  This article discuss about the role of HIF prolyl hydroxylase inhibitors involved for management and treatment of muscle degeneration, colitis and anemia in human and animal model including mouse.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyMsuJ4G6nQbVg90H21EOLACvtfcHk0lhXzyWnJ7SXCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsVOkur3E&md5=abac423377e5ed56a532246f85294b18</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.29200%2Facsmedchemrev-v50.ch5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.29200%252Facsmedchemrev-v50.ch5%26sid%3Dliteratum%253Aachs%26aulast%3DPandya%26aufirst%3DV.%2BB.%26aulast%3DJoharapurkar%26aufirst%3DA.%2BA.%26aulast%3DJain%26aufirst%3DM.%2BR.%26aulast%3DDesai%26aufirst%3DR.%2BC.%26atitle%3DRecent%2520developments%2520in%2520HIF%2520prolyl%2520hydroxylase%2520inhibitors%26jtitle%3DMed.%2520Chem.%2520Rev.%26date%3D2015%26volume%3D50%26spage%3D119%26epage%3D132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bernhardt, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiesener, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scigalla, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmieder, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Günzler, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eckardt, K. U.</span></span> <span> </span><span class="NLM_article-title">Inhibition of prolyl hydroxylases increases erythropoietin production in ESRD</span>. <i>J. Am. Soc. Nephrol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">2151</span>– <span class="NLM_lpage">2156</span>, <span class="refDoi"> DOI: 10.1681/ASN.2010010116</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1681%2FASN.2010010116" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=21115615" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktVGh" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2010&pages=2151-2156&author=W.+M.+Bernhardtauthor=M.+S.+Wiesenerauthor=P.+Scigallaauthor=J.+Chouauthor=R.+E.+Schmiederauthor=V.+G%C3%BCnzlerauthor=K.+U.+Eckardt&title=Inhibition+of+prolyl+hydroxylases+increases+erythropoietin+production+in+ESRD&doi=10.1681%2FASN.2010010116"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of prolyl hydroxylases increases erythropoietin production in ESRD</span></div><div class="casAuthors">Bernhardt, Wanja M.; Wiesener, Michael S.; Scigalla, Paul; Chou, James; Schmieder, Roland E.; Guenzler, Volkmar; Eckardt, Kai-Uwe</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Society of Nephrology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2151-2156</span>CODEN:
                <span class="NLM_cas:coden">JASNEU</span>;
        ISSN:<span class="NLM_cas:issn">1046-6673</span>.
    
            (<span class="NLM_cas:orgname">American Society of Nephrology</span>)
        </div><div class="casAbstract">The reasons for inadequate prodn. of erythropoietin (EPO) in patients with ESRD are poorly understood.  A better understanding of EPO regulation, namely oxygen-dependent hydroxylation of the hypoxia-inducible transcription factor (HIF), may enable targeted pharmacol. intervention.  Here, we tested the ability of fibrotic kidneys and extrarenal tissues to produce EPO.  In this phase 1 study, we used an orally active prolyl-hydroxylase inhibitor, FG-2216, to stabilize HIF independent of oxygen availability in 12 hemodialysis (HD) patients, six of whom were anephric, and in six healthy volunteers.  FG-2216 increased plasma EPO levels 30.8-fold in HD patients with kidneys, 14.5-fold in anephric HD patients, and 12.7-fold in healthy volunteers.  These data demonstrate that pharmacol. manipulation of the HIF system can stimulate endogenous EPO prodn.  Furthermore, the data indicate that deranged oxygen sensing-not a loss of EPO prodn. capacity-causes renal anemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpb0kP9T67TN7Vg90H21EOLACvtfcHk0liKHRGcJb8vZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktVGh&md5=1f2be8449fbb1fd87ae38a0faa534b47</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1681%2FASN.2010010116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1681%252FASN.2010010116%26sid%3Dliteratum%253Aachs%26aulast%3DBernhardt%26aufirst%3DW.%2BM.%26aulast%3DWiesener%26aufirst%3DM.%2BS.%26aulast%3DScigalla%26aufirst%3DP.%26aulast%3DChou%26aufirst%3DJ.%26aulast%3DSchmieder%26aufirst%3DR.%2BE.%26aulast%3DG%25C3%25BCnzler%26aufirst%3DV.%26aulast%3DEckardt%26aufirst%3DK.%2BU.%26atitle%3DInhibition%2520of%2520prolyl%2520hydroxylases%2520increases%2520erythropoietin%2520production%2520in%2520ESRD%26jtitle%3DJ.%2520Am.%2520Soc.%2520Nephrol.%26date%3D2010%26volume%3D21%26spage%3D2151%26epage%3D2156%26doi%3D10.1681%2FASN.2010010116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Salnikow, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donald, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruick, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhitkovich, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phang, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasprzak, K. S.</span></span> <span> </span><span class="NLM_article-title">Depletion of intracellular ascorbate by the carcinogenic metals nickel and cobalt results in the induction of hypoxic stress</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>279</i></span>,  <span class="NLM_fpage">40337</span>– <span class="NLM_lpage">40344</span>, <span class="refDoi"> DOI: 10.1074/jbc.M403057200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1074%2Fjbc.M403057200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=15271983" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnslWns74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=40337-40344&author=K.+Salnikowauthor=S.+P.+Donaldauthor=R.+K.+Bruickauthor=A.+Zhitkovichauthor=J.+M.+Phangauthor=K.+S.+Kasprzak&title=Depletion+of+intracellular+ascorbate+by+the+carcinogenic+metals+nickel+and+cobalt+results+in+the+induction+of+hypoxic+stress&doi=10.1074%2Fjbc.M403057200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Depletion of Intracellular Ascorbate by the Carcinogenic Metals Nickel and Cobalt Results in the Induction of Hypoxic Stress</span></div><div class="casAuthors">Salnikow, Konstantin; Donald, Steven P.; Bruick, Richard K.; Zhitkovich, Anatoly; Phang, James M.; Kasprzak, Kazimierz S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">279</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">40337-40344</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Exposure of cells to carcinogenic compds. of nickel(II) and cobalt(II) causes activation of the HIF-1 transcription factor and up-regulates a battery of hypoxia-inducible genes.  However, the mechanism of HIF-1 activation by these metals is not known.  It was shown recently that hydroxylation of prolines in the HIFα subunit of HIF-1 is required for its binding with the von Hippel-Lindau tumor suppressor protein and the subsequent proteasomal destruction.  Responsible prolyl hydroxylases are targets for both nickel(II) and cobalt(II) because degrdn. of a reporter protein contg. the oxygen-dependent degrdn. domain (Pro 402/564) of HIFα was abolished in a von Hippel-Lindau-dependent manner in cells exposed to nickel(II) or cobalt(II).  The enzymic activity of prolyl hydroxylases depends on iron as the activating metal, 2-oxoglutarate as a co-substrate, and ascorbic acid as a cofactor.  Hydroxylase activity can be impaired by the depletion of any of these factors.  The authors found that exposure of cells to nickel(II) or cobalt(II) did not affect the level of intracellular iron.  Instead, nickel(II) or cobalt(II) exposure greatly depleted intracellular ascorbate.  Co-exposure of cells to metals and ascorbate resulted in the increase of intracellular ascorbate and reversed both metal-induced stabilization of HIF-1α and HIF-1-dependent gene transcription.  Because ascorbate is essential for maintaining iron in prolyl hydroxylases in the active iron(II) state, the authors suggest that the obsd. depletion of ascorbate by nickel(II) or cobalt(II) favors iron oxidn. and thus inactivation of the enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVXquIEpSos7Vg90H21EOLACvtfcHk0liKHRGcJb8vZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnslWns74%253D&md5=bdd1dff71413576441f1fc795bb083be</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M403057200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M403057200%26sid%3Dliteratum%253Aachs%26aulast%3DSalnikow%26aufirst%3DK.%26aulast%3DDonald%26aufirst%3DS.%2BP.%26aulast%3DBruick%26aufirst%3DR.%2BK.%26aulast%3DZhitkovich%26aufirst%3DA.%26aulast%3DPhang%26aufirst%3DJ.%2BM.%26aulast%3DKasprzak%26aufirst%3DK.%2BS.%26atitle%3DDepletion%2520of%2520intracellular%2520ascorbate%2520by%2520the%2520carcinogenic%2520metals%2520nickel%2520and%2520cobalt%2520results%2520in%2520the%2520induction%2520of%2520hypoxic%2520stress%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D40337%26epage%3D40344%26doi%3D10.1074%2Fjbc.M403057200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nagle, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y. D.</span></span> <span> </span><span class="NLM_article-title">Natural product-derived small molecule activators of hypoxia-inducible factor-1 (HIF-1)</span>. <i>Curr. Pharm. Des.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">2673</span>– <span class="NLM_lpage">2688</span>, <span class="refDoi"> DOI: 10.2174/138161206777698783</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.2174%2F138161206777698783" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=2673-2688&author=D.+G.+Nagleauthor=Y.+D.+Zhou&title=Natural+product-derived+small+molecule+activators+of+hypoxia-inducible+factor-1+%28HIF-1%29&doi=10.2174%2F138161206777698783"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.2174%2F138161206777698783&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161206777698783%26sid%3Dliteratum%253Aachs%26aulast%3DNagle%26aufirst%3DD.%2BG.%26aulast%3DZhou%26aufirst%3DY.%2BD.%26atitle%3DNatural%2520product-derived%2520small%2520molecule%2520activators%2520of%2520hypoxia-inducible%2520factor-1%2520%2528HIF-1%2529%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2006%26volume%3D12%26spage%3D2673%26epage%3D2688%26doi%3D10.2174%2F138161206777698783" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tsukiyama, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tokuhara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirota, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katsumata, T.</span></span> <span> </span><span class="NLM_article-title">Gallate, the component of HIF-inducing catechins, inhibits HIF prolyl hydroxylase</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>351</i></span>,  <span class="NLM_fpage">234</span>– <span class="NLM_lpage">239</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2006.10.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1016%2Fj.bbrc.2006.10.025" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=351&publication_year=2006&pages=234-239&author=F.+Tsukiyamaauthor=Y.+Nakaiauthor=M.+Yoshidaauthor=T.+Tokuharaauthor=K.+Hirotaauthor=A.+Sakaiauthor=H.+Hayashiauthor=T.+Katsumata&title=Gallate%2C+the+component+of+HIF-inducing+catechins%2C+inhibits+HIF+prolyl+hydroxylase&doi=10.1016%2Fj.bbrc.2006.10.025"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2006.10.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2006.10.025%26sid%3Dliteratum%253Aachs%26aulast%3DTsukiyama%26aufirst%3DF.%26aulast%3DNakai%26aufirst%3DY.%26aulast%3DYoshida%26aufirst%3DM.%26aulast%3DTokuhara%26aufirst%3DT.%26aulast%3DHirota%26aufirst%3DK.%26aulast%3DSakai%26aufirst%3DA.%26aulast%3DHayashi%26aufirst%3DH.%26aulast%3DKatsumata%26aufirst%3DT.%26atitle%3DGallate%252C%2520the%2520component%2520of%2520HIF-inducing%2520catechins%252C%2520inhibits%2520HIF%2520prolyl%2520hydroxylase%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2006%26volume%3D351%26spage%3D234%26epage%3D239%26doi%3D10.1016%2Fj.bbrc.2006.10.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shui, Y. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arbeit, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beebe, D. C.</span></span> <span> </span><span class="NLM_article-title">HIF-1: an age-dependent regulator of lens cell proliferation</span>. <i>Invest. Ophthalmol. Visual Sci.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">4961</span>– <span class="NLM_lpage">4970</span>, <span class="refDoi"> DOI: 10.1167/iovs.08-2118</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1167%2Fiovs.08-2118" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2008&pages=4961-4970&author=Y.+B.+Shuiauthor=J.+M.+Arbeitauthor=R.+S.+Johnsonauthor=D.+C.+Beebe&title=HIF-1%3A+an+age-dependent+regulator+of+lens+cell+proliferation&doi=10.1167%2Fiovs.08-2118"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1167%2Fiovs.08-2118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1167%252Fiovs.08-2118%26sid%3Dliteratum%253Aachs%26aulast%3DShui%26aufirst%3DY.%2BB.%26aulast%3DArbeit%26aufirst%3DJ.%2BM.%26aulast%3DJohnson%26aufirst%3DR.%2BS.%26aulast%3DBeebe%26aufirst%3DD.%2BC.%26atitle%3DHIF-1%253A%2520an%2520age-dependent%2520regulator%2520of%2520lens%2520cell%2520proliferation%26jtitle%3DInvest.%2520Ophthalmol.%2520Visual%2520Sci.%26date%3D2008%26volume%3D49%26spage%3D4961%26epage%3D4970%26doi%3D10.1167%2Fiovs.08-2118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jeon, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, Y.</span></span> <span> </span><span class="NLM_article-title">Quercetin activates an angiogenic pathway, hypoxia inducible factor (HIF)-1-vascular endothelial growth factor, by inhibiting HIF-prolyl hydroxylase: a structural analysis of quercetin for inhibiting HIF-prolyl hydroxylase</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">1676</span>– <span class="NLM_lpage">1684</span>, <span class="refDoi"> DOI: 10.1124/mol.107.034041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1124%2Fmol.107.034041" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2007&pages=1676-1684&author=H.+Jeonauthor=H.+Kimauthor=D.+Choiauthor=D.+Kimauthor=S.+Y.+Parkauthor=Y.+J.+Kimauthor=Y.+M.+Kimauthor=Y.+Jung&title=Quercetin+activates+an+angiogenic+pathway%2C+hypoxia+inducible+factor+%28HIF%29-1-vascular+endothelial+growth+factor%2C+by+inhibiting+HIF-prolyl+hydroxylase%3A+a+structural+analysis+of+quercetin+for+inhibiting+HIF-prolyl+hydroxylase&doi=10.1124%2Fmol.107.034041"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1124%2Fmol.107.034041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.107.034041%26sid%3Dliteratum%253Aachs%26aulast%3DJeon%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DH.%26aulast%3DChoi%26aufirst%3DD.%26aulast%3DKim%26aufirst%3DD.%26aulast%3DPark%26aufirst%3DS.%2BY.%26aulast%3DKim%26aufirst%3DY.%2BJ.%26aulast%3DKim%26aufirst%3DY.%2BM.%26aulast%3DJung%26aufirst%3DY.%26atitle%3DQuercetin%2520activates%2520an%2520angiogenic%2520pathway%252C%2520hypoxia%2520inducible%2520factor%2520%2528HIF%2529-1-vascular%2520endothelial%2520growth%2520factor%252C%2520by%2520inhibiting%2520HIF-prolyl%2520hydroxylase%253A%2520a%2520structural%2520analysis%2520of%2520quercetin%2520for%2520inhibiting%2520HIF-prolyl%2520hydroxylase%26jtitle%3DMol.%2520Pharmacol.%26date%3D2007%26volume%3D71%26spage%3D1676%26epage%3D1684%26doi%3D10.1124%2Fmol.107.034041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baader, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tschank, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baringhaus, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burghard, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guenzler, V.</span></span> <span> </span><span class="NLM_article-title">Inhibition of prolyl 4-hydroxylase by oxalyl amino acid derivatives in vitro, in isolated microsomes and in embryonic chicken tissues</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>300</i></span>,  <span class="NLM_fpage">525</span>– <span class="NLM_lpage">530</span>, <span class="refDoi"> DOI: 10.1042/bj3000525</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1042%2Fbj3000525" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=300&publication_year=1994&pages=525-530&author=E.+Baaderauthor=G.+Tschankauthor=K.+H.+Baringhausauthor=H.+Burghardauthor=V.+Guenzler&title=Inhibition+of+prolyl+4-hydroxylase+by+oxalyl+amino+acid+derivatives+in+vitro%2C+in+isolated+microsomes+and+in+embryonic+chicken+tissues&doi=10.1042%2Fbj3000525"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1042%2Fbj3000525&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj3000525%26sid%3Dliteratum%253Aachs%26aulast%3DBaader%26aufirst%3DE.%26aulast%3DTschank%26aufirst%3DG.%26aulast%3DBaringhaus%26aufirst%3DK.%2BH.%26aulast%3DBurghard%26aufirst%3DH.%26aulast%3DGuenzler%26aufirst%3DV.%26atitle%3DInhibition%2520of%2520prolyl%25204-hydroxylase%2520by%2520oxalyl%2520amino%2520acid%2520derivatives%2520in%2520vitro%252C%2520in%2520isolated%2520microsomes%2520and%2520in%2520embryonic%2520chicken%2520tissues%26jtitle%3DBiochem.%2520J.%26date%3D1994%26volume%3D300%26spage%3D525%26epage%3D530%26doi%3D10.1042%2Fbj3000525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cunliffe, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franklin, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hales, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, G. B.</span></span> <span> </span><span class="NLM_article-title">Novel inhibitors of prolyl 4-hydroxylase. 3. Inhibition by the substrate analog N-oxaloglycine and its derivatives</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">2652</span>– <span class="NLM_lpage">2658</span>, <span class="refDoi"> DOI: 10.1021/jm00092a016</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00092a016" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1992&pages=2652-2658&author=C.+J.+Cunliffeauthor=T.+J.+Franklinauthor=N.+J.+Halesauthor=G.+B.+Hill&title=Novel+inhibitors+of+prolyl+4-hydroxylase.+3.+Inhibition+by+the+substrate+analog+N-oxaloglycine+and+its+derivatives&doi=10.1021%2Fjm00092a016"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fjm00092a016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00092a016%26sid%3Dliteratum%253Aachs%26aulast%3DCunliffe%26aufirst%3DC.%2BJ.%26aulast%3DFranklin%26aufirst%3DT.%2BJ.%26aulast%3DHales%26aufirst%3DN.%2BJ.%26aulast%3DHill%26aufirst%3DG.%2BB.%26atitle%3DNovel%2520inhibitors%2520of%2520prolyl%25204-hydroxylase.%25203.%2520Inhibition%2520by%2520the%2520substrate%2520analog%2520N-oxaloglycine%2520and%2520its%2520derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1992%26volume%3D35%26spage%3D2652%26epage%3D2658%26doi%3D10.1021%2Fjm00092a016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rabinowitz, M. H.</span></span> <span> </span><span class="NLM_article-title">Inhibition of hypoxia-inducible factor prolyl hydroxylase domain oxygen sensors: tricking the body into mounting orchestrated survival and repair responses</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">9369</span>– <span class="NLM_lpage">9402</span>, <span class="refDoi"> DOI: 10.1021/jm400386j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400386j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlGnur3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=9369-9402&author=M.+H.+Rabinowitz&title=Inhibition+of+hypoxia-inducible+factor+prolyl+hydroxylase+domain+oxygen+sensors%3A+tricking+the+body+into+mounting+orchestrated+survival+and+repair+responses&doi=10.1021%2Fjm400386j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Hypoxia-Inducible Factor Prolyl Hydroxylase Domain Oxygen Sensors: Tricking the Body into Mounting Orchestrated Survival and Repair Responses</span></div><div class="casAuthors">Rabinowitz, Michael H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9369-9402</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Hypoxia-inducible factor (HIF) is an oxygen-sensitive dimeric transcription factor that responds to pathophysiol. low O2 tensions via up-regulation, which leads to an orchestrated biol. response to hypoxia.  The HIF prolyl hydroxylase domain (PHD) enzymes are non-heme, iron-contg. dioxygenases requiring for activity both mol. oxygen and 2-oxoglutarate that, under normoxia, selectively hydroxylate proline residues of HIF, initiating proteosomal degrdn. of the latter.  The dependence of HIF protein levels on the concn. of O2 present, mediated by the PHD enzymes, forms the basis for one of the most significant biol. sensor systems of tissue oxygenation in response to ischemic and inflammatory events.  Consequently, pharmacol. inhibition of PHD enzymes, leading to stabilization of HIF, may be of considerable therapeutic potential in treating conditions of tissue stress and injury.  This Perspective reviews the PHDs and small mol. drug discovery efforts.  A crit. view of this challenging field is offered, which addresses potential concerns and highlights exciting possibilities for the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqznH0RcdCELVg90H21EOLACvtfcHk0lgbiG9RBxfyhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlGnur3P&md5=0b22e70db7f97a51c030b332908fdf77</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fjm400386j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400386j%26sid%3Dliteratum%253Aachs%26aulast%3DRabinowitz%26aufirst%3DM.%2BH.%26atitle%3DInhibition%2520of%2520hypoxia-inducible%2520factor%2520prolyl%2520hydroxylase%2520domain%2520oxygen%2520sensors%253A%2520tricking%2520the%2520body%2520into%2520mounting%2520orchestrated%2520survival%2520and%2520repair%2520responses%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D9369%26epage%3D9402%26doi%3D10.1021%2Fjm400386j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Warshakoon, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawamoto, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheville, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renock, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pokross, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winter, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walter, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mekel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evdokimov, A. G.</span></span> <span> </span><span class="NLM_article-title">Structure-based design, synthesis, and SAR evaluation of a new series of 8-hydroxyquinolines as HIF-1α prolyl hydroxylase inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">5517</span>– <span class="NLM_lpage">5522</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2006.08.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1016%2Fj.bmcl.2006.08.040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=16931007" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVSis7%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=5517-5522&author=N.+C.+Warshakoonauthor=S.+Wuauthor=A.+Boyerauthor=R.+Kawamotoauthor=J.+Shevilleauthor=S.+Renockauthor=K.+Xuauthor=M.+Pokrossauthor=S.+Zhouauthor=C.+Winterauthor=R.+Walterauthor=M.+Mekelauthor=A.+G.+Evdokimov&title=Structure-based+design%2C+synthesis%2C+and+SAR+evaluation+of+a+new+series+of+8-hydroxyquinolines+as+HIF-1%CE%B1+prolyl+hydroxylase+inhibitors&doi=10.1016%2Fj.bmcl.2006.08.040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-based design, synthesis, and SAR evaluation of a new series of 8-hydroxyquinolines as HIF-1α prolyl hydroxylase inhibitors</span></div><div class="casAuthors">Warshakoon, Namal C.; Wu, Shengde; Boyer, Angelique; Kawamoto, Richard; Sheville, Justin; Renock, Sean; Xu, Kevin; Pokross, Matthew; Zhou, Songtao; Winter, Carol; Walter, Richard; Mekel, Marlene; Evdokimov, Artem G.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">5517-5522</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A new series of potent 8-hydroxyquinolines was designed based on the newly resolved x-ray crystal structure of EGLN-1.  Both alkyl and aryl 8-hydroxyquinoline-7-carboxyamides were good HIF-1α prolyl hydroxylase (EGLN) inhibitors.  In subsequent VEGF induction assays, these exhibited potent VEGF activity.  In addn., this class of compds. did show the ability to stabilize HIF-1α.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0-NaS_9GWG7Vg90H21EOLACvtfcHk0lj112WMtXqipA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVSis7%252FI&md5=741e058d467a3345e6cfd41293d1dc37</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.08.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.08.040%26sid%3Dliteratum%253Aachs%26aulast%3DWarshakoon%26aufirst%3DN.%2BC.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DBoyer%26aufirst%3DA.%26aulast%3DKawamoto%26aufirst%3DR.%26aulast%3DSheville%26aufirst%3DJ.%26aulast%3DRenock%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DK.%26aulast%3DPokross%26aufirst%3DM.%26aulast%3DZhou%26aufirst%3DS.%26aulast%3DWinter%26aufirst%3DC.%26aulast%3DWalter%26aufirst%3DR.%26aulast%3DMekel%26aufirst%3DM.%26aulast%3DEvdokimov%26aufirst%3DA.%2BG.%26atitle%3DStructure-based%2520design%252C%2520synthesis%252C%2520and%2520SAR%2520evaluation%2520of%2520a%2520new%2520series%2520of%25208-hydroxyquinolines%2520as%2520HIF-1%25CE%25B1%2520prolyl%2520hydroxylase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D5517%26epage%3D5522%26doi%3D10.1016%2Fj.bmcl.2006.08.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McDonough, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flashman, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chowdhury, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohr, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lienard, B. M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zondlo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oldham, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clifton, I. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNeill, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurzeja, R. J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hewitson, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jordan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Syed, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, C. J.</span></span> <span> </span><span class="NLM_article-title">Cellular oxygen sensing: crystal structure of hypoxia-inducible factor prolyl hydroxylase (PHD2)</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">9814</span>– <span class="NLM_lpage">9819</span>, <span class="refDoi"> DOI: 10.1073/pnas.0601283103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1073%2Fpnas.0601283103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=16782814" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=1%3ACAS%3A528%3ADC%252BD28XmvVajt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=9814-9819&author=M.+A.+McDonoughauthor=V.+Liauthor=E.+Flashmanauthor=R.+Chowdhuryauthor=C.+Mohrauthor=B.+M.+R.+Lienardauthor=J.+Zondloauthor=N.+J.+Oldhamauthor=I.+J.+Cliftonauthor=J.+Lewisauthor=L.+A.+McNeillauthor=R.+J.+M.+Kurzejaauthor=K.+S.+Hewitsonauthor=E.+Yangauthor=S.+Jordanauthor=R.+S.+Syedauthor=C.+J.+Schofield&title=Cellular+oxygen+sensing%3A+crystal+structure+of+hypoxia-inducible+factor+prolyl+hydroxylase+%28PHD2%29&doi=10.1073%2Fpnas.0601283103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Cellular oxygen sensing: crystal structure of hypoxia-inducible factor prolyl hydroxylase (PHD2)</span></div><div class="casAuthors">McDonough, Michael A.; Li, Vivian; Flashman, Emily; Chowdhury, Rasheduzzaman; Mohr, Christopher; Lienard, Benoit M. R.; Zondlo, James; Oldham, Neil J.; Clifton, Ian J.; Lewis, Jeffrey; McNeill, Luke A.; Kurzeja, Robert J. M.; Hewitson, Kirsty S.; Yang, Evelyn; Jordan, Steven; Syed, Rashid S.; Schofield, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">9814-9819</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Cellular and physiol. responses to changes in dioxygen levels in metazoans are mediated via the posttranslational oxidn. of hypoxia-inducible transcription factor (HIF).  Hydroxylation of conserved prolyl residues in the HIF-α subunit, catalyzed by HIF prolyl-hydroxylases (PHDs), signals for its proteasomal degrdn.  The requirement of the PHDs for dioxygen links changes in dioxygen levels with the transcriptional regulation of the gene array that enables the cellular response to chronic hypoxia; the PHDs thus act as an oxygen-sensing component of the HIF system, and their inhibition mimics the hypoxic response.  We describe crystal structures of the catalytic domain of human PHD2, an important prolyl-4-hydroxylase in the human hypoxic response in normal cells, in complex with Fe(II) and an inhibitor to 1.7 Å resoln.  PHD2 crystallizes as a homotrimer and contains a double-stranded β-helix core fold common to the Fe(II) and 2-oxoglutarate-dependent dioxygenase family, the residues of which are well conserved in the three human PHD enzymes (PHD 1-3).  The structure provides insights into the hypoxic response, helps to rationalize a clin. obsd. mutation leading to familial erythrocytosis, and will aid in the design of PHD selective inhibitors for the treatment of anemia and ischemic disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbXKAbBi_2YrVg90H21EOLACvtfcHk0lj112WMtXqipA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmvVajt78%253D&md5=2829121b3017e69b547b95ec5f28cd1b</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0601283103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0601283103%26sid%3Dliteratum%253Aachs%26aulast%3DMcDonough%26aufirst%3DM.%2BA.%26aulast%3DLi%26aufirst%3DV.%26aulast%3DFlashman%26aufirst%3DE.%26aulast%3DChowdhury%26aufirst%3DR.%26aulast%3DMohr%26aufirst%3DC.%26aulast%3DLienard%26aufirst%3DB.%2BM.%2BR.%26aulast%3DZondlo%26aufirst%3DJ.%26aulast%3DOldham%26aufirst%3DN.%2BJ.%26aulast%3DClifton%26aufirst%3DI.%2BJ.%26aulast%3DLewis%26aufirst%3DJ.%26aulast%3DMcNeill%26aufirst%3DL.%2BA.%26aulast%3DKurzeja%26aufirst%3DR.%2BJ.%2BM.%26aulast%3DHewitson%26aufirst%3DK.%2BS.%26aulast%3DYang%26aufirst%3DE.%26aulast%3DJordan%26aufirst%3DS.%26aulast%3DSyed%26aufirst%3DR.%2BS.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26atitle%3DCellular%2520oxygen%2520sensing%253A%2520crystal%2520structure%2520of%2520hypoxia-inducible%2520factor%2520prolyl%2520hydroxylase%2520%2528PHD2%2529%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2006%26volume%3D103%26spage%3D9814%26epage%3D9819%26doi%3D10.1073%2Fpnas.0601283103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chowdhury, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonough, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mecinovic, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loenarz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flashman, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hewitson, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Domene, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, C. J.</span></span> <span> </span><span class="NLM_article-title">Structural basis for binding of hypoxia-inducible factor to the oxygen-sensing prolyl hydroxylases</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">981</span>– <span class="NLM_lpage">989</span>, <span class="refDoi"> DOI: 10.1016/j.str.2009.06.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1016%2Fj.str.2009.06.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=19604478" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosV2gsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=981-989&author=R.+Chowdhuryauthor=M.+A.+McDonoughauthor=J.+Mecinovicauthor=C.+Loenarzauthor=E.+Flashmanauthor=K.+S.+Hewitsonauthor=C.+Domeneauthor=C.+J.+Schofield&title=Structural+basis+for+binding+of+hypoxia-inducible+factor+to+the+oxygen-sensing+prolyl+hydroxylases&doi=10.1016%2Fj.str.2009.06.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis for Binding of Hypoxia-Inducible Factor to the Oxygen-Sensing Prolyl Hydroxylases</span></div><div class="casAuthors">Chowdhury, Rasheduzzaman; McDonough, Michael A.; Mecinovic, Jasmin; Loenarz, Christoph; Flashman, Emily; Hewitson, Kirsty S.; Domene, Carmen; Schofield, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">981-989</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The oxygen-dependent hydroxylation of proline residues in the α subunit of hypoxia-inducible transcription factor (HIFα) is central to the hypoxic response in animals.  Prolyl hydroxylation of HIFα increases its binding to the von Hippel-Lindau protein (pVHL), so signaling for degrdn. via the ubiquitin-proteasome system.  The HIF prolyl hydroxylases (PHDs, prolyl hydroxylase domain enzymes) are related to the collagen prolyl hydroxylases, but form unusually stable complexes with their Fe(II) cofactor and 2-oxoglutarate cosubstrate.  We report crystal structures of the catalytic domain of PHD2, the most important of the human PHDs, in complex with the C-terminal oxygen-dependent degrdn. domain of HIF-1α.  Together with biochem. analyses, the results reveal that PHD catalysis involves a mobile region that isolates the hydroxylation site and stabilizes the PHD2.Fe(II).2OG complex.  The results will be of use in the design of PHD inhibitors aimed at treating anemia and ischemic disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqj4EIAtw-X1LVg90H21EOLACvtfcHk0lj112WMtXqipA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosV2gsrY%253D&md5=c0e60731ac33bdbf947cd0227dc86244</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2009.06.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2009.06.002%26sid%3Dliteratum%253Aachs%26aulast%3DChowdhury%26aufirst%3DR.%26aulast%3DMcDonough%26aufirst%3DM.%2BA.%26aulast%3DMecinovic%26aufirst%3DJ.%26aulast%3DLoenarz%26aufirst%3DC.%26aulast%3DFlashman%26aufirst%3DE.%26aulast%3DHewitson%26aufirst%3DK.%2BS.%26aulast%3DDomene%26aufirst%3DC.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26atitle%3DStructural%2520basis%2520for%2520binding%2520of%2520hypoxia-inducible%2520factor%2520to%2520the%2520oxygen-sensing%2520prolyl%2520hydroxylases%26jtitle%3DStructure%26date%3D2009%26volume%3D17%26spage%3D981%26epage%3D989%26doi%3D10.1016%2Fj.str.2009.06.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chan, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atasoylu, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodson, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tumber, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, I. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chowdhury, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gómez-Pérez, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demetriades, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rydzik, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holt-Martyn, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bishop, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Claridge, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawamura, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pugh, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ratcliffe, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, C. J.</span></span> <span> </span><span class="NLM_article-title">Potent and selective triazole-based inhibitors of the hypoxia-inducible factor prolyl-hydroxylases with activity in the murine brain</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">e0132004</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0132004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1371%2Fjournal.pone.0132004" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=e0132004&author=M.+C.+Chanauthor=O.+Atasoyluauthor=E.+Hodsonauthor=A.+Tumberauthor=I.+K.+Leungauthor=R.+Chowdhuryauthor=V.+G%C3%B3mez-P%C3%A9rezauthor=M.+Demetriadesauthor=A.+M.+Rydzikauthor=J.+Holt-Martynauthor=Y.+M.+Tianauthor=T.+Bishopauthor=T.+D.+Claridgeauthor=A.+Kawamuraauthor=C.+W.+Pughauthor=P.+J.+Ratcliffeauthor=C.+J.+Schofield&title=Potent+and+selective+triazole-based+inhibitors+of+the+hypoxia-inducible+factor+prolyl-hydroxylases+with+activity+in+the+murine+brain&doi=10.1371%2Fjournal.pone.0132004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0132004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0132004%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DM.%2BC.%26aulast%3DAtasoylu%26aufirst%3DO.%26aulast%3DHodson%26aufirst%3DE.%26aulast%3DTumber%26aufirst%3DA.%26aulast%3DLeung%26aufirst%3DI.%2BK.%26aulast%3DChowdhury%26aufirst%3DR.%26aulast%3DG%25C3%25B3mez-P%25C3%25A9rez%26aufirst%3DV.%26aulast%3DDemetriades%26aufirst%3DM.%26aulast%3DRydzik%26aufirst%3DA.%2BM.%26aulast%3DHolt-Martyn%26aufirst%3DJ.%26aulast%3DTian%26aufirst%3DY.%2BM.%26aulast%3DBishop%26aufirst%3DT.%26aulast%3DClaridge%26aufirst%3DT.%2BD.%26aulast%3DKawamura%26aufirst%3DA.%26aulast%3DPugh%26aufirst%3DC.%2BW.%26aulast%3DRatcliffe%26aufirst%3DP.%2BJ.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26atitle%3DPotent%2520and%2520selective%2520triazole-based%2520inhibitors%2520of%2520the%2520hypoxia-inducible%2520factor%2520prolyl-hydroxylases%2520with%2520activity%2520in%2520the%2520murine%2520brain%26jtitle%3DPLoS%2520One%26date%3D2015%26volume%3D10%26spage%3De0132004%26doi%3D10.1371%2Fjournal.pone.0132004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span> <span> </span><span class="NLM_article-title">Application of in-vitro screening methods on hypoxia inducible factor prolyl hydroxylase inhibitors</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">3891</span>– <span class="NLM_lpage">3899</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2017.05.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1016%2Fj.bmc.2017.05.026" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=3891-3899&author=Y.+Wuauthor=Z.+Jiangauthor=Q.+Youauthor=X.+Zhang&title=Application+of+in-vitro+screening+methods+on+hypoxia+inducible+factor+prolyl+hydroxylase+inhibitors&doi=10.1016%2Fj.bmc.2017.05.026"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2017.05.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2017.05.026%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DY.%26aulast%3DJiang%26aufirst%3DZ.%26aulast%3DYou%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DX.%26atitle%3DApplication%2520of%2520in-vitro%2520screening%2520methods%2520on%2520hypoxia%2520inducible%2520factor%2520prolyl%2520hydroxylase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2017%26volume%3D25%26spage%3D3891%26epage%3D3899%26doi%3D10.1016%2Fj.bmc.2017.05.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arend, M. P.</span>; <span class="NLM_string-name">Flippin, L. A.</span>; <span class="NLM_string-name">Guenzler-Pukall, V.</span>; <span class="NLM_string-name">Ho, W.-B.</span>; <span class="NLM_string-name">Turtle, E. D.</span>; <span class="NLM_string-name">Du, X.</span></span> <span> </span><span class="NLM_article-title">Nitrogen-Containing Heteroaryl Compounds and their Use in Increasing Endogenous Erythropoietin</span>. <span class="NLM_patent">WO2004108681A1</span>, <span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=M.+P.+Arend&author=L.+A.+Flippin&author=V.+Guenzler-Pukall&author=W.-B.+Ho&author=E.+D.+Turtle&author=X.+Du&title=Nitrogen-Containing+Heteroaryl+Compounds+and+their+Use+in+Increasing+Endogenous+Erythropoietin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DArend%26aufirst%3DM.%2BP.%26atitle%3DNitrogen-Containing%2520Heteroaryl%2520Compounds%2520and%2520their%2520Use%2520in%2520Increasing%2520Endogenous%2520Erythropoietin%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kawamoto, R. M.</span></span> <span> </span><span class="NLM_article-title">Prolyl Hydroxylase Inhibitors and Method of Use</span>. <span class="NLM_patent">WO2008002576A2</span>, <span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=R.+M.+Kawamoto&title=Prolyl+Hydroxylase+Inhibitors+and+Method+of+Use"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKawamoto%26aufirst%3DR.%2BM.%26atitle%3DProlyl%2520Hydroxylase%2520Inhibitors%2520and%2520Method%2520of%2520Use%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fitch, D. M.</span></span> <span> </span><span class="NLM_article-title">Prolyl Hydroxylase Inhibitors</span>. <span class="NLM_patent">WO2009070644A1</span>, <span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=D.+M.+Fitch&title=Prolyl+Hydroxylase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DFitch%26aufirst%3DD.%2BM.%26atitle%3DProlyl%2520Hydroxylase%2520Inhibitors%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Colon, M.</span>; <span class="NLM_string-name">Fitch, D.
M.</span></span> <span> </span><span class="NLM_article-title">Prolyl Hydroxylase Inhibitors</span>.<span class="NLM_patent">WO2009073497A2</span>, <span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=M.+Colon&author=D.%0AM.+Fitch&title=Prolyl+Hydroxylase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DColon%26aufirst%3DM.%26atitle%3DProlyl%2520Hydroxylase%2520Inhibitors%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chai, D.</span>; <span class="NLM_string-name">Fitch, D.
M.</span></span> <span> </span><span class="NLM_article-title">Prolyl Hydroxylase Inhibitors</span>. <span class="NLM_patent">WO2009134847A1</span>, <span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=D.+Chai&author=D.%0AM.+Fitch&title=Prolyl+Hydroxylase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChai%26aufirst%3DD.%26atitle%3DProlyl%2520Hydroxylase%2520Inhibitors%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chai, D.</span>; <span class="NLM_string-name">Fitch, D.
M.</span></span> <span> </span><span class="NLM_article-title">Prolyl Hydroxylase Inhibitors</span>. <span class="NLM_patent">WO2009134850A1</span>, <span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=D.+Chai&author=D.%0AM.+Fitch&title=Prolyl+Hydroxylase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChai%26aufirst%3DD.%26atitle%3DProlyl%2520Hydroxylase%2520Inhibitors%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rosen, M. D.</span>; <span class="NLM_string-name">Rabinowitz, M. H.</span>; <span class="NLM_string-name">Zhao, L. X.</span>; <span class="NLM_string-name">Hocutt, F. M.</span></span> <span> </span><span class="NLM_article-title">Benzimidazole Glycinamides as Prolyl Hydroxylase Inhibitors</span>. <span class="NLM_patent">WO2009134754A1</span>, <span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=M.+D.+Rosen&author=M.+H.+Rabinowitz&author=L.+X.+Zhao&author=F.+M.+Hocutt&title=Benzimidazole+Glycinamides+as+Prolyl+Hydroxylase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DRosen%26aufirst%3DM.%2BD.%26atitle%3DBenzimidazole%2520Glycinamides%2520as%2520Prolyl%2520Hydroxylase%2520Inhibitors%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barrett, T.
D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palomino, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brondstetter, T. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanelakis, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haug, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hua, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hart, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkatesan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosen, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peltier, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sepassi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizzolio, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bembenek, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mirzadegan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabinowitz, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shankley, N. P.</span></span> <span> </span><span class="NLM_article-title">Pharmacological characterization of 1-(5-chloro-6- (trifluoromethoxy)-1H-benzoimidazol-2-yl)-1H-pyrazole-4-carboxylic acid (JNJ-42041935), a potent and selective hypoxia-inducible factor prolyl hydroxylase inhibitor</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">910</span>– <span class="NLM_lpage">920</span>, <span class="refDoi"> DOI: 10.1124/mol.110.070508</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1124%2Fmol.110.070508" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2011&pages=910-920&author=T.%0AD.+Barrettauthor=H.+L.+Palominoauthor=T.+I.+Brondstetterauthor=K.+C.+Kanelakisauthor=X.+Wuauthor=P.+V.+Haugauthor=W.+Yanauthor=A.+Youngauthor=H.+Huaauthor=J.+C.+Hartauthor=D.+T.+Tranauthor=H.+Venkatesanauthor=M.+D.+Rosenauthor=H.+M.+Peltierauthor=K.+Sepassiauthor=M.+C.+Rizzolioauthor=S.+D.+Bembenekauthor=T.+Mirzadeganauthor=M.+H.+Rabinowitzauthor=N.+P.+Shankley&title=Pharmacological+characterization+of+1-%285-chloro-6-+%28trifluoromethoxy%29-1H-benzoimidazol-2-yl%29-1H-pyrazole-4-carboxylic+acid+%28JNJ-42041935%29%2C+a+potent+and+selective+hypoxia-inducible+factor+prolyl+hydroxylase+inhibitor&doi=10.1124%2Fmol.110.070508"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1124%2Fmol.110.070508&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.110.070508%26sid%3Dliteratum%253Aachs%26aulast%3DBarrett%26aufirst%3DT.%2BD.%26aulast%3DPalomino%26aufirst%3DH.%2BL.%26aulast%3DBrondstetter%26aufirst%3DT.%2BI.%26aulast%3DKanelakis%26aufirst%3DK.%2BC.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DHaug%26aufirst%3DP.%2BV.%26aulast%3DYan%26aufirst%3DW.%26aulast%3DYoung%26aufirst%3DA.%26aulast%3DHua%26aufirst%3DH.%26aulast%3DHart%26aufirst%3DJ.%2BC.%26aulast%3DTran%26aufirst%3DD.%2BT.%26aulast%3DVenkatesan%26aufirst%3DH.%26aulast%3DRosen%26aufirst%3DM.%2BD.%26aulast%3DPeltier%26aufirst%3DH.%2BM.%26aulast%3DSepassi%26aufirst%3DK.%26aulast%3DRizzolio%26aufirst%3DM.%2BC.%26aulast%3DBembenek%26aufirst%3DS.%2BD.%26aulast%3DMirzadegan%26aufirst%3DT.%26aulast%3DRabinowitz%26aufirst%3DM.%2BH.%26aulast%3DShankley%26aufirst%3DN.%2BP.%26atitle%3DPharmacological%2520characterization%2520of%25201-%25285-chloro-6-%2520%2528trifluoromethoxy%2529-1H-benzoimidazol-2-yl%2529-1H-pyrazole-4-carboxylic%2520acid%2520%2528JNJ-42041935%2529%252C%2520a%2520potent%2520and%2520selective%2520hypoxia-inducible%2520factor%2520prolyl%2520hydroxylase%2520inhibitor%26jtitle%3DMol.%2520Pharmacol.%26date%3D2011%26volume%3D79%26spage%3D910%26epage%3D920%26doi%3D10.1124%2Fmol.110.070508" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bembenek, S. D.</span>; <span class="NLM_string-name">Hocutt, F. M.</span>; <span class="NLM_string-name">Leonard, B. E.,  Jr.</span>; <span class="NLM_string-name">Rabinowitz, M. H.</span>; <span class="NLM_string-name">Rosen, M. D.</span>; <span class="NLM_string-name">Tarantino, K. T.</span>; <span class="NLM_string-name">Venkatesan, H.</span></span> <span> </span><span class="NLM_article-title">Quinazolinones as Prolyl Hydroxylase Inhibitors</span>. <span class="NLM_patent">WO2010093727A1</span>, <span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=S.+D.+Bembenek&author=F.+M.+Hocutt&author=B.+E.+Leonard&author=M.+H.+Rabinowitz&author=M.+D.+Rosen&author=K.+T.+Tarantino&author=H.+Venkatesan&title=Quinazolinones+as+Prolyl+Hydroxylase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBembenek%26aufirst%3DS.%2BD.%26atitle%3DQuinazolinones%2520as%2520Prolyl%2520Hydroxylase%2520Inhibitors%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barrett, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palomino, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brondstetter, T. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanelakis, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merton, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schoetens, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skaptason, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, D.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkatesan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosen, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shankley, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabinowitz, M. H.</span></span> <span> </span><span class="NLM_article-title">Prolyl hydroxylase inhibition corrects functional iron deficiency and inflammation-induced anaemia in rats</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>172</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">4078</span>– <span class="NLM_lpage">4088</span>, <span class="refDoi"> DOI: 10.1111/bph.13188</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1111%2Fbph.13188" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=25988595" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVOhurnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=172&publication_year=2015&pages=4078-4088&issue=16&author=T.+D.+Barrettauthor=H.+L.+Palominoauthor=T.+I.+Brondstetterauthor=K.+C.+Kanelakisauthor=X.+Wuauthor=W.+Yanauthor=K.+P.+Mertonauthor=F.+Schoetensauthor=J.+Y.+Maauthor=J.+Skaptasonauthor=J.+Gaoauthor=D.-T.+Tranauthor=H.+Venkatesanauthor=M.+D.+Rosenauthor=N.+P.+Shankleyauthor=M.+H.+Rabinowitz&title=Prolyl+hydroxylase+inhibition+corrects+functional+iron+deficiency+and+inflammation-induced+anaemia+in+rats&doi=10.1111%2Fbph.13188"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Prolyl hydroxylase inhibition corrects functional iron deficiency and inflammation-induced anaemia in rats</span></div><div class="casAuthors">Barrett, Terrance D.; Palomino, Heather L.; Brondstetter, Theresa I.; Kanelakis, Kimon C.; Wu, Xiaodong; Yan, Wen; Merton, Katherine P.; Schoetens, Freddy; Ma, Jing Ying; Skaptason, Judy; Gao, Jingjin; Tran, Da-Thao; Venkatesan, Hariharan; Rosen, Mark D.; Shankley, Nigel P.; Rabinowitz, Michael H.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">172</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">4078-4088</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose : Small-mol. inhibitors of prolyl hydroxylase (PHD) enzymes are a novel target for the treatment of anemia and functional iron deficiency (FID).  Other than being orally bioavailable, the differentiation of PHD inhibitors from recombinant human erythropoietin (rhEPO) has not been demonstrated.  Exptl. Approach : JNJ-42905343 was identified and characterized as a novel inhibitor of PHD and its action was compared with rhEPO in healthy rats and in a rat model of inflammation-induced anemia and FID [peptidoglycan-polysaccharide (PGPS) model].  Key Results : Oral administration of JNJ-42905343 to healthy rats increased the gene expression of cytochrome b (DcytB) and divalent metal-ion transporter 1 (DMT1) in the duodenum, and increased plasma EPO.  Repeated administration of JNJ-42905343 for 28 days increased blood Hb, mean corpuscular Hb (MCH) and mean corpuscular vol. (MCV).  The serum iron concn. was increased with low doses (0.3 mg·kg-1) but reduced at high doses (6 mg·kg-1).  In PGPS-treated rats, administration of JNJ-42905343 for 28 days cor. FID and anemia, as reflected by increased blood Hb, MCH and MCV.  Increased expression of DcytB and DMT1 genes in the duodenum resulting in increased iron availability was defined as the mechanism for these effects. rhEPO did not affect DcytB and DMT1 and was not effective in PGPS-treated rats.  Conclusions and Implications : PHD inhibition has a beneficial effect on iron metab. in addn. to stimulating the release of EPO.  Small-mol. inhibitors of PHD such as JNJ-42905343 represent a mechanism distinct from rhEPO to treat anemia and FID.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDLib9Ge_SCLVg90H21EOLACvtfcHk0li3TJPoF88Ajg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVOhurnM&md5=a6174cd68a11e9240f4e1a879e571819</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1111%2Fbph.13188&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.13188%26sid%3Dliteratum%253Aachs%26aulast%3DBarrett%26aufirst%3DT.%2BD.%26aulast%3DPalomino%26aufirst%3DH.%2BL.%26aulast%3DBrondstetter%26aufirst%3DT.%2BI.%26aulast%3DKanelakis%26aufirst%3DK.%2BC.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DYan%26aufirst%3DW.%26aulast%3DMerton%26aufirst%3DK.%2BP.%26aulast%3DSchoetens%26aufirst%3DF.%26aulast%3DMa%26aufirst%3DJ.%2BY.%26aulast%3DSkaptason%26aufirst%3DJ.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DTran%26aufirst%3DD.-T.%26aulast%3DVenkatesan%26aufirst%3DH.%26aulast%3DRosen%26aufirst%3DM.%2BD.%26aulast%3DShankley%26aufirst%3DN.%2BP.%26aulast%3DRabinowitz%26aufirst%3DM.%2BH.%26atitle%3DProlyl%2520hydroxylase%2520inhibition%2520corrects%2520functional%2520iron%2520deficiency%2520and%2520inflammation-induced%2520anaemia%2520in%2520rats%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2015%26volume%3D172%26issue%3D16%26spage%3D4078%26epage%3D4088%26doi%3D10.1111%2Fbph.13188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rabinowitz, M. H.</span>; <span class="NLM_string-name">Rosen, M. D.</span>; <span class="NLM_string-name">Tarantino, K. T.</span>; <span class="NLM_string-name">Venkatesan, H.</span></span> <span> </span><span class="NLM_article-title">1-(4-Aminoquinazolin-2-yl)-1<i>H</i>-pyrazole-4-carboxylic Acid Compound as Prolyl Hydroxylase Inhibitors</span>. <span class="NLM_patent">WO2012021830A1</span>, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=M.+H.+Rabinowitz&author=M.+D.+Rosen&author=K.+T.+Tarantino&author=H.+Venkatesan&title=1-%284-Aminoquinazolin-2-yl%29-1H-pyrazole-4-carboxylic+Acid+Compound+as+Prolyl+Hydroxylase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DRabinowitz%26aufirst%3DM.%2BH.%26atitle%3D1-%25284-Aminoquinazolin-2-yl%2529-1H-pyrazole-4-carboxylic%2520Acid%2520Compound%2520as%2520Prolyl%2520Hydroxylase%2520Inhibitors%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Seeley, T. W.</span></span> <span> </span><span class="NLM_article-title">Novel and beneficial pharmacodynamic properties of endogenous EPO and ‘complete erythropoiesis’ induced by selective HIF prolyl hydroxylase inhibitors</span>. <i>J. Am. Soc. Nephrol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">761A</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2005&pages=761A&author=T.+W.+Seeley&title=Novel+and+beneficial+pharmacodynamic+properties+of+endogenous+EPO+and+%E2%80%98complete+erythropoiesis%E2%80%99+induced+by+selective+HIF+prolyl+hydroxylase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSeeley%26aufirst%3DT.%2BW.%26atitle%3DNovel%2520and%2520beneficial%2520pharmacodynamic%2520properties%2520of%2520endogenous%2520EPO%2520and%2520%25E2%2580%2598complete%2520erythropoiesis%25E2%2580%2599%2520induced%2520by%2520selective%2520HIF%2520prolyl%2520hydroxylase%2520inhibitors%26jtitle%3DJ.%2520Am.%2520Soc.%2520Nephrol.%26date%3D2005%26volume%3D16%26spage%3D761A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Macdougall, I. C.</span></span> <span> </span><span class="NLM_article-title">New anemia therapies: translating novel strategies from bench to bedside</span>. <i>Am. J. Kidney Dis.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">444</span>– <span class="NLM_lpage">451</span>, <span class="refDoi"> DOI: 10.1053/j.ajkd.2011.11.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1053%2Fj.ajkd.2011.11.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=22192713" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=1%3ACAS%3A280%3ADC%252BC383jsl2gtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2012&pages=444-451&author=I.+C.+Macdougall&title=New+anemia+therapies%3A+translating+novel+strategies+from+bench+to+bedside&doi=10.1053%2Fj.ajkd.2011.11.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">New anemia therapies: translating novel strategies from bench to bedside</span></div><div class="casAuthors">Macdougall Iain C</div><div class="citationInfo"><span class="NLM_cas:title">American journal of kidney diseases : the official journal of the National Kidney Foundation</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">444-51</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Recombinant human erythropoietin (epoetin) has been available for the treatment of renal anemia for more than 20 years, and within the last decade two molecularly engineered analogues darbepoetin alfa and pegylated epoetin beta were introduced as longer-acting erythropoiesis-stimulating agents.  Recently, newer strategies for correcting anemia have been explored, some of which remain in the laboratory while others are translating across into clinical trials.  Peginesatide has completed phase 3 clinical trials for the treatment of anemia associated with chronic kidney disease; this molecule is immunologically distinct from the erythropoietic proteins, with no cross-reactivity with anti-erythropoietin antibodies.  HIF (hypoxia inducible factor) stabilization involves the pharmacologic inhibition of prolyl hydroxylation of HIF-α (the major transcription factor controlling erythropoietin gene expression), thereby preventing its degradation in the proteasome.  Hepcidin is the master regulator of iron metabolism, and this peptide is upregulated in inflammatory conditions, including uremia; its antagonism has been shown to cause amelioration of inflammatory anemia in animal models.  For the time being, erythropoiesis-stimulating agent therapy remains the mainstay of anemia management in chronic kidney disease, but it is possible that one or more of the strategies discussed in this review may have a future role in the treatment of this condition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSUtCOJzerupCEJCPKhJPuqfW6udTcc2eYoqZhXegDC77ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC383jsl2gtQ%253D%253D&md5=066b3c9437dc448d2f96a5fd552a2ef5</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1053%2Fj.ajkd.2011.11.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1053%252Fj.ajkd.2011.11.013%26sid%3Dliteratum%253Aachs%26aulast%3DMacdougall%26aufirst%3DI.%2BC.%26atitle%3DNew%2520anemia%2520therapies%253A%2520translating%2520novel%2520strategies%2520from%2520bench%2520to%2520bedside%26jtitle%3DAm.%2520J.%2520Kidney%2520Dis.%26date%3D2012%26volume%3D59%26spage%3D444%26epage%3D451%26doi%3D10.1053%2Fj.ajkd.2011.11.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guenzler-Pukall, V.</span>; <span class="NLM_string-name">Wang, Q.</span>; <span class="NLM_string-name">Langsetmo, P. I.</span>; <span class="NLM_string-name">Guo, G.</span></span> <span> </span><span class="NLM_article-title">Methods for Reducing Blood Pressure</span>. <span class="NLM_patent">WO2009058403A1</span>, <span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=V.+Guenzler-Pukall&author=Q.+Wang&author=P.+I.+Langsetmo&author=G.+Guo&title=Methods+for+Reducing+Blood+Pressure"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGuenzler-Pukall%26aufirst%3DV.%26atitle%3DMethods%2520for%2520Reducing%2520Blood%2520Pressure%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Long, W.</span>; <span class="NLM_string-name">Zhang, J.</span>; <span class="NLM_string-name">Hu, Y.</span>; <span class="NLM_string-name">Wang, Y.</span></span> <span> </span><span class="NLM_article-title">Polymorphic Forms of Compounds as Prolyl Hydroxylase Inhibitor, and Uses Thereof</span>. <span class="NLM_patent">WO2013013609A1</span>, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=W.+Long&author=J.+Zhang&author=Y.+Hu&author=Y.+Wang&title=Polymorphic+Forms+of+Compounds+as+Prolyl+Hydroxylase+Inhibitor%2C+and+Uses+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLong%26aufirst%3DW.%26atitle%3DPolymorphic%2520Forms%2520of%2520Compounds%2520as%2520Prolyl%2520Hydroxylase%2520Inhibitor%252C%2520and%2520Uses%2520Thereof%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ho, W. B.</span>; <span class="NLM_string-name">Zhao, H.</span>; <span class="NLM_string-name">Deng, S.</span>; <span class="NLM_string-name">NG, D.</span>; <span class="NLM_string-name">Wright, L. R.</span>; <span class="NLM_string-name">Wu, M.</span>; <span class="NLM_string-name">Xiaoti, Z.</span>; <span class="NLM_string-name">Arend, M. P.</span>; <span class="NLM_string-name">Flippin, L. A.</span></span> <span> </span><span class="NLM_article-title">4-Hydroxy-isoquinoline Compounds as HIF Hydroxylase Inhibitors</span>. <span class="NLM_patent">US 20150038528</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=W.+B.+Ho&author=H.+Zhao&author=S.+Deng&author=D.+NG&author=L.+R.+Wright&author=M.+Wu&author=Z.+Xiaoti&author=M.+P.+Arend&author=L.+A.+Flippin&title=4-Hydroxy-isoquinoline+Compounds+as+HIF+Hydroxylase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHo%26aufirst%3DW.%2BB.%26atitle%3D4-Hydroxy-isoquinoline%2520Compounds%2520as%2520HIF%2520Hydroxylase%2520Inhibitors%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span>; <span class="NLM_string-name">Cai, S.</span>; <span class="NLM_string-name">Wang, G.</span>; <span class="NLM_string-name">Jiao, L.</span>; <span class="NLM_string-name">Min, P.</span>; <span class="NLM_string-name">Jing, Y.</span>; <span class="NLM_string-name">Guo, M.</span></span> <span> </span><span class="NLM_article-title">Compound of 5-Hydroxyl-1,7-naphthyridine Substituted by Aryl or Heteroaryl, Preparation Method Thereof and Pharmaceutical Use Thereof</span>. <span class="NLM_patent">WO2016155358A1</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=Y.+Zhou&author=S.+Cai&author=G.+Wang&author=L.+Jiao&author=P.+Min&author=Y.+Jing&author=M.+Guo&title=Compound+of+5-Hydroxyl-1%2C7-naphthyridine+Substituted+by+Aryl+or+Heteroaryl%2C+Preparation+Method+Thereof+and+Pharmaceutical+Use+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DY.%26atitle%3DCompound%2520of%25205-Hydroxyl-1%252C7-naphthyridine%2520Substituted%2520by%2520Aryl%2520or%2520Heteroaryl%252C%2520Preparation%2520Method%2520Thereof%2520and%2520Pharmaceutical%2520Use%2520Thereof%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span>; <span class="NLM_string-name">Cai, S.</span>; <span class="NLM_string-name">Wang, G.</span>; <span class="NLM_string-name">Jiao, L.</span>; <span class="NLM_string-name">Min, P.</span>; <span class="NLM_string-name">Jing, Y.</span>; <span class="NLM_string-name">Guo, M.</span></span> <span> </span><span class="NLM_article-title">Compound of 5-Hydroxyl-1,7-naphthyridine Substituted by Aryloxy or Heteroaryloxy, Preparation Method Thereof and Pharmaceutical Use Thereof</span>. <span class="NLM_patent">WO2016155357A1</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=Y.+Zhou&author=S.+Cai&author=G.+Wang&author=L.+Jiao&author=P.+Min&author=Y.+Jing&author=M.+Guo&title=Compound+of+5-Hydroxyl-1%2C7-naphthyridine+Substituted+by+Aryloxy+or+Heteroaryloxy%2C+Preparation+Method+Thereof+and+Pharmaceutical+Use+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DY.%26atitle%3DCompound%2520of%25205-Hydroxyl-1%252C7-naphthyridine%2520Substituted%2520by%2520Aryloxy%2520or%2520Heteroaryloxy%252C%2520Preparation%2520Method%2520Thereof%2520and%2520Pharmaceutical%2520Use%2520Thereof%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kawamoto, R. M.</span></span> <span> </span><span class="NLM_article-title">Prolyl Hydroxylase Inhibitors and Method of Use</span>. <span class="NLM_patent">WO2008002576A2</span>, <span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=R.+M.+Kawamoto&title=Prolyl+Hydroxylase+Inhibitors+and+Method+of+Use"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKawamoto%26aufirst%3DR.%2BM.%26atitle%3DProlyl%2520Hydroxylase%2520Inhibitors%2520and%2520Method%2520of%2520Use%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shalwitz, R.</span>; <span class="NLM_string-name">Gardner, J. H.</span>; <span class="NLM_string-name">Janusz, J. M.</span></span> <span> </span><span class="NLM_article-title">Compounds and Compositions for Stabilizing Hypoxia Inducible Factor-2 alpha as a Method for Treating Cancer</span>. <span class="NLM_patent">WO2012170442A1</span>, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=R.+Shalwitz&author=J.+H.+Gardner&author=J.+M.+Janusz&title=Compounds+and+Compositions+for+Stabilizing+Hypoxia+Inducible+Factor-2+alpha+as+a+Method+for+Treating+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DShalwitz%26aufirst%3DR.%26atitle%3DCompounds%2520and%2520Compositions%2520for%2520Stabilizing%2520Hypoxia%2520Inducible%2520Factor-2%2520alpha%2520as%2520a%2520Method%2520for%2520Treating%2520Cancer%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Copp, J. D.</span>; <span class="NLM_string-name">Newman, A. W.</span>; <span class="NLM_string-name">Luong, A.</span></span> <span> </span><span class="NLM_article-title">Solid Forms of {[5-(3-Chlorophenyl)-3-Hydroxypyridine-2-carbonyl]amino}acetic acid, Compositions, and Uses Thereof</span>. <span class="NLM_patent">WO2015073779A1</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=J.+D.+Copp&author=A.+W.+Newman&author=A.+Luong&title=Solid+Forms+of+%7B%5B5-%283-Chlorophenyl%29-3-Hydroxypyridine-2-carbonyl%5Damino%7Dacetic+acid%2C+Compositions%2C+and+Uses+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCopp%26aufirst%3DJ.%2BD.%26atitle%3DSolid%2520Forms%2520of%2520%257B%255B5-%25283-Chlorophenyl%2529-3-Hydroxypyridine-2-carbonyl%255Damino%257Dacetic%2520acid%252C%2520Compositions%252C%2520and%2520Uses%2520Thereof%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lanthier, C. M.</span>; <span class="NLM_string-name">Boris, G.</span>; <span class="NLM_string-name">Jan, O.</span>; <span class="NLM_string-name">Edward, D. C.</span>; <span class="NLM_string-name">Quigbo, L. A.</span>; <span class="NLM_string-name">Densmore, C. J.</span>; <span class="NLM_string-name">Michael, J. J.</span></span> <span> </span><span class="NLM_article-title">Process for Preparing [(3-Hydroxypyridine-2-carbonyl)amino]alkanoic Acids, Esters and Amides</span>. <span class="NLM_patent">WO2012170377A1</span>, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=C.+M.+Lanthier&author=G.+Boris&author=O.+Jan&author=D.+C.+Edward&author=L.+A.+Quigbo&author=C.+J.+Densmore&author=J.+J.+Michael&title=Process+for+Preparing+%5B%283-Hydroxypyridine-2-carbonyl%29amino%5Dalkanoic+Acids%2C+Esters+and+Amides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLanthier%26aufirst%3DC.%2BM.%26atitle%3DProcess%2520for%2520Preparing%2520%255B%25283-Hydroxypyridine-2-carbonyl%2529amino%255Dalkanoic%2520Acids%252C%2520Esters%2520and%2520Amides%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Daly, W.</span>; <span class="NLM_string-name">Shalwitz, R.</span></span> <span> </span><span class="NLM_article-title">Compositions and Method for Treating Ocular Diseases</span>. <span class="NLM_patent">WO2015112831A1</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=W.+Daly&author=R.+Shalwitz&title=Compositions+and+Method+for+Treating+Ocular+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDaly%26aufirst%3DW.%26atitle%3DCompositions%2520and%2520Method%2520for%2520Treating%2520Ocular%2520Diseases%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A.</span>; <span class="NLM_string-name">Chandorkar, G. A.</span>; <span class="NLM_string-name">Ette, E. I.</span>; <span class="NLM_string-name">Maroni, B. J.</span>; <span class="NLM_string-name">Hartman, C. S.</span>; <span class="NLM_string-name">Farzaneh-Far, R.</span>; <span class="NLM_string-name">Inrig, J.
K.</span></span> <span> </span><span class="NLM_article-title">Compositions and Method for Treating Anemia</span>. <span class="NLM_patent">WO2016161094A1</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=A.+Smith&author=G.+A.+Chandorkar&author=E.+I.+Ette&author=B.+J.+Maroni&author=C.+S.+Hartman&author=R.+Farzaneh-Far&author=J.%0AK.+Inrig&title=Compositions+and+Method+for+Treating+Anemia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DA.%26atitle%3DCompositions%2520and%2520Method%2520for%2520Treating%2520Anemia%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hanselmann, R.</span></span> <span> </span><span class="NLM_article-title">Deuterium-Enriched Hypoxia-Inducible Factor Prolyl Hydroxylase Enzyme Inhibitors</span>. <span class="NLM_patent">WO2016153996A1</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=R.+Hanselmann&title=Deuterium-Enriched+Hypoxia-Inducible+Factor+Prolyl+Hydroxylase+Enzyme+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHanselmann%26aufirst%3DR.%26atitle%3DDeuterium-Enriched%2520Hypoxia-Inducible%2520Factor%2520Prolyl%2520Hydroxylase%2520Enzyme%2520Inhibitors%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span>; <span class="NLM_string-name">You, Q.</span>; <span class="NLM_string-name">Lei, Y.</span>; <span class="NLM_string-name">Hu, T.</span>; <span class="NLM_string-name">Wu, X.</span>; <span class="NLM_string-name">Sun, H.</span>; <span class="NLM_string-name">Guo, X.</span>; <span class="NLM_string-name">Xu, X.</span></span> <span> </span><span class="NLM_article-title">Alkynyl Pyridine Prolyl Hydroxylase Inhibitor, and Preparation Method and Medical Use Thereof</span>. <span class="NLM_patent">WO2017059623A1</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=X.+Zhang&author=Q.+You&author=Y.+Lei&author=T.+Hu&author=X.+Wu&author=H.+Sun&author=X.+Guo&author=X.+Xu&title=Alkynyl+Pyridine+Prolyl+Hydroxylase+Inhibitor%2C+and+Preparation+Method+and+Medical+Use+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26atitle%3DAlkynyl%2520Pyridine%2520Prolyl%2520Hydroxylase%2520Inhibitor%252C%2520and%2520Preparation%2520Method%2520and%2520Medical%2520Use%2520Thereof%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nakajima, T.</span>; <span class="NLM_string-name">Goi, T.</span>; <span class="NLM_string-name">Kawata, A.</span>; <span class="NLM_string-name">Sugahara, M.</span>; <span class="NLM_string-name">Yamakoshi, S.</span></span> <span> </span><span class="NLM_article-title">Pyrazolopyrimidine Compound</span>. <span class="NLM_patent">WO2014030716A1</span>, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=T.+Nakajima&author=T.+Goi&author=A.+Kawata&author=M.+Sugahara&author=S.+Yamakoshi&title=Pyrazolopyrimidine+Compound"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DNakajima%26aufirst%3DT.%26atitle%3DPyrazolopyrimidine%2520Compound%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, C.</span>; <span class="NLM_string-name">Zou, W.</span>; <span class="NLM_string-name">Hua, Y.</span>; <span class="NLM_string-name">Dang, Q.</span></span> <span> </span><span class="NLM_article-title">Substituted Pyrimidines</span>. <span class="NLM_patent">WO2013040789A1</span>, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=C.+Zhou&author=W.+Zou&author=Y.+Hua&author=Q.+Dang&title=Substituted+Pyrimidines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DC.%26atitle%3DSubstituted%2520Pyrimidines%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dang, Q.</span>; <span class="NLM_string-name">Zhou, C.</span>; <span class="NLM_string-name">Zou, W.</span>; <span class="NLM_string-name">Hua, Y.</span></span> <span> </span><span class="NLM_article-title">Substituted Pyrimidines</span>. <span class="NLM_patent">WO2013043621A1</span>, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=Q.+Dang&author=C.+Zhou&author=W.+Zou&author=Y.+Hua&title=Substituted+Pyrimidines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDang%26aufirst%3DQ.%26atitle%3DSubstituted%2520Pyrimidines%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ujjainwalla, F.</span>; <span class="NLM_string-name">Tan, J. Q.</span>; <span class="NLM_string-name">Dang, Q.</span>; <span class="NLM_string-name">Sinz, C.
J.</span>; <span class="NLM_string-name">Wang, M.</span>; <span class="NLM_string-name">Chen, Y.</span>; <span class="NLM_string-name">Cai, J.</span>; <span class="NLM_string-name">Du, X.</span></span> <span> </span><span class="NLM_article-title">Substituted Pyridine Inhibitors of HIF Prolyl Hydroxylase</span>. <span class="NLM_patent">WO2016054806A1</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=F.+Ujjainwalla&author=J.+Q.+Tan&author=Q.+Dang&author=C.%0AJ.+Sinz&author=M.+Wang&author=Y.+Chen&author=J.+Cai&author=X.+Du&title=Substituted+Pyridine+Inhibitors+of+HIF+Prolyl+Hydroxylase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DUjjainwalla%26aufirst%3DF.%26atitle%3DSubstituted%2520Pyridine%2520Inhibitors%2520of%2520HIF%2520Prolyl%2520Hydroxylase%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ujjainwalla, F.</span>; <span class="NLM_string-name">Tan, J. Q.</span>; <span class="NLM_string-name">Dang, Q.</span>; <span class="NLM_string-name">Sinz, C.
J.</span>; <span class="NLM_string-name">Wang, M.</span>; <span class="NLM_string-name">Cai, J.</span>; <span class="NLM_string-name">Du, X.</span>; <span class="NLM_string-name">Chen, Y.</span></span> <span> </span><span class="NLM_article-title">Substituted Pyridine Inhibitors of HIF Prolyl Hydroxylase</span>. <span class="NLM_patent">WO2016057743A1</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=F.+Ujjainwalla&author=J.+Q.+Tan&author=Q.+Dang&author=C.%0AJ.+Sinz&author=M.+Wang&author=J.+Cai&author=X.+Du&author=Y.+Chen&title=Substituted+Pyridine+Inhibitors+of+HIF+Prolyl+Hydroxylase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DUjjainwalla%26aufirst%3DF.%26atitle%3DSubstituted%2520Pyridine%2520Inhibitors%2520of%2520HIF%2520Prolyl%2520Hydroxylase%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ujjainwalla, F.</span>; <span class="NLM_string-name">Tan, J. Q.</span>; <span class="NLM_string-name">Dang, Q.</span>; <span class="NLM_string-name">Sinz, C.
J.</span>; <span class="NLM_string-name">Crespo, A.</span>; <span class="NLM_string-name">Wang, M.</span>; <span class="NLM_string-name">Chen, Y.</span>; <span class="NLM_string-name">Cai, J.</span>; <span class="NLM_string-name">Wu, F.</span>; <span class="NLM_string-name">Du, X.</span></span> <span> </span><span class="NLM_article-title">Substituted Pyrimidine as Inhibitors of HIF Prolyl Hydroxylase</span>. <span class="NLM_patent">WO2016057762A1</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=F.+Ujjainwalla&author=J.+Q.+Tan&author=Q.+Dang&author=C.%0AJ.+Sinz&author=A.+Crespo&author=M.+Wang&author=Y.+Chen&author=J.+Cai&author=F.+Wu&author=X.+Du&title=Substituted+Pyrimidine+as+Inhibitors+of+HIF+Prolyl+Hydroxylase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DUjjainwalla%26aufirst%3DF.%26atitle%3DSubstituted%2520Pyrimidine%2520as%2520Inhibitors%2520of%2520HIF%2520Prolyl%2520Hydroxylase%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ujjainwalla, F.</span>; <span class="NLM_string-name">Tan, J. Q.</span>; <span class="NLM_string-name">Dang, Q.</span>; <span class="NLM_string-name">Sinz, C.
J.</span>; <span class="NLM_string-name">Crespo, A.</span>; <span class="NLM_string-name">Wang, M.</span>; <span class="NLM_string-name">Chen, Y.</span>; <span class="NLM_string-name">Cai, J.</span>; <span class="NLM_string-name">Wu, F.</span>; <span class="NLM_string-name">Du, X.</span></span> <span> </span><span class="NLM_article-title">Substituted Pyrimidine as Inhibitors of HIF Prolyl Hydroxylase</span>. <span class="NLM_patent">WO2016054804A1</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=F.+Ujjainwalla&author=J.+Q.+Tan&author=Q.+Dang&author=C.%0AJ.+Sinz&author=A.+Crespo&author=M.+Wang&author=Y.+Chen&author=J.+Cai&author=F.+Wu&author=X.+Du&title=Substituted+Pyrimidine+as+Inhibitors+of+HIF+Prolyl+Hydroxylase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DUjjainwalla%26aufirst%3DF.%26atitle%3DSubstituted%2520Pyrimidine%2520as%2520Inhibitors%2520of%2520HIF%2520Prolyl%2520Hydroxylase%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ujjainwalla, F.</span>; <span class="NLM_string-name">Tan, J. Q.</span>; <span class="NLM_string-name">Dang, Q.</span>; <span class="NLM_string-name">Sinz, C.
J.</span>; <span class="NLM_string-name">Wang, M.</span>; <span class="NLM_string-name">Chen, Y.</span>; <span class="NLM_string-name">Cai, J.</span></span> <span> </span><span class="NLM_article-title">Substituted Pyrimidine as Inhibitors of HIF Prolyl Hydroxylase</span>. <span class="NLM_patent">WO2016057753A1</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=F.+Ujjainwalla&author=J.+Q.+Tan&author=Q.+Dang&author=C.%0AJ.+Sinz&author=M.+Wang&author=Y.+Chen&author=J.+Cai&title=Substituted+Pyrimidine+as+Inhibitors+of+HIF+Prolyl+Hydroxylase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DUjjainwalla%26aufirst%3DF.%26atitle%3DSubstituted%2520Pyrimidine%2520as%2520Inhibitors%2520of%2520HIF%2520Prolyl%2520Hydroxylase%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ariazi, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duffy, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fitch, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pappalardi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biju, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Difilippo, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiggall, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erickson-Miller, C.</span></span> <span> </span><span class="NLM_article-title">Discovery and preclinical characterization of GSK1278863 (Daprodustat), a small molecule hypoxia inducible factor-prolyl hydroxylase inhibitor for anemia</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">336</span>– <span class="NLM_lpage">347</span>, <span class="refDoi"> DOI: 10.1124/jpet.117.242503</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1124%2Fjpet.117.242503" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2017&pages=336-347&author=J.+L.+Ariaziauthor=K.+J.+Duffyauthor=D.+F.+Adamsauthor=D.+Fitchauthor=L.+Luoauthor=M.+Pappalardiauthor=M.+Bijuauthor=E.+H.+Difilippoauthor=T.+Shawauthor=K.+Wiggallauthor=C.+Erickson-Miller&title=Discovery+and+preclinical+characterization+of+GSK1278863+%28Daprodustat%29%2C+a+small+molecule+hypoxia+inducible+factor-prolyl+hydroxylase+inhibitor+for+anemia&doi=10.1124%2Fjpet.117.242503"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1124%2Fjpet.117.242503&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.117.242503%26sid%3Dliteratum%253Aachs%26aulast%3DAriazi%26aufirst%3DJ.%2BL.%26aulast%3DDuffy%26aufirst%3DK.%2BJ.%26aulast%3DAdams%26aufirst%3DD.%2BF.%26aulast%3DFitch%26aufirst%3DD.%26aulast%3DLuo%26aufirst%3DL.%26aulast%3DPappalardi%26aufirst%3DM.%26aulast%3DBiju%26aufirst%3DM.%26aulast%3DDifilippo%26aufirst%3DE.%2BH.%26aulast%3DShaw%26aufirst%3DT.%26aulast%3DWiggall%26aufirst%3DK.%26aulast%3DErickson-Miller%26aufirst%3DC.%26atitle%3DDiscovery%2520and%2520preclinical%2520characterization%2520of%2520GSK1278863%2520%2528Daprodustat%2529%252C%2520a%2520small%2520molecule%2520hypoxia%2520inducible%2520factor-prolyl%2520hydroxylase%2520inhibitor%2520for%2520anemia%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2017%26volume%3D36%26spage%3D336%26epage%3D347%26doi%3D10.1124%2Fjpet.117.242503" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takayama, T.</span>; <span class="NLM_string-name">Shibata, T.</span>; <span class="NLM_string-name">Shiozawa, F.</span>; <span class="NLM_string-name">Kawabe, K.</span>; <span class="NLM_string-name">Shimizu, Y.</span>; <span class="NLM_string-name">Hamada, M.</span>; <span class="NLM_string-name">Hiratate, A.</span>; <span class="NLM_string-name">Takahashi, M.</span>; <span class="NLM_string-name">Ushiyama, F.</span>; <span class="NLM_string-name">Takahiro, O. I.</span>; <span class="NLM_string-name">Shirasaki, Y.</span>; <span class="NLM_string-name">Matsuda, D.</span>; <span class="NLM_string-name">Koizumi, C.</span>; <span class="NLM_string-name">Kato, S.</span></span> <span> </span><span class="NLM_article-title">Partially Saturated Nitrogen-Containing Heterocyclic Compound</span>. <span class="NLM_patent">WO2014021281A1</span>, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=T.+Takayama&author=T.+Shibata&author=F.+Shiozawa&author=K.+Kawabe&author=Y.+Shimizu&author=M.+Hamada&author=A.+Hiratate&author=M.+Takahashi&author=F.+Ushiyama&author=O.+I.+Takahiro&author=Y.+Shirasaki&author=D.+Matsuda&author=C.+Koizumi&author=S.+Kato&title=Partially+Saturated+Nitrogen-Containing+Heterocyclic+Compound"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DTakayama%26aufirst%3DT.%26atitle%3DPartially%2520Saturated%2520Nitrogen-Containing%2520Heterocyclic%2520Compound%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Desai, R. C.</span>; <span class="NLM_string-name">Pandya, V.</span>; <span class="NLM_string-name">Patel, P.
R.</span></span> <span> </span><span class="NLM_article-title">Novel Quinolone Derivatives</span>. <span class="NLM_patent">WO2014102818A1</span>. <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=R.+C.+Desai&author=V.+Pandya&author=P.%0AR.+Patel&title=Novel+Quinolone+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDesai%26aufirst%3DR.%2BC.%26atitle%3DNovel%2520Quinolone%2520Derivatives%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kansagra, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parmar, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jani, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srinivas, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lickliter, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, H. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parikh, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heading, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dholakia, V. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sukhadiya, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parmar, K. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barot, K.</span></span> <span> </span><span class="NLM_article-title">Phase I clinical study of ZYAN1, a novel prolyl-hydroxylase (PHD) inhibitor to evaluate the safety, tolerability, and pharmacokinetics following oral administration in healthy volunteers</span>. <i>Clin. Pharmacokinet.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">87</span>– <span class="NLM_lpage">102</span>, <span class="refDoi"> DOI: 10.1007/s40262-017-0551-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1007%2Fs40262-017-0551-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=28508936" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=1%3ACAS%3A528%3ADC%252BC2sXnvVGjtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2018&pages=87-102&issue=1&author=K.+A.+Kansagraauthor=D.+Parmarauthor=R.+H.+Janiauthor=N.+R.+Srinivasauthor=J.+Lickliterauthor=H.+V.+Patelauthor=D.+P.+Parikhauthor=H.+Headingauthor=H.+B.+Patelauthor=R.+J.+Guptaauthor=C.+Y.+Shahauthor=M.+R.+Patelauthor=V.+N.+Dholakiaauthor=R.+Sukhadiyaauthor=M.+R.+Jainauthor=K.+V.+Parmarauthor=K.+Barot&title=Phase+I+clinical+study+of+ZYAN1%2C+a+novel+prolyl-hydroxylase+%28PHD%29+inhibitor+to+evaluate+the+safety%2C+tolerability%2C+and+pharmacokinetics+following+oral+administration+in+healthy+volunteers&doi=10.1007%2Fs40262-017-0551-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I Clinical Study of ZYAN1, A Novel Prolyl-Hydroxylase (PHD) Inhibitor to Evaluate the Safety, Tolerability, and Pharmacokinetics Following Oral Administration in Healthy Volunteers</span></div><div class="casAuthors">Kansagra, Kevinkumar A.; Parmar, Deven; Jani, Rajendra H.; Srinivas, Nuggehally R.; Lickliter, Jason; Patel, Harilal V.; Parikh, Devang P.; Heading, Heather; Patel, Hardik B.; Gupta, Rahul J.; Shah, Chintan Y.; Patel, Maulik R.; Dholakia, Vyom N.; Sukhadiya, Raghav; Jain, Mukul R.; Parmar, Krupi V.; Barot, Kinjal</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacokinetics</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">87-102</span>CODEN:
                <span class="NLM_cas:coden">CPKNDH</span>;
        ISSN:<span class="NLM_cas:issn">0312-5963</span>.
    
            (<span class="NLM_cas:orgname">Springer International Publishing AG</span>)
        </div><div class="casAbstract">Objective: This phase I study of ZYAN1 was conducted to evaluate the safety, tolerability, and pharmacokinetics following oral administration in healthy volunteers.  Methods: The study was a randomized, double-blind, placebo-controlled phase I study carried out in two parts in addn. to a third part involving an open-label study to evaluate the food/sex effect.  A total of 100 subjects were enrolled into the study as follows: part I-single-dose study with ZYAN1 10, 25, 50, 100, 150, 200, and 300 mg (n = 56); part II-multiple-dose study with every other day dosing of ZYAN1 100, 150, 200, and 300 mg (n = 32); and part III-sex and food effect study with ZYAN1 150 mg (n = 12; open-label).  Results: ZYAN1 was well-tolerated after single and multiple oral ascending doses.  No drug-related serious adverse events were reported.  Following a single ascending dose of ZYAN1, the max. concn. (Cmax) ranged from 566.47 ± 163.03 to 17,858.33 ± 2899.19 ng/mL and the median time to Cmax (tmax) was approx. 2.5 h for the studied 30-fold oral doses of ZYAN1.  Regardless of single or multiple doses, mean Cmax and area under the concn.-time curve from time zero to time t (AUCt) values generally showed a dose-proportional increase.  The mean elimination half-life (t1/2) of ZYAN1 ranged from 6.9 to 13 h with negligible accumulation.  Following a single dose of ZYAN1, the mean serum erythropoietin (EPO) Cmax values showed dose response (i.e., 6.6 and 79.9 mIU/L for 10 and 300 mg ZYAN1 doses, resp.), while the time to mean maximal serum EPO concns. ranged from 10 to 72 h.  Conclusion: Oral single (10-300 mg) and multiple dosing (100-300 mg) of ZYAN1 in healthy subjects was found to be safe and well-tolerated.  With increasing ZYAN1 dose, there was almost a proportional increase in mean Cmax and AUCt.  The mean serum EPO concns. showed a trend of dose response.  Based on the t1/2, pharmacodynamic activity, and lack of drug accumulation, a once every 2 days dosing regimen of ZYAN1 was appropriate for phase II study.  Trial Registration: Australian New Zealand Clin. Trials Registry trial ID ACTRN12614001240639.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBByFCzbT49rVg90H21EOLACvtfcHk0lieNXtNqwaLbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXnvVGjtrk%253D&md5=17a24e21816ac53a13c987b8cd2abf0c</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1007%2Fs40262-017-0551-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40262-017-0551-3%26sid%3Dliteratum%253Aachs%26aulast%3DKansagra%26aufirst%3DK.%2BA.%26aulast%3DParmar%26aufirst%3DD.%26aulast%3DJani%26aufirst%3DR.%2BH.%26aulast%3DSrinivas%26aufirst%3DN.%2BR.%26aulast%3DLickliter%26aufirst%3DJ.%26aulast%3DPatel%26aufirst%3DH.%2BV.%26aulast%3DParikh%26aufirst%3DD.%2BP.%26aulast%3DHeading%26aufirst%3DH.%26aulast%3DPatel%26aufirst%3DH.%2BB.%26aulast%3DGupta%26aufirst%3DR.%2BJ.%26aulast%3DShah%26aufirst%3DC.%2BY.%26aulast%3DPatel%26aufirst%3DM.%2BR.%26aulast%3DDholakia%26aufirst%3DV.%2BN.%26aulast%3DSukhadiya%26aufirst%3DR.%26aulast%3DJain%26aufirst%3DM.%2BR.%26aulast%3DParmar%26aufirst%3DK.%2BV.%26aulast%3DBarot%26aufirst%3DK.%26atitle%3DPhase%2520I%2520clinical%2520study%2520of%2520ZYAN1%252C%2520a%2520novel%2520prolyl-hydroxylase%2520%2528PHD%2529%2520inhibitor%2520to%2520evaluate%2520the%2520safety%252C%2520tolerability%252C%2520and%2520pharmacokinetics%2520following%2520oral%2520administration%2520in%2520healthy%2520volunteers%26jtitle%3DClin.%2520Pharmacokinet.%26date%3D2018%26volume%3D57%26issue%3D1%26spage%3D87%26epage%3D102%26doi%3D10.1007%2Fs40262-017-0551-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cai, J.</span>; <span class="NLM_string-name">Colandrea, V.</span>; <span class="NLM_string-name">Crespo, A.</span>; <span class="NLM_string-name">Debenham, J.</span>; <span class="NLM_string-name">Du, X.</span>; <span class="NLM_string-name">Guiadeen, D.</span>; <span class="NLM_string-name">Liu, P.</span>; <span class="NLM_string-name">Liu, R.</span>; <span class="NLM_string-name">Madsen-Duggan, C. B.</span>; <span class="NLM_string-name">Mccoy, J. G.</span>; <span class="NLM_string-name">Quan, W.</span>; <span class="NLM_string-name">Sinz, C.</span>; <span class="NLM_string-name">Wang, L.</span></span> <span> </span><span class="NLM_article-title">Inhibitors of HIF Prolyl Hydroxylase</span>. <span class="NLM_patent">WO2016049097A1</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=J.+Cai&author=V.+Colandrea&author=A.+Crespo&author=J.+Debenham&author=X.+Du&author=D.+Guiadeen&author=P.+Liu&author=R.+Liu&author=C.+B.+Madsen-Duggan&author=J.+G.+Mccoy&author=W.+Quan&author=C.+Sinz&author=L.+Wang&title=Inhibitors+of+HIF+Prolyl+Hydroxylase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DJ.%26atitle%3DInhibitors%2520of%2520HIF%2520Prolyl%2520Hydroxylase%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cai, J.</span>; <span class="NLM_string-name">Colandrea, V.</span>; <span class="NLM_string-name">Crespo, A.</span>; <span class="NLM_string-name">Du, X.</span>; <span class="NLM_string-name">Dubois, B. G.</span>; <span class="NLM_string-name">Guiadeen, D.</span>; <span class="NLM_string-name">Kothandaraman, S.</span>; <span class="NLM_string-name">Liu, P.</span>; <span class="NLM_string-name">Liu, R.</span>; <span class="NLM_string-name">Quan, W.</span>; <span class="NLM_string-name">Sinz, C.</span>; <span class="NLM_string-name">Wang, L.</span></span> <span> </span><span class="NLM_article-title">Inhibitors of HIF Prolyl Hydroxylase</span>. <span class="NLM_patent">WO2016049099A1</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=J.+Cai&author=V.+Colandrea&author=A.+Crespo&author=X.+Du&author=B.+G.+Dubois&author=D.+Guiadeen&author=S.+Kothandaraman&author=P.+Liu&author=R.+Liu&author=W.+Quan&author=C.+Sinz&author=L.+Wang&title=Inhibitors+of+HIF+Prolyl+Hydroxylase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DJ.%26atitle%3DInhibitors%2520of%2520HIF%2520Prolyl%2520Hydroxylase%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cai, J.</span>; <span class="NLM_string-name">Crespo, A.</span>; <span class="NLM_string-name">Debenham, J.</span>; <span class="NLM_string-name">Du, X.</span>; <span class="NLM_string-name">Liu, P.</span>; <span class="NLM_string-name">Liu, R.</span>; <span class="NLM_string-name">Madsen-Duggan, C. B.</span>; <span class="NLM_string-name">Quan, W.</span>; <span class="NLM_string-name">Sinz, C.</span>; <span class="NLM_string-name">Wang, L.</span></span> <span> </span><span class="NLM_article-title">Inhibitors of HIF Prolyl Hydroxylase</span>. <span class="NLM_patent">WO2016049098A1</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=J.+Cai&author=A.+Crespo&author=J.+Debenham&author=X.+Du&author=P.+Liu&author=R.+Liu&author=C.+B.+Madsen-Duggan&author=W.+Quan&author=C.+Sinz&author=L.+Wang&title=Inhibitors+of+HIF+Prolyl+Hydroxylase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DJ.%26atitle%3DInhibitors%2520of%2520HIF%2520Prolyl%2520Hydroxylase%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cai, J.</span>; <span class="NLM_string-name">Crespo, A.</span>; <span class="NLM_string-name">Du, X.</span>; <span class="NLM_string-name">Dubois, B. G.</span>; <span class="NLM_string-name">Liu, P.</span>; <span class="NLM_string-name">Liu, R.</span>; <span class="NLM_string-name">Quan, W.</span>; <span class="NLM_string-name">Sinz, C.</span>; <span class="NLM_string-name">Wang, L.</span></span> <span> </span><span class="NLM_article-title">Inhibitors of HIF Prolyl Hydroxylase</span>. <span class="NLM_patent">WO2016049100A1</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=J.+Cai&author=A.+Crespo&author=X.+Du&author=B.+G.+Dubois&author=P.+Liu&author=R.+Liu&author=W.+Quan&author=C.+Sinz&author=L.+Wang&title=Inhibitors+of+HIF+Prolyl+Hydroxylase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DJ.%26atitle%3DInhibitors%2520of%2520HIF%2520Prolyl%2520Hydroxylase%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ogoshi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsui, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitani, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokota, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terashita, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Motoda, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueyama, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hotta, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hase, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukui, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshiuchi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abe, H.</span></span> <span> </span><span class="NLM_article-title">Discovery of JTZ-951: a HIF prolyl hydroxylase inhibitor for the treatment of renal anemia</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">1320</span>– <span class="NLM_lpage">1325</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.7b00404</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.7b00404" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVCksrbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=1320-1325&issue=12&author=Y.+Ogoshiauthor=T.+Matsuiauthor=I.+Mitaniauthor=M.+Yokotaauthor=M.+Terashitaauthor=D.+Motodaauthor=K.+Ueyamaauthor=T.+Hottaauthor=T.+Itoauthor=Y.+Haseauthor=K.+Fukuiauthor=K.+Deaiauthor=H.+Yoshiuchiauthor=S.+Itoauthor=H.+Abe&title=Discovery+of+JTZ-951%3A+a+HIF+prolyl+hydroxylase+inhibitor+for+the+treatment+of+renal+anemia&doi=10.1021%2Facsmedchemlett.7b00404"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of JTZ-951: A HIF Prolyl Hydroxylase Inhibitor for the Treatment of Renal Anemia</span></div><div class="casAuthors">Ogoshi, Yosuke; Matsui, Takuya; Mitani, Ikuo; Yokota, Masahiro; Terashita, Masakazu; Motoda, Dai; Ueyama, Kazuhito; Hotta, Takahiro; Ito, Takashi; Hase, Yasunori; Fukui, Kenji; Deai, Katsuya; Yoshiuchi, Hiromi; Ito, Soichiro; Abe, Hiroyuki</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1320-1325</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibition of hypoxia inducible factor prolyl hydroxylase (PHD) represents a promising strategy for the discovery of a next generation treatment for renal anemia.  We identified several 5,6-fused ring systems as novel scaffolds of the PHD inhibitor on the basis of pharmacophore anal.  In particular, triazolopyridine derivs. showed potent PHD2 inhibitory activities.  Examn. of the predominance of the triazolopyridines in potency by electrostatic calcns. suggested favorable π-π stacking interactions with Tyr310.  Lead optimization to improve the efficacy of erythropoietin release in cells and in vivo by improving cell permeability led to the discovery of JTZ-951 (compd. 14), with a 5-phenethyl substituent on the triazolopyridine group, which increased Hb levels with daily oral dosing in rats.  Compd. 14 was rapidly absorbed after oral administration and disappeared shortly thereafter, which could be advantageous in terms of safety.  Compd. 14 was selected as a clin. candidate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyv_5DiDhDq7Vg90H21EOLACvtfcHk0lhW1Roftzx-Rw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVCksrbM&md5=f1fb9366a5c92eafabb512f2e2fecc23</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.7b00404&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.7b00404%26sid%3Dliteratum%253Aachs%26aulast%3DOgoshi%26aufirst%3DY.%26aulast%3DMatsui%26aufirst%3DT.%26aulast%3DMitani%26aufirst%3DI.%26aulast%3DYokota%26aufirst%3DM.%26aulast%3DTerashita%26aufirst%3DM.%26aulast%3DMotoda%26aufirst%3DD.%26aulast%3DUeyama%26aufirst%3DK.%26aulast%3DHotta%26aufirst%3DT.%26aulast%3DIto%26aufirst%3DT.%26aulast%3DHase%26aufirst%3DY.%26aulast%3DFukui%26aufirst%3DK.%26aulast%3DDeai%26aufirst%3DK.%26aulast%3DYoshiuchi%26aufirst%3DH.%26aulast%3DIto%26aufirst%3DS.%26aulast%3DAbe%26aufirst%3DH.%26atitle%3DDiscovery%2520of%2520JTZ-951%253A%2520a%2520HIF%2520prolyl%2520hydroxylase%2520inhibitor%2520for%2520the%2520treatment%2520of%2520renal%2520anemia%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D8%26issue%3D12%26spage%3D1320%26epage%3D1325%26doi%3D10.1021%2Facsmedchemlett.7b00404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schulz, M. J.</span>; <span class="NLM_string-name">Wang, Y.</span></span> <span> </span><span class="NLM_article-title">Prolyl Hydroxylase Inhibitors</span>. <span class="NLM_patent">WO2010059549A1</span>, <span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=M.+J.+Schulz&author=Y.+Wang&title=Prolyl+Hydroxylase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSchulz%26aufirst%3DM.%2BJ.%26atitle%3DProlyl%2520Hydroxylase%2520Inhibitors%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gotchev, D. B.</span>; <span class="NLM_string-name">Jin, J.</span>; <span class="NLM_string-name">Wang, Y.</span></span> <span> </span><span class="NLM_article-title">Prolyl Hydroxylase Inhibitors</span>. <span class="NLM_patent">WO2009086044A1</span>, <span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=D.+B.+Gotchev&author=J.+Jin&author=Y.+Wang&title=Prolyl+Hydroxylase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGotchev%26aufirst%3DD.%2BB.%26atitle%3DProlyl%2520Hydroxylase%2520Inhibitors%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span>; <span class="NLM_string-name">Yu, H.</span></span> <span> </span><span class="NLM_article-title">Prolyl Hydroxylase Inhibitors</span>. <span class="NLM_patent">WO2010059552A1</span>, <span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=Y.+Wang&author=H.+Yu&title=Prolyl+Hydroxylase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26atitle%3DProlyl%2520Hydroxylase%2520Inhibitors%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jin, J.</span>; <span class="NLM_string-name">Schulz, M. J.</span>; <span class="NLM_string-name">Wang, Y.</span></span> <span> </span><span class="NLM_article-title">Prolyl Hydroxylase Inhibitors</span>. <span class="NLM_patent">WO2010022308A1</span>, <span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=J.+Jin&author=M.+J.+Schulz&author=Y.+Wang&title=Prolyl+Hydroxylase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DJin%26aufirst%3DJ.%26atitle%3DProlyl%2520Hydroxylase%2520Inhibitors%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schulz, M. J.</span>; <span class="NLM_string-name">Wang, Y.</span>; <span class="NLM_string-name">Ghergurovich, J. M.</span></span> <span> </span><span class="NLM_article-title">Prolyl Hydroxylase Inhibitors</span>. <span class="NLM_patent">WO2010059555A1</span>, <span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=M.+J.+Schulz&author=Y.+Wang&author=J.+M.+Ghergurovich&title=Prolyl+Hydroxylase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSchulz%26aufirst%3DM.%2BJ.%26atitle%3DProlyl%2520Hydroxylase%2520Inhibitors%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gardner, J. H.</span>; <span class="NLM_string-name">Shalwitz, R.</span></span> <span> </span><span class="NLM_article-title">Prolyl Hydroxylase Inhibitors</span>. <span class="NLM_patent">WO2011057115A1</span>, <span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=J.+H.+Gardner&author=R.+Shalwitz&title=Prolyl+Hydroxylase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGardner%26aufirst%3DJ.%2BH.%26atitle%3DProlyl%2520Hydroxylase%2520Inhibitors%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shalwitz, R.</span>; <span class="NLM_string-name">Gardner, J. H.</span></span> <span> </span><span class="NLM_article-title">Methods for Increasing the Stabilization of Hypoxia Inducible Factor-1 Alpha</span>. <span class="NLM_patent">WO2011057112A1</span>, <span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=R.+Shalwitz&author=J.+H.+Gardner&title=Methods+for+Increasing+the+Stabilization+of+Hypoxia+Inducible+Factor-1+Alpha"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DShalwitz%26aufirst%3DR.%26atitle%3DMethods%2520for%2520Increasing%2520the%2520Stabilization%2520of%2520Hypoxia%2520Inducible%2520Factor-1%2520Alpha%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clements, M. J.</span>; <span class="NLM_string-name">Debenham, J. S.</span>; <span class="NLM_string-name">Hale, J. J.</span>; <span class="NLM_string-name">Madsen-Duggan, C. B.</span>; <span class="NLM_string-name">Walsh, T. F.</span></span> <span> </span><span class="NLM_article-title">Preparation of Substituted 4-Hydroxypyrimidine-5- Carboxamides</span>. <span class="NLM_patent">WO2009117269A1</span>, <span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=M.+J.+Clements&author=J.+S.+Debenham&author=J.+J.+Hale&author=C.+B.+Madsen-Duggan&author=T.+F.+Walsh&title=Preparation+of+Substituted+4-Hydroxypyrimidine-5-+Carboxamides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DClements%26aufirst%3DM.%2BJ.%26atitle%3DPreparation%2520of%2520Substituted%25204-Hydroxypyrimidine-5-%2520Carboxamides%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, C.</span>; <span class="NLM_string-name">Zou, W.</span>; <span class="NLM_string-name">Hua, Y.</span>; <span class="NLM_string-name">Dang, Q.</span></span> <span> </span><span class="NLM_article-title">Substituted Pyrimidines</span>. <span class="NLM_patent">WO2011130908A1</span>, <span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=C.+Zhou&author=W.+Zou&author=Y.+Hua&author=Q.+Dang&title=Substituted+Pyrimidines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DC.%26atitle%3DSubstituted%2520Pyrimidines%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Debenham, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madsen-Duggan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clements, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, T. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuethe, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reibarkh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salowe, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sonatore, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hajdu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milligan, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Visco, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lingham, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stickens, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeMartino, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolff, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherer, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hale, J.</span></span> <span> </span><span class="NLM_article-title">Discovery of N-[bis(4-methoxyphenyl)methyl]-4-hydroxy-2-(pyridazin-3-yl)pyrimidine-5-carboxamide (MK-8617), an orally active pan-inhibitor of hypoxia-inducible factor prolyl hydroxylase 1–3 (HIF PHD1–3) for the treatment of anemia</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">11039</span>– <span class="NLM_lpage">11049</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01242</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01242" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVaiurnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=11039-11049&author=J.+S.+Debenhamauthor=C.+Madsen-Dugganauthor=M.+J.+Clementsauthor=T.+F.+Walshauthor=J.+T.+Kuetheauthor=M.+Reibarkhauthor=S.+P.+Saloweauthor=L.+M.+Sonatoreauthor=R.+Hajduauthor=J.+A.+Milliganauthor=D.+M.+Viscoauthor=D.+Zhouauthor=R.+B.+Linghamauthor=D.+Stickensauthor=J.+A.+DeMartinoauthor=X.+Tongauthor=M.+Wolffauthor=J.+Pangauthor=R.+R.+Millerauthor=E.+C.+Shererauthor=J.+Hale&title=Discovery+of+N-%5Bbis%284-methoxyphenyl%29methyl%5D-4-hydroxy-2-%28pyridazin-3-yl%29pyrimidine-5-carboxamide+%28MK-8617%29%2C+an+orally+active+pan-inhibitor+of+hypoxia-inducible+factor+prolyl+hydroxylase+1%E2%80%933+%28HIF+PHD1%E2%80%933%29+for+the+treatment+of+anemia&doi=10.1021%2Facs.jmedchem.6b01242"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of N-[Bis(4-methoxyphenyl)methyl]-4-hydroxy-2-(pyridazin-3-yl)pyrimidine-5-carboxamide (MK-8617), an Orally Active Pan-Inhibitor of Hypoxia-Inducible Factor Prolyl Hydroxylase 1-3 (HIF PHD1-3) for the Treatment of Anemia</span></div><div class="casAuthors">Debenham, John S.; Madsen-Duggan, Christina; Clements, Matthew J.; Walsh, Thomas F.; Kuethe, Jeffrey T.; Reibarkh, Mikhail; Salowe, Scott P.; Sonatore, Lisa M.; Hajdu, Richard; Milligan, James A.; Visco, Denise M.; Zhou, Dan; Lingham, Russell B.; Stickens, Dominique; DeMartino, Julie A.; Tong, Xinchun; Wolff, Michael; Pang, Jianmei; Miller, Randy R.; Sherer, Edward C.; Hale, Jeffrey J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">11039-11049</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The discovery of novel 4-hydroxy-2-(heterocyclic)pyrimidine-5-carboxamide inhibitors of hypoxia-inducible factor (HIF) prolyl hydroxylases (PHD) are described.  These are potent, selective, orally bioavailable across several species and are active in stimulating erythropoiesis.  Mouse and rat studies showed hematol. changes with elevations of plasma EPO and circulating reticulocytes following single oral dose administration while 4 wk QD po administration in rat elevated Hb levels.  A major focus of the optimization process was to decrease the long half-life obsd. in higher species with early compds.  These efforts led to the identification of 28 (MK-8617) which has advanced to human clin. trials for anemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhs63u66yCX7Vg90H21EOLACvtfcHk0lgJ4chZhvowCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVaiurnN&md5=7acb236af3ca035b010a203f7234a5b7</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01242&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01242%26sid%3Dliteratum%253Aachs%26aulast%3DDebenham%26aufirst%3DJ.%2BS.%26aulast%3DMadsen-Duggan%26aufirst%3DC.%26aulast%3DClements%26aufirst%3DM.%2BJ.%26aulast%3DWalsh%26aufirst%3DT.%2BF.%26aulast%3DKuethe%26aufirst%3DJ.%2BT.%26aulast%3DReibarkh%26aufirst%3DM.%26aulast%3DSalowe%26aufirst%3DS.%2BP.%26aulast%3DSonatore%26aufirst%3DL.%2BM.%26aulast%3DHajdu%26aufirst%3DR.%26aulast%3DMilligan%26aufirst%3DJ.%2BA.%26aulast%3DVisco%26aufirst%3DD.%2BM.%26aulast%3DZhou%26aufirst%3DD.%26aulast%3DLingham%26aufirst%3DR.%2BB.%26aulast%3DStickens%26aufirst%3DD.%26aulast%3DDeMartino%26aufirst%3DJ.%2BA.%26aulast%3DTong%26aufirst%3DX.%26aulast%3DWolff%26aufirst%3DM.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DMiller%26aufirst%3DR.%2BR.%26aulast%3DSherer%26aufirst%3DE.%2BC.%26aulast%3DHale%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520N-%255Bbis%25284-methoxyphenyl%2529methyl%255D-4-hydroxy-2-%2528pyridazin-3-yl%2529pyrimidine-5-carboxamide%2520%2528MK-8617%2529%252C%2520an%2520orally%2520active%2520pan-inhibitor%2520of%2520hypoxia-inducible%2520factor%2520prolyl%2520hydroxylase%25201%25E2%2580%25933%2520%2528HIF%2520PHD1%25E2%2580%25933%2529%2520for%2520the%2520treatment%2520of%2520anemia%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D11039%26epage%3D11049%26doi%3D10.1021%2Facs.jmedchem.6b01242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, C.</span>; <span class="NLM_string-name">Zou, W.</span>; <span class="NLM_string-name">Hua, Y.</span>; <span class="NLM_string-name">Dang, Q.</span></span> <span> </span><span class="NLM_article-title">Substituted Pyrimidines</span>. <span class="NLM_patent">WO2013040790A1</span>, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=C.+Zhou&author=W.+Zou&author=Y.+Hua&author=Q.+Dang&title=Substituted+Pyrimidines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DC.%26atitle%3DSubstituted%2520Pyrimidines%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dang, Q.</span>; <span class="NLM_string-name">Zhou, C.</span>; <span class="NLM_string-name">Zou, W.</span>; <span class="NLM_string-name">Hua, Y.</span></span> <span> </span><span class="NLM_article-title">Substituted Pyrimidines</span>. <span class="NLM_patent">WO2013043624A1</span>, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=Q.+Dang&author=C.+Zhou&author=W.+Zou&author=Y.+Hua&title=Substituted+Pyrimidines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDang%26aufirst%3DQ.%26atitle%3DSubstituted%2520Pyrimidines%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fletcher, J. M.</span>; <span class="NLM_string-name">Hale, J. J.</span>; <span class="NLM_string-name">Miao, S.</span>; <span class="NLM_string-name">Vachal, P.</span></span> <span> </span><span class="NLM_article-title">Spiroindalones</span>. <span class="NLM_patent">WO2008144266A1</span>, <span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=J.+M.+Fletcher&author=J.+J.+Hale&author=S.+Miao&author=P.+Vachal&title=Spiroindalones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DFletcher%26aufirst%3DJ.%2BM.%26atitle%3DSpiroindalones%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fletcher, J. M.</span>; <span class="NLM_string-name">Hale, J. J.</span>; <span class="NLM_string-name">Miao, S.</span>; <span class="NLM_string-name">Vachal, P.</span></span> <span> </span><span class="NLM_article-title">Spiroazaindoles</span>. <span class="NLM_patent">WO2009137291A2</span>, <span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=J.+M.+Fletcher&author=J.+J.+Hale&author=S.+Miao&author=P.+Vachal&title=Spiroazaindoles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DFletcher%26aufirst%3DJ.%2BM.%26atitle%3DSpiroazaindoles%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vachal, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierce, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guiadeen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colandrea, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyvratt, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salowe, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sonatore, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milligan, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hajdu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gollapudi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keohane, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lingham, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandala, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeMartino, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolff, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinhuebel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kieczykowski, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleitz, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Athanasopoulos, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adam, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akyuz, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jena, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lusen, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stein, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherer, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hale, J. J.</span></span> <span> </span><span class="NLM_article-title">1,3,8-Triazaspiro[4.5]decane-2,4-diones as efficacious pan-inhibitors of hypoxia-inducible factor prolyl hydroxylase 1–3 (HIF PHD1–3) for the treatment of anemia</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">2945</span>– <span class="NLM_lpage">2959</span>, <span class="refDoi"> DOI: 10.1021/jm201542d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201542d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=1%3ACAS%3A528%3ADC%252BC38XivVOhtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=2945-2959&author=P.+Vachalauthor=S.+Miaoauthor=J.+M.+Pierceauthor=D.+Guiadeenauthor=V.+J.+Colandreaauthor=M.+J.+Wyvrattauthor=S.+P.+Saloweauthor=L.+M.+Sonatoreauthor=J.+A.+Milliganauthor=R.+Hajduauthor=A.+Gollapudiauthor=C.+A.+Keohaneauthor=R.+B.+Linghamauthor=S.+M.+Mandalaauthor=J.+A.+DeMartinoauthor=X.+Tongauthor=M.+Wolffauthor=D.+Steinhuebelauthor=G.+R.+Kieczykowskiauthor=F.+J.+Fleitzauthor=K.+Chapmanauthor=J.+Athanasopoulosauthor=G.+Adamauthor=C.+D.+Akyuzauthor=D.+K.+Jenaauthor=J.+W.+Lusenauthor=J.+Mengauthor=B.+D.+Steinauthor=L.+Xiaauthor=E.+C.+Shererauthor=J.+J.+Hale&title=1%2C3%2C8-Triazaspiro%5B4.5%5Ddecane-2%2C4-diones+as+efficacious+pan-inhibitors+of+hypoxia-inducible+factor+prolyl+hydroxylase+1%E2%80%933+%28HIF+PHD1%E2%80%933%29+for+the+treatment+of+anemia&doi=10.1021%2Fjm201542d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">1,3,8-Triazaspiro[4.5]decane-2,4-diones as Efficacious Pan-Inhibitors of Hypoxia-Inducible Factor Prolyl Hydroxylase 1-3 (HIF PHD1-3) for the Treatment of Anemia</span></div><div class="casAuthors">Vachal, Petr; Miao, Shouwu; Pierce, Joan M.; Guiadeen, Deodial; Colandrea, Vincent J.; Wyvratt, Matthew J.; Salowe, Scott P.; Sonatore, Lisa M.; Milligan, James A.; Hajdu, Richard; Gollapudi, Anantha; Keohane, Carol A.; Lingham, Russell B.; Mandala, Suzanne M.; DeMartino, Julie A.; Tong, Xinchun; Wolff, Michael; Steinhuebel, Dietrich; Kieczykowski, Gerard R.; Fleitz, Fred J.; Chapman, Kevin; Athanasopoulos, John; Adam, Gregory; Akyuz, Can D.; Jena, Dhirendra K.; Lusen, Jeffrey W.; Meng, Juncai; Stein, Benjamin D.; Xia, Lei; Sherer, Edward C.; Hale, Jeffrey J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2945-2959</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The discovery of 1,3,8-triazaspiro[4.5]decane-2,4-diones (spirohydantoins) as a structural class of pan-inhibitors of the prolyl hydroxylase (PHD) family of enzymes for the treatment of anemia is described.  The initial hit class, spirooxindoles, was identified through affinity selection mass spectrometry (AS-MS) and optimized for PHD2 inhibition and optimal PK/PD profile (short-acting PHDi inhibitors). 1,3,8-Triazaspiro[4.5]decane-2,4-diones (spirohydantoins) were optimized as an advanced lead class derived from the original spiroindole hit.  A new set of general conditions for C-N coupling, developed using a high-throughput experimentation (HTE) technique, enabled a full SAR anal. of the spirohydantoins.  This rapid and directed SAR exploration has resulted in the first reported examples of hydantoin derivs. with good PK in preclin. species.  Potassium channel off-target activity (hERG) was successfully eliminated through the systematic introduction of acidic functionality to the mol. structure.  Undesired upregulation of alanine aminotransferase (ALT) liver enzymes was mitigated and a robust on-/off-target margin was achieved.  Spirohydantoins represent a class of highly efficacious, short-acting PHD1-3 inhibitors causing a robust erythropoietin (EPO) upregulation in vivo in multiple preclin. species.  This profile deems spirohydantoins as attractive short-acting PHDi inhibitors with the potential for treatment of anemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMoX0fQFHBsLVg90H21EOLACvtfcHk0lgbQj1F-zJBsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XivVOhtLs%253D&md5=3d23fd3c5379c259eb556d1fac6133de</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1021%2Fjm201542d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201542d%26sid%3Dliteratum%253Aachs%26aulast%3DVachal%26aufirst%3DP.%26aulast%3DMiao%26aufirst%3DS.%26aulast%3DPierce%26aufirst%3DJ.%2BM.%26aulast%3DGuiadeen%26aufirst%3DD.%26aulast%3DColandrea%26aufirst%3DV.%2BJ.%26aulast%3DWyvratt%26aufirst%3DM.%2BJ.%26aulast%3DSalowe%26aufirst%3DS.%2BP.%26aulast%3DSonatore%26aufirst%3DL.%2BM.%26aulast%3DMilligan%26aufirst%3DJ.%2BA.%26aulast%3DHajdu%26aufirst%3DR.%26aulast%3DGollapudi%26aufirst%3DA.%26aulast%3DKeohane%26aufirst%3DC.%2BA.%26aulast%3DLingham%26aufirst%3DR.%2BB.%26aulast%3DMandala%26aufirst%3DS.%2BM.%26aulast%3DDeMartino%26aufirst%3DJ.%2BA.%26aulast%3DTong%26aufirst%3DX.%26aulast%3DWolff%26aufirst%3DM.%26aulast%3DSteinhuebel%26aufirst%3DD.%26aulast%3DKieczykowski%26aufirst%3DG.%2BR.%26aulast%3DFleitz%26aufirst%3DF.%2BJ.%26aulast%3DChapman%26aufirst%3DK.%26aulast%3DAthanasopoulos%26aufirst%3DJ.%26aulast%3DAdam%26aufirst%3DG.%26aulast%3DAkyuz%26aufirst%3DC.%2BD.%26aulast%3DJena%26aufirst%3DD.%2BK.%26aulast%3DLusen%26aufirst%3DJ.%2BW.%26aulast%3DMeng%26aufirst%3DJ.%26aulast%3DStein%26aufirst%3DB.%2BD.%26aulast%3DXia%26aufirst%3DL.%26aulast%3DSherer%26aufirst%3DE.%2BC.%26aulast%3DHale%26aufirst%3DJ.%2BJ.%26atitle%3D1%252C3%252C8-Triazaspiro%255B4.5%255Ddecane-2%252C4-diones%2520as%2520efficacious%2520pan-inhibitors%2520of%2520hypoxia-inducible%2520factor%2520prolyl%2520hydroxylase%25201%25E2%2580%25933%2520%2528HIF%2520PHD1%25E2%2580%25933%2529%2520for%2520the%2520treatment%2520of%2520anemia%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D2945%26epage%3D2959%26doi%3D10.1021%2Fjm201542d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref114"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref114'); return false;" data-citation="" class="refNumLink">114</a></strong><div class="NLM_citation" id="cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pierce, J. M.</span>; <span class="NLM_string-name">Hale, J. J.</span>; <span class="NLM_string-name">Miao, S.</span>; <span class="NLM_string-name">Vachal, P.</span></span> <span> </span><span class="NLM_article-title">Substituted 1,3,8-Triazaspiro[4,5]decane-2,4-diones</span>. <span class="NLM_patent">WO2010147776A1</span>, <span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=J.+M.+Pierce&author=J.+J.+Hale&author=S.+Miao&author=P.+Vachal&title=Substituted+1%2C3%2C8-Triazaspiro%5B4%2C5%5Ddecane-2%2C4-diones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DPierce%26aufirst%3DJ.%2BM.%26atitle%3DSubstituted%25201%252C3%252C8-Triazaspiro%255B4%252C5%255Ddecane-2%252C4-diones%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref115"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref115'); return false;" data-citation="" class="refNumLink">115</a></strong><div class="NLM_citation" id="cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Deng, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, T. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, F.</span></span> <span> </span><span class="NLM_article-title">Novel complex crystal structure of prolyl hydroxylase domain-containing protein 2 (PHD2): 2,8-Diazaspiro[4.5]decan-1-ones as potent, orally bioavailable PHD2 inhibitors</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">6349</span>– <span class="NLM_lpage">6358</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2013.08.046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1016%2Fj.bmc.2013.08.046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=24055079" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVOktL%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=6349-6358&author=G.+Dengauthor=B.+Zhaoauthor=Y.+Maauthor=Q.+Xuauthor=H.+Wangauthor=L.+Yangauthor=Q.+Zhangauthor=T.+B.+Guoauthor=W.+Zhangauthor=Y.+Jiaoauthor=X.+Caiauthor=J.+Zhangauthor=H.+Liuauthor=X.+Guanauthor=H.+Luauthor=J.+Xiangauthor=J.+D.+Elliottauthor=X.+Linauthor=F.+Ren&title=Novel+complex+crystal+structure+of+prolyl+hydroxylase+domain-containing+protein+2+%28PHD2%29%3A+2%2C8-Diazaspiro%5B4.5%5Ddecan-1-ones+as+potent%2C+orally+bioavailable+PHD2+inhibitors&doi=10.1016%2Fj.bmc.2013.08.046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Novel complex crystal structure of prolyl hydroxylase domain-containing protein 2 (PHD2): 2,8-Diazaspiro[4.5]decan-1-ones as potent, orally bioavailable PHD2 inhibitors</span></div><div class="casAuthors">Deng, Guanghui; Zhao, Baowei; Ma, Yingli; Xu, Qiongfeng; Wang, Hailong; Yang, Liuqing; Zhang, Qing; Guo, Taylor B.; Zhang, Wei; Jiao, Yang; Cai, Xin; Zhang, Jinqiang; Liu, Houfu; Guan, Xiaoming; Lu, Hongtao; Xiang, Jianing; Elliott, John D.; Lin, Xichen; Ren, Feng</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6349-6358</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We have discovered a novel complex crystal structure of the PHD2 enzyme with its inhibitor, the 2,8-diazaspiro[4.5]decan-1-one analog 4b.  The widely reported salt bridge between Arg383 of the enzyme and its inhibitors in all complex structures published thus far was not obsd. in our case.  In our complex structure compd. 4b forms several novel interactions with the enzyme, which include a hydrogen bond with Arg322, a π-cation interaction with Arg322, a π-π stacking with Trp389, and a π-π stacking with His313.  Guided by the structural information, SAR studies were performed on the 2,8-diazaspiro[4.5]decan-1-one series leading to the discovery of compd. 9p with high potency and good oral pharmacokinetic profile in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqNWYl7HPN17Vg90H21EOLACvtfcHk0li-DuBQ9ApMjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVOktL%252FE&md5=0031299974826f02e70f62914fa48e49</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2013.08.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2013.08.046%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DG.%26aulast%3DZhao%26aufirst%3DB.%26aulast%3DMa%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DGuo%26aufirst%3DT.%2BB.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DJiao%26aufirst%3DY.%26aulast%3DCai%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DGuan%26aufirst%3DX.%26aulast%3DLu%26aufirst%3DH.%26aulast%3DXiang%26aufirst%3DJ.%26aulast%3DElliott%26aufirst%3DJ.%2BD.%26aulast%3DLin%26aufirst%3DX.%26aulast%3DRen%26aufirst%3DF.%26atitle%3DNovel%2520complex%2520crystal%2520structure%2520of%2520prolyl%2520hydroxylase%2520domain-containing%2520protein%25202%2520%2528PHD2%2529%253A%25202%252C8-Diazaspiro%255B4.5%255Ddecan-1-ones%2520as%2520potent%252C%2520orally%2520bioavailable%2520PHD2%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26spage%3D6349%26epage%3D6358%26doi%3D10.1016%2Fj.bmc.2013.08.046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref116"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref116'); return false;" data-citation="" class="refNumLink">116</a></strong><div class="NLM_citation" id="cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Flamme, I.</span>; <span class="NLM_string-name">Ergueden, J.-K.</span>; <span class="NLM_string-name">Oehme, F.</span>; <span class="NLM_string-name">Thede, K.</span>; <span class="NLM_string-name">Karig, G.</span>; <span class="NLM_string-name">Kuhl, A.</span>; <span class="NLM_string-name">Wild, H.</span>; <span class="NLM_string-name">Schuhmacher, J.</span>; <span class="NLM_string-name">Kolkhof, P.</span>; <span class="NLM_string-name">Baerfacker, L.</span>; <span class="NLM_string-name">Huetter, J.</span></span> <span> </span><span class="NLM_article-title">Dipyridyl-Dihydropyrazolones and Their Use</span>. <span class="NLM_patent">US2010035906A1</span>, <span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=I.+Flamme&author=J.-K.+Ergueden&author=F.+Oehme&author=K.+Thede&author=G.+Karig&author=A.+Kuhl&author=H.+Wild&author=J.+Schuhmacher&author=P.+Kolkhof&author=L.+Baerfacker&author=J.+Huetter&title=Dipyridyl-Dihydropyrazolones+and+Their+Use"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DFlamme%26aufirst%3DI.%26atitle%3DDipyridyl-Dihydropyrazolones%2520and%2520Their%2520Use%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref117"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref117'); return false;" data-citation="" class="refNumLink">117</a></strong><div class="NLM_citation" id="cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thede, K.</span>; <span class="NLM_string-name">Flamme, I.</span>; <span class="NLM_string-name">Oehme, F.</span>; <span class="NLM_string-name">Ergueden, J. K.</span>; <span class="NLM_string-name">Stoll, F.</span>; <span class="NLM_string-name">Schuhmacher, J.</span>; <span class="NLM_string-name">Wild, H.</span>; <span class="NLM_string-name">Kolkhof, P.</span>; <span class="NLM_string-name">Beck, H.</span>; <span class="NLM_string-name">Keldenich, J.</span>; <span class="NLM_string-name">Akbaba, M.</span>; <span class="NLM_string-name">Jeske, M.</span></span> <span> </span><span class="NLM_article-title">Substituted Dihydropyrazolones for Treating Cardiovascular and Hematological Diseases</span>. <span class="NLM_patent">US20100305085A1</span>, <span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=K.+Thede&author=I.+Flamme&author=F.+Oehme&author=J.+K.+Ergueden&author=F.+Stoll&author=J.+Schuhmacher&author=H.+Wild&author=P.+Kolkhof&author=H.+Beck&author=J.+Keldenich&author=M.+Akbaba&author=M.+Jeske&title=Substituted+Dihydropyrazolones+for+Treating+Cardiovascular+and+Hematological+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DThede%26aufirst%3DK.%26atitle%3DSubstituted%2520Dihydropyrazolones%2520for%2520Treating%2520Cardiovascular%2520and%2520Hematological%2520Diseases%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref118"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref118'); return false;" data-citation="" class="refNumLink">118</a></strong><div class="NLM_citation" id="cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jeske, M.</span>; <span class="NLM_string-name">Flamme, I.</span>; <span class="NLM_string-name">Stoll, F.</span>; <span class="NLM_string-name">Oehme, F.</span></span> <span> </span><span class="NLM_article-title">Dihydropyrazolthiones as HIF Prolylhydroxylase Inhibitors</span>. <span class="NLM_patent">DE102007048447A1</span>, <span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=M.+Jeske&author=I.+Flamme&author=F.+Stoll&author=F.+Oehme&title=Dihydropyrazolthiones+as+HIF+Prolylhydroxylase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DJeske%26aufirst%3DM.%26atitle%3DDihydropyrazolthiones%2520as%2520HIF%2520Prolylhydroxylase%2520Inhibitors%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref119"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref119'); return false;" data-citation="" class="refNumLink">119</a></strong><div class="NLM_citation" id="cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jeske, M.</span>; <span class="NLM_string-name">Flamme, I.</span>; <span class="NLM_string-name">Stoll, F.</span>; <span class="NLM_string-name">Oehme, F.</span>; <span class="NLM_string-name">Akbaba, M.</span></span> <span> </span><span class="NLM_article-title">Dihydrotriazolones as HIF Prolylhydroxylase Inhibitors</span>. <span class="NLM_patent">DE102007049157A1</span>, <span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=M.+Jeske&author=I.+Flamme&author=F.+Stoll&author=F.+Oehme&author=M.+Akbaba&title=Dihydrotriazolones+as+HIF+Prolylhydroxylase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DJeske%26aufirst%3DM.%26atitle%3DDihydrotriazolones%2520as%2520HIF%2520Prolylhydroxylase%2520Inhibitors%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref120"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref120'); return false;" data-citation="" class="refNumLink">120</a></strong><div class="NLM_citation" id="cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beck, H.</span>; <span class="NLM_string-name">Jeske, M.</span>; <span class="NLM_string-name">Thede, K.</span>; <span class="NLM_string-name">Stoll, F.</span>; <span class="NLM_string-name">Flamme, I.</span>; <span class="NLM_string-name">Akbaba, M.</span>; <span class="NLM_string-name">Ergüden, J. K.</span>; <span class="NLM_string-name">Karig, G.</span>; <span class="NLM_string-name">Keldenich, J.</span>; <span class="NLM_string-name">Oehme, F.</span>; <span class="NLM_string-name">Militzer, H. C.</span>; <span class="NLM_string-name">Hartung, I. V.</span>; <span class="NLM_string-name">Thuss, U.</span></span> <span> </span><span class="NLM_article-title">Discovery of Molidustat (BAY 85-3934): A small-molecule oral HIF-prolyl hydroxylase (HIF-PH) inhibitor for the treatment of renal anemia</span>.  <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2018</span>, DOI: <span class="refDoi"> DOI: 10.1002/cmdc.201700783</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1002%2Fcmdc.201700783" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=H.+Beck&author=M.+Jeske&author=K.+Thede&author=F.+Stoll&author=I.+Flamme&author=M.+Akbaba&author=J.+K.+Erg%C3%BCden&author=G.+Karig&author=J.+Keldenich&author=F.+Oehme&author=H.+C.+Militzer&author=I.+V.+Hartung&author=U.+Thuss&title=Discovery+of+Molidustat+%28BAY+85-3934%29%3A+A+small-molecule+oral+HIF-prolyl+hydroxylase+%28HIF-PH%29+inhibitor+for+the+treatment+of+renal+anemia&doi=10.1002%2Fcmdc.201700783"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201700783&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201700783%26sid%3Dliteratum%253Aachs%26aulast%3DBeck%26aufirst%3DH.%26atitle%3DDiscovery%2520of%2520Molidustat%2520%2528BAY%252085-3934%2529%253A%2520A%2520small-molecule%2520oral%2520HIF-prolyl%2520hydroxylase%2520%2528HIF-PH%2529%2520inhibitor%2520for%2520the%2520treatment%2520of%2520renal%2520anemia%26jtitle%3DChemMedChem%26date%3D2018%26doi%3D10.1002%2Fcmdc.201700783" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref121"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref121'); return false;" data-citation="" class="refNumLink">121</a></strong><div class="NLM_citation" id="cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Flamme, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oehme, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellinghaus, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeske, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keldenich, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thuss, U.</span></span> <span> </span><span class="NLM_article-title">Mimicking hypoxia to treat anemia: HIF-stabilizer BAY 85–3934 (Molidustat) stimulates erythropoietin production without hypertensive effects</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">e111838</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0111838</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1371%2Fjournal.pone.0111838" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=e111838&author=I.+Flammeauthor=F.+Oehmeauthor=P.+Ellinghausauthor=M.+Jeskeauthor=J.+Keldenichauthor=U.+Thuss&title=Mimicking+hypoxia+to+treat+anemia%3A+HIF-stabilizer+BAY+85%E2%80%933934+%28Molidustat%29+stimulates+erythropoietin+production+without+hypertensive+effects&doi=10.1371%2Fjournal.pone.0111838"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0111838&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0111838%26sid%3Dliteratum%253Aachs%26aulast%3DFlamme%26aufirst%3DI.%26aulast%3DOehme%26aufirst%3DF.%26aulast%3DEllinghaus%26aufirst%3DP.%26aulast%3DJeske%26aufirst%3DM.%26aulast%3DKeldenich%26aufirst%3DJ.%26aulast%3DThuss%26aufirst%3DU.%26atitle%3DMimicking%2520hypoxia%2520to%2520treat%2520anemia%253A%2520HIF-stabilizer%2520BAY%252085%25E2%2580%25933934%2520%2528Molidustat%2529%2520stimulates%2520erythropoietin%2520production%2520without%2520hypertensive%2520effects%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26spage%3De111838%26doi%3D10.1371%2Fjournal.pone.0111838" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref122"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref122'); return false;" data-citation="" class="refNumLink">122</a></strong><div class="NLM_citation" id="cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brown, J. W.</span>; <span class="NLM_string-name">Davis, M.</span>; <span class="NLM_string-name">Ivetac, A.</span>; <span class="NLM_string-name">Jones, B.</span>; <span class="NLM_string-name">Kiryanov, A. A.</span>; <span class="NLM_string-name">Kuehler, J.</span>; <span class="NLM_string-name">Lanier, M.</span>; <span class="NLM_string-name">Miura, J.</span>; <span class="NLM_string-name">Murphy, S.</span>; <span class="NLM_string-name">Wang, X.</span></span> <span> </span><span class="NLM_article-title">6-(5-Hydroxy-1<i>H</i>-pyrazol-1-yl)nicotinamide Derivatives and Their Use as PHD Inhibitors</span>. <span class="NLM_patent">WO2014160810A1</span>, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=J.+W.+Brown&author=M.+Davis&author=A.+Ivetac&author=B.+Jones&author=A.+A.+Kiryanov&author=J.+Kuehler&author=M.+Lanier&author=J.+Miura&author=S.+Murphy&author=X.+Wang&title=6-%285-Hydroxy-1H-pyrazol-1-yl%29nicotinamide+Derivatives+and+Their+Use+as+PHD+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DJ.%2BW.%26atitle%3D6-%25285-Hydroxy-1H-pyrazol-1-yl%2529nicotinamide%2520Derivatives%2520and%2520Their%2520Use%2520as%2520PHD%2520Inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref123"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref123'); return false;" data-citation="" class="refNumLink">123</a></strong><div class="NLM_citation" id="cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carmeliet, P.</span></span> <span> </span><span class="NLM_article-title">Angiogenesis in health and disease</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">653</span>– <span class="NLM_lpage">660</span>, <span class="refDoi"> DOI: 10.1038/nm0603-653</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1038%2Fnm0603-653" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=12778163" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=1%3ACAS%3A528%3ADC%252BD3sXktFOntbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2003&pages=653-660&author=P.+Carmeliet&title=Angiogenesis+in+health+and+disease&doi=10.1038%2Fnm0603-653"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">Angiogenesis in health and disease</span></div><div class="casAuthors">Carmeliet, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">653-660</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Blood vessels constitute the first organ in the embryo and form the largest network in our body but, sadly, are also often deadly.  When dysregulated, the formation of new blood vessels contributes to numerous malignant, ischemic, inflammatory, infectious and immune disorders.  Mol. insights into these processes are being generated at a rapidly increasing pace, offering new therapeutic opportunities that are currently being evaluated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVe6HXO3QPLbVg90H21EOLACvtfcHk0liBut5AKGc31Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXktFOntbY%253D&md5=501ed35c48dbcc7c9d18b804c996284a</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1038%2Fnm0603-653&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm0603-653%26sid%3Dliteratum%253Aachs%26aulast%3DCarmeliet%26aufirst%3DP.%26atitle%3DAngiogenesis%2520in%2520health%2520and%2520disease%26jtitle%3DNat.%2520Med.%26date%3D2003%26volume%3D9%26spage%3D653%26epage%3D660%26doi%3D10.1038%2Fnm0603-653" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref124"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref124'); return false;" data-citation="" class="refNumLink">124</a></strong><div class="NLM_citation" id="cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sakamoto, A.</span>; <span class="NLM_string-name">Tanaka, N.</span>; <span class="NLM_string-name">Fukuda, T.</span></span> <span> </span><span class="NLM_article-title">4-Alkanoylamino-3-pyrazolone Derivative</span>. <span class="NLM_patent">US2015011552A1</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=A.+Sakamoto&author=N.+Tanaka&author=T.+Fukuda&title=4-Alkanoylamino-3-pyrazolone+Derivative"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSakamoto%26aufirst%3DA.%26atitle%3D4-Alkanoylamino-3-pyrazolone%2520Derivative%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref125"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref125'); return false;" data-citation="" class="refNumLink">125</a></strong><div class="NLM_citation" id="cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Suga, Y.</span>; <span class="NLM_string-name">Shimizu, Y.</span>; <span class="NLM_string-name">Kawabe, K.</span>; <span class="NLM_string-name">Bohno, A.</span>; <span class="NLM_string-name">Hamada, M.</span>; <span class="NLM_string-name">Takahashi, M.</span></span> <span> </span><span class="NLM_article-title">Heteroaryl Compound Substituted by Triazolyl</span>. <span class="NLM_patent">WO2015163472A1</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=Y.+Suga&author=Y.+Shimizu&author=K.+Kawabe&author=A.+Bohno&author=M.+Hamada&author=M.+Takahashi&title=Heteroaryl+Compound+Substituted+by+Triazolyl"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSuga%26aufirst%3DY.%26atitle%3DHeteroaryl%2520Compound%2520Substituted%2520by%2520Triazolyl%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref126"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref126'); return false;" data-citation="" class="refNumLink">126</a></strong><div class="NLM_citation" id="cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hong, Y. R.</span>; <span class="NLM_string-name">Shin, D.</span>; <span class="NLM_string-name">Ro, S.</span>; <span class="NLM_string-name">Cho, J.
M.</span>; <span class="NLM_string-name">Kim, H. T.</span>; <span class="NLM_string-name">Lee, J. H.</span>; <span class="NLM_string-name">Kim, J. M.</span>; <span class="NLM_string-name">Lee, W. S.</span>; <span class="NLM_string-name">Choi, J. R.</span></span> <span> </span><span class="NLM_article-title">Phenol Derivatives and Methods of Use Thereof</span>. <span class="NLM_patent">WO2010018458A2</span>, <span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=Y.+R.+Hong&author=D.+Shin&author=S.+Ro&author=J.%0AM.+Cho&author=H.+T.+Kim&author=J.+H.+Lee&author=J.+M.+Kim&author=W.+S.+Lee&author=J.+R.+Choi&title=Phenol+Derivatives+and+Methods+of+Use+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHong%26aufirst%3DY.%2BR.%26atitle%3DPhenol%2520Derivatives%2520and%2520Methods%2520of%2520Use%2520Thereof%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref127"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref127'); return false;" data-citation="" class="refNumLink">127</a></strong><div class="NLM_citation" id="cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hong, Y. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, I. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, Y. H.</span></span> <span> </span><span class="NLM_article-title">Discovery of novel 2-[2-(3-hydroxy-pyridin-2-yl)-thiazol-4-yl]-acetamide derivatives as HIF prolyl 4-hydroxylase inhibitors; SAR, synthesis and modeling evaluation</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">3142</span>– <span class="NLM_lpage">3145</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2014.05.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1016%2Fj.bmcl.2014.05.003" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=3142-3145&author=Y.+R.+Hongauthor=H.+T.+Kimauthor=S.+Roauthor=J.+M.+Choauthor=S.+H.+Leeauthor=I.+S.+Kimauthor=Y.+H.+Jung&title=Discovery+of+novel+2-%5B2-%283-hydroxy-pyridin-2-yl%29-thiazol-4-yl%5D-acetamide+derivatives+as+HIF+prolyl+4-hydroxylase+inhibitors%3B+SAR%2C+synthesis+and+modeling+evaluation&doi=10.1016%2Fj.bmcl.2014.05.003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.05.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.05.003%26sid%3Dliteratum%253Aachs%26aulast%3DHong%26aufirst%3DY.%2BR.%26aulast%3DKim%26aufirst%3DH.%2BT.%26aulast%3DRo%26aufirst%3DS.%26aulast%3DCho%26aufirst%3DJ.%2BM.%26aulast%3DLee%26aufirst%3DS.%2BH.%26aulast%3DKim%26aufirst%3DI.%2BS.%26aulast%3DJung%26aufirst%3DY.%2BH.%26atitle%3DDiscovery%2520of%2520novel%25202-%255B2-%25283-hydroxy-pyridin-2-yl%2529-thiazol-4-yl%255D-acetamide%2520derivatives%2520as%2520HIF%2520prolyl%25204-hydroxylase%2520inhibitors%253B%2520SAR%252C%2520synthesis%2520and%2520modeling%2520evaluation%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D3142%26epage%3D3145%26doi%3D10.1016%2Fj.bmcl.2014.05.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref128"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref128'); return false;" data-citation="" class="refNumLink">128</a></strong><div class="NLM_citation" id="cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, S.</span>; <span class="NLM_string-name">Barker, G.</span>; <span class="NLM_string-name">Canning, H.</span>; <span class="NLM_string-name">Davenport, R.</span>; <span class="NLM_string-name">Harrison, D.</span>; <span class="NLM_string-name">Jenkins, K.</span>; <span class="NLM_string-name">Livermore, D.</span>; <span class="NLM_string-name">Wright, S.</span>; <span class="NLM_string-name">Kinsella, N.</span></span> <span> </span><span class="NLM_article-title">Fused Bicyclic Heteroaryl Derivatives having Activity as PHD Inhibitors</span>. <span class="NLM_patent">WO2016148306A1</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=S.+Ahmed&author=G.+Barker&author=H.+Canning&author=R.+Davenport&author=D.+Harrison&author=K.+Jenkins&author=D.+Livermore&author=S.+Wright&author=N.+Kinsella&title=Fused+Bicyclic+Heteroaryl+Derivatives+having+Activity+as+PHD+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAhmed%26aufirst%3DS.%26atitle%3DFused%2520Bicyclic%2520Heteroaryl%2520Derivatives%2520having%2520Activity%2520as%2520PHD%2520Inhibitors%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref129"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref129'); return false;" data-citation="" class="refNumLink">129</a></strong><div class="NLM_citation" id="cit129"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ayscough, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barker, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canning, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davenport, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Downham, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenkins, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinsella, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Livermore, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ivetac, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skene, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkens, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webster, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hendrick, A. G.</span></span> <span> </span><span class="NLM_article-title">1,2,4-Triazolo-[1,5-a]pyridine HIF prolyl hydroxylase domain-1 (PHD-1) inhibitors with a novel monodentate binding interaction</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">5663</span>– <span class="NLM_lpage">5672</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00352</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00352" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=5663-5672&author=S.+Ahmedauthor=A.+Ayscoughauthor=G.+R.+Barkerauthor=H.+E.+Canningauthor=R.+Davenportauthor=R.+Downhamauthor=D.+Harrisonauthor=K.+Jenkinsauthor=N.+Kinsellaauthor=D.+G.+Livermoreauthor=S.+Wrightauthor=A.+D.+Ivetacauthor=R.+Skeneauthor=S.+J.+Wilkensauthor=N.+A.+Websterauthor=A.+G.+Hendrick&title=1%2C2%2C4-Triazolo-%5B1%2C5-a%5Dpyridine+HIF+prolyl+hydroxylase+domain-1+%28PHD-1%29+inhibitors+with+a+novel+monodentate+binding+interaction&doi=10.1021%2Facs.jmedchem.7b00352"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00352&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00352%26sid%3Dliteratum%253Aachs%26aulast%3DAhmed%26aufirst%3DS.%26aulast%3DAyscough%26aufirst%3DA.%26aulast%3DBarker%26aufirst%3DG.%2BR.%26aulast%3DCanning%26aufirst%3DH.%2BE.%26aulast%3DDavenport%26aufirst%3DR.%26aulast%3DDownham%26aufirst%3DR.%26aulast%3DHarrison%26aufirst%3DD.%26aulast%3DJenkins%26aufirst%3DK.%26aulast%3DKinsella%26aufirst%3DN.%26aulast%3DLivermore%26aufirst%3DD.%2BG.%26aulast%3DWright%26aufirst%3DS.%26aulast%3DIvetac%26aufirst%3DA.%2BD.%26aulast%3DSkene%26aufirst%3DR.%26aulast%3DWilkens%26aufirst%3DS.%2BJ.%26aulast%3DWebster%26aufirst%3DN.%2BA.%26aulast%3DHendrick%26aufirst%3DA.%2BG.%26atitle%3D1%252C2%252C4-Triazolo-%255B1%252C5-a%255Dpyridine%2520HIF%2520prolyl%2520hydroxylase%2520domain-1%2520%2528PHD-1%2529%2520inhibitors%2520with%2520a%2520novel%2520monodentate%2520binding%2520interaction%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D5663%26epage%3D5672%26doi%3D10.1021%2Facs.jmedchem.7b00352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref130"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref130'); return false;" data-citation="" class="refNumLink">130</a></strong><div class="NLM_citation" id="cit130"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yeoh, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thalhammer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demetriades, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chowdhury, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stolze, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNeill, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woon, E. C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackeen, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawamura, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ratcliffe, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mecinović, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, C.</span></span> <span> </span><span class="NLM_article-title">Dual-action inhibitors of HIF prolyl hydroxylases that induce binding of a second iron ion</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">732</span>– <span class="NLM_lpage">745</span>, <span class="refDoi"> DOI: 10.1039/C2OB26648B</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1039%2FC2OB26648B" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=23151668" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjtlGitA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2013&pages=732-745&author=K.+K.+Yeohauthor=M.+C.+Chanauthor=A.+Thalhammerauthor=M.+Demetriadesauthor=R.+Chowdhuryauthor=Y.+M.+Tianauthor=I.+Stolzeauthor=L.+A.+McNeillauthor=M.+K.+Leeauthor=E.+C.+Y.+Woonauthor=M.+M.+Mackeenauthor=A.+Kawamuraauthor=P.+J.+Ratcliffeauthor=J.+Mecinovi%C4%87author=C.+Schofield&title=Dual-action+inhibitors+of+HIF+prolyl+hydroxylases+that+induce+binding+of+a+second+iron+ion&doi=10.1039%2FC2OB26648B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">Dual-action inhibitors of HIF prolyl hydroxylases that induce binding of a second iron ion</span></div><div class="casAuthors">Yeoh, Kar Kheng; Chan, Mun Chiang; Thalhammer, Armin; Demetriades, Marina; Chowdhury, Rasheduzzaman; Tian, Ya-Min; Stolze, Ineke; McNeill, Luke A.; Lee, Myung Kyu; Woon, Esther C. Y.; Mackeen, Mukram M.; Kawamura, Akane; Ratcliffe, Peter J.; Mecinovic, Jasmin; Schofield, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">732-745</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Inhibition of the hypoxia-inducible factor (HIF) prolyl hydroxylases (PHD or EGLN enzymes) is of interest for the treatment of anemia and ischemia-related diseases.  Most PHD inhibitors work by binding to the single ferrous ion and competing with 2-oxoglutarate (2OG) co-substrate for binding at the PHD active site.  Non-specific iron chelators also inhibit the PHDs, both in vitro and in cells.  The authors report the identification of dual action PHD inhibitors, which bind to the active site iron and also induce the binding of a second iron ion at the active site.  Following anal. of small-mol. iron complexes and application of non-denaturing protein mass spectrometry to assess PHD2·iron·inhibitor stoichiometry, selected diacylhydrazines were identified as PHD2 inhibitors that induce the binding of a second iron ion.  Some compds. were shown to inhibit the HIF hydroxylases in human hepatoma and renal carcinoma cell lines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGph9TkImzYXwLVg90H21EOLACvtfcHk0ljGSLXcRCIOGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjtlGitA%253D%253D&md5=797d732fe07a58d6e1f1c82ebb507b1e</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1039%2FC2OB26648B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC2OB26648B%26sid%3Dliteratum%253Aachs%26aulast%3DYeoh%26aufirst%3DK.%2BK.%26aulast%3DChan%26aufirst%3DM.%2BC.%26aulast%3DThalhammer%26aufirst%3DA.%26aulast%3DDemetriades%26aufirst%3DM.%26aulast%3DChowdhury%26aufirst%3DR.%26aulast%3DTian%26aufirst%3DY.%2BM.%26aulast%3DStolze%26aufirst%3DI.%26aulast%3DMcNeill%26aufirst%3DL.%2BA.%26aulast%3DLee%26aufirst%3DM.%2BK.%26aulast%3DWoon%26aufirst%3DE.%2BC.%2BY.%26aulast%3DMackeen%26aufirst%3DM.%2BM.%26aulast%3DKawamura%26aufirst%3DA.%26aulast%3DRatcliffe%26aufirst%3DP.%2BJ.%26aulast%3DMecinovi%25C4%2587%26aufirst%3DJ.%26aulast%3DSchofield%26aufirst%3DC.%26atitle%3DDual-action%2520inhibitors%2520of%2520HIF%2520prolyl%2520hydroxylases%2520that%2520induce%2520binding%2520of%2520a%2520second%2520iron%2520ion%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2013%26volume%3D11%26spage%3D732%26epage%3D745%26doi%3D10.1039%2FC2OB26648B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref131"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref131'); return false;" data-citation="" class="refNumLink">131</a></strong><div class="NLM_citation" id="cit131"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Na, Y. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woo, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, E. G.</span></span> <span> </span><span class="NLM_article-title">Pyrithione Zn selectively inhibits hypoxia-inducible factor prolyl hydroxylase PHD3</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>472</i></span>,  <span class="NLM_fpage">313</span>– <span class="NLM_lpage">318</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2016.02.115</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1016%2Fj.bbrc.2016.02.115" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=472&publication_year=2016&pages=313-318&author=Y.+R.+Naauthor=D.+J.+Wooauthor=S.+Y.+Kimauthor=E.+G.+Yang&title=Pyrithione+Zn+selectively+inhibits+hypoxia-inducible+factor+prolyl+hydroxylase+PHD3&doi=10.1016%2Fj.bbrc.2016.02.115"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2016.02.115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2016.02.115%26sid%3Dliteratum%253Aachs%26aulast%3DNa%26aufirst%3DY.%2BR.%26aulast%3DWoo%26aufirst%3DD.%2BJ.%26aulast%3DKim%26aufirst%3DS.%2BY.%26aulast%3DYang%26aufirst%3DE.%2BG.%26atitle%3DPyrithione%2520Zn%2520selectively%2520inhibits%2520hypoxia-inducible%2520factor%2520prolyl%2520hydroxylase%2520PHD3%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2016%26volume%3D472%26spage%3D313%26epage%3D318%26doi%3D10.1016%2Fj.bbrc.2016.02.115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref132"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref132'); return false;" data-citation="" class="refNumLink">132</a></strong><div class="NLM_citation" id="cit132"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Seeley, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sternlicht, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klaus, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neff, T. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D. Y.</span></span> <span> </span><span class="NLM_article-title">Induction of erythropoiesis by hypoxia-inducible factor prolyl hydroxylase inhibitors without promotion of tumor initiation, progression, or metastasis in a VEGF-sensitive model of spontaneous breast cancer</span>. <i>Hypoxia</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">9</span>, <span class="refDoi"> DOI: 10.2147/HP.S130526</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.2147%2FHP.S130526" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2017&pages=1-9&author=T.+W.+Seeleyauthor=M.+D.+Sternlichtauthor=S.+J.+Klausauthor=T.+B.+Neffauthor=D.+Y.+Liu&title=Induction+of+erythropoiesis+by+hypoxia-inducible+factor+prolyl+hydroxylase+inhibitors+without+promotion+of+tumor+initiation%2C+progression%2C+or+metastasis+in+a+VEGF-sensitive+model+of+spontaneous+breast+cancer&doi=10.2147%2FHP.S130526"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.2147%2FHP.S130526&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FHP.S130526%26sid%3Dliteratum%253Aachs%26aulast%3DSeeley%26aufirst%3DT.%2BW.%26aulast%3DSternlicht%26aufirst%3DM.%2BD.%26aulast%3DKlaus%26aufirst%3DS.%2BJ.%26aulast%3DNeff%26aufirst%3DT.%2BB.%26aulast%3DLiu%26aufirst%3DD.%2BY.%26atitle%3DInduction%2520of%2520erythropoiesis%2520by%2520hypoxia-inducible%2520factor%2520prolyl%2520hydroxylase%2520inhibitors%2520without%2520promotion%2520of%2520tumor%2520initiation%252C%2520progression%252C%2520or%2520metastasis%2520in%2520a%2520VEGF-sensitive%2520model%2520of%2520spontaneous%2520breast%2520cancer%26jtitle%3DHypoxia%26date%3D2017%26volume%3D5%26spage%3D1%26epage%3D9%26doi%3D10.2147%2FHP.S130526" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref133"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref133'); return false;" data-citation="" class="refNumLink">133</a></strong><div class="NLM_citation" id="cit133"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Akizawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsubakihara, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nangaku, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Endo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakajima, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohno, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawase, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lepore, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cobitz, A.</span></span> <span> </span><span class="NLM_article-title">Effects of Daprodustat, a novel hypoxia-inducible factor prolyl hydroxylase inhibitor on anemia management in Japanese hemodialysis subjects</span>. <i>Am. J. Nephrol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">127</span>– <span class="NLM_lpage">135</span>, <span class="refDoi"> DOI: 10.1159/000454818</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1159%2F000454818" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=27978511" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjtVGqu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2017&pages=127-135&author=T.+Akizawaauthor=Y.+Tsubakiharaauthor=M.+Nangakuauthor=Y.+Endoauthor=H.+Nakajimaauthor=T.+Kohnoauthor=Y.+Imaiauthor=N.+Kawaseauthor=K.+Haraauthor=J.+Leporeauthor=A.+Cobitz&title=Effects+of+Daprodustat%2C+a+novel+hypoxia-inducible+factor+prolyl+hydroxylase+inhibitor+on+anemia+management+in+Japanese+hemodialysis+subjects&doi=10.1159%2F000454818"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of Daprodustat, a Novel Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor on Anemia Management in Japanese Hemodialysis Subjects</span></div><div class="casAuthors">Akizawa, Tadao; Tsubakihara, Yoshiharu; Nangaku, Masaomi; Endo, Yukihiro; Nakajima, Hiromu; Kohno, Tomoko; Imai, Yukiko; Kawase, Natsumi; Hara, Katsutoshi; Lepore, John; Cobitz, Alexander</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Nephrology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">127-135</span>CODEN:
                <span class="NLM_cas:coden">AJNED9</span>;
        ISSN:<span class="NLM_cas:issn">0250-8095</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">Background: Daprodustat (GSK1278863) is an oral hypoxia-inducible factor prolyl hydroxylase inhibitor being developed for treatment of anemia assocd. with chronic kidney disease (CKD).  The effect of daprodustat in Japanese CKD patients with anemia has not been previously investigated.  Methods: We evaluated the relationship between daprodustat dose and Hb response in Japanese patients on hemodialysis (HD) with anemia in a 4-wk, phase II, double-blind, placebo-controlled study.  After interrupting their erythropoiesis-stimulating agent for between 2 and 8 wk, subjects with Hb 8.5-10.5 g/dL were randomized to placebo or daprodustat 4, 6, 8, or 10 mg orally once daily.  Hb, erythropoietin (EPO), and vascular endothelial growth factor (VEGF) levels during therapy were evaluated.  Results: Eighty-six of 97 randomized subjects completed the study.  Mean baseline Hb ranged from 9.68 to 9.92 g/dL across groups.  After 4-wk administration, mean Hb changes were -0.28, -0.01, 0.54, and 0.97 g/dL in the 4, 6, 8, and 10 mg groups, resp., as compared to -1.41 g/dL for placebo.  Dose-dependent increase in plasma EPO concn. were obsd. up to 8 mg, with the 10 mg dose responses being similar to 8 mg.  Plasma VEGF concns. were minimally changed, even though 5 subjects treated with 6-10 mg reached EPO >500 mIU/mL.  Conclusion: Daprodustat 4-10 mg once-daily produced dose-dependent increase in Hb relative to placebo in Japanese HD subjects.  The doses evaluated in the study have moderately increased endogenous EPO without changes in circulating VEGF levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyY5upHTQiSLVg90H21EOLACvtfcHk0lgvEbTOsfW7Rw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjtVGqu7c%253D&md5=58ea3d73ec47776ca16ffe46dea7c56c</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1159%2F000454818&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000454818%26sid%3Dliteratum%253Aachs%26aulast%3DAkizawa%26aufirst%3DT.%26aulast%3DTsubakihara%26aufirst%3DY.%26aulast%3DNangaku%26aufirst%3DM.%26aulast%3DEndo%26aufirst%3DY.%26aulast%3DNakajima%26aufirst%3DH.%26aulast%3DKohno%26aufirst%3DT.%26aulast%3DImai%26aufirst%3DY.%26aulast%3DKawase%26aufirst%3DN.%26aulast%3DHara%26aufirst%3DK.%26aulast%3DLepore%26aufirst%3DJ.%26aulast%3DCobitz%26aufirst%3DA.%26atitle%3DEffects%2520of%2520Daprodustat%252C%2520a%2520novel%2520hypoxia-inducible%2520factor%2520prolyl%2520hydroxylase%2520inhibitor%2520on%2520anemia%2520management%2520in%2520Japanese%2520hemodialysis%2520subjects%26jtitle%3DAm.%2520J.%2520Nephrol.%26date%3D2017%26volume%3D45%26spage%3D127%26epage%3D135%26doi%3D10.1159%2F000454818" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref134"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref134'); return false;" data-citation="" class="refNumLink">134</a></strong><div class="NLM_citation" id="cit134"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Caltabiano, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serbest, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravindranath, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cobitz, A. R.</span></span> <span> </span><span class="NLM_article-title">A randomized, placebo- and positive-controlled, single-dose, crossover thorough QT/QTc study assessing the effect of Daprodustat on cardiac repolarization in healthy subjects. Clin</span>. <i>Pharmacol. Drug. Dev.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">627</span>– <span class="NLM_lpage">640</span>, <span class="refDoi"> DOI: 10.1002/cpdd.342</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1002%2Fcpdd.342" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=28419747" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslymsLvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2017&pages=627-640&author=S.+Caltabianoauthor=J.+Collinsauthor=G.+Serbestauthor=L.+Morganauthor=D.+A.+Smithauthor=R.+Ravindranathauthor=A.+R.+Cobitz&title=A+randomized%2C+placebo-+and+positive-controlled%2C+single-dose%2C+crossover+thorough+QT%2FQTc+study+assessing+the+effect+of+Daprodustat+on+cardiac+repolarization+in+healthy+subjects.+Clin&doi=10.1002%2Fcpdd.342"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">A Randomized, Placebo- and Positive-Controlled, Single-Dose, Crossover Thorough QT/QTc Study Assessing the Effect of Daprodustat on Cardiac Repolarization in Healthy Subjects</span></div><div class="casAuthors">Caltabiano, Stephen; Collins, Jon; Serbest, Gul; Morgan, Lisa; Smith, Deborah A.; Ravindranath, Ramiya; Cobitz, Alexander R.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacology in Drug Development</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">627-640</span>CODEN:
                <span class="NLM_cas:coden">CPDDAH</span>;
        ISSN:<span class="NLM_cas:issn">2160-7648</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Daprodustat (GSK1278863) is a prolyl hydroxylase inhibitor in phase 3 clin. studies for the treatment of anemia assocd. with chronic kidney disease.  This study was conducted to evaluate the effect of daprodustat on cardiac repolarization and enrolled 55 healthy adult male (29) and female (26) subjects who received single-dose 75 and 500 mg daprodustat, 400 mg moxifloxacin, and placebo.  Mean placebo-cor. change from baseline QT interval for daprodustat showed no statistically significant increase.  However, statistically significant decreases in the ΔΔQTcF were obsd. for both doses of daprodustat, reaching a lowest value of -2.74 ms for 75 mg and -5.93 ms for 500 mg daprodustat; this minor shortening effect is not considered clin. significant.  The moxifloxacin group showed a statistically significant increase in the ΔΔQTcF value, reaching a maximal increase of 11.47 ms at 4 h.  Forty subjects (73%) reported at least 1 adverse event, with the highest incidence with 500 mg daprodustat.  This group had a higher incidence of gastrointestinal adverse events compared to the other treatment groups.  These results suggest that 500 mg daprodustat was not well tolerated; however, daprodustat at 75 mg was generally well tolerated.  No new safety concerns were identified in subjects who received 500 mg daprodustat.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvUSuZnIyGm7Vg90H21EOLACvtfcHk0lg_d95CjB4A3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslymsLvO&md5=dae5a9b0d2700402da22e5f25d6680c3</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1002%2Fcpdd.342&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcpdd.342%26sid%3Dliteratum%253Aachs%26aulast%3DCaltabiano%26aufirst%3DS.%26aulast%3DCollins%26aufirst%3DJ.%26aulast%3DSerbest%26aufirst%3DG.%26aulast%3DMorgan%26aufirst%3DL.%26aulast%3DSmith%26aufirst%3DD.%2BA.%26aulast%3DRavindranath%26aufirst%3DR.%26aulast%3DCobitz%26aufirst%3DA.%2BR.%26atitle%3DA%2520randomized%252C%2520placebo-%2520and%2520positive-controlled%252C%2520single-dose%252C%2520crossover%2520thorough%2520QT%252FQTc%2520study%2520assessing%2520the%2520effect%2520of%2520Daprodustat%2520on%2520cardiac%2520repolarization%2520in%2520healthy%2520subjects.%2520Clin%26jtitle%3DPharmacol.%2520Drug.%2520Dev.%26date%3D2017%26volume%3D6%26spage%3D627%26epage%3D640%26doi%3D10.1002%2Fcpdd.342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref135"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref135'); return false;" data-citation="" class="refNumLink">135</a></strong><div class="NLM_citation" id="cit135"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pergola, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spinowitz, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartman, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maroni, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haase, V. H.</span></span> <span> </span><span class="NLM_article-title">Vadadustat, a novel oral HIF stabilizer, provides effective anemia treatment in nondialysis-dependent chronic kidney disease</span>. <i>Kidney Int.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>90</i></span>,  <span class="NLM_fpage">1115</span>– <span class="NLM_lpage">1122</span>, <span class="refDoi"> DOI: 10.1016/j.kint.2016.07.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1016%2Fj.kint.2016.07.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=27650732" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFenur7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2016&pages=1115-1122&author=P.+E.+Pergolaauthor=B.+S.+Spinowitzauthor=C.+S.+Hartmanauthor=B.+J.+Maroniauthor=V.+H.+Haase&title=Vadadustat%2C+a+novel+oral+HIF+stabilizer%2C+provides+effective+anemia+treatment+in+nondialysis-dependent+chronic+kidney+disease&doi=10.1016%2Fj.kint.2016.07.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">Vadadustat, a novel oral HIF stabilizer, provides effective anemia treatment in nondialysis-dependent chronic kidney disease</span></div><div class="casAuthors">Pergola, Pablo E.; Spinowitz, Bruce S.; Hartman, Charlotte S.; Maroni, Bradley J.; Haase, Volker H.</div><div class="citationInfo"><span class="NLM_cas:title">Kidney International</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1115-1122</span>CODEN:
                <span class="NLM_cas:coden">KDYIA5</span>;
        ISSN:<span class="NLM_cas:issn">0085-2538</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Current treatment of anemia in chronic kidney disease (CKD) with erythropoiesis-stimulating agents can lead to substantial Hb oscillations above target range and high levels of circulating erythropoietin.  Vadadustat (AKB-6548), a novel, titratable, oral hypoxia-inducible factor prolyl hydroxylase inhibitor induces endogenous erythropoietin synthesis and enhances iron mobilization.  In this 20-wk, double-blind, randomized, placebo-controlled, phase 2b study, we evaluated the efficacy and safety of once-daily vadadustat in patients with stages 3a to 5 non-dialysis-dependent CKD.  The primary endpoint was the percentage of patients who, during the last 2 wk of treatment, achieved or maintained either a mean Hb level of 11.0 g/dL or more or a mean increase in Hb of 1.2 g/dL or more over the predose av.  Significantly, the primary endpoint was met in 54.9% of patients on vadadustat and 10.3% of patients on placebo.  Significant increases in both reticulocytes and total iron-binding capacity and significant decreases in both serum hepcidin and ferritin levels were obsd. in patients on vadadustat compared with placebo.  The overall incidence of adverse events was comparable between the 2 groups.  Serious adverse events occurred in 23.9% and 15.3% of the vadadustat- and placebo-treated patients, resp.  Three deaths occurred in the vadadustat arm.  Thus, this phase 2b study demonstrated that vadadustat raised and maintained Hb levels in a predictable and controlled manner while enhancing iron mobilization in patients with nondialysis-dependent CKD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAqp2IOl9lT7Vg90H21EOLACvtfcHk0lg_d95CjB4A3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFenur7M&md5=4e4f226a11b371b8bc7de145a1d0c2e1</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1016%2Fj.kint.2016.07.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.kint.2016.07.019%26sid%3Dliteratum%253Aachs%26aulast%3DPergola%26aufirst%3DP.%2BE.%26aulast%3DSpinowitz%26aufirst%3DB.%2BS.%26aulast%3DHartman%26aufirst%3DC.%2BS.%26aulast%3DMaroni%26aufirst%3DB.%2BJ.%26aulast%3DHaase%26aufirst%3DV.%2BH.%26atitle%3DVadadustat%252C%2520a%2520novel%2520oral%2520HIF%2520stabilizer%252C%2520provides%2520effective%2520anemia%2520treatment%2520in%2520nondialysis-dependent%2520chronic%2520kidney%2520disease%26jtitle%3DKidney%2520Int.%26date%3D2016%26volume%3D90%26spage%3D1115%26epage%3D1122%26doi%3D10.1016%2Fj.kint.2016.07.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref136"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref136'); return false;" data-citation="" class="refNumLink">136</a></strong><div class="NLM_citation" id="cit136"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martin, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maroni, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuraw, Q. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">deGoma, E. M.</span></span> <span> </span><span class="NLM_article-title">Clinical trial of Vadadustat in patients with anemia secondary to Stage 3 or 4 chronic kidney disease</span>. <i>Am. J. Nephrol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">380</span>– <span class="NLM_lpage">388</span>, <span class="refDoi"> DOI: 10.1159/000464476</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1159%2F000464476" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=28343225" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=1%3ACAS%3A528%3ADC%252BC2sXotVOisrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2017&pages=380-388&author=E.+R.+Martinauthor=M.+T.+Smithauthor=B.+J.+Maroniauthor=Q.+C.+Zurawauthor=E.+M.+deGoma&title=Clinical+trial+of+Vadadustat+in+patients+with+anemia+secondary+to+Stage+3+or+4+chronic+kidney+disease&doi=10.1159%2F000464476"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical Trial of Vadadustat in Patients with Anemia Secondary to Stage 3 or 4 Chronic Kidney Disease</span></div><div class="casAuthors">Martin, Edouard R.; Smith, Mark T.; Maroni, Bradley J.; Zuraw, Qing C.; de Goma, Emil M.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Nephrology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">380-388</span>CODEN:
                <span class="NLM_cas:coden">AJNED9</span>;
        ISSN:<span class="NLM_cas:issn">0250-8095</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">Background: Therapeutic options for the treatment of anemia secondary to chronic kidney disease (CKD) remain limited.  Vadadustat (AKB-6548) is an oral hypoxia-inducible factor prolyl-hydroxylase domain (HIF-PHD) inhibitor that is being investigated for the treatment of anemia secondary to CKD.  Methods: A phase 2a, multicenter, randomized, double-blind, placebo-controlled, dose-ranging trial (NCT01381094) was undertaken in adults with anemia secondary to CKD stage 3 or 4.  Eligible subjects were evenly randomized to 5 groups: 240, 370, 500, or 630 mg of once-daily oral vadadustat or placebo for 6 wk.  All subjects received low-dose supplemental oral iron (50 mg daily).  The primary endpoint was the mean abs. change in Hb (Hb) from baseline to the end of treatment.  Secondary endpoints included iron indexes, safety, and tolerability.  Results: Ninety-three subjects were randomized.  Compared with placebo, vadadustat significantly increased Hb after 6 wk in a dose-dependent manner (anal. of variance; p < 0.0001).  Vadadustat increased the total iron-binding capacity and decreased concns. of ferritin and hepcidin.  The proportion of subjects with at least 1 treatment-emergent adverse event was similar between vadadustat- and placebo-treated groups.  No significant changes in blood pressure, vascular endothelial growth factor, C-reactive protein, or total cholesterol were obsd.  Limitations of this study included its small sample size and short treatment duration.  Conclusions: Vadadustat increased Hb levels and improved biomarkers of iron mobilization and utilization in patients with anemia secondary to stage 3 or 4 CKD.  Global multicenter, randomized phase 3 trials are ongoing in non-dialysis-dependent and dialysis-dependent patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgKvwpkpLVLrVg90H21EOLACvtfcHk0lg_d95CjB4A3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXotVOisrg%253D&md5=c8966ae7f2b5e59f0b031da132c3d26a</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1159%2F000464476&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000464476%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DE.%2BR.%26aulast%3DSmith%26aufirst%3DM.%2BT.%26aulast%3DMaroni%26aufirst%3DB.%2BJ.%26aulast%3DZuraw%26aufirst%3DQ.%2BC.%26aulast%3DdeGoma%26aufirst%3DE.%2BM.%26atitle%3DClinical%2520trial%2520of%2520Vadadustat%2520in%2520patients%2520with%2520anemia%2520secondary%2520to%2520Stage%25203%2520or%25204%2520chronic%2520kidney%2520disease%26jtitle%3DAm.%2520J.%2520Nephrol.%26date%3D2017%26volume%3D45%26spage%3D380%26epage%3D388%26doi%3D10.1159%2F000464476" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref137"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref137'); return false;" data-citation="" class="refNumLink">137</a></strong><div class="NLM_citation" id="cit137"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boettcher, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lentini, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flamme, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kubitza, D.</span></span> <span> </span><span class="NLM_article-title">First-in-man study with BAY 85-3934—a new oral selective HIF-PH inhibitor for the treatment of renal anemia</span>. <i>J. Am. Soc. Nephrol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">347A</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2013&pages=347A&author=M.+Boettcherauthor=S.+Lentiniauthor=A.+Kaiserauthor=I.+Flammeauthor=D.+Kubitza&title=First-in-man+study+with+BAY+85-3934%E2%80%94a+new+oral+selective+HIF-PH+inhibitor+for+the+treatment+of+renal+anemia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBoettcher%26aufirst%3DM.%26aulast%3DLentini%26aufirst%3DS.%26aulast%3DKaiser%26aufirst%3DA.%26aulast%3DFlamme%26aufirst%3DI.%26aulast%3DKubitza%26aufirst%3DD.%26atitle%3DFirst-in-man%2520study%2520with%2520BAY%252085-3934%25E2%2580%2594a%2520new%2520oral%2520selective%2520HIF-PH%2520inhibitor%2520for%2520the%2520treatment%2520of%2520renal%2520anemia%26jtitle%3DJ.%2520Am.%2520Soc.%2520Nephrol.%26date%3D2013%26volume%3D24%26spage%3D347A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref138"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref138'); return false;" data-citation="" class="refNumLink">138</a></strong><div class="NLM_citation" id="cit138"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jain, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joharapurkar, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandya, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joshi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kshirsagar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desai, R. C.</span></span> <span> </span><span class="NLM_article-title">Pharmacological characterization of ZYAN1, a novel prolyl hydroxylase inhibitor for the treatment of anemia</span>. <i>Drug Res. (Stuttgart, Ger.)</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">107</span>– <span class="NLM_lpage">112</span>, <span class="refDoi"> DOI: 10.1055/s-0035-1554630</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1055%2Fs-0035-1554630" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=26367279" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=1%3ACAS%3A528%3ADC%252BC28XitlGhtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2016&pages=107-112&author=M.+R.+Jainauthor=A.+A.+Joharapurkarauthor=V.+Pandyaauthor=V.+Patelauthor=J.+Joshiauthor=S.+Kshirsagarauthor=K.+Patelauthor=P.+R.+Patelauthor=R.+C.+Desai&title=Pharmacological+characterization+of+ZYAN1%2C+a+novel+prolyl+hydroxylase+inhibitor+for+the+treatment+of+anemia&doi=10.1055%2Fs-0035-1554630"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological Characterization of ZYAN1, a Novel Prolyl Hydroxylase Inhibitor for the Treatment of Anemia</span></div><div class="casAuthors">Jain, M. R.; Joharapurkar, A. A.; Pandya, V.; Patel, V.; Joshi, J.; Kshirsagar, S.; Patel, K.; Patel, P. R.; Desai, R. C.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Research (Stuttgart, Germany)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">107-112</span>CODEN:
                <span class="NLM_cas:coden">DRSGAO</span>;
        ISSN:<span class="NLM_cas:issn">2194-9379</span>.
    
            (<span class="NLM_cas:orgname">Georg Thieme Verlag</span>)
        </div><div class="casAbstract">Prolyl hydroxylase (PHD) inhibitors stabilize hypoxia inducible factor (HIF), and exert antianemic effect by potentiating erythropoietin (EPO) expression and down-regulation of hepcidin.  ZYAN1 is a novel PHD inhibitor under clin. development for the treatment of anemia.  The pharmacodynamic effects of acute and chronic dosing of ZYAN1 were assessed in normal and 5/6 nephrectomized Wistar rats.  The effect of ZYAN1 was also investigated in cisplatin-induced anemia using C57 mice.  Acute treatment with ZYAN1 increased circulating EPO levels (10.3±3.7 and 40.0±8.5 fold rise at 15 and 30 mg/kg, resp.), reticulocyte count (4.2±0.5 and 6.0±0.2 fold rise at 15 and 30 mg/kg, resp.) and stabilized HIF (28% increase at 45 mg/kg) in normal rats.  Nephrectomized rats showed similar dose-related pharmacodynamic effects.  In a 28-day study in nephrectomized rats, ZYAN1 administered every alternate day, caused increase in Hb (1.9±0.3 and 2.5±0.4 g/dL) and RBC count (10.7±4.0 and 14.0±4.1%) at 15 and 30 mg/kg resp.  In cisplatin-treated mice also an increase in Hb (3.4±0.2 and 5.9±0.2 g/dL) and RBC count (22.5±2.2 and 37.3±1.7%) at 15 and 30 mg/kg resp. was obsd.  ZYAN1's effects on Hb and RBC count were distinct from darbepoietin.  ZYAN1 demonstrated hematinic potential by combined effects on EPO release and efficient iron utilization.  The efficacy of ZYAN1 in disease models of different etiologies suggests that it will be useful in treating wide spectrum of anemia patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsV4aoOEPUh7Vg90H21EOLACvtfcHk0ljNGvdSVE-XIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitlGhtbw%253D&md5=7e208ae1360c3835387bea38f355e671</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1055%2Fs-0035-1554630&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-0035-1554630%26sid%3Dliteratum%253Aachs%26aulast%3DJain%26aufirst%3DM.%2BR.%26aulast%3DJoharapurkar%26aufirst%3DA.%2BA.%26aulast%3DPandya%26aufirst%3DV.%26aulast%3DPatel%26aufirst%3DV.%26aulast%3DJoshi%26aufirst%3DJ.%26aulast%3DKshirsagar%26aufirst%3DS.%26aulast%3DPatel%26aufirst%3DK.%26aulast%3DPatel%26aufirst%3DP.%2BR.%26aulast%3DDesai%26aufirst%3DR.%2BC.%26atitle%3DPharmacological%2520characterization%2520of%2520ZYAN1%252C%2520a%2520novel%2520prolyl%2520hydroxylase%2520inhibitor%2520for%2520the%2520treatment%2520of%2520anemia%26jtitle%3DDrug%2520Res.%2520%2528Stuttgart%252C%2520Ger.%2529%26date%3D2016%26volume%3D66%26spage%3D107%26epage%3D112%26doi%3D10.1055%2Fs-0035-1554630" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref139"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref139'); return false;" data-citation="" class="refNumLink">139</a></strong><div class="NLM_citation" id="cit139"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patel, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joharapurkar, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandya, V. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kshirsagar, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gevriya, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srinivas, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desai, R. C.</span></span> <span> </span><span class="NLM_article-title">Influence of acute and chronic kidney failure in rats on the disposition and pharmacokinetics of ZYAN1, a novel prolyl hydroxylase inhibitor, for the treatment of chronic kidney disease-induced anemia</span>. <i>Xenobiotica</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">37</span>– <span class="NLM_lpage">44</span>, <span class="refDoi"> DOI: 10.1080/00498254.2016.1278287</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1080%2F00498254.2016.1278287" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2017&pages=37-44&author=H.+Patelauthor=A.+A.+Joharapurkarauthor=V.+B.+Pandyaauthor=V.+J.+Patelauthor=S.+G.+Kshirsagarauthor=P.+Patelauthor=B.+Gevriyaauthor=M.+R.+Jainauthor=N.+R.+Srinivasauthor=P.+R.+Patelauthor=R.+C.+Desai&title=Influence+of+acute+and+chronic+kidney+failure+in+rats+on+the+disposition+and+pharmacokinetics+of+ZYAN1%2C+a+novel+prolyl+hydroxylase+inhibitor%2C+for+the+treatment+of+chronic+kidney+disease-induced+anemia&doi=10.1080%2F00498254.2016.1278287"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1080%2F00498254.2016.1278287&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00498254.2016.1278287%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DH.%26aulast%3DJoharapurkar%26aufirst%3DA.%2BA.%26aulast%3DPandya%26aufirst%3DV.%2BB.%26aulast%3DPatel%26aufirst%3DV.%2BJ.%26aulast%3DKshirsagar%26aufirst%3DS.%2BG.%26aulast%3DPatel%26aufirst%3DP.%26aulast%3DGevriya%26aufirst%3DB.%26aulast%3DJain%26aufirst%3DM.%2BR.%26aulast%3DSrinivas%26aufirst%3DN.%2BR.%26aulast%3DPatel%26aufirst%3DP.%2BR.%26aulast%3DDesai%26aufirst%3DR.%2BC.%26atitle%3DInfluence%2520of%2520acute%2520and%2520chronic%2520kidney%2520failure%2520in%2520rats%2520on%2520the%2520disposition%2520and%2520pharmacokinetics%2520of%2520ZYAN1%252C%2520a%2520novel%2520prolyl%2520hydroxylase%2520inhibitor%252C%2520for%2520the%2520treatment%2520of%2520chronic%2520kidney%2520disease-induced%2520anemia%26jtitle%3DXenobiotica%26date%3D2017%26volume%3D48%26spage%3D37%26epage%3D44%26doi%3D10.1080%2F00498254.2016.1278287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110'],'ref111':['cit111'],'ref112':['cit112'],'ref113':['cit113'],'ref114':['cit114'],'ref115':['cit115'],'ref116':['cit116'],'ref117':['cit117'],'ref118':['cit118'],'ref119':['cit119'],'ref120':['cit120'],'ref121':['cit121'],'ref122':['cit122'],'ref123':['cit123'],'ref124':['cit124'],'ref125':['cit125'],'ref126':['cit126'],'ref127':['cit127'],'ref128':['cit128'],'ref129':['cit129'],'ref130':['cit130'],'ref131':['cit131'],'ref132':['cit132'],'ref133':['cit133'],'ref134':['cit134'],'ref135':['cit135'],'ref136':['cit136'],'ref137':['cit137'],'ref138':['cit138'],'ref139':['cit139']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 52 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Biyue Lin, Jingping Kou, Shuming Wu, Xuerong Cai, Qingbo Xiao, Yinglong Li, Jian Hu, Jianbing Li, <span class="NLM_string-name hlFld-ContribAuthor">Zhongqing Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Development of a Robust and Scalable Process for the Large-Scale Preparation of Vadadustat. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2021,</strong> <em>25 </em>
                                    (4)
                                     , 960-968. <a href="https://doi.org/10.1021/acs.oprd.1c00004" title="DOI URL">https://doi.org/10.1021/acs.oprd.1c00004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.oprd.1c00004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.oprd.1c00004%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DDevelopment%252Bof%252Ba%252BRobust%252Band%252BScalable%252BProcess%252Bfor%252Bthe%252BLarge-Scale%252BPreparation%252Bof%252BVadadustat%26aulast%3DLin%26aufirst%3DBiyue%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D06012021%26date%3D05032021%26volume%3D25%26issue%3D4%26spage%3D960%26epage%3D968" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Xiaojin Zhang, Yonghua Lei, Tianhan Hu, Yue Wu, Zhihong Li, Zhensheng Jiang, Changyong Yang, Lianshan Zhang, <span class="NLM_string-name hlFld-ContribAuthor">Qidong You</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Clinical Candidate (5-(3-(4-Chlorophenoxy)prop-1-yn-1-yl)-3-hydroxypicolinoyl)glycine, an Orally Bioavailable Prolyl Hydroxylase Inhibitor for the Treatment of Anemia. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (17)
                                     , 10045-10060. <a href="https://doi.org/10.1021/acs.jmedchem.0c01161" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01161</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01161&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01161%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BClinical%252BCandidate%252B%2525285-%2525283-%2525284-Chlorophenoxy%252529prop-1-yn-1-yl%252529-3-hydroxypicolinoyl%252529glycine%25252C%252Ban%252BOrally%252BBioavailable%252BProlyl%252BHydroxylase%252BInhibitor%252Bfor%252Bthe%252BTreatment%252Bof%252BAnemia%26aulast%3DZhang%26aufirst%3DXiaojin%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D06072020%26date%3D05082020%26date%3D28072020%26volume%3D63%26issue%3D17%26spage%3D10045%26epage%3D10060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Mario Thevis, Katja Walpurgis, <span class="NLM_string-name hlFld-ContribAuthor">Andreas Thomas</span>. </span><span class="cited-content_cbyCitation_article-title">Analytical Approaches in Human Sports Drug Testing: Recent Advances, Challenges, and Solutions. </span><span class="cited-content_cbyCitation_journal-name">Analytical Chemistry</span><span> <strong>2020,</strong> <em>92 </em>
                                    (1)
                                     , 506-523. <a href="https://doi.org/10.1021/acs.analchem.9b04639" title="DOI URL">https://doi.org/10.1021/acs.analchem.9b04639</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.analchem.9b04639&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.analchem.9b04639%26sid%3Dliteratum%253Aachs%26jtitle%3DAnalytical%2520Chemistry%26atitle%3DAnalytical%252BApproaches%252Bin%252BHuman%252BSports%252BDrug%252BTesting%25253A%252BRecent%252BAdvances%25252C%252BChallenges%25252C%252Band%252BSolutions%26aulast%3DThevis%26aufirst%3DMario%26date%3D2020%26date%3D2019%26date%3D31102019%26date%3D14102019%26volume%3D92%26issue%3D1%26spage%3D506%26epage%3D523" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Zhihong Li, Kaijun Su, Zhensheng Jiang, Yancheng Yu, Qidong You, <span class="NLM_string-name hlFld-ContribAuthor">Xiaojin Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Photoactivatable Prolyl Hydroxylase 2 Inhibitors for Stabilizing the Hypoxia-Inducible Factor with Light. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (16)
                                     , 7583-7588. <a href="https://doi.org/10.1021/acs.jmedchem.9b00688" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00688</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00688&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00688%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPhotoactivatable%252BProlyl%252BHydroxylase%252B2%252BInhibitors%252Bfor%252BStabilizing%252Bthe%252BHypoxia-Inducible%252BFactor%252Bwith%252BLight%26aulast%3DLi%26aufirst%3DZhihong%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D27042019%26date%3D25062019%26date%3D17062019%26volume%3D62%26issue%3D16%26spage%3D7583%26epage%3D7588" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Zhihong Li, Qidong You, <span class="NLM_string-name hlFld-ContribAuthor">Xiaojin Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Small-Molecule Modulators of the Hypoxia-Inducible Factor Pathway: Development and Therapeutic Applications. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (12)
                                     , 5725-5749. <a href="https://doi.org/10.1021/acs.jmedchem.8b01596" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01596</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01596&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01596%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSmall-Molecule%252BModulators%252Bof%252Bthe%252BHypoxia-Inducible%252BFactor%252BPathway%25253A%252BDevelopment%252Band%252BTherapeutic%252BApplications%26aulast%3DLi%26aufirst%3DZhihong%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D13102018%26date%3D08022019%26date%3D25012019%26volume%3D62%26issue%3D12%26spage%3D5725%26epage%3D5749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Ping Liu, Liping Wang, Byron G. DuBois, Vincent J. Colandrea, Rongqiang Liu, Jiaqiang Cai, Xiaoxing Du, Weiguo Quan, William Morris, Jianwu Bai, Bimjhana Bishwokarma, Mangeng Cheng, Jennifer Piesvaux, Kallol Ray, Carla Alpert, Chi-Sung Chiu, Mark Zielstorff, Joseph M. Metzger, Liming Yang, Dennis Leung, Candice Alleyne, Stella H. Vincent, Vincenzo Pucci, Xiaofang Li, Alejandro Crespo, Dominique Stickens, Jeffrey J. Hale, Feroze Ujjainwalla, <span class="NLM_string-name hlFld-ContribAuthor">Christopher J. Sinz</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Orally Bioavailable and Liver-Targeted Hypoxia-Inducible Factor Prolyl Hydroxylase (HIF-PHD) Inhibitors for the Treatment of Anemia. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>9 </em>
                                    (12)
                                     , 1193-1198. <a href="https://doi.org/10.1021/acsmedchemlett.8b00274" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.8b00274</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.8b00274&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.8b00274%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252BOrally%252BBioavailable%252Band%252BLiver-Targeted%252BHypoxia-Inducible%252BFactor%252BProlyl%252BHydroxylase%252B%252528HIF-PHD%252529%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BAnemia%26aulast%3DLiu%26aufirst%3DPing%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D04082018%26date%3D13112018%26date%3D19112018%26date%3D13112018%26volume%3D9%26issue%3D12%26spage%3D1193%26epage%3D1198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lisheng  Zhu</span>, <span class="hlFld-ContribAuthor ">Yangyang  Shi</span>, <span class="hlFld-ContribAuthor ">Ying  Xiong</span>, <span class="hlFld-ContribAuthor ">Li  Ba</span>, <span class="hlFld-ContribAuthor ">Qiuting  Li</span>, <span class="hlFld-ContribAuthor ">Mengjun  Qiu</span>, <span class="hlFld-ContribAuthor ">Zhenwei  Zou</span>, <span class="hlFld-ContribAuthor ">Gang  Peng</span>. </span><span class="cited-content_cbyCitation_article-title">Emerging self-assembling peptide nanomaterial for anti-cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomaterials Applications</span><span> <strong>2021,</strong> <em>14 </em>, 088532822110278. <a href="https://doi.org/10.1177/08853282211027882" title="DOI URL">https://doi.org/10.1177/08853282211027882</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/08853282211027882&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F08853282211027882%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomaterials%2520Applications%26atitle%3DEmerging%252Bself-assembling%252Bpeptide%252Bnanomaterial%252Bfor%252Banti-cancer%252Btherapy%26aulast%3DZhu%26aufirst%3DLisheng%26date%3D2021%26date%3D2021%26volume%3D14%26spage%3D088532822110278" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kiichi  Hirota</span>. </span><span class="cited-content_cbyCitation_article-title">HIF-α Prolyl Hydroxylase Inhibitors and Their Implications for Biomedicine: A Comprehensive Review. </span><span class="cited-content_cbyCitation_journal-name">Biomedicines</span><span> <strong>2021,</strong> <em>9 </em>
                                    (5)
                                     , 468. <a href="https://doi.org/10.3390/biomedicines9050468" title="DOI URL">https://doi.org/10.3390/biomedicines9050468</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biomedicines9050468&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiomedicines9050468%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomedicines%26atitle%3DHIF-%2525CE%2525B1%252BProlyl%252BHydroxylase%252BInhibitors%252Band%252BTheir%252BImplications%252Bfor%252BBiomedicine%25253A%252BA%252BComprehensive%252BReview%26aulast%3DHirota%26aufirst%3DKiichi%26date%3D2021%26date%3D2021%26volume%3D9%26issue%3D5%26spage%3D468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mahesh Kumar  Teli</span>, <span class="hlFld-ContribAuthor ">Surendra  Kumar</span>, <span class="hlFld-ContribAuthor ">Dharmendra Kumar  Yadav</span>, <span class="hlFld-ContribAuthor ">Mi‐hyun  Kim</span>. </span><span class="cited-content_cbyCitation_article-title">In silico identification of prolyl hydroxylase inhibitor by per‐residue energy decomposition‐based pharmacophore approach. </span><span class="cited-content_cbyCitation_journal-name">Journal of Cellular Biochemistry</span><span> <strong>2021,</strong> <em>13 </em><a href="https://doi.org/10.1002/jcb.29933" title="DOI URL">https://doi.org/10.1002/jcb.29933</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jcb.29933&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjcb.29933%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Cellular%2520Biochemistry%26atitle%3DIn%252Bsilico%252Bidentification%252Bof%252Bprolyl%252Bhydroxylase%252Binhibitor%252Bby%252Bper%2525E2%252580%252590residue%252Benergy%252Bdecomposition%2525E2%252580%252590based%252Bpharmacophore%252Bapproach%26aulast%3DTeli%26aufirst%3DMahesh%2BKumar%26date%3D2021%26date%3D2021%26volume%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tao  Li</span>, <span class="hlFld-ContribAuthor ">Song  Wang</span>, <span class="hlFld-ContribAuthor ">Hao  Zhang</span>, <span class="hlFld-ContribAuthor ">Jiankang  Yu</span>. </span><span class="cited-content_cbyCitation_article-title">The study on the inhibitory mechanism of JTZ-951 and its analogue against prolyl hydroxylase-2 to mediate the response to hypoxia in the process of sports. </span><span class="cited-content_cbyCitation_journal-name">Molecular Physics</span><span> <strong>2021,</strong> <em>119 </em>
                                    (7)
                                     , e1853268. <a href="https://doi.org/10.1080/00268976.2020.1853268" title="DOI URL">https://doi.org/10.1080/00268976.2020.1853268</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/00268976.2020.1853268&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F00268976.2020.1853268%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Physics%26atitle%3DThe%252Bstudy%252Bon%252Bthe%252Binhibitory%252Bmechanism%252Bof%252BJTZ-951%252Band%252Bits%252Banalogue%252Bagainst%252Bprolyl%252Bhydroxylase-2%252Bto%252Bmediate%252Bthe%252Bresponse%252Bto%252Bhypoxia%252Bin%252Bthe%252Bprocess%252Bof%252Bsports%26aulast%3DLi%26aufirst%3DTao%26date%3D2021%26date%3D2021%26volume%3D119%26issue%3D7%26spage%3De1853268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Min  Li</span>, <span class="hlFld-ContribAuthor ">Jiarong  Lan</span>, <span class="hlFld-ContribAuthor ">Feixia  Dong</span>, <span class="hlFld-ContribAuthor ">Peixin  Duan</span>. </span><span class="cited-content_cbyCitation_article-title">Effectiveness of hypoxia-induced factor prolyl hydroxylase inhibitor for managing anemia in chronic kidney disease: a systematic review and meta-analysis. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Clinical Pharmacology</span><span> <strong>2021,</strong> <em>77 </em>
                                    (4)
                                     , 491-507. <a href="https://doi.org/10.1007/s00228-020-03037-1" title="DOI URL">https://doi.org/10.1007/s00228-020-03037-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00228-020-03037-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00228-020-03037-1%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Clinical%2520Pharmacology%26atitle%3DEffectiveness%252Bof%252Bhypoxia-induced%252Bfactor%252Bprolyl%252Bhydroxylase%252Binhibitor%252Bfor%252Bmanaging%252Banemia%252Bin%252Bchronic%252Bkidney%252Bdisease%25253A%252Ba%252Bsystematic%252Breview%252Band%252Bmeta-analysis%26aulast%3DLi%26aufirst%3DMin%26date%3D2021%26date%3D2020%26volume%3D77%26issue%3D4%26spage%3D491%26epage%3D507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tadao  Akizawa</span>, <span class="hlFld-ContribAuthor ">Manabu  Iwasaki</span>, <span class="hlFld-ContribAuthor ">Tetsuro  Otsuka</span>, <span class="hlFld-ContribAuthor ">Yusuke  Yamaguchi</span>, <span class="hlFld-ContribAuthor ">Michael  Reusch</span>. </span><span class="cited-content_cbyCitation_article-title">Phase 3 Study of Roxadustat to Treat Anemia in Non–Dialysis-Dependant CKD. </span><span class="cited-content_cbyCitation_journal-name">Kidney International Reports</span><span> <strong>2021,</strong> <em>117 </em><a href="https://doi.org/10.1016/j.ekir.2021.04.003" title="DOI URL">https://doi.org/10.1016/j.ekir.2021.04.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ekir.2021.04.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ekir.2021.04.003%26sid%3Dliteratum%253Aachs%26jtitle%3DKidney%2520International%2520Reports%26atitle%3DPhase%252B3%252BStudy%252Bof%252BRoxadustat%252Bto%252BTreat%252BAnemia%252Bin%252BNon%2525E2%252580%252593Dialysis-Dependant%252BCKD%26aulast%3DAkizawa%26aufirst%3DTadao%26date%3D2021%26volume%3D117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Evgeny  Shutov</span>, <span class="hlFld-ContribAuthor ">Władysław  Sułowicz</span>, <span class="hlFld-ContribAuthor ">Ciro  Esposito</span>, <span class="hlFld-ContribAuthor ">Avtandil  Tataradze</span>, <span class="hlFld-ContribAuthor ">Branislav  Andric</span>, <span class="hlFld-ContribAuthor ">Michael  Reusch</span>, <span class="hlFld-ContribAuthor ">Udaya  Valluri</span>, <span class="hlFld-ContribAuthor ">Nada  Dimkovic</span>. </span><span class="cited-content_cbyCitation_article-title">Roxadustat for the treatment of anemia in chronic kidney disease patients not on dialysis: a Phase 3, randomized, double-blind, placebo-controlled study (ALPS). </span><span class="cited-content_cbyCitation_journal-name">Nephrology Dialysis Transplantation</span><span> <strong>2021,</strong> <em>117 </em><a href="https://doi.org/10.1093/ndt/gfab057" title="DOI URL">https://doi.org/10.1093/ndt/gfab057</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/ndt/gfab057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fndt%2Fgfab057%26sid%3Dliteratum%253Aachs%26jtitle%3DNephrology%2520Dialysis%2520Transplantation%26atitle%3DRoxadustat%252Bfor%252Bthe%252Btreatment%252Bof%252Banemia%252Bin%252Bchronic%252Bkidney%252Bdisease%252Bpatients%252Bnot%252Bon%252Bdialysis%25253A%252Ba%252BPhase%252B3%25252C%252Brandomized%25252C%252Bdouble-blind%25252C%252Bplacebo-controlled%252Bstudy%252B%252528ALPS%252529%26aulast%3DShutov%26aufirst%3DEvgeny%26date%3D2021%26date%3D2021%26volume%3D117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrey A.  Poloznikov</span>, <span class="hlFld-ContribAuthor ">Stepan A.  Nersisyan</span>, <span class="hlFld-ContribAuthor ">Dmitry M.  Hushpulian</span>, <span class="hlFld-ContribAuthor ">Eliot H.  Kazakov</span>, <span class="hlFld-ContribAuthor ">Alexander G.  Tonevitsky</span>, <span class="hlFld-ContribAuthor ">Sergey V.  Kazakov</span>, <span class="hlFld-ContribAuthor ">Valery I.  Vechorko</span>, <span class="hlFld-ContribAuthor ">Sergey V.  Nikulin</span>, <span class="hlFld-ContribAuthor ">Julia A.  Makarova</span>, <span class="hlFld-ContribAuthor ">Irina G.  Gazaryan</span>. </span><span class="cited-content_cbyCitation_article-title">HIF Prolyl Hydroxylase Inhibitors for COVID-19 Treatment: Pros and Cons. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Pharmacology</span><span> <strong>2021,</strong> <em>11 </em><a href="https://doi.org/10.3389/fphar.2020.621054" title="DOI URL">https://doi.org/10.3389/fphar.2020.621054</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fphar.2020.621054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffphar.2020.621054%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Pharmacology%26atitle%3DHIF%252BProlyl%252BHydroxylase%252BInhibitors%252Bfor%252BCOVID-19%252BTreatment%25253A%252BPros%252Band%252BCons%26aulast%3DPoloznikov%26aufirst%3DAndrey%2BA.%26date%3D2021%26date%3D2021%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amit A.  Joharapurkar</span>, <span class="hlFld-ContribAuthor ">Vishal J.  Patel</span>, <span class="hlFld-ContribAuthor ">Samadhan G.  Kshirsagar</span>, <span class="hlFld-ContribAuthor ">Maulik S.  Patel</span>, <span class="hlFld-ContribAuthor ">Hardikkumar H.  Savsani</span>, <span class="hlFld-ContribAuthor ">Mukul R.  Jain</span>. </span><span class="cited-content_cbyCitation_article-title">Prolyl hydroxylase inhibitor desidustat protects against acute and chronic kidney injury by reducing inflammatory cytokines and oxidative stress. </span><span class="cited-content_cbyCitation_journal-name">Drug Development Research</span><span> <strong>2021,</strong> <em>78 </em><a href="https://doi.org/10.1002/ddr.21792" title="DOI URL">https://doi.org/10.1002/ddr.21792</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ddr.21792&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fddr.21792%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Development%2520Research%26atitle%3DProlyl%252Bhydroxylase%252Binhibitor%252Bdesidustat%252Bprotects%252Bagainst%252Bacute%252Band%252Bchronic%252Bkidney%252Binjury%252Bby%252Breducing%252Binflammatory%252Bcytokines%252Band%252Boxidative%252Bstress%26aulast%3DJoharapurkar%26aufirst%3DAmit%2BA.%26date%3D2021%26date%3D2021%26volume%3D78" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mahesh Kumar  Teli</span>, <span class="hlFld-ContribAuthor ">Surendra  Kumar</span>, <span class="hlFld-ContribAuthor ">Dharmendra Kumar  Yadav</span>, <span class="hlFld-ContribAuthor ">Mi-hyun  Kim</span>. </span><span class="cited-content_cbyCitation_article-title">In silico
              identification of hydantoin derivatives: a novel natural prolyl hydroxylase inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2021,</strong> <em>39 </em>
                                    (2)
                                     , 703-717. <a href="https://doi.org/10.1080/07391102.2020.1714480" title="DOI URL">https://doi.org/10.1080/07391102.2020.1714480</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2020.1714480&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2020.1714480%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DIn%252Bsilico%252Bidentification%252Bof%252Bhydantoin%252Bderivatives%25253A%252Ba%252Bnovel%252Bnatural%252Bprolyl%252Bhydroxylase%252Binhibitor%26aulast%3DTeli%26aufirst%3DMahesh%2BKumar%26date%3D2021%26date%3D2020%26volume%3D39%26issue%3D2%26spage%3D703%26epage%3D717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qingkui  Jiang</span>, <span class="hlFld-ContribAuthor ">Maria Laura  Gennaro</span>, <span class="hlFld-ContribAuthor ">Lanbo  Shi</span>. </span><span class="cited-content_cbyCitation_article-title">HIF-1α as a Potential Therapeutic Target for Tuberculosis Treatment. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 41-59. <a href="https://doi.org/10.1007/978-3-030-56905-1_4" title="DOI URL">https://doi.org/10.1007/978-3-030-56905-1_4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-030-56905-1_4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-030-56905-1_4%26sid%3Dliteratum%253Aachs%26atitle%3DHIF-1%2525CE%2525B1%252Bas%252Ba%252BPotential%252BTherapeutic%252BTarget%252Bfor%252BTuberculosis%252BTreatment%26aulast%3DJiang%26aufirst%3DQingkui%26date%3D2021%26date%3D2020%26spage%3D41%26epage%3D59%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DAdvances%252Bin%252BHost-Directed%252BTherapies%252BAgainst%252BTuberculosis%26aulast%3DKarakousis%26aufirst%3DPetros%2BC.%26date%3D2021%26volume%3D45" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tina  Schönberger</span>, <span class="hlFld-ContribAuthor ">Joachim  Fandrey</span>, <span class="hlFld-ContribAuthor ">Katrin  Prost-Fingerle</span>. </span><span class="cited-content_cbyCitation_article-title">Ways into Understanding HIF Inhibition. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2021,</strong> <em>13 </em>
                                    (1)
                                     , 159. <a href="https://doi.org/10.3390/cancers13010159" title="DOI URL">https://doi.org/10.3390/cancers13010159</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers13010159&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers13010159%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DWays%252Binto%252BUnderstanding%252BHIF%252BInhibition%26aulast%3DSch%25C3%25B6nberger%26aufirst%3DTina%26date%3D2021%26date%3D2021%26volume%3D13%26issue%3D1%26spage%3D159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Siyao  Li</span>, <span class="hlFld-ContribAuthor ">Lu  Wen</span>, <span class="hlFld-ContribAuthor ">Xiaoru  Hu</span>, <span class="hlFld-ContribAuthor ">Qingqing  Wei</span>, <span class="hlFld-ContribAuthor ">Zheng  Dong</span>. </span><span class="cited-content_cbyCitation_article-title">HIF in Nephrotoxicity during Cisplatin Chemotherapy: Regulation, Function and Therapeutic Potential. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2021,</strong> <em>13 </em>
                                    (2)
                                     , 180. <a href="https://doi.org/10.3390/cancers13020180" title="DOI URL">https://doi.org/10.3390/cancers13020180</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers13020180&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers13020180%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DHIF%252Bin%252BNephrotoxicity%252Bduring%252BCisplatin%252BChemotherapy%25253A%252BRegulation%25252C%252BFunction%252Band%252BTherapeutic%252BPotential%26aulast%3DLi%26aufirst%3DSiyao%26date%3D2021%26date%3D2021%26volume%3D13%26issue%3D2%26spage%3D180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tohru  Ugawa</span>, <span class="hlFld-ContribAuthor ">Mizue  Ashizaki</span>, <span class="hlFld-ContribAuthor ">Asami  Murata</span>, <span class="hlFld-ContribAuthor ">Yoshikatsu  Majikawa</span>. </span><span class="cited-content_cbyCitation_article-title">Roxadustat (Evrenzo® tablet), a therapeutic drug for renal anemia: pharmacological characteristics and clinical evidence in Japan. </span><span class="cited-content_cbyCitation_journal-name">Folia Pharmacologica Japonica</span><span> <strong>2021,</strong> <em>156 </em>
                                    (3)
                                     , 187-197. <a href="https://doi.org/10.1254/fpj.21001" title="DOI URL">https://doi.org/10.1254/fpj.21001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1254/fpj.21001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1254%2Ffpj.21001%26sid%3Dliteratum%253Aachs%26jtitle%3DFolia%2520Pharmacologica%2520Japonica%26atitle%3DRoxadustat%252B%252528Evrenzo%2525C2%2525AE%252Btablet%252529%25252C%252Ba%252Btherapeutic%252Bdrug%252Bfor%252Brenal%252Banemia%25253A%252Bpharmacological%252Bcharacteristics%252Band%252Bclinical%252Bevidence%252Bin%252BJapan%26aulast%3DUgawa%26aufirst%3DTohru%26date%3D2021%26volume%3D156%26issue%3D3%26spage%3D187%26epage%3D197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Samantha J.  Wong</span>, <span class="hlFld-ContribAuthor ">Alison E.  Ringel</span>, <span class="hlFld-ContribAuthor ">William  Yuan</span>, <span class="hlFld-ContribAuthor ">Joao A.  Paulo</span>, <span class="hlFld-ContribAuthor ">Haejin  Yoon</span>, <span class="hlFld-ContribAuthor ">Mark A.  Currie</span>, <span class="hlFld-ContribAuthor ">Marcia C.  Haigis</span>. </span><span class="cited-content_cbyCitation_article-title">Development of a colorimetric α-ketoglutarate detection assay for prolyl hydroxylase domain (PHD) proteins. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biological Chemistry</span><span> <strong>2021,</strong> <em>296 </em>, 100397. <a href="https://doi.org/10.1016/j.jbc.2021.100397" title="DOI URL">https://doi.org/10.1016/j.jbc.2021.100397</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jbc.2021.100397&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jbc.2021.100397%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biological%2520Chemistry%26atitle%3DDevelopment%252Bof%252Ba%252Bcolorimetric%252B%2525CE%2525B1-ketoglutarate%252Bdetection%252Bassay%252Bfor%252Bprolyl%252Bhydroxylase%252Bdomain%252B%252528PHD%252529%252Bproteins%26aulast%3DWong%26aufirst%3DSamantha%2BJ.%26date%3D2021%26volume%3D296%26spage%3D100397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Senthilnathan  Palaniyandi</span>, <span class="hlFld-ContribAuthor ">Reena  Kumari</span>, <span class="hlFld-ContribAuthor ">Sabarinath  Venniyil Radhakrishnan</span>, <span class="hlFld-ContribAuthor ">Ethan  Strattan</span>, <span class="hlFld-ContribAuthor ">Natalya  Hakim</span>, <span class="hlFld-ContribAuthor ">Reinhold  Munker</span>, <span class="hlFld-ContribAuthor ">Melissa V.  Kesler</span>, <span class="hlFld-ContribAuthor ">Gerhard C.  Hildebrandt</span>. </span><span class="cited-content_cbyCitation_article-title">The Prolyl Hydroxylase Inhibitor Dimethyl Oxalyl Glycine Decreases Early Gastrointestinal GVHD in Experimental Allogeneic Hematopoietic Cell Transplantation. </span><span class="cited-content_cbyCitation_journal-name">Transplantation</span><span> <strong>2020,</strong> <em>104 </em>
                                    (12)
                                     , 2507-2515. <a href="https://doi.org/10.1097/TP.0000000000003383" title="DOI URL">https://doi.org/10.1097/TP.0000000000003383</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1097/TP.0000000000003383&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1097%2FTP.0000000000003383%26sid%3Dliteratum%253Aachs%26jtitle%3DTransplantation%26atitle%3DThe%252BProlyl%252BHydroxylase%252BInhibitor%252BDimethyl%252BOxalyl%252BGlycine%252BDecreases%252BEarly%252BGastrointestinal%252BGVHD%252Bin%252BExperimental%252BAllogeneic%252BHematopoietic%252BCell%252BTransplantation%26aulast%3DPalaniyandi%26aufirst%3DSenthilnathan%26date%3D2020%26date%3D2020%26volume%3D104%26issue%3D12%26spage%3D2507%26epage%3D2515" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lennart  Brewitz</span>, <span class="hlFld-ContribAuthor ">Anthony  Tumber</span>, <span class="hlFld-ContribAuthor ">Inga  Pfeffer</span>, <span class="hlFld-ContribAuthor ">Michael A.  McDonough</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Schofield</span>. </span><span class="cited-content_cbyCitation_article-title">Aspartate/asparagine-β-hydroxylase: a high-throughput mass spectrometric assay for discovery of small molecule inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2020,</strong> <em>10 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-020-65123-9" title="DOI URL">https://doi.org/10.1038/s41598-020-65123-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-020-65123-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-020-65123-9%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DAspartate%25252Fasparagine-%2525CE%2525B2-hydroxylase%25253A%252Ba%252Bhigh-throughput%252Bmass%252Bspectrometric%252Bassay%252Bfor%252Bdiscovery%252Bof%252Bsmall%252Bmolecule%252Binhibitors%26aulast%3DBrewitz%26aufirst%3DLennart%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhihong  Li</span>, <span class="hlFld-ContribAuthor ">Shuai  Zhen</span>, <span class="hlFld-ContribAuthor ">Kaijun  Su</span>, <span class="hlFld-ContribAuthor ">Anthony  Tumber</span>, <span class="hlFld-ContribAuthor ">Quanwei  Yu</span>, <span class="hlFld-ContribAuthor ">Ying  Dong</span>, <span class="hlFld-ContribAuthor ">Michael  McDonough</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Schofield</span>, <span class="hlFld-ContribAuthor ">Xiaojin  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">A small-molecule probe for monitoring binding to prolyl hydroxylase domain 2 by fluorescence polarisation. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2020,</strong> <em>56 </em>
                                    (91)
                                     , 14199-14202. <a href="https://doi.org/10.1039/D0CC06353C" title="DOI URL">https://doi.org/10.1039/D0CC06353C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0CC06353C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0CC06353C%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DA%252Bsmall-molecule%252Bprobe%252Bfor%252Bmonitoring%252Bbinding%252Bto%252Bprolyl%252Bhydroxylase%252Bdomain%252B2%252Bby%252Bfluorescence%252Bpolarisation%26aulast%3DLi%26aufirst%3DZhihong%26date%3D2020%26date%3D2020%26volume%3D56%26issue%3D91%26spage%3D14199%26epage%3D14202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zesen  Lin</span>, <span class="hlFld-ContribAuthor ">Richard  King</span>, <span class="hlFld-ContribAuthor ">Vi  Tang</span>, <span class="hlFld-ContribAuthor ">Greggory  Myers</span>, <span class="hlFld-ContribAuthor ">Ginette  Balbin-Cuesta</span>, <span class="hlFld-ContribAuthor ">Ann  Friedman</span>, <span class="hlFld-ContribAuthor ">Beth  McGee</span>, <span class="hlFld-ContribAuthor ">Karl  Desch</span>, <span class="hlFld-ContribAuthor ">Ayse Bilge  Ozel</span>, <span class="hlFld-ContribAuthor ">David  Siemieniak</span>, <span class="hlFld-ContribAuthor ">Pavan  Reddy</span>, <span class="hlFld-ContribAuthor ">Brian  Emmer</span>, <span class="hlFld-ContribAuthor ">Rami  Khoriaty</span>. </span><span class="cited-content_cbyCitation_article-title">The Endoplasmic Reticulum Cargo Receptor SURF4 Facilitates Efficient Erythropoietin Secretion. </span><span class="cited-content_cbyCitation_journal-name">Molecular and Cellular Biology</span><span> <strong>2020,</strong> <em>40 </em>
                                    (23)
                                     <a href="https://doi.org/10.1128/MCB.00180-20" title="DOI URL">https://doi.org/10.1128/MCB.00180-20</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/MCB.00180-20&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2FMCB.00180-20%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520and%2520Cellular%2520Biology%26atitle%3DThe%252BEndoplasmic%252BReticulum%252BCargo%252BReceptor%252BSURF4%252BFacilitates%252BEfficient%252BErythropoietin%252BSecretion%26aulast%3DLin%26aufirst%3DZesen%26date%3D2020%26volume%3D40%26issue%3D23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthew  Riopel</span>, <span class="hlFld-ContribAuthor ">Jae-Su  Moon</span>, <span class="hlFld-ContribAuthor ">Gautam K.  Bandyopadhyay</span>, <span class="hlFld-ContribAuthor ">Seohee  You</span>, <span class="hlFld-ContribAuthor ">Kevin  Lam</span>, <span class="hlFld-ContribAuthor ">Xiao  Liu</span>, <span class="hlFld-ContribAuthor ">Tatiana  Kisseleva</span>, <span class="hlFld-ContribAuthor ">David  Brenner</span>, <span class="hlFld-ContribAuthor ">Yun Sok  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition of prolyl hydroxylases increases hepatic insulin and decreases glucagon sensitivity by an HIF-2α-dependent mechanism. </span><span class="cited-content_cbyCitation_journal-name">Molecular Metabolism</span><span> <strong>2020,</strong> <em>41 </em>, 101039. <a href="https://doi.org/10.1016/j.molmet.2020.101039" title="DOI URL">https://doi.org/10.1016/j.molmet.2020.101039</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molmet.2020.101039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molmet.2020.101039%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Metabolism%26atitle%3DInhibition%252Bof%252Bprolyl%252Bhydroxylases%252Bincreases%252Bhepatic%252Binsulin%252Band%252Bdecreases%252Bglucagon%252Bsensitivity%252Bby%252Ban%252BHIF-2%2525CE%2525B1-dependent%252Bmechanism%26aulast%3DRiopel%26aufirst%3DMatthew%26date%3D2020%26volume%3D41%26spage%3D101039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Deepika  Watts</span>, <span class="hlFld-ContribAuthor ">Diana  Gaete</span>, <span class="hlFld-ContribAuthor ">Diego  Rodriguez</span>, <span class="hlFld-ContribAuthor ">David  Hoogewijs</span>, <span class="hlFld-ContribAuthor ">Martina  Rauner</span>, <span class="hlFld-ContribAuthor ">Sundary  Sormendi</span>, <span class="hlFld-ContribAuthor ">Ben  Wielockx</span>. </span><span class="cited-content_cbyCitation_article-title">Hypoxia Pathway Proteins are Master Regulators of Erythropoiesis. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2020,</strong> <em>21 </em>
                                    (21)
                                     , 8131. <a href="https://doi.org/10.3390/ijms21218131" title="DOI URL">https://doi.org/10.3390/ijms21218131</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms21218131&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms21218131%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DHypoxia%252BPathway%252BProteins%252Bare%252BMaster%252BRegulators%252Bof%252BErythropoiesis%26aulast%3DWatts%26aufirst%3DDeepika%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D21%26spage%3D8131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Katharina A.E.  Broeker</span>, <span class="hlFld-ContribAuthor ">Michaela A.A.  Fuchs</span>, <span class="hlFld-ContribAuthor ">Julia  Schrankl</span>, <span class="hlFld-ContribAuthor ">Birgül  Kurt</span>, <span class="hlFld-ContribAuthor ">Karen A.  Nolan</span>, <span class="hlFld-ContribAuthor ">Roland H.  Wenger</span>, <span class="hlFld-ContribAuthor ">Rafael  Kramann</span>, <span class="hlFld-ContribAuthor ">Charlotte  Wagner</span>, <span class="hlFld-ContribAuthor ">Armin  Kurtz</span>. </span><span class="cited-content_cbyCitation_article-title">Different subpopulations of kidney interstitial cells produce erythropoietin and factors supporting tissue oxygenation in response to hypoxia in vivo. </span><span class="cited-content_cbyCitation_journal-name">Kidney International</span><span> <strong>2020,</strong> <em>98 </em>
                                    (4)
                                     , 918-931. <a href="https://doi.org/10.1016/j.kint.2020.04.040" title="DOI URL">https://doi.org/10.1016/j.kint.2020.04.040</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.kint.2020.04.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.kint.2020.04.040%26sid%3Dliteratum%253Aachs%26jtitle%3DKidney%2520International%26atitle%3DDifferent%252Bsubpopulations%252Bof%252Bkidney%252Binterstitial%252Bcells%252Bproduce%252Berythropoietin%252Band%252Bfactors%252Bsupporting%252Btissue%252Boxygenation%252Bin%252Bresponse%252Bto%252Bhypoxia%252Bin%2525C2%2525A0vivo%26aulast%3DBroeker%26aufirst%3DKatharina%2BA.E.%26date%3D2020%26volume%3D98%26issue%3D4%26spage%3D918%26epage%3D931" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Helen T.  McKenna</span>, <span class="hlFld-ContribAuthor ">Andrew J.  Murray</span>, <span class="hlFld-ContribAuthor ">Daniel S.  Martin</span>. </span><span class="cited-content_cbyCitation_article-title">Human adaptation to hypoxia in critical illness. </span><span class="cited-content_cbyCitation_journal-name">Journal of Applied Physiology</span><span> <strong>2020,</strong> <em>129 </em>
                                    (4)
                                     , 656-663. <a href="https://doi.org/10.1152/japplphysiol.00818.2019" title="DOI URL">https://doi.org/10.1152/japplphysiol.00818.2019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1152/japplphysiol.00818.2019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1152%2Fjapplphysiol.00818.2019%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Applied%2520Physiology%26atitle%3DHuman%252Badaptation%252Bto%252Bhypoxia%252Bin%252Bcritical%252Billness%26aulast%3DMcKenna%26aufirst%3DHelen%2BT.%26date%3D2020%26volume%3D129%26issue%3D4%26spage%3D656%26epage%3D663" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jicong  Du</span>, <span class="hlFld-ContribAuthor ">Pei  Zhang</span>, <span class="hlFld-ContribAuthor ">Ying  Cheng</span>, <span class="hlFld-ContribAuthor ">Ruling  Liu</span>, <span class="hlFld-ContribAuthor ">Hu  Liu</span>, <span class="hlFld-ContribAuthor ">Fu  Gao</span>, <span class="hlFld-ContribAuthor ">Chunmeng  Shi</span>, <span class="hlFld-ContribAuthor ">Cong  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">General principles of developing novel radioprotective agents for nuclear emergency. </span><span class="cited-content_cbyCitation_journal-name">Radiation Medicine and Protection</span><span> <strong>2020,</strong> <em>1 </em>
                                    (3)
                                     , 120-126. <a href="https://doi.org/10.1016/j.radmp.2020.08.003" title="DOI URL">https://doi.org/10.1016/j.radmp.2020.08.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.radmp.2020.08.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.radmp.2020.08.003%26sid%3Dliteratum%253Aachs%26jtitle%3DRadiation%2520Medicine%2520and%2520Protection%26atitle%3DGeneral%252Bprinciples%252Bof%252Bdeveloping%252Bnovel%252Bradioprotective%252Bagents%252Bfor%252Bnuclear%252Bemergency%26aulast%3DDu%26aufirst%3DJicong%26date%3D2020%26volume%3D1%26issue%3D3%26spage%3D120%26epage%3D126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ernane  Souza</span>, <span class="hlFld-ContribAuthor ">Katherine H.  Cho</span>, <span class="hlFld-ContribAuthor ">Shelby T.  Harris</span>, <span class="hlFld-ContribAuthor ">Naomi R.  Flindt</span>, <span class="hlFld-ContribAuthor ">Richard K.  Watt</span>, <span class="hlFld-ContribAuthor ">Amy Barton  Pai</span>. </span><span class="cited-content_cbyCitation_article-title">Hypoxia-inducible factor prolyl hydroxylase inhibitors: a paradigm shift for treatment of anemia in chronic kidney disease?. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Investigational Drugs</span><span> <strong>2020,</strong> <em>29 </em>
                                    (8)
                                     , 831-844. <a href="https://doi.org/10.1080/13543784.2020.1777276" title="DOI URL">https://doi.org/10.1080/13543784.2020.1777276</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543784.2020.1777276&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543784.2020.1777276%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Investigational%2520Drugs%26atitle%3DHypoxia-inducible%252Bfactor%252Bprolyl%252Bhydroxylase%252Binhibitors%25253A%252Ba%252Bparadigm%252Bshift%252Bfor%252Btreatment%252Bof%252Banemia%252Bin%252Bchronic%252Bkidney%252Bdisease%25253F%26aulast%3DSouza%26aufirst%3DErnane%26date%3D2020%26date%3D2020%26volume%3D29%26issue%3D8%26spage%3D831%26epage%3D844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Philippa A  Hulley</span>, <span class="hlFld-ContribAuthor ">Ioanna  Papadimitriou‐Olivgeri</span>, <span class="hlFld-ContribAuthor ">Helen J  Knowles</span>. </span><span class="cited-content_cbyCitation_article-title">Osteoblast–Osteoclast Coculture Amplifies Inhibitory Effects of
              FG
              ‐4592 on Human Osteoclastogenesis and Reduces Bone Resorption. </span><span class="cited-content_cbyCitation_journal-name">JBMR Plus</span><span> <strong>2020,</strong> <em>4 </em>
                                    (7)
                                     <a href="https://doi.org/10.1002/jbm4.10370" title="DOI URL">https://doi.org/10.1002/jbm4.10370</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jbm4.10370&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjbm4.10370%26sid%3Dliteratum%253Aachs%26jtitle%3DJBMR%2520Plus%26atitle%3DOsteoblast%2525E2%252580%252593Osteoclast%252BCoculture%252BAmplifies%252BInhibitory%252BEffects%252Bof%252BFG%252B%2525E2%252580%2525904592%252Bon%252BHuman%252BOsteoclastogenesis%252Band%252BReduces%252BBone%252BResorption%26aulast%3DHulley%26aufirst%3DPhilippa%2BA%26date%3D2020%26date%3D2020%26volume%3D4%26issue%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kaijun  Su</span>, <span class="hlFld-ContribAuthor ">Zhihong  Li</span>, <span class="hlFld-ContribAuthor ">Yancheng  Yu</span>, <span class="hlFld-ContribAuthor ">Xiaojin  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">The prolyl hydroxylase inhibitor roxadustat: Paradigm in drug discovery and prospects for clinical application beyond anemia. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2020,</strong> <em>25 </em>
                                    (7)
                                     , 1262-1269. <a href="https://doi.org/10.1016/j.drudis.2020.04.017" title="DOI URL">https://doi.org/10.1016/j.drudis.2020.04.017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2020.04.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2020.04.017%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DThe%252Bprolyl%252Bhydroxylase%252Binhibitor%252Broxadustat%25253A%252BParadigm%252Bin%252Bdrug%252Bdiscovery%252Band%252Bprospects%252Bfor%252Bclinical%252Bapplication%252Bbeyond%252Banemia%26aulast%3DSu%26aufirst%3DKaijun%26date%3D2020%26volume%3D25%26issue%3D7%26spage%3D1262%26epage%3D1269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vijesh J.  Bhute</span>, <span class="hlFld-ContribAuthor ">James  Harte</span>, <span class="hlFld-ContribAuthor ">Jack W.  Houghton</span>, <span class="hlFld-ContribAuthor ">Patrick H.  Maxwell</span>. </span><span class="cited-content_cbyCitation_article-title">Mannose Binding Lectin Is Hydroxylated by Collagen Prolyl-4-hydroxylase and Inhibited by Some PHD Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Kidney360</span><span> <strong>2020,</strong> <em>1 </em>
                                    (6)
                                     , 447-457. <a href="https://doi.org/10.34067/KID.0000092020" title="DOI URL">https://doi.org/10.34067/KID.0000092020</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.34067/KID.0000092020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.34067%2FKID.0000092020%26sid%3Dliteratum%253Aachs%26jtitle%3DKidney360%26atitle%3DMannose%252BBinding%252BLectin%252BIs%252BHydroxylated%252Bby%252BCollagen%252BProlyl-4-hydroxylase%252Band%252BInhibited%252Bby%252BSome%252BPHD%252BInhibitors%26aulast%3DBhute%26aufirst%3DVijesh%2BJ.%26date%3D2020%26date%3D2020%26volume%3D1%26issue%3D6%26spage%3D447%26epage%3D457" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Roger  Valle-Tenney</span>, <span class="hlFld-ContribAuthor ">Daniela  Rebolledo</span>, <span class="hlFld-ContribAuthor ">María José  Acuña</span>, <span class="hlFld-ContribAuthor ">Enrique  Brandan</span>. </span><span class="cited-content_cbyCitation_article-title">HIF-hypoxia signaling in skeletal muscle physiology and fibrosis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Cell Communication and Signaling</span><span> <strong>2020,</strong> <em>14 </em>
                                    (2)
                                     , 147-158. <a href="https://doi.org/10.1007/s12079-020-00553-8" title="DOI URL">https://doi.org/10.1007/s12079-020-00553-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s12079-020-00553-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs12079-020-00553-8%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Cell%2520Communication%2520and%2520Signaling%26atitle%3DHIF-hypoxia%252Bsignaling%252Bin%252Bskeletal%252Bmuscle%252Bphysiology%252Band%252Bfibrosis%26aulast%3DValle-Tenney%26aufirst%3DRoger%26date%3D2020%26date%3D2020%26volume%3D14%26issue%3D2%26spage%3D147%26epage%3D158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michał  Wiciński</span>, <span class="hlFld-ContribAuthor ">Grzegorz  Liczner</span>, <span class="hlFld-ContribAuthor ">Karol  Cadelski</span>, <span class="hlFld-ContribAuthor ">Tadeusz  Kołnierzak</span>, <span class="hlFld-ContribAuthor ">Magdalena  Nowaczewska</span>, <span class="hlFld-ContribAuthor ">Bartosz  Malinowski</span>. </span><span class="cited-content_cbyCitation_article-title">Anemia of Chronic Diseases: Wider Diagnostics—Better Treatment?. </span><span class="cited-content_cbyCitation_journal-name">Nutrients</span><span> <strong>2020,</strong> <em>12 </em>
                                    (6)
                                     , 1784. <a href="https://doi.org/10.3390/nu12061784" title="DOI URL">https://doi.org/10.3390/nu12061784</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/nu12061784&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fnu12061784%26sid%3Dliteratum%253Aachs%26jtitle%3DNutrients%26atitle%3DAnemia%252Bof%252BChronic%252BDiseases%25253A%252BWider%252BDiagnostics%2525E2%252580%252594Better%252BTreatment%25253F%26aulast%3DWici%25C5%2584ski%26aufirst%3DMicha%25C5%2582%26date%3D2020%26date%3D2020%26volume%3D12%26issue%3D6%26spage%3D1784" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Neli  Kachamakova-Trojanowska</span>, <span class="hlFld-ContribAuthor ">Paulina  Podkalicka</span>, <span class="hlFld-ContribAuthor ">Tomasz  Bogacz</span>, <span class="hlFld-ContribAuthor ">Szymon  Barwacz</span>, <span class="hlFld-ContribAuthor ">Alicja  Józkowicz</span>, <span class="hlFld-ContribAuthor ">Józef  Dulak</span>, <span class="hlFld-ContribAuthor ">Agnieszka  Łoboda</span>. </span><span class="cited-content_cbyCitation_article-title">HIF-1 stabilization exerts anticancer effects in breast cancer cells in vitro and in vivo. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Pharmacology</span><span> <strong>2020,</strong> <em>175 </em>, 113922. <a href="https://doi.org/10.1016/j.bcp.2020.113922" title="DOI URL">https://doi.org/10.1016/j.bcp.2020.113922</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bcp.2020.113922&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bcp.2020.113922%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Pharmacology%26atitle%3DHIF-1%252Bstabilization%252Bexerts%252Banticancer%252Beffects%252Bin%252Bbreast%252Bcancer%252Bcells%252Bin%252Bvitro%252Band%252Bin%252Bvivo%26aulast%3DKachamakova-Trojanowska%26aufirst%3DNeli%26date%3D2020%26volume%3D175%26spage%3D113922" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhan  Yu</span>, <span class="hlFld-ContribAuthor ">Zhihong  Li</span>, <span class="hlFld-ContribAuthor ">Quanwei  Yu</span>, <span class="hlFld-ContribAuthor ">Zhi  Wang</span>, <span class="hlFld-ContribAuthor ">Huilin  Song</span>, <span class="hlFld-ContribAuthor ">Hanyu  Sun</span>, <span class="hlFld-ContribAuthor ">Rufeng  Fan</span>, <span class="hlFld-ContribAuthor ">Angzhi  Bi</span>, <span class="hlFld-ContribAuthor ">Jun  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiaojin  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of prolyl hydroxylase 2 inhibitors with new chemical scaffolds as in vivo active erythropoietin inducers through a combined virtual screening strategy. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2020,</strong> <em>95 </em>
                                    (2)
                                     , 270-278. <a href="https://doi.org/10.1111/cbdd.13640" title="DOI URL">https://doi.org/10.1111/cbdd.13640</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.13640&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.13640%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DDiscovery%252Bof%252Bprolyl%252Bhydroxylase%252B2%252Binhibitors%252Bwith%252Bnew%252Bchemical%252Bscaffolds%252Bas%252Bin%252Bvivo%252Bactive%252Berythropoietin%252Binducers%252Bthrough%252Ba%252Bcombined%252Bvirtual%252Bscreening%252Bstrategy%26aulast%3DYu%26aufirst%3DZhan%26date%3D2020%26date%3D2019%26volume%3D95%26issue%3D2%26spage%3D270%26epage%3D278" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bijin  Thajudeen</span>, <span class="hlFld-ContribAuthor ">Sangeetha  Murugapandian</span>, <span class="hlFld-ContribAuthor ">Prabir  Roy-Chaudhury</span>. </span><span class="cited-content_cbyCitation_article-title">Emerging Therapies. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 1189-1205. <a href="https://doi.org/10.1016/B978-0-12-815876-0.00072-3" title="DOI URL">https://doi.org/10.1016/B978-0-12-815876-0.00072-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-815876-0.00072-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-815876-0.00072-3%26sid%3Dliteratum%253Aachs%26atitle%3DEmerging%252BTherapies%26aulast%3DThajudeen%26aufirst%3DBijin%26date%3D2020%26spage%3D1189%26epage%3D1205%26pub%3DElsevier%26atitle%3DChronic%252BRenal%252BDisease%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yong-Joon  Choi</span>, <span class="hlFld-ContribAuthor ">Iljin  Kim</span>, <span class="hlFld-ContribAuthor ">Jae Eun  Lee</span>, <span class="hlFld-ContribAuthor ">Jong-Wan  Park</span>. </span><span class="cited-content_cbyCitation_article-title">PIN1 transcript variant 2 acts as a long non-coding RNA that controls the HIF-1-driven hypoxic response. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2019,</strong> <em>9 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-019-47071-1" title="DOI URL">https://doi.org/10.1038/s41598-019-47071-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-019-47071-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-019-47071-1%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DPIN1%252Btranscript%252Bvariant%252B2%252Bacts%252Bas%252Ba%252Blong%252Bnon-coding%252BRNA%252Bthat%252Bcontrols%252Bthe%252BHIF-1-driven%252Bhypoxic%252Bresponse%26aulast%3DChoi%26aufirst%3DYong-Joon%26date%3D2019%26date%3D2019%26volume%3D9%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei-Ting  Chang</span>, <span class="hlFld-ContribAuthor ">Yi-Ching  Lo</span>, <span class="hlFld-ContribAuthor ">Zi-Han  Gao</span>, <span class="hlFld-ContribAuthor ">Sheng-Nan  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Evidence for the Capability of Roxadustat (FG-4592), an Oral HIF Prolyl-Hydroxylase Inhibitor, to Perturb Membrane Ionic Currents: An Unidentified yet Important Action. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2019,</strong> <em>20 </em>
                                    (23)
                                     , 6027. <a href="https://doi.org/10.3390/ijms20236027" title="DOI URL">https://doi.org/10.3390/ijms20236027</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms20236027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms20236027%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DEvidence%252Bfor%252Bthe%252BCapability%252Bof%252BRoxadustat%252B%252528FG-4592%252529%25252C%252Ban%252BOral%252BHIF%252BProlyl-Hydroxylase%252BInhibitor%25252C%252Bto%252BPerturb%252BMembrane%252BIonic%252BCurrents%25253A%252BAn%252BUnidentified%252Byet%252BImportant%252BAction%26aulast%3DChang%26aufirst%3DWei-Ting%26date%3D2019%26date%3D2019%26volume%3D20%26issue%3D23%26spage%3D6027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lina K.  Sciesielski</span>, <span class="hlFld-ContribAuthor ">Karin M.  Kirschner</span>. </span><span class="cited-content_cbyCitation_article-title">ExActa HIF prolyl hydroxylase inhibitors—The new lifestyle drug?. </span><span class="cited-content_cbyCitation_journal-name">Acta Physiologica</span><span> <strong>2019,</strong> <em>227 </em>
                                    (3)
                                     <a href="https://doi.org/10.1111/apha.13370" title="DOI URL">https://doi.org/10.1111/apha.13370</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/apha.13370&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fapha.13370%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Physiologica%26atitle%3DExActa%252BHIF%252Bprolyl%252Bhydroxylase%252Binhibitors%2525E2%252580%252594The%252Bnew%252Blifestyle%252Bdrug%25253F%26aulast%3DSciesielski%26aufirst%3DLina%2BK.%26date%3D2019%26date%3D2019%26volume%3D227%26issue%3D3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rui-yan  Xie</span>, <span class="hlFld-ContribAuthor ">Xue-ling  Fang</span>, <span class="hlFld-ContribAuthor ">Xiao-bin  Zheng</span>, <span class="hlFld-ContribAuthor ">Wei-ze  Lv</span>, <span class="hlFld-ContribAuthor ">Yi-jie  Li</span>, <span class="hlFld-ContribAuthor ">Hamze  Ibrahim Rage</span>, <span class="hlFld-ContribAuthor ">Qiao-lan  He</span>, <span class="hlFld-ContribAuthor ">Wei-ping  Zhu</span>, <span class="hlFld-ContribAuthor ">Tong-xia  Cui</span>. </span><span class="cited-content_cbyCitation_article-title">Salidroside and FG-4592 ameliorate high glucose-induced glomerular endothelial cells injury via HIF upregulation. </span><span class="cited-content_cbyCitation_journal-name">Biomedicine & Pharmacotherapy</span><span> <strong>2019,</strong> <em>118 </em>, 109175. <a href="https://doi.org/10.1016/j.biopha.2019.109175" title="DOI URL">https://doi.org/10.1016/j.biopha.2019.109175</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.biopha.2019.109175&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.biopha.2019.109175%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomedicine%2520%2526%2520Pharmacotherapy%26atitle%3DSalidroside%252Band%252BFG-4592%252Bameliorate%252Bhigh%252Bglucose-induced%252Bglomerular%252Bendothelial%252Bcells%252Binjury%252Bvia%252BHIF%252Bupregulation%26aulast%3DXie%26aufirst%3DRui-yan%26date%3D2019%26volume%3D118%26spage%3D109175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Luke  Erber</span>, <span class="hlFld-ContribAuthor ">Ang  Luo</span>, <span class="hlFld-ContribAuthor ">Yue  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Targeted and Interactome Proteomics Revealed the Role of PHD2 in Regulating BRD4 Proline Hydroxylation. </span><span class="cited-content_cbyCitation_journal-name">Molecular & Cellular Proteomics</span><span> <strong>2019,</strong> <em>18 </em>
                                    (9)
                                     , 1772-1781. <a href="https://doi.org/10.1074/mcp.RA119.001535" title="DOI URL">https://doi.org/10.1074/mcp.RA119.001535</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1074/mcp.RA119.001535&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1074%2Fmcp.RA119.001535%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520%2526%2520Cellular%2520Proteomics%26atitle%3DTargeted%252Band%252BInteractome%252BProteomics%252BRevealed%252Bthe%252BRole%252Bof%252BPHD2%252Bin%252BRegulating%252BBRD4%252BProline%252BHydroxylation%26aulast%3DErber%26aufirst%3DLuke%26date%3D2019%26volume%3D18%26issue%3D9%26spage%3D1772%26epage%3D1781" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sinead M.  Lanigan</span>, <span class="hlFld-ContribAuthor ">John J.  O'Connor</span>. </span><span class="cited-content_cbyCitation_article-title">Prolyl hydroxylase domain inhibitors: can multiple mechanisms be an opportunity for ischemic stroke?. </span><span class="cited-content_cbyCitation_journal-name">Neuropharmacology</span><span> <strong>2019,</strong> <em>148 </em>, 117-130. <a href="https://doi.org/10.1016/j.neuropharm.2018.12.021" title="DOI URL">https://doi.org/10.1016/j.neuropharm.2018.12.021</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neuropharm.2018.12.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neuropharm.2018.12.021%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropharmacology%26atitle%3DProlyl%252Bhydroxylase%252Bdomain%252Binhibitors%25253A%252Bcan%252Bmultiple%252Bmechanisms%252Bbe%252Ban%252Bopportunity%252Bfor%252Bischemic%252Bstroke%25253F%26aulast%3DLanigan%26aufirst%3DSinead%2BM.%26date%3D2019%26volume%3D148%26spage%3D117%26epage%3D130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wenxia  Gong</span>, <span class="hlFld-ContribAuthor ">Shiwei  Zhu</span>, <span class="hlFld-ContribAuthor ">Congcong  Chen</span>, <span class="hlFld-ContribAuthor ">Qicai  Yin</span>, <span class="hlFld-ContribAuthor ">Xiao  Li</span>, <span class="hlFld-ContribAuthor ">Guanhua  Du</span>, <span class="hlFld-ContribAuthor ">Yuzhi  Zhou</span>, <span class="hlFld-ContribAuthor ">Xuemei  Qin</span>. </span><span class="cited-content_cbyCitation_article-title">The Anti-depression Effect of Angelicae Sinensis Radix Is Related to the Pharmacological Activity of Modulating the Hematological Anomalies. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Pharmacology</span><span> <strong>2019,</strong> <em>10 </em><a href="https://doi.org/10.3389/fphar.2019.00192" title="DOI URL">https://doi.org/10.3389/fphar.2019.00192</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fphar.2019.00192&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffphar.2019.00192%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Pharmacology%26atitle%3DThe%252BAnti-depression%252BEffect%252Bof%252BAngelicae%252BSinensis%252BRadix%252BIs%252BRelated%252Bto%252Bthe%252BPharmacological%252BActivity%252Bof%252BModulating%252Bthe%252BHematological%252BAnomalies%26aulast%3DGong%26aufirst%3DWenxia%26date%3D2019%26date%3D2019%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jianping  Chen</span>, <span class="hlFld-ContribAuthor ">Fochang  Wang</span>, <span class="hlFld-ContribAuthor ">Shiying  Huang</span>, <span class="hlFld-ContribAuthor ">Xiaoyan  Liu</span>, <span class="hlFld-ContribAuthor ">Zhonggui  Li</span>, <span class="hlFld-ContribAuthor ">Airong  Qi</span>, <span class="hlFld-ContribAuthor ">Xinhui  Liu</span>, <span class="hlFld-ContribAuthor ">Tiegang  Yi</span>, <span class="hlFld-ContribAuthor ">Shunmin  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Jian-Pi-Yi-Shen Decoction Relieves Renal Anemia in 5/6 Nephrectomized Rats: Production of Erythropoietin via Hypoxia Inducible Factor Signaling. </span><span class="cited-content_cbyCitation_journal-name">Evidence-Based Complementary and Alternative Medicine</span><span> <strong>2019,</strong> <em>2019 </em>, 1-8. <a href="https://doi.org/10.1155/2019/2807926" title="DOI URL">https://doi.org/10.1155/2019/2807926</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1155/2019/2807926&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1155%2F2019%2F2807926%26sid%3Dliteratum%253Aachs%26jtitle%3DEvidence-Based%2520Complementary%2520and%2520Alternative%2520Medicine%26atitle%3DJian-Pi-Yi-Shen%252BDecoction%252BRelieves%252BRenal%252BAnemia%252Bin%252B5%25252F6%252BNephrectomized%252BRats%25253A%252BProduction%252Bof%252BErythropoietin%252Bvia%252BHypoxia%252BInducible%252BFactor%252BSignaling%26aulast%3DChen%26aufirst%3DJianping%26date%3D2019%26volume%3D2019%26spage%3D1%26epage%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Iglika G.  Ivanova</span>, <span class="hlFld-ContribAuthor ">Catherine V.  Park</span>, <span class="hlFld-ContribAuthor ">Niall S.  Kenneth</span>. </span><span class="cited-content_cbyCitation_article-title">Translating the Hypoxic Response—the Role of HIF Protein Translation in the Cellular Response to Low Oxygen. </span><span class="cited-content_cbyCitation_journal-name">Cells</span><span> <strong>2019,</strong> <em>8 </em>
                                    (2)
                                     , 114. <a href="https://doi.org/10.3390/cells8020114" title="DOI URL">https://doi.org/10.3390/cells8020114</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cells8020114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcells8020114%26sid%3Dliteratum%253Aachs%26jtitle%3DCells%26atitle%3DTranslating%252Bthe%252BHypoxic%252BResponse%2525E2%252580%252594the%252BRole%252Bof%252BHIF%252BProtein%252BTranslation%252Bin%252Bthe%252BCellular%252BResponse%252Bto%252BLow%252BOxygen%26aulast%3DIvanova%26aufirst%3DIglika%2BG.%26date%3D2019%26date%3D2019%26volume%3D8%26issue%3D2%26spage%3D114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A. A.  Poloznikov</span>, <span class="hlFld-ContribAuthor ">A. Yu.  Khristichenko</span>, <span class="hlFld-ContribAuthor ">N. A.  Smirnova</span>, <span class="hlFld-ContribAuthor ">D. M.  Hushpulian</span>, <span class="hlFld-ContribAuthor ">I. N.  Gaisina</span>, <span class="hlFld-ContribAuthor ">A. I.  Osipyants</span>, <span class="hlFld-ContribAuthor ">V. I.  Tishkov</span>, <span class="hlFld-ContribAuthor ">I. G.  Gazaryan</span>. </span><span class="cited-content_cbyCitation_article-title">Structural optimization of adaptaquin, a HIF prolyl hydroxylase inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Russian Chemical Bulletin</span><span> <strong>2019,</strong> <em>68 </em>
                                    (1)
                                     , 168-173. <a href="https://doi.org/10.1007/s11172-019-2433-3" title="DOI URL">https://doi.org/10.1007/s11172-019-2433-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11172-019-2433-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11172-019-2433-3%26sid%3Dliteratum%253Aachs%26jtitle%3DRussian%2520Chemical%2520Bulletin%26atitle%3DStructural%252Boptimization%252Bof%252Badaptaquin%25252C%252Ba%252BHIF%252Bprolyl%252Bhydroxylase%252Binhibitor%26aulast%3DPoloznikov%26aufirst%3DA.%2BA.%26date%3D2019%26date%3D2019%26volume%3D68%26issue%3D1%26spage%3D168%26epage%3D173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mukul  Jain</span>, <span class="hlFld-ContribAuthor ">Amit  Joharapurkar</span>, <span class="hlFld-ContribAuthor ">Vishal  Patel</span>, <span class="hlFld-ContribAuthor ">Samadhan  Kshirsagar</span>, <span class="hlFld-ContribAuthor ">Brijesh  Sutariya</span>, <span class="hlFld-ContribAuthor ">Maulik  Patel</span>, <span class="hlFld-ContribAuthor ">Hiren  Patel</span>, <span class="hlFld-ContribAuthor ">Pankaj R.  Patel</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacological inhibition of prolyl hydroxylase protects against inflammation-induced anemia via efficient erythropoiesis and hepcidin downregulation. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmacology</span><span> <strong>2019,</strong> <em>843 </em>, 113-120. <a href="https://doi.org/10.1016/j.ejphar.2018.11.023" title="DOI URL">https://doi.org/10.1016/j.ejphar.2018.11.023</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejphar.2018.11.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejphar.2018.11.023%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmacology%26atitle%3DPharmacological%252Binhibition%252Bof%252Bprolyl%252Bhydroxylase%252Bprotects%252Bagainst%252Binflammation-induced%252Banemia%252Bvia%252Befficient%252Berythropoiesis%252Band%252Bhepcidin%252Bdownregulation%26aulast%3DJain%26aufirst%3DMukul%26date%3D2019%26volume%3D843%26spage%3D113%26epage%3D120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">C. L.  Stothers</span>, <span class="hlFld-ContribAuthor ">L.  Luan</span>, <span class="hlFld-ContribAuthor ">B. A.  Fensterheim</span>, <span class="hlFld-ContribAuthor ">J. K.  Bohannon</span>. </span><span class="cited-content_cbyCitation_article-title">Hypoxia-inducible factor-1α regulation of myeloid cells. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Medicine</span><span> <strong>2018,</strong> <em>96 </em>
                                    (12)
                                     , 1293-1306. <a href="https://doi.org/10.1007/s00109-018-1710-1" title="DOI URL">https://doi.org/10.1007/s00109-018-1710-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00109-018-1710-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00109-018-1710-1%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Medicine%26atitle%3DHypoxia-inducible%252Bfactor-1%2525CE%2525B1%252Bregulation%252Bof%252Bmyeloid%252Bcells%26aulast%3DStothers%26aufirst%3DC.%2BL.%26date%3D2018%26date%3D2018%26volume%3D96%26issue%3D12%26spage%3D1293%26epage%3D1306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">I. N.  Gaisina</span>, <span class="hlFld-ContribAuthor ">A. Yu.  Khristichenko</span>, <span class="hlFld-ContribAuthor ">A. M.  Gaisin</span>, <span class="hlFld-ContribAuthor ">N. A.  Smirnova</span>, <span class="hlFld-ContribAuthor ">I. G.  Gazaryan</span>, <span class="hlFld-ContribAuthor ">A. A.  Poloznikov</span>. </span><span class="cited-content_cbyCitation_article-title">Antihypoxic activity of adaptaquin enantiomers. </span><span class="cited-content_cbyCitation_journal-name">Russian Chemical Bulletin</span><span> <strong>2018,</strong> <em>67 </em>
                                    (12)
                                     , 2320-2322. <a href="https://doi.org/10.1007/s11172-018-2376-0" title="DOI URL">https://doi.org/10.1007/s11172-018-2376-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11172-018-2376-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11172-018-2376-0%26sid%3Dliteratum%253Aachs%26jtitle%3DRussian%2520Chemical%2520Bulletin%26atitle%3DAntihypoxic%252Bactivity%252Bof%252Badaptaquin%252Benantiomers%26aulast%3DGaisina%26aufirst%3DI.%2BN.%26date%3D2018%26date%3D2019%26volume%3D67%26issue%3D12%26spage%3D2320%26epage%3D2322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01686/20180816/images/medium/jm-2017-01686a_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01686/20180816/images/large/jm-2017-01686a_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01686&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01686/20180816/images/medium/jm-2017-01686a_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01686/20180816/images/large/jm-2017-01686a_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Stages of erythropoiesis. The process of erythropoiesis occurs in the bone marrow. Erythropoiesis is the process of proliferation and differentiation of erythroid progenitors into reticulocytes and erythrocytes (RBC). The common myeloid progenitors, also known as stem cells, form RBC, white blood cells, and platelets. Stem cells are differentiated into early stage burst-forming unit–erythroid (BFU-E) and then later stage colony-forming unit–erythroid (CFU-E) progenitors. CFU-Es differentiate into proerythroblasts, which then undergo mitosis to form erythroblasts. The erythroblast is basophilic, polychromatic, and orthochromatic. The erythroblast denucleates to become a reticulocyte, which enters the bloodstream. Reticulocytes mature to become RBCs after shedding cellular organelles such as mitochondria, Golgi apparatus, and endoplasmic reticulum. A stage of erythropoiesis from BFU-E to erythroblast differentiation requires EPO. Maturation of RBCs from erythroblasts requires iron.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01686/20180816/images/large/jm-2017-01686a_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01686&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01686/20180816/images/medium/jm-2017-01686a_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01686/20180816/images/large/jm-2017-01686a_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. PHD-HIF mechanism of enzyme action. At normal oxygen concentration (normoxia), prolyl hydroxylase domain-containing (PHD) enzymes (PHD1, PHD2, or PHD3) are active. Active PHDs hydroxylate HIF-α residues. Once hydroxylated, HIF-α is recognized by Hippel–Lindau tumor suppressor protein (pVHL), which facilitates its proteasomal degradation by E3 ubiquitin ligase. Thus, E3 ubiquitin ligase does not cause degradation of HIF but rather ligates HIF, thereby tagging it with a signal to carry it to proteasome for degradation. For this reaction, PHDs require 2-oxoglutarate (2-OG) as a substrate and iron (Fe) as a cofactor. On the other hand, in hypoxic conditions, or by pharmacological inhibition of PHDs, HIF-α is protected from degradation and heterodimerizes with HIF-β. The HIF complex is then translocated to the nucleus and stimulates EPO gene expression. Stimulation of EPO gene expression under hypoxia or PHD inhibition translates into efficient erythropoiesis. HIF complex is also involved in the regulation of angiogenesis, glucose metabolism, lipid metabolism, and vasodilation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01686/20180816/images/large/jm-2017-01686a_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01686&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01686/20180816/images/medium/jm-2017-01686a_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01686/20180816/images/large/jm-2017-01686a_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Iron metabolism and the role of hepcidin. Absorption of iron mainly occurs in the intestine. The nonheme iron in the ferric form is converted in the ferrous form by duodenal cytochrome <i>b</i> (Dcytb). Divalent metal transporter 1 (DMT1) facilitates the transfer of iron into enterocytes. Hepcidin is a regulator of iron homeostasis that downregulates DMT1 and limits iron absorption. Ferritin is the soluble and nontoxic form of iron in plasma. Ferritin is the form of stored iron. Iron in the ferrous state enters into blood circulation with the help of the transport protein ferroportin. Hephastin converts ferrous iron to ferric iron, which then binds to transferrin (TRF) and circulates as TRF bound ferric iron. It is taken up into the metabolic tissues such as macrophage or the liver by transferrin receptor (TRFR). TRF-bound ferric iron is then released free into the cell. Inside the cell, DMT1 converts ferric iron into ferrous iron, after which it is stored as ferritin or released from the cell by ferroportin. Hepcidin inhibits ferroportin, by which it can block iron uptake into cellular stores and decreases iron in circulation. Like hephastin, ceruloplasmin present in blood converts ferrous iron into the ferric form. The ferric form binds to TRF and circulates in the blood. TRF-bound ferric iron is taken up by reticulocytes for hemoglobin synthesis, which then mature into RBCs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01686/20180816/images/large/jm-2017-01686a_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01686&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01686/20180816/images/medium/jm-2017-01686a_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01686/20180816/images/large/jm-2017-01686a_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Structure of a 247-residue C-terminal catalytic domain of PHD2 bound to <b>15</b> (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2HBT">2HBT</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01686/20180816/images/large/jm-2017-01686a_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01686&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01686/20180816/images/medium/jm-2017-01686a_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01686/20180816/images/large/jm-2017-01686a_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Chemotypes derived from 2-OG.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01686/20180816/images/large/jm-2017-01686a_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01686&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01686/20180816/images/medium/jm-2017-01686a_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01686/20180816/images/large/jm-2017-01686a_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Carboxylic acid-based PHD inhibitors (part 1).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01686/20180816/images/large/jm-2017-01686a_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01686&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01686/20180816/images/medium/jm-2017-01686a_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01686/20180816/images/large/jm-2017-01686a_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Carboxylic acid-based PHD inhibitors (part 2).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01686/20180816/images/large/jm-2017-01686a_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01686&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01686/20180816/images/medium/jm-2017-01686a_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01686/20180816/images/large/jm-2017-01686a_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Non-carboxylic acid PHD inhibitors (part 1).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01686/20180816/images/large/jm-2017-01686a_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01686&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01686/20180816/images/medium/jm-2017-01686a_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01686/20180816/images/large/jm-2017-01686a_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Noncarboxylic acid PHD inhibitors (part 2).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01686/20180816/images/large/jm-2017-01686a_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01686&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01686/20180816/images/medium/jm-2017-01686a_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01686/20180816/images/large/jm-2017-01686a_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. PHD inhibitors with the nonconventional binding mode.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01686/20180816/images/large/jm-2017-01686a_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01686&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01686/20180816/images/medium/jm-2017-01686a_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01686/20180816/images/large/jm-2017-01686a_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Mechanism of action of HIF-PHD inhibitors. The chronic inflammatory condition or kidney disease increases the release of inflammatory cytokines and decreases erythropoietin release. Inflammatory cytokines stimulate hepcidin synthesis. Increased levels of hepcidin downregulate DMT1, Dcytb, and block ferroportin and inhibit iron absorption. Hepcidin degrades ferroportin in macrophages and the liver, which leads to reduced iron availability in the blood and increases intracellular iron. The decrease in EPO and increased hepcidin inhibit hemoglobin synthesis and the maturation of RBCs, resulting in anemia. PHD inhibitors stabilize HIF and stimulate EPO release and decrease hepcidin levels and thus stimulate efficient erythropoiesis.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01686/20180816/images/large/jm-2017-01686a_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01686&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i18">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28212" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28212" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 139 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smith, R. E.,  Jr.</span></span> <span> </span><span class="NLM_article-title">The clinical and economic burden of anemia</span>. <i>Am. J. Manag. Care</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">S59</span>– <span class="NLM_lpage">S66</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=20297873" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2010&pages=S59-S66&author=R.+E.+Smith&title=The+clinical+and+economic+burden+of+anemia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DR.%2BE.%26atitle%3DThe%2520clinical%2520and%2520economic%2520burden%2520of%2520anemia%26jtitle%3DAm.%2520J.%2520Manag.%2520Care%26date%3D2010%26volume%3D16%26spage%3DS59%26epage%3DS66" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">West, C. E.</span></span> <span> </span><span class="NLM_article-title">Strategies to control nutritional anemia</span>. <i>Am. J. Clin. Nutr.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">789</span>– <span class="NLM_lpage">790</span>, <span class="refDoi"> DOI: 10.1093/ajcn/64.5.789</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1093%2Fajcn%2F64.5.789" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=8901803" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=1%3ACAS%3A280%3ADyaK2s%252FlslCltg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=1996&pages=789-790&author=C.+E.+West&title=Strategies+to+control+nutritional+anemia&doi=10.1093%2Fajcn%2F64.5.789"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Strategies to control nutritional anemia</span></div><div class="casAuthors">West C E</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of clinical nutrition</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">789-90</span>
        ISSN:<span class="NLM_cas:issn">0002-9165</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQTTaj7VO7kTpHZzFRCXxVKfW6udTcc2eZbqHVUFGzHK7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2s%252FlslCltg%253D%253D&md5=c222ed1160937e62c4b1d70f86b838d0</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1093%2Fajcn%2F64.5.789&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fajcn%252F64.5.789%26sid%3Dliteratum%253Aachs%26aulast%3DWest%26aufirst%3DC.%2BE.%26atitle%3DStrategies%2520to%2520control%2520nutritional%2520anemia%26jtitle%3DAm.%2520J.%2520Clin.%2520Nutr.%26date%3D1996%26volume%3D64%26spage%3D789%26epage%3D790%26doi%3D10.1093%2Fajcn%2F64.5.789" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haines, D.</span></span> <span> </span><span class="NLM_article-title">Clinical management of patients with thalassemia syndromes</span>. <i>Clin. J. Oncol. Nurs.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">310</span>– <span class="NLM_lpage">317</span>, <span class="refDoi"> DOI: 10.1188/16.CJON.310-317</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1188%2F16.CJON.310-317" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=27206298" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=1%3ACAS%3A280%3ADC%252BC2s%252FitVersA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2016&pages=310-317&author=M.+Martinauthor=D.+Haines&title=Clinical+management+of+patients+with+thalassemia+syndromes&doi=10.1188%2F16.CJON.310-317"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical Management of Patients With Thalassemia Syndromes</span></div><div class="casAuthors">Martin Marie; Haines Drucilla</div><div class="citationInfo"><span class="NLM_cas:title">Clinical journal of oncology nursing</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">310-7</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Thalassemia is a chronic inherited blood disorder that reduces hemoglobin production, causing chronic hemolytic anemia.  Patients often are diagnosed via newborn screening programs.  Patients diagnosed with the most severe form of thalassemia often require chronic red blood cell transfusions to control their anemia.  The side effect of chronic transfusions is cumulative iron overload for which chelation therapy is required.  The incidence of thalassemia is low; therefore, care is best delivered at specialized treatment centers that offer multidisciplinary coordination.  OBJECTIVES:  This article reviews the diagnosis, management, and curative options for thalassemia.  METHODS:  This review follows a hypothetical patient with thalassemia and his family through the major stages of the disease.  FINDINGS:  Increasing knowledge about thalassemia and its management among healthcare providers can improve patient outcomes and quality of life.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQGyO0rO3dB09yzdcP07UmufW6udTcc2eZbqHVUFGzHK7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s%252FitVersA%253D%253D&md5=e2150496666740757f9cb805e4f5e058</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1188%2F16.CJON.310-317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1188%252F16.CJON.310-317%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DM.%26aulast%3DHaines%26aufirst%3DD.%26atitle%3DClinical%2520management%2520of%2520patients%2520with%2520thalassemia%2520syndromes%26jtitle%3DClin.%2520J.%2520Oncol.%2520Nurs.%26date%3D2016%26volume%3D20%26spage%3D310%26epage%3D317%26doi%3D10.1188%2F16.CJON.310-317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Babitt, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, H. Y.</span></span> <span> </span><span class="NLM_article-title">Mechanisms of anemia in CKD</span>. <i>J. Am. Soc. Nephrol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">1631</span>– <span class="NLM_lpage">1634</span>, <span class="refDoi"> DOI: 10.1681/ASN.2011111078</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1681%2FASN.2011111078" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=22935483" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1SqtrbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2012&pages=1631-1634&author=J.+L.+Babittauthor=H.+Y.+Lin&title=Mechanisms+of+anemia+in+CKD&doi=10.1681%2FASN.2011111078"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of anemia in CKD</span></div><div class="casAuthors">Babitt, Jodie L.; Lin, Herbert Y.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Society of Nephrology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1631-1634</span>CODEN:
                <span class="NLM_cas:coden">JASNEU</span>;
        ISSN:<span class="NLM_cas:issn">1046-6673</span>.
    
            (<span class="NLM_cas:orgname">American Society of Nephrology</span>)
        </div><div class="casAbstract">A review.  Anemia is a common feature of CKD assocd. with poor outcomes.  The current management of patients with anemia in CKD is controversial, with recent clin. trials demonstrating increased morbidity and mortality related to erythropoiesis stimulating agents.  Here, we examine recent insights into the mol. mechanisms underlying anemia of CKD.  These insights hold promise for the development of new diagnostic tests and therapies that directly target the pathophysiol. processes underlying this form of anemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHLv6v984Sy7Vg90H21EOLACvtfcHk0lhhHp2pqoc6UA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1SqtrbI&md5=61eb06e56feaca437b459809fb007ed3</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1681%2FASN.2011111078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1681%252FASN.2011111078%26sid%3Dliteratum%253Aachs%26aulast%3DBabitt%26aufirst%3DJ.%2BL.%26aulast%3DLin%26aufirst%3DH.%2BY.%26atitle%3DMechanisms%2520of%2520anemia%2520in%2520CKD%26jtitle%3DJ.%2520Am.%2520Soc.%2520Nephrol.%26date%3D2012%26volume%3D23%26spage%3D1631%26epage%3D1634%26doi%3D10.1681%2FASN.2011111078" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eschbach, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egrie, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Downing, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Browne, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adamson, J. W.</span></span> <span> </span><span class="NLM_article-title">Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>316</i></span>,  <span class="NLM_fpage">73</span>– <span class="NLM_lpage">78</span>, <span class="refDoi"> DOI: 10.1056/NEJM198701083160203</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1056%2FNEJM198701083160203" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=3537801" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=1%3ACAS%3A280%3ADyaL2s%252FmsFSjsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=316&publication_year=1987&pages=73-78&author=J.+W.+Eschbachauthor=J.+C.+Egrieauthor=M.+R.+Downingauthor=J.+K.+Browneauthor=J.+W.+Adamson&title=Correction+of+the+anemia+of+end-stage+renal+disease+with+recombinant+human+erythropoietin.+Results+of+a+combined+phase+I+and+II+clinical+trial&doi=10.1056%2FNEJM198701083160203"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial</span></div><div class="casAuthors">Eschbach J W; Egrie J C; Downing M R; Browne J K; Adamson J W</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">316</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">73-8</span>
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    </div><div class="casAbstract">We administered recombinant human erythropoietin to 25 anemic patients with end-stage renal disease who were undergoing hemodialysis.  The recombinant human erythropoietin was given intravenously three times weekly after dialysis, and transfusion requirements, hematocrit, ferrokinetics, and reticulocyte responses were monitored.  Over a range of doses between 15 and 500 units per kilogram of body weight, dose-dependent increases in effective erythropoiesis were noted.  At 500 units per kilogram, changes in the hematocrit of as much as 10 percentage points were seen within three weeks, and increases in ferrokinetics of three to four times basal values, as measured by erythron transferrin uptake, were observed.  Of 18 patients receiving effective doses of recombinant human erythropoietin, 12 who had required transfusions no longer needed them, and in 11 the hematocrit increased to 35 percent or more.  Along with the rise in hematocrit, four patients had an increase in blood pressure, and a majority had increases in serum creatinine and potassium levels.  No organ dysfunction or other toxic effects were observed, and no antibodies to the recombinant hormone were formed.  These results demonstrate that recombinant human erythropoietin is effective, can eliminate the need for transfusions with their risks of immunologic sensitization, infection, and iron overload, and can restore the hematocrit to normal in many patients with the anemia of end-stage renal disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTXnooNhxprRmmbXvSEQle5fW6udTcc2eabh9iG3d1qTrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL2s%252FmsFSjsw%253D%253D&md5=0133a0923268a2aa5d3fcf0e1305c4e3</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1056%2FNEJM198701083160203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM198701083160203%26sid%3Dliteratum%253Aachs%26aulast%3DEschbach%26aufirst%3DJ.%2BW.%26aulast%3DEgrie%26aufirst%3DJ.%2BC.%26aulast%3DDowning%26aufirst%3DM.%2BR.%26aulast%3DBrowne%26aufirst%3DJ.%2BK.%26aulast%3DAdamson%26aufirst%3DJ.%2BW.%26atitle%3DCorrection%2520of%2520the%2520anemia%2520of%2520end-stage%2520renal%2520disease%2520with%2520recombinant%2520human%2520erythropoietin.%2520Results%2520of%2520a%2520combined%2520phase%2520I%2520and%2520II%2520clinical%2520trial%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1987%26volume%3D316%26spage%3D73%26epage%3D78%26doi%3D10.1056%2FNEJM198701083160203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Skali, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parving, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parfrey, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burdmann, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ivanovich, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keithi-Reddy, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGill, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMurray, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solomon, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uno, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfeffer, M. A.</span></span> <span> </span><span class="NLM_article-title">Stroke in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia treated with Darbepoetin Alfa: the trial to reduce cardiovascular events with Aranesp therapy (TREAT) experience</span>. <i>Circulation</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>124</i></span>,  <span class="NLM_fpage">2903</span>– <span class="NLM_lpage">2908</span>, <span class="refDoi"> DOI: 10.1161/CIRCULATIONAHA.111.030411</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1161%2FCIRCULATIONAHA.111.030411" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2011&pages=2903-2908&author=H.+Skaliauthor=H.+H.+Parvingauthor=P.+S.+Parfreyauthor=E.+A.+Burdmannauthor=E.+F.+Lewisauthor=P.+Ivanovichauthor=S.+R.+Keithi-Reddyauthor=J.+B.+McGillauthor=J.+J.+McMurrayauthor=A.+K.+Singhauthor=S.+D.+Solomonauthor=H.+Unoauthor=M.+A.+Pfeffer&title=Stroke+in+patients+with+type+2+diabetes+mellitus%2C+chronic+kidney+disease%2C+and+anemia+treated+with+Darbepoetin+Alfa%3A+the+trial+to+reduce+cardiovascular+events+with+Aranesp+therapy+%28TREAT%29+experience&doi=10.1161%2FCIRCULATIONAHA.111.030411"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1161%2FCIRCULATIONAHA.111.030411&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIRCULATIONAHA.111.030411%26sid%3Dliteratum%253Aachs%26aulast%3DSkali%26aufirst%3DH.%26aulast%3DParving%26aufirst%3DH.%2BH.%26aulast%3DParfrey%26aufirst%3DP.%2BS.%26aulast%3DBurdmann%26aufirst%3DE.%2BA.%26aulast%3DLewis%26aufirst%3DE.%2BF.%26aulast%3DIvanovich%26aufirst%3DP.%26aulast%3DKeithi-Reddy%26aufirst%3DS.%2BR.%26aulast%3DMcGill%26aufirst%3DJ.%2BB.%26aulast%3DMcMurray%26aufirst%3DJ.%2BJ.%26aulast%3DSingh%26aufirst%3DA.%2BK.%26aulast%3DSolomon%26aufirst%3DS.%2BD.%26aulast%3DUno%26aufirst%3DH.%26aulast%3DPfeffer%26aufirst%3DM.%2BA.%26atitle%3DStroke%2520in%2520patients%2520with%2520type%25202%2520diabetes%2520mellitus%252C%2520chronic%2520kidney%2520disease%252C%2520and%2520anemia%2520treated%2520with%2520Darbepoetin%2520Alfa%253A%2520the%2520trial%2520to%2520reduce%2520cardiovascular%2520events%2520with%2520Aranesp%2520therapy%2520%2528TREAT%2529%2520experience%26jtitle%3DCirculation%26date%3D2011%26volume%3D124%26spage%3D2903%26epage%3D2908%26doi%3D10.1161%2FCIRCULATIONAHA.111.030411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraut, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samaras, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">West, D. P.</span></span> <span> </span><span class="NLM_article-title">Intersecting guidelines: administering erythropoiesis-stimulating agents to chronic kidney disease patients with cancer</span>. <i>Semin. Dial.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">4</span>, <span class="refDoi"> DOI: 10.1111/j.1525-139X.2008.00524.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1111%2Fj.1525-139X.2008.00524.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=19175532" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=1%3ACAS%3A280%3ADC%252BD1M7ntl2ltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2009&pages=1-4&author=C.+L.+Bennettauthor=P.+S.+Beckerauthor=E.+H.+Krautauthor=A.+T.+Samarasauthor=D.+P.+West&title=Intersecting+guidelines%3A+administering+erythropoiesis-stimulating+agents+to+chronic+kidney+disease+patients+with+cancer&doi=10.1111%2Fj.1525-139X.2008.00524.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Intersecting guidelines: administering erythropoiesis-stimulating agents to chronic kidney disease patients with cancer</span></div><div class="casAuthors">Bennett Charles L; Becker Pamela S; Kraut Eric H; Samaras Athena T; West Dennis P</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in dialysis</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-4</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">There has been a dramatic sea change in the use of erythropoiesis-stimulating agents (ESAs) for anemic persons with chronic kidney disease (CKD) or cancer patients undergoing chemotherapy.  An important area that has not been addressed previously is a CKD patient who also has a malignancy.  Clinical guidelines exist that outline recommended treatments for each disease, but the intersection of the two disease processes presents difficult decisions for patients and physicians.  Herein, we review the background underlying recent revisions in clinical alerts and guidelines for ESAs, and provide guidance for treating anemia among CKD patients who are receiving no therapy, chemotherapy with curative intent, or chemotherapy with palliative intent.  The guiding principle is that comprehensive assessment of risks and benefits in the relevant clinical setting is imperative.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRmLOr97pz6HBJ5E29YNGvQfW6udTcc2eb8WVP9ZTZgA7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M7ntl2ltw%253D%253D&md5=bdb7646c345f63999ff2a3c1673874c7</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1111%2Fj.1525-139X.2008.00524.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1525-139X.2008.00524.x%26sid%3Dliteratum%253Aachs%26aulast%3DBennett%26aufirst%3DC.%2BL.%26aulast%3DBecker%26aufirst%3DP.%2BS.%26aulast%3DKraut%26aufirst%3DE.%2BH.%26aulast%3DSamaras%26aufirst%3DA.%2BT.%26aulast%3DWest%26aufirst%3DD.%2BP.%26atitle%3DIntersecting%2520guidelines%253A%2520administering%2520erythropoiesis-stimulating%2520agents%2520to%2520chronic%2520kidney%2520disease%2520patients%2520with%2520cancer%26jtitle%3DSemin.%2520Dial.%26date%3D2009%26volume%3D22%26spage%3D1%26epage%3D4%26doi%3D10.1111%2Fj.1525-139X.2008.00524.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zaritsky, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westerman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olbina, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nemeth, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivera, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nissenson, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salusky, I. B.</span></span> <span> </span><span class="NLM_article-title">Hepcidin--a potential novel biomarker for iron status in chronic kidney disease</span>. <i>Clin. J. Am. Soc. Nephrol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">1051</span>– <span class="NLM_lpage">1056</span>, <span class="refDoi"> DOI: 10.2215/CJN.05931108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.2215%2FCJN.05931108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=19406957" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnsF2rtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=1051-1056&author=J.+Zaritskyauthor=B.+Youngauthor=H.+J.+Wangauthor=M.+Westermanauthor=G.+Olbinaauthor=E.+Nemethauthor=T.+Ganzauthor=S.+Riveraauthor=A.+R.+Nissensonauthor=I.+B.+Salusky&title=Hepcidin%2D%2Da+potential+novel+biomarker+for+iron+status+in+chronic+kidney+disease&doi=10.2215%2FCJN.05931108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Hepcidin-A potential novel biomarker for iron status in chronic kidney disease</span></div><div class="casAuthors">Zaritsky, Joshua; Young, Brian; Wang, He-Jing; Westerman, Mark; Olbina, Gordana; Nemeth, Elizabeta; Ganz, Tomas; Rivera, Seth; Nissenson, Allen R.; Salusky, Isidro B.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Journal of the American Society of Nephrology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1051-1056</span>CODEN:
                <span class="NLM_cas:coden">CJASC7</span>;
        ISSN:<span class="NLM_cas:issn">1555-9041</span>.
    
            (<span class="NLM_cas:orgname">American Society of Nephrology</span>)
        </div><div class="casAbstract">Hepcidin is a key regulator of iron homeostasis, but its study in the setting of chronic kidney disease (CKD) has been hampered by the lack of validated serum assays.  This study reports the first measurements of bioactive serum hepcidin using a novel competitive ELISA in 48 pediatric (PCKD2-4) and 32 adult (ACKD2-4) patients with stages 2 to 4 CKD along with 26 pediatric patients with stage 5 CKD (PCKD5D) on peritoneal dialysis.  When compared with their resp. controls (pediatric median = 25.3 ng/mL, adult = 72.9 ng/mL), hepcidin was significantly increased in PCKD2-4 (127.3 ng/mL), ACKD2-4 (269.9 ng/mL), and PCKD5D (652.4 ng/mL).  Multivariate regression anal. was used to assess the relationship between hepcidin and indicators of anemia, iron status, inflammation, and renal function.  In PCKD2-4 (R2 = 0.57), only ferritin correlated with hepcidin.  In ACKD2-4 (R2 = 0.78), ferritin and sol. transferrin receptor were assocd. with hepcidin, whereas GFR was inversely correlated.  In PCKD5D (R2 = 0.52), percent iron satn. and ferritin were predictors of hepcidin.  In a multivariate anal. that incorporated all three groups (R2 = 0.6), hepcidin was predicted by ferritin, C-reactive protein, and whether the patient had stage 5D vs. stages 2 to 4 CKD.  These findings suggest that increased hepcidin across the spectrum of CKD may contribute to abnormal iron regulation and erythropoiesis and may be a novel biomarker of iron status and erythropoietin resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrd-xo6YQbyF7Vg90H21EOLACvtfcHk0lhLsK2do8Bd7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnsF2rtbk%253D&md5=70e1413497a5a855c51cebd4e42b8570</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.2215%2FCJN.05931108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2215%252FCJN.05931108%26sid%3Dliteratum%253Aachs%26aulast%3DZaritsky%26aufirst%3DJ.%26aulast%3DYoung%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DH.%2BJ.%26aulast%3DWesterman%26aufirst%3DM.%26aulast%3DOlbina%26aufirst%3DG.%26aulast%3DNemeth%26aufirst%3DE.%26aulast%3DGanz%26aufirst%3DT.%26aulast%3DRivera%26aufirst%3DS.%26aulast%3DNissenson%26aufirst%3DA.%2BR.%26aulast%3DSalusky%26aufirst%3DI.%2BB.%26atitle%3DHepcidin--a%2520potential%2520novel%2520biomarker%2520for%2520iron%2520status%2520in%2520chronic%2520kidney%2520disease%26jtitle%3DClin.%2520J.%2520Am.%2520Soc.%2520Nephrol.%26date%3D2009%26volume%3D4%26spage%3D1051%26epage%3D1056%26doi%3D10.2215%2FCJN.05931108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tarng, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, W. C.</span></span> <span> </span><span class="NLM_article-title">Erythropoietin hyporesponsiveness: from iron deficiency to iron overload</span>. <i>Kidney Int.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">S107</span>– <span class="NLM_lpage">S118</span>, <span class="refDoi"> DOI: 10.1038/sj.ki.4490858</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1038%2Fsj.ki.4490858" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1999&pages=S107-S118&author=D.+C.+Tarngauthor=T.+P.+Huangauthor=T.+W.+Chenauthor=W.+C.+Yang&title=Erythropoietin+hyporesponsiveness%3A+from+iron+deficiency+to+iron+overload&doi=10.1038%2Fsj.ki.4490858"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fsj.ki.4490858&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.ki.4490858%26sid%3Dliteratum%253Aachs%26aulast%3DTarng%26aufirst%3DD.%2BC.%26aulast%3DHuang%26aufirst%3DT.%2BP.%26aulast%3DChen%26aufirst%3DT.%2BW.%26aulast%3DYang%26aufirst%3DW.%2BC.%26atitle%3DErythropoietin%2520hyporesponsiveness%253A%2520from%2520iron%2520deficiency%2520to%2520iron%2520overload%26jtitle%3DKidney%2520Int.%26date%3D1999%26volume%3D55%26spage%3DS107%26epage%3DS118%26doi%3D10.1038%2Fsj.ki.4490858" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Holdstock, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meadowcroft, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maier, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rastogi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeig, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lepore, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cobitz, A. R.</span></span> <span> </span><span class="NLM_article-title">Four-Week Studies of Oral Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor GSK1278863 for Treatment of Anemia</span>. <i>J. Am. Soc. Nephrol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>27</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1234</span>– <span class="NLM_lpage">1244</span>, <span class="refDoi"> DOI: 10.1681/ASN.2014111139</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1681%2FASN.2014111139" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=26494831" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=1%3ACAS%3A528%3ADC%252BC2sXptVeltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2016&pages=1234-1244&issue=4&author=L.+Holdstockauthor=A.+M.+Meadowcroftauthor=R.+Maierauthor=B.+M.+Johnsonauthor=D.+Jonesauthor=A.+Rastogiauthor=S.+Zeigauthor=J.+J.+Leporeauthor=A.+R.+Cobitz&title=Four-Week+Studies+of+Oral+Hypoxia-Inducible+Factor-Prolyl+Hydroxylase+Inhibitor+GSK1278863+for+Treatment+of+Anemia&doi=10.1681%2FASN.2014111139"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Four-week studies of oral hypoxia-inducible factor-prolyl hydroxylase inhibitor GSK1278863 for treatment of anemia</span></div><div class="casAuthors">Holdstock, Louis; Meadowcroft, Amy M.; Maier, Rayma; Johnson, Brendan M.; Jones, Delyth; Rastogi, Anjay; Zeig, Steven; Lepore, John J.; Cobitz, Alexander R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Society of Nephrology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1234-1244</span>CODEN:
                <span class="NLM_cas:coden">JASNEU</span>;
        ISSN:<span class="NLM_cas:issn">1046-6673</span>.
    
            (<span class="NLM_cas:orgname">American Society of Nephrology</span>)
        </div><div class="casAbstract">Hypoxia-inducible factor prolyl hydroxylase inhibitors stabilize levels of hypoxia-inducible factor that upregulate transcription of multiple genes assocd. with the response to hypoxia, including prodn. of erythropoietin.  We conducted two phase 2a studies to explore the relationship between the dose of the hypoxia-inducible factor-prolyl hydroxylase inhibitor GSK1278863 and Hb response in patients with anemia of CKD (baseline Hb 8.5-11.0 g/dL) not undergoing dialysis and not receiving recombinant human erythropoietin (nondialysis study) and in patients with anemia of CKD (baseline Hb 9.5-12.0 g/dL) on hemodialysis and being treated with stable doses of recombinant human erythropoietin (hemodialysis study).  Participants were randomized 1:1:1:1 to a once-daily oral dose of GSK1278863 (0.5 mg, 2 mg, or 5 mg) or control (placebo for the nondialysis study; continuing on recombinant human erythropoietin for the hemodialysis study) for 4 wk, with a 2-wk follow-up.  In the nondialysis study, GSK1278863 produced dose-dependent effects on Hb, with the highest dose resulting in a mean increase of 1 g/dL at week 4.  In the hemodialysis study, treatment with GSK1278863 in the 5-mg arm maintained mean Hb concns. after the switch from recombinant human erythropoietin, whereas mean Hb decreased in the lower-dose arms.  In both studies, the effects on Hb occurred with elevations in endogenous erythropoietin within the range usually obsd. in the resp. populations and markedly lower than those in the recombinant human erythropoietin control arm in the hemodialysis study, and without clin. significant elevations in plasma vascular endothelial growth factor concns.  GSK1278863 was generally safe and well tolerated at the doses and duration studied.  GSK1278863 may prove an effective alternative for managing anemia of CKD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVJzuvw1x6JbVg90H21EOLACvtfcHk0lgztezOUukoVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXptVeltA%253D%253D&md5=e105ac25308286d9b4512285920cc032</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1681%2FASN.2014111139&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1681%252FASN.2014111139%26sid%3Dliteratum%253Aachs%26aulast%3DHoldstock%26aufirst%3DL.%26aulast%3DMeadowcroft%26aufirst%3DA.%2BM.%26aulast%3DMaier%26aufirst%3DR.%26aulast%3DJohnson%26aufirst%3DB.%2BM.%26aulast%3DJones%26aufirst%3DD.%26aulast%3DRastogi%26aufirst%3DA.%26aulast%3DZeig%26aufirst%3DS.%26aulast%3DLepore%26aufirst%3DJ.%2BJ.%26aulast%3DCobitz%26aufirst%3DA.%2BR.%26atitle%3DFour-Week%2520Studies%2520of%2520Oral%2520Hypoxia-Inducible%2520Factor-Prolyl%2520Hydroxylase%2520Inhibitor%2520GSK1278863%2520for%2520Treatment%2520of%2520Anemia%26jtitle%3DJ.%2520Am.%2520Soc.%2520Nephrol.%26date%3D2016%26volume%3D27%26issue%3D4%26spage%3D1234%26epage%3D1244%26doi%3D10.1681%2FASN.2014111139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Koury, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bondurant, M. C.</span></span> <span> </span><span class="NLM_article-title">The mechanism of erythropoietin action</span>. <i>Am. J. Kidney Dis.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">4 Suppl 1</span>),  <span class="NLM_fpage">20</span>– <span class="NLM_lpage">23</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=1656733" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=1%3ACAS%3A528%3ADyaK38XhsFymsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1991&pages=20-23&issue=4+Suppl+1&author=M.+J.+Kouryauthor=M.+C.+Bondurant&title=The+mechanism+of+erythropoietin+action"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">The mechanism of erythropoietin action</span></div><div class="casAuthors">Koury, Mark J.; Bondurant, Maurice C.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Kidney Diseases</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">4, Suppl. 1</span>),
    <span class="NLM_cas:pages">20-3</span>CODEN:
                <span class="NLM_cas:coden">AJKDDP</span>;
        ISSN:<span class="NLM_cas:issn">0272-6386</span>.
    </div><div class="casAbstract">A review, with 24 refs., on the mechanism of erythropoietin action with emphasis on its effects on target cells (committed erythroid progenitor cells), and its control of red blood cell prodn. (mainly by preventing programmed cell death).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoK3AHSyqD5X7Vg90H21EOLACvtfcHk0lgztezOUukoVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XhsFymsw%253D%253D&md5=964b05daee82342aca6c36099ee7b4a5</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKoury%26aufirst%3DM.%2BJ.%26aulast%3DBondurant%26aufirst%3DM.%2BC.%26atitle%3DThe%2520mechanism%2520of%2520erythropoietin%2520action%26jtitle%3DAm.%2520J.%2520Kidney%2520Dis.%26date%3D1991%26volume%3D18%26issue%3D4%2520Suppl%25201%26spage%3D20%26epage%3D23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Willekens, F. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Werre, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groenen-Döpp, Y.
A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roerdinkholder-Stoelwinder, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Pauw, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bosman, G. J.</span></span> <span> </span><span class="NLM_article-title">Erythrocyte vesiculation: a self-protective mechanism?</span>. <i>Br. J. Haematol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>141</i></span>,  <span class="NLM_fpage">549</span>– <span class="NLM_lpage">556</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2141.2008.07055.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1111%2Fj.1365-2141.2008.07055.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=18419623" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnt1eisbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=141&publication_year=2008&pages=549-556&author=F.+L.+Willekensauthor=J.+M.+Werreauthor=Y.%0AA.+Groenen-D%C3%B6ppauthor=B.+Roerdinkholder-Stoelwinderauthor=B.+De+Pauwauthor=G.+J.+Bosman&title=Erythrocyte+vesiculation%3A+a+self-protective+mechanism%3F&doi=10.1111%2Fj.1365-2141.2008.07055.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Erythrocyte vesiculation: a self-protective mechanism?</span></div><div class="casAuthors">Willekens, Frans L. A.; Werre, Jan M.; Groenen-Doepp, Yvonne A. M.; Roerdinkholder-Stoelwinder, Bregt; de Pauw, Ben; Bosman, Giel J. C. G. M.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Haematology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">141</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">549-556</span>CODEN:
                <span class="NLM_cas:coden">BJHEAL</span>;
        ISSN:<span class="NLM_cas:issn">0007-1048</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Previous studies demonstrated that 20% of Hb is lost from circulating erythrocytes during their total lifespan by vesiculation.  To study whether removal mols. other than membrane-bound Hb were present in erythrocyte-derived vesicles, flow cytometry and immunoblot anal. were employed to examine the presence of phosphatidylserine (PS) and IgG, and senescent cell antigens resp.  It was demonstrated that 67% of glycophorin A-pos. vesicles exposed PS, and that half of these vesicles also contained IgG.  Immunoblot anal. revealed the presence of a breakdown product of band 3 that reacted with antibodies directed against senescent erythrocyte antigen-assocd. band 3 sequences.  In contrast, only the oldest erythrocytes contained senescent cell antigens and IgG, and only 0.1% of erythrocytes, of all ages, exposed PS.  It was concluded that vesiculation constitutes a mechanism for the removal of erythrocyte membrane patches contg. removal mols., thereby postponing the untimely elimination of otherwise healthy erythrocytes.  Consequently, these same removal mols. mediate the rapid removal of erythrocyte-derived vesicles from the circulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpai9cuG9I_7bVg90H21EOLACvtfcHk0liy0q-4_IBt_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnt1eisbs%253D&md5=6b2c58d6179a4ddd0cb2f0c78aa371ca</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2141.2008.07055.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2141.2008.07055.x%26sid%3Dliteratum%253Aachs%26aulast%3DWillekens%26aufirst%3DF.%2BL.%26aulast%3DWerre%26aufirst%3DJ.%2BM.%26aulast%3DGroenen-D%25C3%25B6pp%26aufirst%3DY.%2BA.%26aulast%3DRoerdinkholder-Stoelwinder%26aufirst%3DB.%26aulast%3DDe%2BPauw%26aufirst%3DB.%26aulast%3DBosman%26aufirst%3DG.%2BJ.%26atitle%3DErythrocyte%2520vesiculation%253A%2520a%2520self-protective%2520mechanism%253F%26jtitle%3DBr.%2520J.%2520Haematol.%26date%3D2008%26volume%3D141%26spage%3D549%26epage%3D556%26doi%3D10.1111%2Fj.1365-2141.2008.07055.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Constantinescu, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lodish, H. F.</span></span> <span> </span><span class="NLM_article-title">The N-terminal domain of janus kinase 2 is required for golgi processing and cell surface expression of erythropoietin receptor</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1327</span>– <span class="NLM_lpage">1338</span>, <span class="refDoi"> DOI: 10.1016/S1097-2765(01)00401-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1016%2FS1097-2765%2801%2900401-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2001&pages=1327-1338&author=L.+J.+Huangauthor=S.+N.+Constantinescuauthor=H.+F.+Lodish&title=The+N-terminal+domain+of+janus+kinase+2+is+required+for+golgi+processing+and+cell+surface+expression+of+erythropoietin+receptor&doi=10.1016%2FS1097-2765%2801%2900401-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2FS1097-2765%2801%2900401-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1097-2765%252801%252900401-4%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DL.%2BJ.%26aulast%3DConstantinescu%26aufirst%3DS.%2BN.%26aulast%3DLodish%26aufirst%3DH.%2BF.%26atitle%3DThe%2520N-terminal%2520domain%2520of%2520janus%2520kinase%25202%2520is%2520required%2520for%2520golgi%2520processing%2520and%2520cell%2520surface%2520expression%2520of%2520erythropoietin%2520receptor%26jtitle%3DMol.%2520Cell%26date%3D2001%26volume%3D8%26spage%3D1327%26epage%3D1338%26doi%3D10.1016%2FS1097-2765%2801%2900401-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Richmond, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chohan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barber, D. L.</span></span> <span> </span><span class="NLM_article-title">Turning cells red: signal transduction mediated by erythropoietin</span>. <i>Trends Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">146</span>– <span class="NLM_lpage">155</span>, <span class="refDoi"> DOI: 10.1016/j.tcb.2005.01.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1016%2Fj.tcb.2005.01.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=15752978" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitVeit78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=146-155&author=T.+D.+Richmondauthor=M.+Chohanauthor=D.+L.+Barber&title=Turning+cells+red%3A+signal+transduction+mediated+by+erythropoietin&doi=10.1016%2Fj.tcb.2005.01.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Turning cells red: signal transduction mediated by erythropoietin</span></div><div class="casAuthors">Richmond, Terri D.; Chohan, Manprit; Barber, Dwayne L.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Cell Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">146-155</span>CODEN:
                <span class="NLM_cas:coden">TCBIEK</span>;
        ISSN:<span class="NLM_cas:issn">0962-8924</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Erythropoietin (EPO) is the crucial cytokine regulator of red blood-cell prodn.  Since the discovery of EPO in 1985 and the isolation of its cognate receptor four years later, there has been significant interest in understanding the unique ability of this ligand-receptor pair to promote erythroid mitogenesis, survival and differentiation.  The development of knockout mice has elucidated the precise role of the ligand, receptor and downstream players in murine erythroid development.  In this review, we summarize EPO-mediated signaling pathways and examine their significance in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqC0ZGqvvOp9bVg90H21EOLACvtfcHk0liy0q-4_IBt_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitVeit78%253D&md5=e2dc801d032c6f080da38e83507cb265</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.tcb.2005.01.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tcb.2005.01.007%26sid%3Dliteratum%253Aachs%26aulast%3DRichmond%26aufirst%3DT.%2BD.%26aulast%3DChohan%26aufirst%3DM.%26aulast%3DBarber%26aufirst%3DD.%2BL.%26atitle%3DTurning%2520cells%2520red%253A%2520signal%2520transduction%2520mediated%2520by%2520erythropoietin%26jtitle%3DTrends%2520Cell%2520Biol.%26date%3D2005%26volume%3D15%26spage%3D146%26epage%3D155%26doi%3D10.1016%2Fj.tcb.2005.01.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De
Maria, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Testa, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luchetti, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeuner, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stassi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelosi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riccioni, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felli, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samoggia, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peschle, C.</span></span> <span> </span><span class="NLM_article-title">Apoptotic role of Fas/Fas ligand system in the regulation of erythropoiesis</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>93</i></span>,  <span class="NLM_fpage">796</span>– <span class="NLM_lpage">803</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1999&pages=796-803&author=R.+De%0AMariaauthor=U.+Testaauthor=L.+Luchettiauthor=A.+Zeunerauthor=G.+Stassiauthor=E.+Pelosiauthor=R.+Riccioniauthor=N.+Felliauthor=P.+Samoggiaauthor=C.+Peschle&title=Apoptotic+role+of+Fas%2FFas+ligand+system+in+the+regulation+of+erythropoiesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BMaria%26aufirst%3DR.%26aulast%3DTesta%26aufirst%3DU.%26aulast%3DLuchetti%26aufirst%3DL.%26aulast%3DZeuner%26aufirst%3DA.%26aulast%3DStassi%26aufirst%3DG.%26aulast%3DPelosi%26aufirst%3DE.%26aulast%3DRiccioni%26aufirst%3DR.%26aulast%3DFelli%26aufirst%3DN.%26aulast%3DSamoggia%26aufirst%3DP.%26aulast%3DPeschle%26aufirst%3DC.%26atitle%3DApoptotic%2520role%2520of%2520Fas%252FFas%2520ligand%2520system%2520in%2520the%2520regulation%2520of%2520erythropoiesis%26jtitle%3DBlood%26date%3D1999%26volume%3D93%26spage%3D796%26epage%3D803" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sebastiani, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pantopoulos, K.</span></span> <span> </span><span class="NLM_article-title">Pharmacological targeting of the hepcidin/ferroportin axis</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">160</span>, <span class="refDoi"> DOI: 10.3389/fphar.2016.00160</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.3389%2Ffphar.2016.00160" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=27445804" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsV2gtLbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=160&author=G.+Sebastianiauthor=N.+Wilkinsonauthor=K.+Pantopoulos&title=Pharmacological+targeting+of+the+hepcidin%2Fferroportin+axis&doi=10.3389%2Ffphar.2016.00160"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological targeting of the hepcidin/ferroportin axis</span></div><div class="casAuthors">Sebastiani, Giada; Wilkinson, Nicole; Pantopoulos, Kostas</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Pharmacology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">160/1-160/11</span>CODEN:
                <span class="NLM_cas:coden">FPRHAU</span>;
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">The iron regulatory hormone hepcidin limits iron fluxes to the bloodstream by promoting degrdn. of the iron exporter ferroportin in target cells.  Hepcidin insufficiency causes hyperabsorption of dietary iron, hyperferremia and tissue iron overload, which are hallmarks of hereditary hemochromatosis.  Similar responses are also obsd. in iron-loading anemias due to ineffective erythropoiesis (such as thalassemias, dyserythropoietic anemias and myelodysplastic syndromes) and in chronic liver diseases.  On the other hand, excessive hepcidin expression inhibits dietary iron absorption and leads to hypoferremia and iron retention within tissue macrophages.  This reduces iron availability for erythroblasts and contributes to the development of anemias with iron-restricted erythropoiesis (such as anemia of chronic disease and iron-refractory iron-deficiency anemia).  Pharmacol. targeting of the hepcidin/ferroportin axis may offer considerable therapeutic benefits by correcting iron traffic.  This review summarizes the principles underlying the development of hepcidin-based therapies for the treatment of iron-related disorders, and discusses the emerging strategies for manipulating hepcidin pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpovZjDSpbqLLVg90H21EOLACvtfcHk0lgl35_VfBrscA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsV2gtLbJ&md5=da5e0178edf870b1ec304a7203e5ef96</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2016.00160&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2016.00160%26sid%3Dliteratum%253Aachs%26aulast%3DSebastiani%26aufirst%3DG.%26aulast%3DWilkinson%26aufirst%3DN.%26aulast%3DPantopoulos%26aufirst%3DK.%26atitle%3DPharmacological%2520targeting%2520of%2520the%2520hepcidin%252Fferroportin%2520axis%26jtitle%3DFront.%2520Pharmacol.%26date%3D2016%26volume%3D7%26spage%3D160%26doi%3D10.3389%2Ffphar.2016.00160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Semenza, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G. L.</span></span> <span> </span><span class="NLM_article-title">A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">5447</span>– <span class="NLM_lpage">5454</span>, <span class="refDoi"> DOI: 10.1128/MCB.12.12.5447</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1128%2FMCB.12.12.5447" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=1448077" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=1%3ACAS%3A528%3ADyaK3sXltFShsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1992&pages=5447-5454&author=G.+L.+Semenzaauthor=G.+L.+Wang&title=A+nuclear+factor+induced+by+hypoxia+via+de+novo+protein+synthesis+binds+to+the+human+erythropoietin+gene+enhancer+at+a+site+required+for+transcriptional+activation&doi=10.1128%2FMCB.12.12.5447"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation</span></div><div class="casAuthors">Semenza, Gregg L.; Wang, Guang L.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5447-54</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    </div><div class="casAbstract">A 50-nucleotide enhancer from the human erythropoietin gene 3'-flanking sequence was identified which can mediate a 7-fold transcriptional induction in response to hypoxia when cloned 3' to a simian virus 40 promoter-chloramphenicol acetyltransferase reporter gene and transiently expressed in Hep3B cells.  Nucleotides (nt) 1 to 33 of this sequence mediate 7-fold induction of reporter gene expression when present in 2 tandem copies compared with 3-fold induction when present in a single copy, suggesting that nt 34 to 50 bind a factor which amplifies the induction signal.  DNase I footprinting demonstrated binding of a constitutive nuclear factor to nt 26 to 48.  Mutagenesis studies revealed that nt 4 to 12 and 19 to 23 are essential for induction, as substitutions at either site eliminated hypoxia-induced expression.  Electrophoretic mobility shift assays identified a nuclear factor which bound to a probe spanning nt 1 to 18 but not to a probe contg. a mutation which eliminated enhancer function.  Factor binding was induced by hypoxia, and its induction was sensitive to cycloheximide treatment.  Thus, this is a functionally tripartite, 50-nt hypoxia-inducible enhancer which binds several nuclear factors, one of which is induced by hypoxia via de novo protein synthesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEJEpkpLpOV7Vg90H21EOLACvtfcHk0lgl35_VfBrscA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXltFShsr0%253D&md5=672c5097c32e993177fd89f02223a20a</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1128%2FMCB.12.12.5447&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.12.12.5447%26sid%3Dliteratum%253Aachs%26aulast%3DSemenza%26aufirst%3DG.%2BL.%26aulast%3DWang%26aufirst%3DG.%2BL.%26atitle%3DA%2520nuclear%2520factor%2520induced%2520by%2520hypoxia%2520via%2520de%2520novo%2520protein%2520synthesis%2520binds%2520to%2520the%2520human%2520erythropoietin%2520gene%2520enhancer%2520at%2520a%2520site%2520required%2520for%2520transcriptional%2520activation%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D1992%26volume%3D12%26spage%3D5447%26epage%3D5454%26doi%3D10.1128%2FMCB.12.12.5447" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marxsen, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stengel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doege, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heikkinen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jokilehto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jelkmann, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaakkola, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metzen, E.</span></span> <span> </span><span class="NLM_article-title">Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by induction of HIF-α-prolyl-4-hydroxylases</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>381</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">761</span>– <span class="NLM_lpage">767</span>, <span class="refDoi"> DOI: 10.1042/BJ20040620</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1042%2FBJ20040620" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=381&publication_year=2004&pages=761-767&issue=3&author=J.+H.+Marxsenauthor=P.+Stengelauthor=K.+Doegeauthor=P.+Heikkinenauthor=T.+Jokilehtoauthor=T.+Wagnerauthor=W.+Jelkmannauthor=P.+Jaakkolaauthor=E.+Metzen&title=Hypoxia-inducible+factor-1+%28HIF-1%29+promotes+its+degradation+by+induction+of+HIF-%CE%B1-prolyl-4-hydroxylases&doi=10.1042%2FBJ20040620"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1042%2FBJ20040620&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20040620%26sid%3Dliteratum%253Aachs%26aulast%3DMarxsen%26aufirst%3DJ.%2BH.%26aulast%3DStengel%26aufirst%3DP.%26aulast%3DDoege%26aufirst%3DK.%26aulast%3DHeikkinen%26aufirst%3DP.%26aulast%3DJokilehto%26aufirst%3DT.%26aulast%3DWagner%26aufirst%3DT.%26aulast%3DJelkmann%26aufirst%3DW.%26aulast%3DJaakkola%26aufirst%3DP.%26aulast%3DMetzen%26aufirst%3DE.%26atitle%3DHypoxia-inducible%2520factor-1%2520%2528HIF-1%2529%2520promotes%2520its%2520degradation%2520by%2520induction%2520of%2520HIF-%25CE%25B1-prolyl-4-hydroxylases%26jtitle%3DBiochem.%2520J.%26date%3D2004%26volume%3D381%26issue%3D3%26spage%3D761%26epage%3D767%26doi%3D10.1042%2FBJ20040620" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Geyte, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fraisl, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiss, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aragonés, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzone, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mairbäurl, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Bock, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeoung, N. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mollenhauer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Georgiadou, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bishop, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roncal, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutherland, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jordan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallez, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weitz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maxwell, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ratcliffe, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carmeliet, P.</span></span> <span> </span><span class="NLM_article-title">Loss or silencing of the PHD1 prolyl hydroxylase protects livers of mice against ischemia/reperfusion injury</span>. <i>Gastroenterology</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>138</i></span>,  <span class="NLM_fpage">1143</span>– <span class="NLM_lpage">1154</span>, <span class="refDoi"> DOI: 10.1053/j.gastro.2009.09.057</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1053%2Fj.gastro.2009.09.057" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2010&pages=1143-1154&author=M.+Schneiderauthor=K.+Van+Geyteauthor=P.+Fraislauthor=J.+Kissauthor=J.+Aragon%C3%A9sauthor=M.+Mazzoneauthor=H.+Mairb%C3%A4urlauthor=K.+De+Bockauthor=N.+H.+Jeoungauthor=M.+Mollenhauerauthor=M.+Georgiadouauthor=T.+Bishopauthor=C.+Roncalauthor=A.+Sutherlandauthor=B.+Jordanauthor=B.+Gallezauthor=J.+Weitzauthor=R.+A.+Harrisauthor=P.+Maxwellauthor=M.+Baesauthor=P.+Ratcliffeauthor=P.+Carmeliet&title=Loss+or+silencing+of+the+PHD1+prolyl+hydroxylase+protects+livers+of+mice+against+ischemia%2Freperfusion+injury&doi=10.1053%2Fj.gastro.2009.09.057"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1053%2Fj.gastro.2009.09.057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1053%252Fj.gastro.2009.09.057%26sid%3Dliteratum%253Aachs%26aulast%3DSchneider%26aufirst%3DM.%26aulast%3DVan%2BGeyte%26aufirst%3DK.%26aulast%3DFraisl%26aufirst%3DP.%26aulast%3DKiss%26aufirst%3DJ.%26aulast%3DAragon%25C3%25A9s%26aufirst%3DJ.%26aulast%3DMazzone%26aufirst%3DM.%26aulast%3DMairb%25C3%25A4url%26aufirst%3DH.%26aulast%3DDe%2BBock%26aufirst%3DK.%26aulast%3DJeoung%26aufirst%3DN.%2BH.%26aulast%3DMollenhauer%26aufirst%3DM.%26aulast%3DGeorgiadou%26aufirst%3DM.%26aulast%3DBishop%26aufirst%3DT.%26aulast%3DRoncal%26aufirst%3DC.%26aulast%3DSutherland%26aufirst%3DA.%26aulast%3DJordan%26aufirst%3DB.%26aulast%3DGallez%26aufirst%3DB.%26aulast%3DWeitz%26aufirst%3DJ.%26aulast%3DHarris%26aufirst%3DR.%2BA.%26aulast%3DMaxwell%26aufirst%3DP.%26aulast%3DBaes%26aufirst%3DM.%26aulast%3DRatcliffe%26aufirst%3DP.%26aulast%3DCarmeliet%26aufirst%3DP.%26atitle%3DLoss%2520or%2520silencing%2520of%2520the%2520PHD1%2520prolyl%2520hydroxylase%2520protects%2520livers%2520of%2520mice%2520against%2520ischemia%252Freperfusion%2520injury%26jtitle%3DGastroenterology%26date%3D2010%26volume%3D138%26spage%3D1143%26epage%3D1154%26doi%3D10.1053%2Fj.gastro.2009.09.057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aragonés, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Geyte, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fraisl, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dresselaers, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzone, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dirkx, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zacchigna, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemieux, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeoung, N. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambrechts, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bishop, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lafuste, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diez-Juan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harten, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Noten, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Bock, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willam, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tjwa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosfeld, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Navet, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moons, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandendriessche, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deroose, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wijeyekoon, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nuyts, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jordan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silasi-Mansat, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lupu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dewerchin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pugh, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salmon, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mortelmans, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallez, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorus, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buyse, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sluse, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gnaiger, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hespel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Hecke, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuit, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Veldhoven, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ratcliffe, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maxwell, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carmeliet, P.</span></span> <span> </span><span class="NLM_article-title">Deficiency or inhibition of oxygen sensor Phd1 induces hypoxia tolerance by reprogramming basal metabolism</span>. <i>Nat. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">170</span>– <span class="NLM_lpage">180</span>, <span class="refDoi"> DOI: 10.1038/ng.2007.62</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1038%2Fng.2007.62" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=18176562" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtl2rt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2008&pages=170-180&author=J.+Aragon%C3%A9sauthor=M.+Schneiderauthor=K.+Van+Geyteauthor=P.+Fraislauthor=T.+Dresselaersauthor=M.+Mazzoneauthor=R.+Dirkxauthor=S.+Zacchignaauthor=H.+Lemieuxauthor=N.+H.+Jeoungauthor=D.+Lambrechtsauthor=T.+Bishopauthor=P.+Lafusteauthor=A.+Diez-Juanauthor=S.+K.+Hartenauthor=P.+Van+Notenauthor=K.+De+Bockauthor=C.+Willamauthor=M.+Tjwaauthor=A.+Grosfeldauthor=R.+Navetauthor=L.+Moonsauthor=T.+Vandendriesscheauthor=C.+Derooseauthor=B.+Wijeyekoonauthor=J.+Nuytsauthor=B.+Jordanauthor=R.+Silasi-Mansatauthor=F.+Lupuauthor=M.+Dewerchinauthor=C.+Pughauthor=P.+Salmonauthor=L.+Mortelmansauthor=B.+Gallezauthor=F.+Gorusauthor=J.+Buyseauthor=F.+Sluseauthor=R.+A.+Harrisauthor=E.+Gnaigerauthor=P.+Hespelauthor=P.+Van+Heckeauthor=F.+Schuitauthor=P.+Van+Veldhovenauthor=P.+Ratcliffeauthor=M.+Baesauthor=P.+Maxwellauthor=P.+Carmeliet&title=Deficiency+or+inhibition+of+oxygen+sensor+Phd1+induces+hypoxia+tolerance+by+reprogramming+basal+metabolism&doi=10.1038%2Fng.2007.62"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Deficiency or inhibition of oxygen sensor Phd1 induces hypoxia tolerance by reprogramming basal metabolism</span></div><div class="casAuthors">Aragones, Julian; Schneider, Martin; Van Geyte, Katie; Fraisl, Peter; Dresselaers, Tom; Mazzone, Massimiliano; Dirkx, Ruud; Zacchigna, Serena; Lemieux, Helene; Jeoung, Nam Ho; Lambrechts, Diether; Bishop, Tammie; Lafuste, Peggy; Diez-Juan, Antonio; Harten, Sarah K.; Van Noten, Pieter; De Bock, Katrien; William, Carsten; Tjwa, Marc; Grosfeld, Alexandra; Navet, Rachel; Moons, Lieve; Vandendriessche, Thierry; Deroose, Christophe; Wijeyekoon, Bhathiya; Nuyts, Johan; Jordan, Benedicte; Silasi-Mansat, Robert; Lupu, Florea; Dewerchin, Mieke; Pugh, Chris; Salmon, Phil; Mortelmans, Luc; Gallez, Bernard; Gorus, Frans; Buyse, Johan; Sluse, Francis; Harris, Robert A.; Gnaiger, Erich; Hespel, Peter; Van Hecke, Paul; Schuit, Frans; Van Veldhoven, Paul; Ratcliffe, Peter; Baes, Myriam; Maxwell, Patrick; Carmeliet, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">170-180</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">HIF prolyl hydroxylases (PHD1-3) are oxygen sensors that regulate the stability of the hypoxia-inducible factors (HIFs) in an oxygen-dependent manner.  Here, we show that loss of Pdh1 lowers oxygen consumption in skeletal muscle by reprogramming glucose metab. from oxidative to more anaerobic ATP prodn. through activation of a Pparα pathway.  This metabolic adaptation to oxygen conservation impairs oxidative muscle performance in healthy conditions, but it provides acute protection of myofibers against lethal ischemia.  Hypoxia tolerance is not due to HIF-dependent angiogenesis, erythropoiesis or vasodilation, but rather to reduced generation of oxidative stress, which allows Pdh1-deficient myofibers to preserve mitochondrial respiration.  Hypoxia tolerance relies primarily on Hif-2α and was not obsd. in heterozygous Phd2-deficient or homozygous Phd3-deficient mice.  Of medical importance, conditional knockdown of Pdh1 also rapidly induces hypoxia tolerance.  These findings delineate a new role of Pdh1 in hypoxia tolerance and offer new treatment perspectives for disorders characterized by oxidative stress.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqarAfjz9dFZrVg90H21EOLACvtfcHk0ljVzfXAiD2SGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtl2rt7w%253D&md5=b69ff5cabf19da183639bb2bc79e054a</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fng.2007.62&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng.2007.62%26sid%3Dliteratum%253Aachs%26aulast%3DAragon%25C3%25A9s%26aufirst%3DJ.%26aulast%3DSchneider%26aufirst%3DM.%26aulast%3DVan%2BGeyte%26aufirst%3DK.%26aulast%3DFraisl%26aufirst%3DP.%26aulast%3DDresselaers%26aufirst%3DT.%26aulast%3DMazzone%26aufirst%3DM.%26aulast%3DDirkx%26aufirst%3DR.%26aulast%3DZacchigna%26aufirst%3DS.%26aulast%3DLemieux%26aufirst%3DH.%26aulast%3DJeoung%26aufirst%3DN.%2BH.%26aulast%3DLambrechts%26aufirst%3DD.%26aulast%3DBishop%26aufirst%3DT.%26aulast%3DLafuste%26aufirst%3DP.%26aulast%3DDiez-Juan%26aufirst%3DA.%26aulast%3DHarten%26aufirst%3DS.%2BK.%26aulast%3DVan%2BNoten%26aufirst%3DP.%26aulast%3DDe%2BBock%26aufirst%3DK.%26aulast%3DWillam%26aufirst%3DC.%26aulast%3DTjwa%26aufirst%3DM.%26aulast%3DGrosfeld%26aufirst%3DA.%26aulast%3DNavet%26aufirst%3DR.%26aulast%3DMoons%26aufirst%3DL.%26aulast%3DVandendriessche%26aufirst%3DT.%26aulast%3DDeroose%26aufirst%3DC.%26aulast%3DWijeyekoon%26aufirst%3DB.%26aulast%3DNuyts%26aufirst%3DJ.%26aulast%3DJordan%26aufirst%3DB.%26aulast%3DSilasi-Mansat%26aufirst%3DR.%26aulast%3DLupu%26aufirst%3DF.%26aulast%3DDewerchin%26aufirst%3DM.%26aulast%3DPugh%26aufirst%3DC.%26aulast%3DSalmon%26aufirst%3DP.%26aulast%3DMortelmans%26aufirst%3DL.%26aulast%3DGallez%26aufirst%3DB.%26aulast%3DGorus%26aufirst%3DF.%26aulast%3DBuyse%26aufirst%3DJ.%26aulast%3DSluse%26aufirst%3DF.%26aulast%3DHarris%26aufirst%3DR.%2BA.%26aulast%3DGnaiger%26aufirst%3DE.%26aulast%3DHespel%26aufirst%3DP.%26aulast%3DVan%2BHecke%26aufirst%3DP.%26aulast%3DSchuit%26aufirst%3DF.%26aulast%3DVan%2BVeldhoven%26aufirst%3DP.%26aulast%3DRatcliffe%26aufirst%3DP.%26aulast%3DBaes%26aufirst%3DM.%26aulast%3DMaxwell%26aufirst%3DP.%26aulast%3DCarmeliet%26aufirst%3DP.%26atitle%3DDeficiency%2520or%2520inhibition%2520of%2520oxygen%2520sensor%2520Phd1%2520induces%2520hypoxia%2520tolerance%2520by%2520reprogramming%2520basal%2520metabolism%26jtitle%3DNat.%2520Genet.%26date%3D2008%26volume%3D40%26spage%3D170%26epage%3D180%26doi%3D10.1038%2Fng.2007.62" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takeda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fong, G. H.</span></span> <span> </span><span class="NLM_article-title">Essential role for prolyl hydroxylase domain protein 2 in oxygen homeostasis of the adult vascular system</span>. <i>Circulation</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">774</span>– <span class="NLM_lpage">781</span>, <span class="refDoi"> DOI: 10.1161/CIRCULATIONAHA.107.701516</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1161%2FCIRCULATIONAHA.107.701516" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2007&pages=774-781&author=K.+Takedaauthor=A.+Cowanauthor=G.+H.+Fong&title=Essential+role+for+prolyl+hydroxylase+domain+protein+2+in+oxygen+homeostasis+of+the+adult+vascular+system&doi=10.1161%2FCIRCULATIONAHA.107.701516"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1161%2FCIRCULATIONAHA.107.701516&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIRCULATIONAHA.107.701516%26sid%3Dliteratum%253Aachs%26aulast%3DTakeda%26aufirst%3DK.%26aulast%3DCowan%26aufirst%3DA.%26aulast%3DFong%26aufirst%3DG.%2BH.%26atitle%3DEssential%2520role%2520for%2520prolyl%2520hydroxylase%2520domain%2520protein%25202%2520in%2520oxygen%2520homeostasis%2520of%2520the%2520adult%2520vascular%2520system%26jtitle%3DCirculation%26date%3D2007%26volume%3D116%26spage%3D774%26epage%3D781%26doi%3D10.1161%2FCIRCULATIONAHA.107.701516" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takeda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aguila, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parikh, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamothe, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeda, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fong, G. H.</span></span> <span> </span><span class="NLM_article-title">Regulation of adult erythropoiesis by prolyl hydroxylase domain proteins</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">3229</span>– <span class="NLM_lpage">3235</span>, <span class="refDoi"> DOI: 10.1182/blood-2007-09-114561</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1182%2Fblood-2007-09-114561" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2008&pages=3229-3235&author=K.+Takedaauthor=H.+L.+Aguilaauthor=N.+S.+Parikhauthor=X.+Liauthor=K.+Lamotheauthor=L.+J.+Duanauthor=H.+Takedaauthor=F.+S.+Leeauthor=G.+H.+Fong&title=Regulation+of+adult+erythropoiesis+by+prolyl+hydroxylase+domain+proteins&doi=10.1182%2Fblood-2007-09-114561"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1182%2Fblood-2007-09-114561&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2007-09-114561%26sid%3Dliteratum%253Aachs%26aulast%3DTakeda%26aufirst%3DK.%26aulast%3DAguila%26aufirst%3DH.%2BL.%26aulast%3DParikh%26aufirst%3DN.%2BS.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLamothe%26aufirst%3DK.%26aulast%3DDuan%26aufirst%3DL.%2BJ.%26aulast%3DTakeda%26aufirst%3DH.%26aulast%3DLee%26aufirst%3DF.%2BS.%26aulast%3DFong%26aufirst%3DG.%2BH.%26atitle%3DRegulation%2520of%2520adult%2520erythropoiesis%2520by%2520prolyl%2520hydroxylase%2520domain%2520proteins%26jtitle%3DBlood%26date%3D2008%26volume%3D111%26spage%3D3229%26epage%3D3235%26doi%3D10.1182%2Fblood-2007-09-114561" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Binns, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urrutia, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davidoff, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapitsinou, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfaff, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olauson, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wernerson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fogo, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fong, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gross, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haase, V. H.</span></span> <span> </span><span class="NLM_article-title">Distinct subpopulations of FOXD1 stroma-derived cells regulate renal erythropoietin</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>126</i></span>,  <span class="NLM_fpage">1926</span>– <span class="NLM_lpage">1938</span>, <span class="refDoi"> DOI: 10.1172/JCI83551</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1172%2FJCI83551" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2016&pages=1926-1938&author=H.+Kobayashiauthor=Q.+Liuauthor=T.+C.+Binnsauthor=A.+A.+Urrutiaauthor=O.+Davidoffauthor=P.+P.+Kapitsinouauthor=A.+S.+Pfaffauthor=H.+Olausonauthor=A.+Wernersonauthor=A.+B.+Fogoauthor=G.+H.+Fongauthor=K.+W.+Grossauthor=V.+H.+Haase&title=Distinct+subpopulations+of+FOXD1+stroma-derived+cells+regulate+renal+erythropoietin&doi=10.1172%2FJCI83551"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1172%2FJCI83551&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI83551%26sid%3Dliteratum%253Aachs%26aulast%3DKobayashi%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DBinns%26aufirst%3DT.%2BC.%26aulast%3DUrrutia%26aufirst%3DA.%2BA.%26aulast%3DDavidoff%26aufirst%3DO.%26aulast%3DKapitsinou%26aufirst%3DP.%2BP.%26aulast%3DPfaff%26aufirst%3DA.%2BS.%26aulast%3DOlauson%26aufirst%3DH.%26aulast%3DWernerson%26aufirst%3DA.%26aulast%3DFogo%26aufirst%3DA.%2BB.%26aulast%3DFong%26aufirst%3DG.%2BH.%26aulast%3DGross%26aufirst%3DK.%2BW.%26aulast%3DHaase%26aufirst%3DV.%2BH.%26atitle%3DDistinct%2520subpopulations%2520of%2520FOXD1%2520stroma-derived%2520cells%2520regulate%2520renal%2520erythropoietin%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2016%26volume%3D126%26spage%3D1926%26epage%3D1938%26doi%3D10.1172%2FJCI83551" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Souma, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nezu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakano, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamazaki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirano, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sekine, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fong, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishiyama, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyata, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, N.</span></span> <span> </span><span class="NLM_article-title">Erythropoietin synthesis in renal myofibroblasts is restored by activation of hypoxia signaling</span>. <i>J. Am. Soc. Nephrol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">428</span>– <span class="NLM_lpage">438</span>, <span class="refDoi"> DOI: 10.1681/ASN.2014121184</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1681%2FASN.2014121184" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=26054543" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=1%3ACAS%3A528%3ADC%252BC2sXktFGmtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2016&pages=428-438&author=T.+Soumaauthor=M.+Nezuauthor=D.+Nakanoauthor=S.+Yamazakiauthor=I.+Hiranoauthor=H.+Sekineauthor=T.+Danauthor=K.+Takedaauthor=G.+H.+Fongauthor=A.+Nishiyamaauthor=S.+Itoauthor=T.+Miyataauthor=M.+Yamamotoauthor=N.+Suzuki&title=Erythropoietin+synthesis+in+renal+myofibroblasts+is+restored+by+activation+of+hypoxia+signaling&doi=10.1681%2FASN.2014121184"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Erythropoietin synthesis in renal myofibroblasts is restored by activation of hypoxia signaling</span></div><div class="casAuthors">Souma, Tomokazu; Nezu, Masahiro; Nakano, Daisuke; Yamazaki, Shun; Hirano, Ikuo; Sekine, Hiroki; Dan, Takashi; Takeda, Kotaro; Fong, Guo-Hua; Nishiyama, Akira; Ito, Sadayoshi; Miyata, Toshio; Yamamoto, Masayuki; Suzuki, Norio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Society of Nephrology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">428-438</span>CODEN:
                <span class="NLM_cas:coden">JASNEU</span>;
        ISSN:<span class="NLM_cas:issn">1046-6673</span>.
    
            (<span class="NLM_cas:orgname">American Society of Nephrology</span>)
        </div><div class="casAbstract">Erythropoietin (Epo) is produced by renal Epo-producing cells (REPs) in a hypoxia-inducible manner.  The conversion of REPs into myofibroblasts and coincident loss of Epo-producing ability are the major cause of renal fibrosis and anemia.  However, the hypoxic response of these transformed myofibroblasts remains unclear.  Here, we used complementary in vivo transgenic and live imaging approaches to better understand the importance of hypoxia signaling in Epo prodn.  Live imaging of REPs in transgenic mice expressing green fluorescent protein from a modified Epo-gene locus revealed that healthy REPs tightly assocd. with endothelium by wrapping processes around capillaries.  However, this assocn. was hampered in states of renal injury-induced inflammation previously shown to correlate with the transition to myofibroblast-transformed renal Epo-producing cells (MF-REPs).  Furthermore, activation of hypoxia-inducible factors (HIFs) by genetic inactivation of HIF-prolyl hydroxylases (PHD1, PHD2, and PHD3) selectively in Epo-producing cells reactivated Epo prodn. in MF-REPs.  Loss of PHD2 in REPs restored Epo-gene expression in injured kidneys but caused polycythemia.  Notably, combined deletions of PHD1 and PHD3 prevented loss of Epo expression without provoking polycythemia.  Mice with PHD-deficient REPs also showed resistance to LPS-induced Epo repression in kidneys, suggesting that augmented HIF signaling counterbalances inflammatory stimuli in regulation of Epo prodn.  Thus, augmentation of HIF signaling may be an attractive therapeutic strategy for treating renal anemia by reactivating Epo synthesis in MF-REPs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZeN-xtIH0MLVg90H21EOLACvtfcHk0lhfEw__KDsIwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXktFGmtw%253D%253D&md5=e0776344f30caac64ba73db07436dea6</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1681%2FASN.2014121184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1681%252FASN.2014121184%26sid%3Dliteratum%253Aachs%26aulast%3DSouma%26aufirst%3DT.%26aulast%3DNezu%26aufirst%3DM.%26aulast%3DNakano%26aufirst%3DD.%26aulast%3DYamazaki%26aufirst%3DS.%26aulast%3DHirano%26aufirst%3DI.%26aulast%3DSekine%26aufirst%3DH.%26aulast%3DDan%26aufirst%3DT.%26aulast%3DTakeda%26aufirst%3DK.%26aulast%3DFong%26aufirst%3DG.%2BH.%26aulast%3DNishiyama%26aufirst%3DA.%26aulast%3DIto%26aufirst%3DS.%26aulast%3DMiyata%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DSuzuki%26aufirst%3DN.%26atitle%3DErythropoietin%2520synthesis%2520in%2520renal%2520myofibroblasts%2520is%2520restored%2520by%2520activation%2520of%2520hypoxia%2520signaling%26jtitle%3DJ.%2520Am.%2520Soc.%2520Nephrol.%26date%3D2016%26volume%3D27%26spage%3D428%26epage%3D438%26doi%3D10.1681%2FASN.2014121184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obara, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jishage, K. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minegishi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span> <span> </span><span class="NLM_article-title">Specific contribution of the erythropoietin gene 3′ enhancer to hepatic erythropoiesis after late embryonic stages</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">3896</span>– <span class="NLM_lpage">3905</span>, <span class="refDoi"> DOI: 10.1128/MCB.05463-11</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1128%2FMCB.05463-11" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=21746884" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFGmu7zN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2011&pages=3896-3905&author=N.+Suzukiauthor=N.+Obaraauthor=X.+Panauthor=M.+Watanabeauthor=K.+I.+Jishageauthor=N.+Minegishiauthor=M.+Yamamoto&title=Specific+contribution+of+the+erythropoietin+gene+3%E2%80%B2+enhancer+to+hepatic+erythropoiesis+after+late+embryonic+stages&doi=10.1128%2FMCB.05463-11"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Specific contribution of the erythropoietin gene 3' enhancer to hepatic erythropoiesis after late embryonic stages</span></div><div class="casAuthors">Suzuki, Norio; Obara, Naoshi; Pan, Xiaoqing; Watanabe, Miho; Jishage, Kou-ichi; Minegishi, Naoko; Yamamoto, Masayuki</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">3896-3905</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Erythropoietin (Epo) is secreted from the liver and kidney, where Epo prodn. is strictly regulated at the transcriptional level in a hypoxia- and/or anemia-inducible manner.  Here, we examd. the in vivo function of the enhancer located 3' to the Epo gene (EpoE-3').  Reporter transgenic-mouse analyses revealed that the EpoE-3' enhancer is necessary and sufficient for the liver-specific and hypoxia-responsive expression of the gene after embryonic day 14.5 (E14.5).  However, the enhancer is dispensable for Epo gene expression in the kidney and early-stage embryonic liver.  Genetic removal of EpoE-3' from the endogenous Epo gene resulted in mice with severe anemia at late embryonic and neonatal stages due to defects in hepatic erythropoiesis, but early hepatic and splenic erythropoiesis was not affected.  The mutant mice recover from the anemia in the juvenile period when major Epo prodn. switches from the liver to the kidney.  These results demonstrate that EpoE-3' is necessary for late hepatic erythropoiesis by specifically supporting paracrine prodn. of Epo in the liver.  In contrast, Epo prodn. in the kidney utilizes distinct regulatory machinery and supports erythropoiesis in the bone marrow and spleen in adult animals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpamPXxpc3jrVg90H21EOLACvtfcHk0lj5V1ouA9_2kQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFGmu7zN&md5=c9c0df05c96c2748695ce55b5719f5b6</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1128%2FMCB.05463-11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.05463-11%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DN.%26aulast%3DObara%26aufirst%3DN.%26aulast%3DPan%26aufirst%3DX.%26aulast%3DWatanabe%26aufirst%3DM.%26aulast%3DJishage%26aufirst%3DK.%2BI.%26aulast%3DMinegishi%26aufirst%3DN.%26aulast%3DYamamoto%26aufirst%3DM.%26atitle%3DSpecific%2520contribution%2520of%2520the%2520erythropoietin%2520gene%25203%25E2%2580%25B2%2520enhancer%2520to%2520hepatic%2520erythropoiesis%2520after%2520late%2520embryonic%2520stages%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2011%26volume%3D31%26spage%3D3896%26epage%3D3905%26doi%3D10.1128%2FMCB.05463-11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mastrogiannaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matak, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keith, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simon, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaulont, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peyssonnaux, C.</span></span> <span> </span><span class="NLM_article-title">HIF-2α, but not HIF-1α, promotes iron absorption in mice</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>119</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1159</span>– <span class="NLM_lpage">1166</span>, <span class="refDoi"> DOI: 10.1172/JCI38499</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1172%2FJCI38499" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2009&pages=1159-1166&issue=5&author=M.+Mastrogiannakiauthor=P.+Matakauthor=B.+Keithauthor=M.+C.+Simonauthor=S.+Vaulontauthor=C.+Peyssonnaux&title=HIF-2%CE%B1%2C+but+not+HIF-1%CE%B1%2C+promotes+iron+absorption+in+mice&doi=10.1172%2FJCI38499"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1172%2FJCI38499&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI38499%26sid%3Dliteratum%253Aachs%26aulast%3DMastrogiannaki%26aufirst%3DM.%26aulast%3DMatak%26aufirst%3DP.%26aulast%3DKeith%26aufirst%3DB.%26aulast%3DSimon%26aufirst%3DM.%2BC.%26aulast%3DVaulont%26aufirst%3DS.%26aulast%3DPeyssonnaux%26aufirst%3DC.%26atitle%3DHIF-2%25CE%25B1%252C%2520but%2520not%2520HIF-1%25CE%25B1%252C%2520promotes%2520iron%2520absorption%2520in%2520mice%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2009%26volume%3D119%26issue%3D5%26spage%3D1159%26epage%3D1166%26doi%3D10.1172%2FJCI38499" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yamashita, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohneda, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakiyama, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwata, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohneda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujii-Kuriyama, Y.</span></span> <span> </span><span class="NLM_article-title">The microenvironment for erythropoiesis is regulated by HIF-2α through VCAM-1 in endothelial cells</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>112</i></span>,  <span class="NLM_fpage">1482</span>– <span class="NLM_lpage">1492</span>, <span class="refDoi"> DOI: 10.1182/blood-2007-11-122648</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1182%2Fblood-2007-11-122648" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2008&pages=1482-1492&author=T.+Yamashitaauthor=O.+Ohnedaauthor=A.+Sakiyamaauthor=F.+Iwataauthor=K.+Ohnedaauthor=Y.+Fujii-Kuriyama&title=The+microenvironment+for+erythropoiesis+is+regulated+by+HIF-2%CE%B1+through+VCAM-1+in+endothelial+cells&doi=10.1182%2Fblood-2007-11-122648"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1182%2Fblood-2007-11-122648&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2007-11-122648%26sid%3Dliteratum%253Aachs%26aulast%3DYamashita%26aufirst%3DT.%26aulast%3DOhneda%26aufirst%3DO.%26aulast%3DSakiyama%26aufirst%3DA.%26aulast%3DIwata%26aufirst%3DF.%26aulast%3DOhneda%26aufirst%3DK.%26aulast%3DFujii-Kuriyama%26aufirst%3DY.%26atitle%3DThe%2520microenvironment%2520for%2520erythropoiesis%2520is%2520regulated%2520by%2520HIF-2%25CE%25B1%2520through%2520VCAM-1%2520in%2520endothelial%2520cells%26jtitle%3DBlood%26date%3D2008%26volume%3D112%26spage%3D1482%26epage%3D1492%26doi%3D10.1182%2Fblood-2007-11-122648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Paliege, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberger, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bondke, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sciesielski, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shina, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heyman, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flippin, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arend, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klaus, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bachmann, S.</span></span> <span> </span><span class="NLM_article-title">Hypoxia-inducible factor-2α-expressing interstitial fibroblasts are the only renal cells that express erythropoietin under hypoxia-inducible factor stabilization</span>. <i>Kidney Int.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">312</span>– <span class="NLM_lpage">318</span>, <span class="refDoi"> DOI: 10.1038/ki.2009.460</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1038%2Fki.2009.460" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=20016470" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1Kksrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2010&pages=312-318&author=A.+Paliegeauthor=C.+Rosenbergerauthor=A.+Bondkeauthor=L.+Sciesielskiauthor=A.+Shinaauthor=S.+N.+Heymanauthor=L.+A.+Flippinauthor=M.+Arendauthor=S.+J.+Klausauthor=S.+Bachmann&title=Hypoxia-inducible+factor-2%CE%B1-expressing+interstitial+fibroblasts+are+the+only+renal+cells+that+express+erythropoietin+under+hypoxia-inducible+factor+stabilization&doi=10.1038%2Fki.2009.460"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Hypoxia-inducible factor-2α-expressing interstitial fibroblasts are the only renal cells that express erythropoietin under hypoxia-inducible factor stabilization</span></div><div class="casAuthors">Paliege, Alexander; Rosenberger, Christian; Bondke, Anja; Sciesielski, Lina; Shina, Ahuva; Heyman, Samuel N.; Flippin, Lee A.; Arend, Michael; Klaus, Stephen J.; Bachmann, Sebastian</div><div class="citationInfo"><span class="NLM_cas:title">Kidney International</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">312-318</span>CODEN:
                <span class="NLM_cas:coden">KDYIA5</span>;
        ISSN:<span class="NLM_cas:issn">0085-2538</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The adaptation of erythropoietin prodn. to oxygen supply is detd. by the abundance of hypoxia-inducible factor (HIF), a regulation that is induced by a prolyl hydroxylase.  To identify cells that express HIF subunits (HIF-1α and HIF-2α) and erythropoietin, we treated Sprague-Dawley rats with the prolyl hydroxylase inhibitor FG-4497 for 6 h to induce HIF-dependent erythropoietin transcription.  The kidneys were analyzed for colocalization of erythropoietin mRNA with HIF-1α and/or HIF-2α protein along with cell-specific identification markers.  FG-4497 treatment strongly induced erythropoietin mRNA exclusively in cortical interstitial fibroblasts.  Accumulation of HIF-2α was obsd. in these fibroblasts and in endothelial and glomerular cells, whereas HIF-1α was induced only in tubular epithelia.  A large proportion (over 90% in the juxtamedullary cortex) of erythropoietin-expressing cells coexpressed HIF-2α.  No colocalization of erythropoietin and HIF-1α was found.  Hence, we conclude that in the adult kidney, HIF-2α and erythropoietin mRNA colocalize only in cortical interstitial fibroblasts, which makes them the key cell type for renal erythropoietin synthesis as regulated by HIF-2α.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoA0JLj3LtNL7Vg90H21EOLACvtfcHk0lhAdA9FJpy4PQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1Kksrc%253D&md5=104167e2f6230ad05e5a38f331e5cbcb</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2Fki.2009.460&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fki.2009.460%26sid%3Dliteratum%253Aachs%26aulast%3DPaliege%26aufirst%3DA.%26aulast%3DRosenberger%26aufirst%3DC.%26aulast%3DBondke%26aufirst%3DA.%26aulast%3DSciesielski%26aufirst%3DL.%26aulast%3DShina%26aufirst%3DA.%26aulast%3DHeyman%26aufirst%3DS.%2BN.%26aulast%3DFlippin%26aufirst%3DL.%2BA.%26aulast%3DArend%26aufirst%3DM.%26aulast%3DKlaus%26aufirst%3DS.%2BJ.%26aulast%3DBachmann%26aufirst%3DS.%26atitle%3DHypoxia-inducible%2520factor-2%25CE%25B1-expressing%2520interstitial%2520fibroblasts%2520are%2520the%2520only%2520renal%2520cells%2520that%2520express%2520erythropoietin%2520under%2520hypoxia-inducible%2520factor%2520stabilization%26jtitle%3DKidney%2520Int.%26date%3D2010%26volume%3D77%26spage%3D312%26epage%3D318%26doi%3D10.1038%2Fki.2009.460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sahai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mei, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schrier, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tannen, R. L.</span></span> <span> </span><span class="NLM_article-title">Mechanisms of chronic hypoxia-induced renal cell growth</span>. <i>Kidney Int.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">1277</span>– <span class="NLM_lpage">1281</span>, <span class="refDoi"> DOI: 10.1046/j.1523-1755.1999.00703.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1046%2Fj.1523-1755.1999.00703.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10504474" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=1%3ACAS%3A528%3ADyaK1MXmslGntL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=1999&pages=1277-1281&author=A.+Sahaiauthor=C.+Meiauthor=R.+W.+Schrierauthor=R.+L.+Tannen&title=Mechanisms+of+chronic+hypoxia-induced+renal+cell+growth&doi=10.1046%2Fj.1523-1755.1999.00703.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of chronic hypoxia-induced renal cell growth</span></div><div class="casAuthors">Sahai, Atul; Mei, Changlin; Schrier, Robert W.; Tannen, Richard L.</div><div class="citationInfo"><span class="NLM_cas:title">Kidney International</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1277-1281</span>CODEN:
                <span class="NLM_cas:coden">KDYIA5</span>;
        ISSN:<span class="NLM_cas:issn">0085-2538</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science, Inc.</span>)
        </div><div class="casAbstract">A review with 29 refs.  Chronic local tissue hypoxia appears to play an important role in the initiation and progression of chronic renal disease.  The authors examd. the effect of local hypoxia on cultured renal tubular epithelial and mesangial cell proliferation, dedifferentiation, and extracellular matrix synthesis.  The underlying signaling mechanisms whereby hypoxia induces renal cell growth were evaluated.  The roles of protein kinase C, p38 mitogen-activated protein kinase, TGF-β1, osteopontin, and nitric oxide were detd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjliQ5s4z2yLVg90H21EOLACvtfcHk0lhAdA9FJpy4PQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmslGntL8%253D&md5=4212fdc0ba3b72e347463c3b609c685b</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1046%2Fj.1523-1755.1999.00703.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1523-1755.1999.00703.x%26sid%3Dliteratum%253Aachs%26aulast%3DSahai%26aufirst%3DA.%26aulast%3DMei%26aufirst%3DC.%26aulast%3DSchrier%26aufirst%3DR.%2BW.%26aulast%3DTannen%26aufirst%3DR.%2BL.%26atitle%3DMechanisms%2520of%2520chronic%2520hypoxia-induced%2520renal%2520cell%2520growth%26jtitle%3DKidney%2520Int.%26date%3D1999%26volume%3D56%26spage%3D1277%26epage%3D1281%26doi%3D10.1046%2Fj.1523-1755.1999.00703.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dame, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sola, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leach, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fandrey, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knöpfle, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engel, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bungert, J.</span></span> <span> </span><span class="NLM_article-title">Hepatic erythropoietin gene regulation by GATA-4</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>279</i></span>,  <span class="NLM_fpage">2955</span>– <span class="NLM_lpage">2961</span>, <span class="refDoi"> DOI: 10.1074/jbc.M310404200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1074%2Fjbc.M310404200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=2955-2961&author=C.+Dameauthor=M.+C.+Solaauthor=K.+C.+Limauthor=K.+M.+Leachauthor=J.+Fandreyauthor=Y.+Maauthor=G.+Kn%C3%B6pfleauthor=J.+D.+Engelauthor=J.+Bungert&title=Hepatic+erythropoietin+gene+regulation+by+GATA-4&doi=10.1074%2Fjbc.M310404200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M310404200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M310404200%26sid%3Dliteratum%253Aachs%26aulast%3DDame%26aufirst%3DC.%26aulast%3DSola%26aufirst%3DM.%2BC.%26aulast%3DLim%26aufirst%3DK.%2BC.%26aulast%3DLeach%26aufirst%3DK.%2BM.%26aulast%3DFandrey%26aufirst%3DJ.%26aulast%3DMa%26aufirst%3DY.%26aulast%3DKn%25C3%25B6pfle%26aufirst%3DG.%26aulast%3DEngel%26aufirst%3DJ.%2BD.%26aulast%3DBungert%26aufirst%3DJ.%26atitle%3DHepatic%2520erythropoietin%2520gene%2520regulation%2520by%2520GATA-4%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D2955%26epage%3D2961%26doi%3D10.1074%2Fjbc.M310404200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Querbes, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogorad, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moslehi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, A. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bulgakova, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuchimanchi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akinc, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fitzgerald, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koteliansky, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaelin, W. G.</span></span> <span> </span><span class="NLM_article-title">Treatment of erythropoietin deficiency in mice with systemically administered siRNA</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>120</i></span>,  <span class="NLM_fpage">1916</span>– <span class="NLM_lpage">1922</span>, <span class="refDoi"> DOI: 10.1182/blood-2012-04-423715</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1182%2Fblood-2012-04-423715" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2012&pages=1916-1922&author=W.+Querbesauthor=R.+L.+Bogoradauthor=J.+Moslehiauthor=J.+Wongauthor=A.+Y.+Chanauthor=E.+Bulgakovaauthor=S.+Kuchimanchiauthor=A.+Akincauthor=K.+Fitzgeraldauthor=V.+Kotelianskyauthor=W.+G.+Kaelin&title=Treatment+of+erythropoietin+deficiency+in+mice+with+systemically+administered+siRNA&doi=10.1182%2Fblood-2012-04-423715"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1182%2Fblood-2012-04-423715&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2012-04-423715%26sid%3Dliteratum%253Aachs%26aulast%3DQuerbes%26aufirst%3DW.%26aulast%3DBogorad%26aufirst%3DR.%2BL.%26aulast%3DMoslehi%26aufirst%3DJ.%26aulast%3DWong%26aufirst%3DJ.%26aulast%3DChan%26aufirst%3DA.%2BY.%26aulast%3DBulgakova%26aufirst%3DE.%26aulast%3DKuchimanchi%26aufirst%3DS.%26aulast%3DAkinc%26aufirst%3DA.%26aulast%3DFitzgerald%26aufirst%3DK.%26aulast%3DKoteliansky%26aufirst%3DV.%26aulast%3DKaelin%26aufirst%3DW.%2BG.%26atitle%3DTreatment%2520of%2520erythropoietin%2520deficiency%2520in%2520mice%2520with%2520systemically%2520administered%2520siRNA%26jtitle%3DBlood%26date%3D2012%26volume%3D120%26spage%3D1916%26epage%3D1922%26doi%3D10.1182%2Fblood-2012-04-423715" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Minamishima, Y. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaelin, W. G.,  Jr.</span></span> <span> </span><span class="NLM_article-title">Reactivation of hepatic EPO synthesis in mice after PHD loss</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>329</i></span>,  <span class="NLM_fpage">407</span>, <span class="refDoi"> DOI: 10.1126/science.1192811</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1126%2Fscience.1192811" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=329&publication_year=2010&pages=407&author=Y.+A.+Minamishimaauthor=W.+G.+Kaelin&title=Reactivation+of+hepatic+EPO+synthesis+in+mice+after+PHD+loss&doi=10.1126%2Fscience.1192811"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1126%2Fscience.1192811&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1192811%26sid%3Dliteratum%253Aachs%26aulast%3DMinamishima%26aufirst%3DY.%2BA.%26aulast%3DKaelin%26aufirst%3DW.%2BG.%26atitle%3DReactivation%2520of%2520hepatic%2520EPO%2520synthesis%2520in%2520mice%2520after%2520PHD%2520loss%26jtitle%3DScience%26date%3D2010%26volume%3D329%26spage%3D407%26doi%3D10.1126%2Fscience.1192811" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chiang, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inagi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujita, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nangaku, M.</span></span> <span> </span><span class="NLM_article-title">Indoxyl sulfate, a representative uremic toxin, suppresses erythropoietin production in a HIF-dependent manner</span>. <i>Lab. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>91</i></span>,  <span class="NLM_fpage">1564</span>– <span class="NLM_lpage">1571</span>, <span class="refDoi"> DOI: 10.1038/labinvest.2011.114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1038%2Flabinvest.2011.114" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2011&pages=1564-1571&author=C.+K.+Chiangauthor=T.+Tanakaauthor=R.+Inagiauthor=T.+Fujitaauthor=M.+Nangaku&title=Indoxyl+sulfate%2C+a+representative+uremic+toxin%2C+suppresses+erythropoietin+production+in+a+HIF-dependent+manner&doi=10.1038%2Flabinvest.2011.114"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1038%2Flabinvest.2011.114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Flabinvest.2011.114%26sid%3Dliteratum%253Aachs%26aulast%3DChiang%26aufirst%3DC.%2BK.%26aulast%3DTanaka%26aufirst%3DT.%26aulast%3DInagi%26aufirst%3DR.%26aulast%3DFujita%26aufirst%3DT.%26aulast%3DNangaku%26aufirst%3DM.%26atitle%3DIndoxyl%2520sulfate%252C%2520a%2520representative%2520uremic%2520toxin%252C%2520suppresses%2520erythropoietin%2520production%2520in%2520a%2520HIF-dependent%2520manner%26jtitle%3DLab.%2520Invest.%26date%3D2011%26volume%3D91%26spage%3D1564%26epage%3D1571%26doi%3D10.1038%2Flabinvest.2011.114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eckardt, K. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurtz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, C.</span></span> <span> </span><span class="NLM_article-title">Regulation of erythropoietin production is related to proximal tubular function</span>. <i>Am. J. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>256</i></span>,  <span class="NLM_fpage">F942</span>– <span class="NLM_lpage">F947</span>, <span class="refDoi"> DOI: 10.1152/ajprenal.1989.256.5.F942</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1152%2Fajprenal.1989.256.5.F942" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=256&publication_year=1989&pages=F942-F947&author=K.+U.+Eckardtauthor=A.+Kurtzauthor=C.+Bauer&title=Regulation+of+erythropoietin+production+is+related+to+proximal+tubular+function&doi=10.1152%2Fajprenal.1989.256.5.F942"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1152%2Fajprenal.1989.256.5.F942&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajprenal.1989.256.5.F942%26sid%3Dliteratum%253Aachs%26aulast%3DEckardt%26aufirst%3DK.%2BU.%26aulast%3DKurtz%26aufirst%3DA.%26aulast%3DBauer%26aufirst%3DC.%26atitle%3DRegulation%2520of%2520erythropoietin%2520production%2520is%2520related%2520to%2520proximal%2520tubular%2520function%26jtitle%3DAm.%2520J.%2520Physiol.%26date%3D1989%26volume%3D256%26spage%3DF942%26epage%3DF947%26doi%3D10.1152%2Fajprenal.1989.256.5.F942" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nangaku, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eckardt, K. U.</span></span> <span> </span><span class="NLM_article-title">Pathogenesis of renal anemia</span>. <i>Semin. Nephrol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">261</span>– <span class="NLM_lpage">268</span>, <span class="refDoi"> DOI: 10.1016/j.semnephrol.2006.06.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1016%2Fj.semnephrol.2006.06.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=16949463" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVyqt7vE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2006&pages=261-268&author=M.+Nangakuauthor=K.+U.+Eckardt&title=Pathogenesis+of+renal+anemia&doi=10.1016%2Fj.semnephrol.2006.06.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Pathogenesis of renal anemia</span></div><div class="casAuthors">Nangaku, Masaomi; Eckardt, Kai-Uwe</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in Nephrology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">261-268</span>CODEN:
                <span class="NLM_cas:coden">SNEPDJ</span>;
        ISSN:<span class="NLM_cas:issn">0270-9295</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Anemia is a common complication of chronic kidney disease.  Although mechanisms involved in the pathogenesis of renal anemia include chronic inflammation, iron deficiency, and shortened half-life of erythrocytes, the primary cause is deficiency of erythropoietin (EPO).  Serum EPO levels in patients with chronic kidney disease are usually within the normal range and thus fail to show an appropriate increase; with decreasing Hb levels, as found in nonrenal anemias.  Studies elucidating the regulation of EPO expression led to the identification of the hypoxia inducible factor-hypoxia responsive element system.  However, despite much progress in understanding the mol. mechanisms through which cells can sense oxygen availability and translate this information into altered gene expression, the reason why EPO prodn. is inappropriately low in diseased kidneys remains incompletely understood.  Both alterations in the function of EPO-producing cells and perturbations of the oxygen-sensing mechanism in the kidney may contribute.  As with other anemias, the consequences of renal anemia are a moderate decrease in tissue oxygen tensions and counterregulatory mechanisms that maintain total oxygen consumption, including a persistent increase in cardiac output.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4KOp5mhHKSrVg90H21EOLACvtfcHk0linF631cibsBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVyqt7vE&md5=fdb43cf481a881151d5da10fdbe9f1df</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.semnephrol.2006.06.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.semnephrol.2006.06.001%26sid%3Dliteratum%253Aachs%26aulast%3DNangaku%26aufirst%3DM.%26aulast%3DEckardt%26aufirst%3DK.%2BU.%26atitle%3DPathogenesis%2520of%2520renal%2520anemia%26jtitle%3DSemin.%2520Nephrol.%26date%3D2006%26volume%3D26%26spage%3D261%26epage%3D268%26doi%3D10.1016%2Fj.semnephrol.2006.06.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baer, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dessypris, E. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldwasser, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krantz, S. B.</span></span> <span> </span><span class="NLM_article-title">Blunted erythropoietin response to anaemia in rheumatoid arthritis</span>. <i>Br. J. Haematol.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">559</span>– <span class="NLM_lpage">564</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2141.1987.tb01344.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1111%2Fj.1365-2141.1987.tb01344.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=3663512" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=1%3ACAS%3A280%3ADyaL1c%252FisVOrsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=1987&pages=559-564&author=A.+N.+Baerauthor=E.+N.+Dessyprisauthor=E.+Goldwasserauthor=S.+B.+Krantz&title=Blunted+erythropoietin+response+to+anaemia+in+rheumatoid+arthritis&doi=10.1111%2Fj.1365-2141.1987.tb01344.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Blunted erythropoietin response to anaemia in rheumatoid arthritis</span></div><div class="casAuthors">Baer A N; Dessypris E N; Goldwasser E; Krantz S B</div><div class="citationInfo"><span class="NLM_cas:title">British journal of haematology</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">559-64</span>
        ISSN:<span class="NLM_cas:issn">0007-1048</span>.
    </div><div class="casAbstract">The relationship of serum immunoreactive erythropoietin to haemoglobin concentration was defined for 54 patients with rheumatoid arthritis (RA) and 41 patients with anaemia of varying aetiology (excluding pregnancy and renal insufficiency), not associated with RA.  Significant inverse correlations between the logarithm of serum immunoreactive erythropoietin and the haemoglobin concentration were noted for the anaemic patients in both groups.  The regression line for the RA patients had a similar slope, but a significantly lower y-intercept as compared to that for the non-RA patients.  Erythropoietin levels were also significantly lower for the group of RA patients than for the group of non-RA patients when matched for comparable haemoglobin concentrations.  These studies suggest that the erythropoietin response to anaemia in RA is intact but blunted relative to that for anaemia of other aetiologies.  Lower levels of serum erythropoietin in anaemic RA patients may contribute to the pathogenesis of their anaemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSh9RcTOZNQYH6oPH0mYWL1fW6udTcc2eYWN7Z0XBeSlrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL1c%252FisVOrsQ%253D%253D&md5=4a0958d5574977700738cb4478f1b7cb</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2141.1987.tb01344.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2141.1987.tb01344.x%26sid%3Dliteratum%253Aachs%26aulast%3DBaer%26aufirst%3DA.%2BN.%26aulast%3DDessypris%26aufirst%3DE.%2BN.%26aulast%3DGoldwasser%26aufirst%3DE.%26aulast%3DKrantz%26aufirst%3DS.%2BB.%26atitle%3DBlunted%2520erythropoietin%2520response%2520to%2520anaemia%2520in%2520rheumatoid%2520arthritis%26jtitle%3DBr.%2520J.%2520Haematol.%26date%3D1987%26volume%3D66%26spage%3D559%26epage%3D564%26doi%3D10.1111%2Fj.1365-2141.1987.tb01344.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodnough, L. T.</span></span> <span> </span><span class="NLM_article-title">Anemia of chronic disease</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>352</i></span>,  <span class="NLM_fpage">1011</span>– <span class="NLM_lpage">1023</span>, <span class="refDoi"> DOI: 10.1056/NEJMra041809</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1056%2FNEJMra041809" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=15758012" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=1%3ACAS%3A528%3ADC%252BD2MXit1Wkt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=352&publication_year=2005&pages=1011-1023&author=G.+Weissauthor=L.+T.+Goodnough&title=Anemia+of+chronic+disease&doi=10.1056%2FNEJMra041809"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Anemia of chronic disease</span></div><div class="casAuthors">Weiss, Guenter; Goodnough, Lawrence T.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">352</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1011-1023</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review on pathophysiol. factors of anemia of chronic diseases (dysregulation of the Fe homeostasis, impaired proliferation of erythroid progenitor cells, bluntet erythropoietin response), lab. evaluation (Fe status, erythropoietin), and therapeutic options for the treatment of patients with anemia of chronic disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtoN5biPrYS7Vg90H21EOLACvtfcHk0lgiuGXp5n_CUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXit1Wkt7Y%253D&md5=bbd706522030bf9e0b333bb442b158e0</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1056%2FNEJMra041809&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra041809%26sid%3Dliteratum%253Aachs%26aulast%3DWeiss%26aufirst%3DG.%26aulast%3DGoodnough%26aufirst%3DL.%2BT.%26atitle%3DAnemia%2520of%2520chronic%2520disease%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2005%26volume%3D352%26spage%3D1011%26epage%3D1023%26doi%3D10.1056%2FNEJMra041809" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pantopoulos, K.</span></span> <span> </span><span class="NLM_article-title">IRP1 regulates erythropoiesis and systemic iron homeostasis by controlling HIF2α mRNA translation</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>122</i></span>,  <span class="NLM_fpage">1658</span>– <span class="NLM_lpage">1668</span>, <span class="refDoi"> DOI: 10.1182/blood-2013-03-492454</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1182%2Fblood-2013-03-492454" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2013&pages=1658-1668&author=N.+Wilkinsonauthor=K.+Pantopoulos&title=IRP1+regulates+erythropoiesis+and+systemic+iron+homeostasis+by+controlling+HIF2%CE%B1+mRNA+translation&doi=10.1182%2Fblood-2013-03-492454"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1182%2Fblood-2013-03-492454&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2013-03-492454%26sid%3Dliteratum%253Aachs%26aulast%3DWilkinson%26aufirst%3DN.%26aulast%3DPantopoulos%26aufirst%3DK.%26atitle%3DIRP1%2520regulates%2520erythropoiesis%2520and%2520systemic%2520iron%2520homeostasis%2520by%2520controlling%2520HIF2%25CE%25B1%2520mRNA%2520translation%26jtitle%3DBlood%26date%3D2013%26volume%3D122%26spage%3D1658%26epage%3D1668%26doi%3D10.1182%2Fblood-2013-03-492454" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Becker, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saad, M.</span></span> <span> </span><span class="NLM_article-title">A new approach to the management of anemia in CKD patients: A review on Roxadustat</span>. <i>Adv. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">848</span>– <span class="NLM_lpage">853</span>, <span class="refDoi"> DOI: 10.1007/s12325-017-0508-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1007%2Fs12325-017-0508-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2017&pages=848-853&author=K.+Beckerauthor=M.+Saad&title=A+new+approach+to+the+management+of+anemia+in+CKD+patients%3A+A+review+on+Roxadustat&doi=10.1007%2Fs12325-017-0508-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1007%2Fs12325-017-0508-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12325-017-0508-9%26sid%3Dliteratum%253Aachs%26aulast%3DBecker%26aufirst%3DK.%26aulast%3DSaad%26aufirst%3DM.%26atitle%3DA%2520new%2520approach%2520to%2520the%2520management%2520of%2520anemia%2520in%2520CKD%2520patients%253A%2520A%2520review%2520on%2520Roxadustat%26jtitle%3DAdv.%2520Ther.%26date%3D2017%26volume%3D34%26spage%3D848%26epage%3D853%26doi%3D10.1007%2Fs12325-017-0508-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Provenzano, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Besarab, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dua, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeig, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poole, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saikali, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saha, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hemmerich, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szczech, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, K. H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neff, T. B.</span></span> <span> </span><span class="NLM_article-title">Roxadustat (FG-4592) versus epoetin alfa for anemia in patients receiving maintenance hemodialysis: a phase 2, randomized, 6-to 19-week, open-label, active-comparator, dose-ranging, safety and exploratory efficacy study</span>. <i>Am. J. Kidney Dis.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">912</span>– <span class="NLM_lpage">924</span>, <span class="refDoi"> DOI: 10.1053/j.ajkd.2015.12.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1053%2Fj.ajkd.2015.12.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=26846333" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFSqu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2016&pages=912-924&author=R.+Provenzanoauthor=A.+Besarabauthor=S.+Wrightauthor=S.+Duaauthor=S.+Zeigauthor=P.+Nguyenauthor=L.+Pooleauthor=K.+G.+Saikaliauthor=G.+Sahaauthor=S.+Hemmerichauthor=L.+Szczechauthor=K.+H.+P.+Yuauthor=T.+B.+Neff&title=Roxadustat+%28FG-4592%29+versus+epoetin+alfa+for+anemia+in+patients+receiving+maintenance+hemodialysis%3A+a+phase+2%2C+randomized%2C+6-to+19-week%2C+open-label%2C+active-comparator%2C+dose-ranging%2C+safety+and+exploratory+efficacy+study&doi=10.1053%2Fj.ajkd.2015.12.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Roxadustat (FG-4592) Versus Epoetin Alfa for Anemia in Patients Receiving Maintenance Hemodialysis: A Phase 2, Randomized, 6- to 19-Week, Open-Label, Active-Comparator, Dose-Ranging, Safety and Exploratory Efficacy Study</span></div><div class="casAuthors">Provenzano, Robert; Besarab, Anatole; Wright, Steven; Dua, Sohan; Zeig, Steven; Nguyen, Peter; Poole, Lona; Saikali, Khalil G.; Saha, Gopal; Hemmerich, Stefan; Szczech, Lynda; Yu, K. H. Peony; Neff, Thomas B.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Kidney Diseases</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">912-924</span>CODEN:
                <span class="NLM_cas:coden">AJKDDP</span>;
        ISSN:<span class="NLM_cas:issn">0272-6386</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Roxadustat (FG-4592) is an oral hypoxia-inducible factor prolyl-hydroxylase inhibitor that promotes erythropoiesis through increasing endogenous erythropoietin, improving iron regulation, and reducing hepcidin.  Phase 2, randomized (3:1), open-label, active-comparator, safety and efficacy study.  Patients with stable end-stage renal disease treated with hemodialysis who previously had Hb (Hb) levels maintained with epoetin alfa.  Part 1: 6-wk dose-ranging study in 54 individuals of thrice-weekly oral roxadustat doses vs. continuation of i.v. epoetin alfa.  Part 2: 19-wk treatment in 90 individuals in 6 cohorts with various starting doses and adjustment rules (1.0-2.0 mg/kg or tiered wt. based) in individuals with a range of epoetin alfa responsiveness.  I.v. iron was prohibited.  Primary end point was Hb level response, defined as end-of-treatment Hb level change (ΔHb) of -0.5 g/dL or greater from baseline (part 1) and as mean Hb level ≥ 11.0 g/dL during the last 4 treatment weeks (part 2).  Hepcidin, iron parameters, cholesterol, and plasma erythropoietin (the latter in a subset).  Baseline epoetin alfa doses were 138.3 ± 51.3 (SD) and 136.3 ± 47.7 U/kg/wk in part 1 and 152.8 ± 80.6 and 173.4 ± 83.7 U/kg/wk in part 2, in individuals randomly assigned to roxadustat and epoetin alfa, resp.  Hb level responder rates in part 1 were 79% in pooled roxadustat 1.5 to 2.0 mg/kg compared to 33% in the epoetin alfa control arm (P = 0.03).  Hepcidin level redn. was greater at roxadustat 2.0 mg/kg vs. epoetin alfa (P < 0.05).  In part 2, the av. roxadustat dose requirement for Hb level maintenance was ∼1.7 mg/kg.  The least-squares-mean ΔHb in roxadustat-treated individuals was comparable to that in epoetin alfa-treated individuals (about -0.5 g/dL) and the least-squares-mean difference in ΔHb between both treatment arms was 0.03 (95% CI, -0.39 to 0.33) g/dL (mixed effect model-repeated measure).  Roxadustat significantly reduced mean total cholesterol levels, not obsd. with epoetin alfa.  No safety concerns were raised.  Short treatment duration and small sample size.  In this phase 2 study of anemia therapy in patients with end-stage renal disease on maintenance hemodialysis therapy, roxadustat was well tolerated and effectively maintained Hb levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3nbuyEB4IJbVg90H21EOLACvtfcHk0ljnYA3klUAH8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFSqu70%253D&md5=45cd30b7888f622312a2c13a4a43f610</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1053%2Fj.ajkd.2015.12.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1053%252Fj.ajkd.2015.12.020%26sid%3Dliteratum%253Aachs%26aulast%3DProvenzano%26aufirst%3DR.%26aulast%3DBesarab%26aufirst%3DA.%26aulast%3DWright%26aufirst%3DS.%26aulast%3DDua%26aufirst%3DS.%26aulast%3DZeig%26aufirst%3DS.%26aulast%3DNguyen%26aufirst%3DP.%26aulast%3DPoole%26aufirst%3DL.%26aulast%3DSaikali%26aufirst%3DK.%2BG.%26aulast%3DSaha%26aufirst%3DG.%26aulast%3DHemmerich%26aufirst%3DS.%26aulast%3DSzczech%26aufirst%3DL.%26aulast%3DYu%26aufirst%3DK.%2BH.%2BP.%26aulast%3DNeff%26aufirst%3DT.%2BB.%26atitle%3DRoxadustat%2520%2528FG-4592%2529%2520versus%2520epoetin%2520alfa%2520for%2520anemia%2520in%2520patients%2520receiving%2520maintenance%2520hemodialysis%253A%2520a%2520phase%25202%252C%2520randomized%252C%25206-to%252019-week%252C%2520open-label%252C%2520active-comparator%252C%2520dose-ranging%252C%2520safety%2520and%2520exploratory%2520efficacy%2520study%26jtitle%3DAm.%2520J.%2520Kidney%2520Dis.%26date%3D2016%26volume%3D67%26spage%3D912%26epage%3D924%26doi%3D10.1053%2Fj.ajkd.2015.12.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pandya, V. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joharapurkar, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desai, R. C.</span></span> <span> </span><span class="NLM_article-title">Recent developments in HIF prolyl hydroxylase inhibitors</span>. <i>Med. Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">119</span>– <span class="NLM_lpage">132</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.29200%2Facsmedchemrev-v50.ch5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsVOkur3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2015&pages=119-132&author=V.+B.+Pandyaauthor=A.+A.+Joharapurkarauthor=M.+R.+Jainauthor=R.+C.+Desai&title=Recent+developments+in+HIF+prolyl+hydroxylase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Recent developments in HIF prolyl hydroxylase inhibitors</span></div><div class="casAuthors">Pandya, Vrajesh B.; Joharapurkar, Amit A.; Jain, Mukul R.; Desai, Ranjit C.</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Chemistry Reviews</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">119-133</span>CODEN:
                <span class="NLM_cas:coden">MCREGD</span>;
        ISSN:<span class="NLM_cas:issn">2575-9175</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society, Division of Medicinal Chemistry</span>)
        </div><div class="casAbstract">A review.  This article discuss about the role of HIF prolyl hydroxylase inhibitors involved for management and treatment of muscle degeneration, colitis and anemia in human and animal model including mouse.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyMsuJ4G6nQbVg90H21EOLACvtfcHk0ljnYA3klUAH8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsVOkur3E&md5=abac423377e5ed56a532246f85294b18</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.29200%2Facsmedchemrev-v50.ch5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.29200%252Facsmedchemrev-v50.ch5%26sid%3Dliteratum%253Aachs%26aulast%3DPandya%26aufirst%3DV.%2BB.%26aulast%3DJoharapurkar%26aufirst%3DA.%2BA.%26aulast%3DJain%26aufirst%3DM.%2BR.%26aulast%3DDesai%26aufirst%3DR.%2BC.%26atitle%3DRecent%2520developments%2520in%2520HIF%2520prolyl%2520hydroxylase%2520inhibitors%26jtitle%3DMed.%2520Chem.%2520Rev.%26date%3D2015%26volume%3D50%26spage%3D119%26epage%3D132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bernhardt, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiesener, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scigalla, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmieder, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Günzler, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eckardt, K. U.</span></span> <span> </span><span class="NLM_article-title">Inhibition of prolyl hydroxylases increases erythropoietin production in ESRD</span>. <i>J. Am. Soc. Nephrol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">2151</span>– <span class="NLM_lpage">2156</span>, <span class="refDoi"> DOI: 10.1681/ASN.2010010116</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1681%2FASN.2010010116" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=21115615" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktVGh" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2010&pages=2151-2156&author=W.+M.+Bernhardtauthor=M.+S.+Wiesenerauthor=P.+Scigallaauthor=J.+Chouauthor=R.+E.+Schmiederauthor=V.+G%C3%BCnzlerauthor=K.+U.+Eckardt&title=Inhibition+of+prolyl+hydroxylases+increases+erythropoietin+production+in+ESRD&doi=10.1681%2FASN.2010010116"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of prolyl hydroxylases increases erythropoietin production in ESRD</span></div><div class="casAuthors">Bernhardt, Wanja M.; Wiesener, Michael S.; Scigalla, Paul; Chou, James; Schmieder, Roland E.; Guenzler, Volkmar; Eckardt, Kai-Uwe</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Society of Nephrology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2151-2156</span>CODEN:
                <span class="NLM_cas:coden">JASNEU</span>;
        ISSN:<span class="NLM_cas:issn">1046-6673</span>.
    
            (<span class="NLM_cas:orgname">American Society of Nephrology</span>)
        </div><div class="casAbstract">The reasons for inadequate prodn. of erythropoietin (EPO) in patients with ESRD are poorly understood.  A better understanding of EPO regulation, namely oxygen-dependent hydroxylation of the hypoxia-inducible transcription factor (HIF), may enable targeted pharmacol. intervention.  Here, we tested the ability of fibrotic kidneys and extrarenal tissues to produce EPO.  In this phase 1 study, we used an orally active prolyl-hydroxylase inhibitor, FG-2216, to stabilize HIF independent of oxygen availability in 12 hemodialysis (HD) patients, six of whom were anephric, and in six healthy volunteers.  FG-2216 increased plasma EPO levels 30.8-fold in HD patients with kidneys, 14.5-fold in anephric HD patients, and 12.7-fold in healthy volunteers.  These data demonstrate that pharmacol. manipulation of the HIF system can stimulate endogenous EPO prodn.  Furthermore, the data indicate that deranged oxygen sensing-not a loss of EPO prodn. capacity-causes renal anemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpb0kP9T67TN7Vg90H21EOLACvtfcHk0lj4Q2hJAZzTXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktVGh&md5=1f2be8449fbb1fd87ae38a0faa534b47</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1681%2FASN.2010010116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1681%252FASN.2010010116%26sid%3Dliteratum%253Aachs%26aulast%3DBernhardt%26aufirst%3DW.%2BM.%26aulast%3DWiesener%26aufirst%3DM.%2BS.%26aulast%3DScigalla%26aufirst%3DP.%26aulast%3DChou%26aufirst%3DJ.%26aulast%3DSchmieder%26aufirst%3DR.%2BE.%26aulast%3DG%25C3%25BCnzler%26aufirst%3DV.%26aulast%3DEckardt%26aufirst%3DK.%2BU.%26atitle%3DInhibition%2520of%2520prolyl%2520hydroxylases%2520increases%2520erythropoietin%2520production%2520in%2520ESRD%26jtitle%3DJ.%2520Am.%2520Soc.%2520Nephrol.%26date%3D2010%26volume%3D21%26spage%3D2151%26epage%3D2156%26doi%3D10.1681%2FASN.2010010116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Salnikow, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donald, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruick, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhitkovich, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phang, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasprzak, K. S.</span></span> <span> </span><span class="NLM_article-title">Depletion of intracellular ascorbate by the carcinogenic metals nickel and cobalt results in the induction of hypoxic stress</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>279</i></span>,  <span class="NLM_fpage">40337</span>– <span class="NLM_lpage">40344</span>, <span class="refDoi"> DOI: 10.1074/jbc.M403057200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1074%2Fjbc.M403057200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=15271983" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnslWns74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=40337-40344&author=K.+Salnikowauthor=S.+P.+Donaldauthor=R.+K.+Bruickauthor=A.+Zhitkovichauthor=J.+M.+Phangauthor=K.+S.+Kasprzak&title=Depletion+of+intracellular+ascorbate+by+the+carcinogenic+metals+nickel+and+cobalt+results+in+the+induction+of+hypoxic+stress&doi=10.1074%2Fjbc.M403057200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Depletion of Intracellular Ascorbate by the Carcinogenic Metals Nickel and Cobalt Results in the Induction of Hypoxic Stress</span></div><div class="casAuthors">Salnikow, Konstantin; Donald, Steven P.; Bruick, Richard K.; Zhitkovich, Anatoly; Phang, James M.; Kasprzak, Kazimierz S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">279</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">40337-40344</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Exposure of cells to carcinogenic compds. of nickel(II) and cobalt(II) causes activation of the HIF-1 transcription factor and up-regulates a battery of hypoxia-inducible genes.  However, the mechanism of HIF-1 activation by these metals is not known.  It was shown recently that hydroxylation of prolines in the HIFα subunit of HIF-1 is required for its binding with the von Hippel-Lindau tumor suppressor protein and the subsequent proteasomal destruction.  Responsible prolyl hydroxylases are targets for both nickel(II) and cobalt(II) because degrdn. of a reporter protein contg. the oxygen-dependent degrdn. domain (Pro 402/564) of HIFα was abolished in a von Hippel-Lindau-dependent manner in cells exposed to nickel(II) or cobalt(II).  The enzymic activity of prolyl hydroxylases depends on iron as the activating metal, 2-oxoglutarate as a co-substrate, and ascorbic acid as a cofactor.  Hydroxylase activity can be impaired by the depletion of any of these factors.  The authors found that exposure of cells to nickel(II) or cobalt(II) did not affect the level of intracellular iron.  Instead, nickel(II) or cobalt(II) exposure greatly depleted intracellular ascorbate.  Co-exposure of cells to metals and ascorbate resulted in the increase of intracellular ascorbate and reversed both metal-induced stabilization of HIF-1α and HIF-1-dependent gene transcription.  Because ascorbate is essential for maintaining iron in prolyl hydroxylases in the active iron(II) state, the authors suggest that the obsd. depletion of ascorbate by nickel(II) or cobalt(II) favors iron oxidn. and thus inactivation of the enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVXquIEpSos7Vg90H21EOLACvtfcHk0lj4Q2hJAZzTXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnslWns74%253D&md5=bdd1dff71413576441f1fc795bb083be</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M403057200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M403057200%26sid%3Dliteratum%253Aachs%26aulast%3DSalnikow%26aufirst%3DK.%26aulast%3DDonald%26aufirst%3DS.%2BP.%26aulast%3DBruick%26aufirst%3DR.%2BK.%26aulast%3DZhitkovich%26aufirst%3DA.%26aulast%3DPhang%26aufirst%3DJ.%2BM.%26aulast%3DKasprzak%26aufirst%3DK.%2BS.%26atitle%3DDepletion%2520of%2520intracellular%2520ascorbate%2520by%2520the%2520carcinogenic%2520metals%2520nickel%2520and%2520cobalt%2520results%2520in%2520the%2520induction%2520of%2520hypoxic%2520stress%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D40337%26epage%3D40344%26doi%3D10.1074%2Fjbc.M403057200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nagle, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y. D.</span></span> <span> </span><span class="NLM_article-title">Natural product-derived small molecule activators of hypoxia-inducible factor-1 (HIF-1)</span>. <i>Curr. Pharm. Des.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">2673</span>– <span class="NLM_lpage">2688</span>, <span class="refDoi"> DOI: 10.2174/138161206777698783</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.2174%2F138161206777698783" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=2673-2688&author=D.+G.+Nagleauthor=Y.+D.+Zhou&title=Natural+product-derived+small+molecule+activators+of+hypoxia-inducible+factor-1+%28HIF-1%29&doi=10.2174%2F138161206777698783"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.2174%2F138161206777698783&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161206777698783%26sid%3Dliteratum%253Aachs%26aulast%3DNagle%26aufirst%3DD.%2BG.%26aulast%3DZhou%26aufirst%3DY.%2BD.%26atitle%3DNatural%2520product-derived%2520small%2520molecule%2520activators%2520of%2520hypoxia-inducible%2520factor-1%2520%2528HIF-1%2529%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2006%26volume%3D12%26spage%3D2673%26epage%3D2688%26doi%3D10.2174%2F138161206777698783" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tsukiyama, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tokuhara, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirota, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katsumata, T.</span></span> <span> </span><span class="NLM_article-title">Gallate, the component of HIF-inducing catechins, inhibits HIF prolyl hydroxylase</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>351</i></span>,  <span class="NLM_fpage">234</span>– <span class="NLM_lpage">239</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2006.10.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1016%2Fj.bbrc.2006.10.025" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=351&publication_year=2006&pages=234-239&author=F.+Tsukiyamaauthor=Y.+Nakaiauthor=M.+Yoshidaauthor=T.+Tokuharaauthor=K.+Hirotaauthor=A.+Sakaiauthor=H.+Hayashiauthor=T.+Katsumata&title=Gallate%2C+the+component+of+HIF-inducing+catechins%2C+inhibits+HIF+prolyl+hydroxylase&doi=10.1016%2Fj.bbrc.2006.10.025"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2006.10.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2006.10.025%26sid%3Dliteratum%253Aachs%26aulast%3DTsukiyama%26aufirst%3DF.%26aulast%3DNakai%26aufirst%3DY.%26aulast%3DYoshida%26aufirst%3DM.%26aulast%3DTokuhara%26aufirst%3DT.%26aulast%3DHirota%26aufirst%3DK.%26aulast%3DSakai%26aufirst%3DA.%26aulast%3DHayashi%26aufirst%3DH.%26aulast%3DKatsumata%26aufirst%3DT.%26atitle%3DGallate%252C%2520the%2520component%2520of%2520HIF-inducing%2520catechins%252C%2520inhibits%2520HIF%2520prolyl%2520hydroxylase%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2006%26volume%3D351%26spage%3D234%26epage%3D239%26doi%3D10.1016%2Fj.bbrc.2006.10.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shui, Y. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arbeit, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beebe, D. C.</span></span> <span> </span><span class="NLM_article-title">HIF-1: an age-dependent regulator of lens cell proliferation</span>. <i>Invest. Ophthalmol. Visual Sci.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">4961</span>– <span class="NLM_lpage">4970</span>, <span class="refDoi"> DOI: 10.1167/iovs.08-2118</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1167%2Fiovs.08-2118" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2008&pages=4961-4970&author=Y.+B.+Shuiauthor=J.+M.+Arbeitauthor=R.+S.+Johnsonauthor=D.+C.+Beebe&title=HIF-1%3A+an+age-dependent+regulator+of+lens+cell+proliferation&doi=10.1167%2Fiovs.08-2118"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1167%2Fiovs.08-2118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1167%252Fiovs.08-2118%26sid%3Dliteratum%253Aachs%26aulast%3DShui%26aufirst%3DY.%2BB.%26aulast%3DArbeit%26aufirst%3DJ.%2BM.%26aulast%3DJohnson%26aufirst%3DR.%2BS.%26aulast%3DBeebe%26aufirst%3DD.%2BC.%26atitle%3DHIF-1%253A%2520an%2520age-dependent%2520regulator%2520of%2520lens%2520cell%2520proliferation%26jtitle%3DInvest.%2520Ophthalmol.%2520Visual%2520Sci.%26date%3D2008%26volume%3D49%26spage%3D4961%26epage%3D4970%26doi%3D10.1167%2Fiovs.08-2118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jeon, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, Y.</span></span> <span> </span><span class="NLM_article-title">Quercetin activates an angiogenic pathway, hypoxia inducible factor (HIF)-1-vascular endothelial growth factor, by inhibiting HIF-prolyl hydroxylase: a structural analysis of quercetin for inhibiting HIF-prolyl hydroxylase</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">1676</span>– <span class="NLM_lpage">1684</span>, <span class="refDoi"> DOI: 10.1124/mol.107.034041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1124%2Fmol.107.034041" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2007&pages=1676-1684&author=H.+Jeonauthor=H.+Kimauthor=D.+Choiauthor=D.+Kimauthor=S.+Y.+Parkauthor=Y.+J.+Kimauthor=Y.+M.+Kimauthor=Y.+Jung&title=Quercetin+activates+an+angiogenic+pathway%2C+hypoxia+inducible+factor+%28HIF%29-1-vascular+endothelial+growth+factor%2C+by+inhibiting+HIF-prolyl+hydroxylase%3A+a+structural+analysis+of+quercetin+for+inhibiting+HIF-prolyl+hydroxylase&doi=10.1124%2Fmol.107.034041"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1124%2Fmol.107.034041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.107.034041%26sid%3Dliteratum%253Aachs%26aulast%3DJeon%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DH.%26aulast%3DChoi%26aufirst%3DD.%26aulast%3DKim%26aufirst%3DD.%26aulast%3DPark%26aufirst%3DS.%2BY.%26aulast%3DKim%26aufirst%3DY.%2BJ.%26aulast%3DKim%26aufirst%3DY.%2BM.%26aulast%3DJung%26aufirst%3DY.%26atitle%3DQuercetin%2520activates%2520an%2520angiogenic%2520pathway%252C%2520hypoxia%2520inducible%2520factor%2520%2528HIF%2529-1-vascular%2520endothelial%2520growth%2520factor%252C%2520by%2520inhibiting%2520HIF-prolyl%2520hydroxylase%253A%2520a%2520structural%2520analysis%2520of%2520quercetin%2520for%2520inhibiting%2520HIF-prolyl%2520hydroxylase%26jtitle%3DMol.%2520Pharmacol.%26date%3D2007%26volume%3D71%26spage%3D1676%26epage%3D1684%26doi%3D10.1124%2Fmol.107.034041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baader, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tschank, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baringhaus, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burghard, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guenzler, V.</span></span> <span> </span><span class="NLM_article-title">Inhibition of prolyl 4-hydroxylase by oxalyl amino acid derivatives in vitro, in isolated microsomes and in embryonic chicken tissues</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>300</i></span>,  <span class="NLM_fpage">525</span>– <span class="NLM_lpage">530</span>, <span class="refDoi"> DOI: 10.1042/bj3000525</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1042%2Fbj3000525" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=300&publication_year=1994&pages=525-530&author=E.+Baaderauthor=G.+Tschankauthor=K.+H.+Baringhausauthor=H.+Burghardauthor=V.+Guenzler&title=Inhibition+of+prolyl+4-hydroxylase+by+oxalyl+amino+acid+derivatives+in+vitro%2C+in+isolated+microsomes+and+in+embryonic+chicken+tissues&doi=10.1042%2Fbj3000525"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1042%2Fbj3000525&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj3000525%26sid%3Dliteratum%253Aachs%26aulast%3DBaader%26aufirst%3DE.%26aulast%3DTschank%26aufirst%3DG.%26aulast%3DBaringhaus%26aufirst%3DK.%2BH.%26aulast%3DBurghard%26aufirst%3DH.%26aulast%3DGuenzler%26aufirst%3DV.%26atitle%3DInhibition%2520of%2520prolyl%25204-hydroxylase%2520by%2520oxalyl%2520amino%2520acid%2520derivatives%2520in%2520vitro%252C%2520in%2520isolated%2520microsomes%2520and%2520in%2520embryonic%2520chicken%2520tissues%26jtitle%3DBiochem.%2520J.%26date%3D1994%26volume%3D300%26spage%3D525%26epage%3D530%26doi%3D10.1042%2Fbj3000525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cunliffe, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franklin, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hales, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, G. B.</span></span> <span> </span><span class="NLM_article-title">Novel inhibitors of prolyl 4-hydroxylase. 3. Inhibition by the substrate analog N-oxaloglycine and its derivatives</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">2652</span>– <span class="NLM_lpage">2658</span>, <span class="refDoi"> DOI: 10.1021/jm00092a016</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00092a016" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1992&pages=2652-2658&author=C.+J.+Cunliffeauthor=T.+J.+Franklinauthor=N.+J.+Halesauthor=G.+B.+Hill&title=Novel+inhibitors+of+prolyl+4-hydroxylase.+3.+Inhibition+by+the+substrate+analog+N-oxaloglycine+and+its+derivatives&doi=10.1021%2Fjm00092a016"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fjm00092a016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00092a016%26sid%3Dliteratum%253Aachs%26aulast%3DCunliffe%26aufirst%3DC.%2BJ.%26aulast%3DFranklin%26aufirst%3DT.%2BJ.%26aulast%3DHales%26aufirst%3DN.%2BJ.%26aulast%3DHill%26aufirst%3DG.%2BB.%26atitle%3DNovel%2520inhibitors%2520of%2520prolyl%25204-hydroxylase.%25203.%2520Inhibition%2520by%2520the%2520substrate%2520analog%2520N-oxaloglycine%2520and%2520its%2520derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1992%26volume%3D35%26spage%3D2652%26epage%3D2658%26doi%3D10.1021%2Fjm00092a016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rabinowitz, M. H.</span></span> <span> </span><span class="NLM_article-title">Inhibition of hypoxia-inducible factor prolyl hydroxylase domain oxygen sensors: tricking the body into mounting orchestrated survival and repair responses</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">9369</span>– <span class="NLM_lpage">9402</span>, <span class="refDoi"> DOI: 10.1021/jm400386j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400386j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlGnur3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=9369-9402&author=M.+H.+Rabinowitz&title=Inhibition+of+hypoxia-inducible+factor+prolyl+hydroxylase+domain+oxygen+sensors%3A+tricking+the+body+into+mounting+orchestrated+survival+and+repair+responses&doi=10.1021%2Fjm400386j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Hypoxia-Inducible Factor Prolyl Hydroxylase Domain Oxygen Sensors: Tricking the Body into Mounting Orchestrated Survival and Repair Responses</span></div><div class="casAuthors">Rabinowitz, Michael H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9369-9402</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Hypoxia-inducible factor (HIF) is an oxygen-sensitive dimeric transcription factor that responds to pathophysiol. low O2 tensions via up-regulation, which leads to an orchestrated biol. response to hypoxia.  The HIF prolyl hydroxylase domain (PHD) enzymes are non-heme, iron-contg. dioxygenases requiring for activity both mol. oxygen and 2-oxoglutarate that, under normoxia, selectively hydroxylate proline residues of HIF, initiating proteosomal degrdn. of the latter.  The dependence of HIF protein levels on the concn. of O2 present, mediated by the PHD enzymes, forms the basis for one of the most significant biol. sensor systems of tissue oxygenation in response to ischemic and inflammatory events.  Consequently, pharmacol. inhibition of PHD enzymes, leading to stabilization of HIF, may be of considerable therapeutic potential in treating conditions of tissue stress and injury.  This Perspective reviews the PHDs and small mol. drug discovery efforts.  A crit. view of this challenging field is offered, which addresses potential concerns and highlights exciting possibilities for the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqznH0RcdCELVg90H21EOLACvtfcHk0lgvh3ajf4YgtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlGnur3P&md5=0b22e70db7f97a51c030b332908fdf77</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fjm400386j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400386j%26sid%3Dliteratum%253Aachs%26aulast%3DRabinowitz%26aufirst%3DM.%2BH.%26atitle%3DInhibition%2520of%2520hypoxia-inducible%2520factor%2520prolyl%2520hydroxylase%2520domain%2520oxygen%2520sensors%253A%2520tricking%2520the%2520body%2520into%2520mounting%2520orchestrated%2520survival%2520and%2520repair%2520responses%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D9369%26epage%3D9402%26doi%3D10.1021%2Fjm400386j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Warshakoon, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawamoto, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheville, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renock, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pokross, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winter, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walter, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mekel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evdokimov, A. G.</span></span> <span> </span><span class="NLM_article-title">Structure-based design, synthesis, and SAR evaluation of a new series of 8-hydroxyquinolines as HIF-1α prolyl hydroxylase inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">5517</span>– <span class="NLM_lpage">5522</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2006.08.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1016%2Fj.bmcl.2006.08.040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=16931007" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVSis7%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=5517-5522&author=N.+C.+Warshakoonauthor=S.+Wuauthor=A.+Boyerauthor=R.+Kawamotoauthor=J.+Shevilleauthor=S.+Renockauthor=K.+Xuauthor=M.+Pokrossauthor=S.+Zhouauthor=C.+Winterauthor=R.+Walterauthor=M.+Mekelauthor=A.+G.+Evdokimov&title=Structure-based+design%2C+synthesis%2C+and+SAR+evaluation+of+a+new+series+of+8-hydroxyquinolines+as+HIF-1%CE%B1+prolyl+hydroxylase+inhibitors&doi=10.1016%2Fj.bmcl.2006.08.040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-based design, synthesis, and SAR evaluation of a new series of 8-hydroxyquinolines as HIF-1α prolyl hydroxylase inhibitors</span></div><div class="casAuthors">Warshakoon, Namal C.; Wu, Shengde; Boyer, Angelique; Kawamoto, Richard; Sheville, Justin; Renock, Sean; Xu, Kevin; Pokross, Matthew; Zhou, Songtao; Winter, Carol; Walter, Richard; Mekel, Marlene; Evdokimov, Artem G.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">5517-5522</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A new series of potent 8-hydroxyquinolines was designed based on the newly resolved x-ray crystal structure of EGLN-1.  Both alkyl and aryl 8-hydroxyquinoline-7-carboxyamides were good HIF-1α prolyl hydroxylase (EGLN) inhibitors.  In subsequent VEGF induction assays, these exhibited potent VEGF activity.  In addn., this class of compds. did show the ability to stabilize HIF-1α.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0-NaS_9GWG7Vg90H21EOLACvtfcHk0lgvh3ajf4YgtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVSis7%252FI&md5=741e058d467a3345e6cfd41293d1dc37</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.08.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.08.040%26sid%3Dliteratum%253Aachs%26aulast%3DWarshakoon%26aufirst%3DN.%2BC.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DBoyer%26aufirst%3DA.%26aulast%3DKawamoto%26aufirst%3DR.%26aulast%3DSheville%26aufirst%3DJ.%26aulast%3DRenock%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DK.%26aulast%3DPokross%26aufirst%3DM.%26aulast%3DZhou%26aufirst%3DS.%26aulast%3DWinter%26aufirst%3DC.%26aulast%3DWalter%26aufirst%3DR.%26aulast%3DMekel%26aufirst%3DM.%26aulast%3DEvdokimov%26aufirst%3DA.%2BG.%26atitle%3DStructure-based%2520design%252C%2520synthesis%252C%2520and%2520SAR%2520evaluation%2520of%2520a%2520new%2520series%2520of%25208-hydroxyquinolines%2520as%2520HIF-1%25CE%25B1%2520prolyl%2520hydroxylase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D5517%26epage%3D5522%26doi%3D10.1016%2Fj.bmcl.2006.08.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McDonough, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flashman, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chowdhury, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohr, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lienard, B. M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zondlo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oldham, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clifton, I. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNeill, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurzeja, R. J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hewitson, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jordan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Syed, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, C. J.</span></span> <span> </span><span class="NLM_article-title">Cellular oxygen sensing: crystal structure of hypoxia-inducible factor prolyl hydroxylase (PHD2)</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">9814</span>– <span class="NLM_lpage">9819</span>, <span class="refDoi"> DOI: 10.1073/pnas.0601283103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1073%2Fpnas.0601283103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=16782814" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=1%3ACAS%3A528%3ADC%252BD28XmvVajt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=9814-9819&author=M.+A.+McDonoughauthor=V.+Liauthor=E.+Flashmanauthor=R.+Chowdhuryauthor=C.+Mohrauthor=B.+M.+R.+Lienardauthor=J.+Zondloauthor=N.+J.+Oldhamauthor=I.+J.+Cliftonauthor=J.+Lewisauthor=L.+A.+McNeillauthor=R.+J.+M.+Kurzejaauthor=K.+S.+Hewitsonauthor=E.+Yangauthor=S.+Jordanauthor=R.+S.+Syedauthor=C.+J.+Schofield&title=Cellular+oxygen+sensing%3A+crystal+structure+of+hypoxia-inducible+factor+prolyl+hydroxylase+%28PHD2%29&doi=10.1073%2Fpnas.0601283103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Cellular oxygen sensing: crystal structure of hypoxia-inducible factor prolyl hydroxylase (PHD2)</span></div><div class="casAuthors">McDonough, Michael A.; Li, Vivian; Flashman, Emily; Chowdhury, Rasheduzzaman; Mohr, Christopher; Lienard, Benoit M. R.; Zondlo, James; Oldham, Neil J.; Clifton, Ian J.; Lewis, Jeffrey; McNeill, Luke A.; Kurzeja, Robert J. M.; Hewitson, Kirsty S.; Yang, Evelyn; Jordan, Steven; Syed, Rashid S.; Schofield, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">9814-9819</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Cellular and physiol. responses to changes in dioxygen levels in metazoans are mediated via the posttranslational oxidn. of hypoxia-inducible transcription factor (HIF).  Hydroxylation of conserved prolyl residues in the HIF-α subunit, catalyzed by HIF prolyl-hydroxylases (PHDs), signals for its proteasomal degrdn.  The requirement of the PHDs for dioxygen links changes in dioxygen levels with the transcriptional regulation of the gene array that enables the cellular response to chronic hypoxia; the PHDs thus act as an oxygen-sensing component of the HIF system, and their inhibition mimics the hypoxic response.  We describe crystal structures of the catalytic domain of human PHD2, an important prolyl-4-hydroxylase in the human hypoxic response in normal cells, in complex with Fe(II) and an inhibitor to 1.7 Å resoln.  PHD2 crystallizes as a homotrimer and contains a double-stranded β-helix core fold common to the Fe(II) and 2-oxoglutarate-dependent dioxygenase family, the residues of which are well conserved in the three human PHD enzymes (PHD 1-3).  The structure provides insights into the hypoxic response, helps to rationalize a clin. obsd. mutation leading to familial erythrocytosis, and will aid in the design of PHD selective inhibitors for the treatment of anemia and ischemic disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbXKAbBi_2YrVg90H21EOLACvtfcHk0lisStCi3EmkAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmvVajt78%253D&md5=2829121b3017e69b547b95ec5f28cd1b</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0601283103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0601283103%26sid%3Dliteratum%253Aachs%26aulast%3DMcDonough%26aufirst%3DM.%2BA.%26aulast%3DLi%26aufirst%3DV.%26aulast%3DFlashman%26aufirst%3DE.%26aulast%3DChowdhury%26aufirst%3DR.%26aulast%3DMohr%26aufirst%3DC.%26aulast%3DLienard%26aufirst%3DB.%2BM.%2BR.%26aulast%3DZondlo%26aufirst%3DJ.%26aulast%3DOldham%26aufirst%3DN.%2BJ.%26aulast%3DClifton%26aufirst%3DI.%2BJ.%26aulast%3DLewis%26aufirst%3DJ.%26aulast%3DMcNeill%26aufirst%3DL.%2BA.%26aulast%3DKurzeja%26aufirst%3DR.%2BJ.%2BM.%26aulast%3DHewitson%26aufirst%3DK.%2BS.%26aulast%3DYang%26aufirst%3DE.%26aulast%3DJordan%26aufirst%3DS.%26aulast%3DSyed%26aufirst%3DR.%2BS.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26atitle%3DCellular%2520oxygen%2520sensing%253A%2520crystal%2520structure%2520of%2520hypoxia-inducible%2520factor%2520prolyl%2520hydroxylase%2520%2528PHD2%2529%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2006%26volume%3D103%26spage%3D9814%26epage%3D9819%26doi%3D10.1073%2Fpnas.0601283103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chowdhury, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonough, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mecinovic, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loenarz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flashman, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hewitson, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Domene, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, C. J.</span></span> <span> </span><span class="NLM_article-title">Structural basis for binding of hypoxia-inducible factor to the oxygen-sensing prolyl hydroxylases</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">981</span>– <span class="NLM_lpage">989</span>, <span class="refDoi"> DOI: 10.1016/j.str.2009.06.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1016%2Fj.str.2009.06.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=19604478" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosV2gsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=981-989&author=R.+Chowdhuryauthor=M.+A.+McDonoughauthor=J.+Mecinovicauthor=C.+Loenarzauthor=E.+Flashmanauthor=K.+S.+Hewitsonauthor=C.+Domeneauthor=C.+J.+Schofield&title=Structural+basis+for+binding+of+hypoxia-inducible+factor+to+the+oxygen-sensing+prolyl+hydroxylases&doi=10.1016%2Fj.str.2009.06.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis for Binding of Hypoxia-Inducible Factor to the Oxygen-Sensing Prolyl Hydroxylases</span></div><div class="casAuthors">Chowdhury, Rasheduzzaman; McDonough, Michael A.; Mecinovic, Jasmin; Loenarz, Christoph; Flashman, Emily; Hewitson, Kirsty S.; Domene, Carmen; Schofield, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">981-989</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The oxygen-dependent hydroxylation of proline residues in the α subunit of hypoxia-inducible transcription factor (HIFα) is central to the hypoxic response in animals.  Prolyl hydroxylation of HIFα increases its binding to the von Hippel-Lindau protein (pVHL), so signaling for degrdn. via the ubiquitin-proteasome system.  The HIF prolyl hydroxylases (PHDs, prolyl hydroxylase domain enzymes) are related to the collagen prolyl hydroxylases, but form unusually stable complexes with their Fe(II) cofactor and 2-oxoglutarate cosubstrate.  We report crystal structures of the catalytic domain of PHD2, the most important of the human PHDs, in complex with the C-terminal oxygen-dependent degrdn. domain of HIF-1α.  Together with biochem. analyses, the results reveal that PHD catalysis involves a mobile region that isolates the hydroxylation site and stabilizes the PHD2.Fe(II).2OG complex.  The results will be of use in the design of PHD inhibitors aimed at treating anemia and ischemic disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqj4EIAtw-X1LVg90H21EOLACvtfcHk0lisStCi3EmkAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosV2gsrY%253D&md5=c0e60731ac33bdbf947cd0227dc86244</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2009.06.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2009.06.002%26sid%3Dliteratum%253Aachs%26aulast%3DChowdhury%26aufirst%3DR.%26aulast%3DMcDonough%26aufirst%3DM.%2BA.%26aulast%3DMecinovic%26aufirst%3DJ.%26aulast%3DLoenarz%26aufirst%3DC.%26aulast%3DFlashman%26aufirst%3DE.%26aulast%3DHewitson%26aufirst%3DK.%2BS.%26aulast%3DDomene%26aufirst%3DC.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26atitle%3DStructural%2520basis%2520for%2520binding%2520of%2520hypoxia-inducible%2520factor%2520to%2520the%2520oxygen-sensing%2520prolyl%2520hydroxylases%26jtitle%3DStructure%26date%3D2009%26volume%3D17%26spage%3D981%26epage%3D989%26doi%3D10.1016%2Fj.str.2009.06.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chan, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atasoylu, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodson, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tumber, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, I. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chowdhury, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gómez-Pérez, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demetriades, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rydzik, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holt-Martyn, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bishop, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Claridge, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawamura, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pugh, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ratcliffe, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, C. J.</span></span> <span> </span><span class="NLM_article-title">Potent and selective triazole-based inhibitors of the hypoxia-inducible factor prolyl-hydroxylases with activity in the murine brain</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">e0132004</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0132004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1371%2Fjournal.pone.0132004" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=e0132004&author=M.+C.+Chanauthor=O.+Atasoyluauthor=E.+Hodsonauthor=A.+Tumberauthor=I.+K.+Leungauthor=R.+Chowdhuryauthor=V.+G%C3%B3mez-P%C3%A9rezauthor=M.+Demetriadesauthor=A.+M.+Rydzikauthor=J.+Holt-Martynauthor=Y.+M.+Tianauthor=T.+Bishopauthor=T.+D.+Claridgeauthor=A.+Kawamuraauthor=C.+W.+Pughauthor=P.+J.+Ratcliffeauthor=C.+J.+Schofield&title=Potent+and+selective+triazole-based+inhibitors+of+the+hypoxia-inducible+factor+prolyl-hydroxylases+with+activity+in+the+murine+brain&doi=10.1371%2Fjournal.pone.0132004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0132004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0132004%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DM.%2BC.%26aulast%3DAtasoylu%26aufirst%3DO.%26aulast%3DHodson%26aufirst%3DE.%26aulast%3DTumber%26aufirst%3DA.%26aulast%3DLeung%26aufirst%3DI.%2BK.%26aulast%3DChowdhury%26aufirst%3DR.%26aulast%3DG%25C3%25B3mez-P%25C3%25A9rez%26aufirst%3DV.%26aulast%3DDemetriades%26aufirst%3DM.%26aulast%3DRydzik%26aufirst%3DA.%2BM.%26aulast%3DHolt-Martyn%26aufirst%3DJ.%26aulast%3DTian%26aufirst%3DY.%2BM.%26aulast%3DBishop%26aufirst%3DT.%26aulast%3DClaridge%26aufirst%3DT.%2BD.%26aulast%3DKawamura%26aufirst%3DA.%26aulast%3DPugh%26aufirst%3DC.%2BW.%26aulast%3DRatcliffe%26aufirst%3DP.%2BJ.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26atitle%3DPotent%2520and%2520selective%2520triazole-based%2520inhibitors%2520of%2520the%2520hypoxia-inducible%2520factor%2520prolyl-hydroxylases%2520with%2520activity%2520in%2520the%2520murine%2520brain%26jtitle%3DPLoS%2520One%26date%3D2015%26volume%3D10%26spage%3De0132004%26doi%3D10.1371%2Fjournal.pone.0132004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span> <span> </span><span class="NLM_article-title">Application of in-vitro screening methods on hypoxia inducible factor prolyl hydroxylase inhibitors</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">3891</span>– <span class="NLM_lpage">3899</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2017.05.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1016%2Fj.bmc.2017.05.026" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=3891-3899&author=Y.+Wuauthor=Z.+Jiangauthor=Q.+Youauthor=X.+Zhang&title=Application+of+in-vitro+screening+methods+on+hypoxia+inducible+factor+prolyl+hydroxylase+inhibitors&doi=10.1016%2Fj.bmc.2017.05.026"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2017.05.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2017.05.026%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DY.%26aulast%3DJiang%26aufirst%3DZ.%26aulast%3DYou%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DX.%26atitle%3DApplication%2520of%2520in-vitro%2520screening%2520methods%2520on%2520hypoxia%2520inducible%2520factor%2520prolyl%2520hydroxylase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2017%26volume%3D25%26spage%3D3891%26epage%3D3899%26doi%3D10.1016%2Fj.bmc.2017.05.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arend, M. P.</span>; <span class="NLM_string-name">Flippin, L. A.</span>; <span class="NLM_string-name">Guenzler-Pukall, V.</span>; <span class="NLM_string-name">Ho, W.-B.</span>; <span class="NLM_string-name">Turtle, E. D.</span>; <span class="NLM_string-name">Du, X.</span></span> <span> </span><span class="NLM_article-title">Nitrogen-Containing Heteroaryl Compounds and their Use in Increasing Endogenous Erythropoietin</span>. <span class="NLM_patent">WO2004108681A1</span>, <span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=M.+P.+Arend&author=L.+A.+Flippin&author=V.+Guenzler-Pukall&author=W.-B.+Ho&author=E.+D.+Turtle&author=X.+Du&title=Nitrogen-Containing+Heteroaryl+Compounds+and+their+Use+in+Increasing+Endogenous+Erythropoietin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DArend%26aufirst%3DM.%2BP.%26atitle%3DNitrogen-Containing%2520Heteroaryl%2520Compounds%2520and%2520their%2520Use%2520in%2520Increasing%2520Endogenous%2520Erythropoietin%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kawamoto, R. M.</span></span> <span> </span><span class="NLM_article-title">Prolyl Hydroxylase Inhibitors and Method of Use</span>. <span class="NLM_patent">WO2008002576A2</span>, <span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=R.+M.+Kawamoto&title=Prolyl+Hydroxylase+Inhibitors+and+Method+of+Use"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKawamoto%26aufirst%3DR.%2BM.%26atitle%3DProlyl%2520Hydroxylase%2520Inhibitors%2520and%2520Method%2520of%2520Use%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fitch, D. M.</span></span> <span> </span><span class="NLM_article-title">Prolyl Hydroxylase Inhibitors</span>. <span class="NLM_patent">WO2009070644A1</span>, <span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=D.+M.+Fitch&title=Prolyl+Hydroxylase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DFitch%26aufirst%3DD.%2BM.%26atitle%3DProlyl%2520Hydroxylase%2520Inhibitors%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Colon, M.</span>; <span class="NLM_string-name">Fitch, D.
M.</span></span> <span> </span><span class="NLM_article-title">Prolyl Hydroxylase Inhibitors</span>.<span class="NLM_patent">WO2009073497A2</span>, <span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=M.+Colon&author=D.%0AM.+Fitch&title=Prolyl+Hydroxylase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DColon%26aufirst%3DM.%26atitle%3DProlyl%2520Hydroxylase%2520Inhibitors%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chai, D.</span>; <span class="NLM_string-name">Fitch, D.
M.</span></span> <span> </span><span class="NLM_article-title">Prolyl Hydroxylase Inhibitors</span>. <span class="NLM_patent">WO2009134847A1</span>, <span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=D.+Chai&author=D.%0AM.+Fitch&title=Prolyl+Hydroxylase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChai%26aufirst%3DD.%26atitle%3DProlyl%2520Hydroxylase%2520Inhibitors%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chai, D.</span>; <span class="NLM_string-name">Fitch, D.
M.</span></span> <span> </span><span class="NLM_article-title">Prolyl Hydroxylase Inhibitors</span>. <span class="NLM_patent">WO2009134850A1</span>, <span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=D.+Chai&author=D.%0AM.+Fitch&title=Prolyl+Hydroxylase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChai%26aufirst%3DD.%26atitle%3DProlyl%2520Hydroxylase%2520Inhibitors%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rosen, M. D.</span>; <span class="NLM_string-name">Rabinowitz, M. H.</span>; <span class="NLM_string-name">Zhao, L. X.</span>; <span class="NLM_string-name">Hocutt, F. M.</span></span> <span> </span><span class="NLM_article-title">Benzimidazole Glycinamides as Prolyl Hydroxylase Inhibitors</span>. <span class="NLM_patent">WO2009134754A1</span>, <span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=M.+D.+Rosen&author=M.+H.+Rabinowitz&author=L.+X.+Zhao&author=F.+M.+Hocutt&title=Benzimidazole+Glycinamides+as+Prolyl+Hydroxylase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DRosen%26aufirst%3DM.%2BD.%26atitle%3DBenzimidazole%2520Glycinamides%2520as%2520Prolyl%2520Hydroxylase%2520Inhibitors%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barrett, T.
D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palomino, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brondstetter, T. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanelakis, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haug, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hua, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hart, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkatesan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosen, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peltier, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sepassi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizzolio, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bembenek, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mirzadegan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabinowitz, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shankley, N. P.</span></span> <span> </span><span class="NLM_article-title">Pharmacological characterization of 1-(5-chloro-6- (trifluoromethoxy)-1H-benzoimidazol-2-yl)-1H-pyrazole-4-carboxylic acid (JNJ-42041935), a potent and selective hypoxia-inducible factor prolyl hydroxylase inhibitor</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">910</span>– <span class="NLM_lpage">920</span>, <span class="refDoi"> DOI: 10.1124/mol.110.070508</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1124%2Fmol.110.070508" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2011&pages=910-920&author=T.%0AD.+Barrettauthor=H.+L.+Palominoauthor=T.+I.+Brondstetterauthor=K.+C.+Kanelakisauthor=X.+Wuauthor=P.+V.+Haugauthor=W.+Yanauthor=A.+Youngauthor=H.+Huaauthor=J.+C.+Hartauthor=D.+T.+Tranauthor=H.+Venkatesanauthor=M.+D.+Rosenauthor=H.+M.+Peltierauthor=K.+Sepassiauthor=M.+C.+Rizzolioauthor=S.+D.+Bembenekauthor=T.+Mirzadeganauthor=M.+H.+Rabinowitzauthor=N.+P.+Shankley&title=Pharmacological+characterization+of+1-%285-chloro-6-+%28trifluoromethoxy%29-1H-benzoimidazol-2-yl%29-1H-pyrazole-4-carboxylic+acid+%28JNJ-42041935%29%2C+a+potent+and+selective+hypoxia-inducible+factor+prolyl+hydroxylase+inhibitor&doi=10.1124%2Fmol.110.070508"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1124%2Fmol.110.070508&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.110.070508%26sid%3Dliteratum%253Aachs%26aulast%3DBarrett%26aufirst%3DT.%2BD.%26aulast%3DPalomino%26aufirst%3DH.%2BL.%26aulast%3DBrondstetter%26aufirst%3DT.%2BI.%26aulast%3DKanelakis%26aufirst%3DK.%2BC.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DHaug%26aufirst%3DP.%2BV.%26aulast%3DYan%26aufirst%3DW.%26aulast%3DYoung%26aufirst%3DA.%26aulast%3DHua%26aufirst%3DH.%26aulast%3DHart%26aufirst%3DJ.%2BC.%26aulast%3DTran%26aufirst%3DD.%2BT.%26aulast%3DVenkatesan%26aufirst%3DH.%26aulast%3DRosen%26aufirst%3DM.%2BD.%26aulast%3DPeltier%26aufirst%3DH.%2BM.%26aulast%3DSepassi%26aufirst%3DK.%26aulast%3DRizzolio%26aufirst%3DM.%2BC.%26aulast%3DBembenek%26aufirst%3DS.%2BD.%26aulast%3DMirzadegan%26aufirst%3DT.%26aulast%3DRabinowitz%26aufirst%3DM.%2BH.%26aulast%3DShankley%26aufirst%3DN.%2BP.%26atitle%3DPharmacological%2520characterization%2520of%25201-%25285-chloro-6-%2520%2528trifluoromethoxy%2529-1H-benzoimidazol-2-yl%2529-1H-pyrazole-4-carboxylic%2520acid%2520%2528JNJ-42041935%2529%252C%2520a%2520potent%2520and%2520selective%2520hypoxia-inducible%2520factor%2520prolyl%2520hydroxylase%2520inhibitor%26jtitle%3DMol.%2520Pharmacol.%26date%3D2011%26volume%3D79%26spage%3D910%26epage%3D920%26doi%3D10.1124%2Fmol.110.070508" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bembenek, S. D.</span>; <span class="NLM_string-name">Hocutt, F. M.</span>; <span class="NLM_string-name">Leonard, B. E.,  Jr.</span>; <span class="NLM_string-name">Rabinowitz, M. H.</span>; <span class="NLM_string-name">Rosen, M. D.</span>; <span class="NLM_string-name">Tarantino, K. T.</span>; <span class="NLM_string-name">Venkatesan, H.</span></span> <span> </span><span class="NLM_article-title">Quinazolinones as Prolyl Hydroxylase Inhibitors</span>. <span class="NLM_patent">WO2010093727A1</span>, <span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=S.+D.+Bembenek&author=F.+M.+Hocutt&author=B.+E.+Leonard&author=M.+H.+Rabinowitz&author=M.+D.+Rosen&author=K.+T.+Tarantino&author=H.+Venkatesan&title=Quinazolinones+as+Prolyl+Hydroxylase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBembenek%26aufirst%3DS.%2BD.%26atitle%3DQuinazolinones%2520as%2520Prolyl%2520Hydroxylase%2520Inhibitors%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barrett, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palomino, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brondstetter, T. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanelakis, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merton, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schoetens, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skaptason, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, D.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkatesan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosen, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shankley, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabinowitz, M. H.</span></span> <span> </span><span class="NLM_article-title">Prolyl hydroxylase inhibition corrects functional iron deficiency and inflammation-induced anaemia in rats</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>172</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">4078</span>– <span class="NLM_lpage">4088</span>, <span class="refDoi"> DOI: 10.1111/bph.13188</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1111%2Fbph.13188" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=25988595" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVOhurnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=172&publication_year=2015&pages=4078-4088&issue=16&author=T.+D.+Barrettauthor=H.+L.+Palominoauthor=T.+I.+Brondstetterauthor=K.+C.+Kanelakisauthor=X.+Wuauthor=W.+Yanauthor=K.+P.+Mertonauthor=F.+Schoetensauthor=J.+Y.+Maauthor=J.+Skaptasonauthor=J.+Gaoauthor=D.-T.+Tranauthor=H.+Venkatesanauthor=M.+D.+Rosenauthor=N.+P.+Shankleyauthor=M.+H.+Rabinowitz&title=Prolyl+hydroxylase+inhibition+corrects+functional+iron+deficiency+and+inflammation-induced+anaemia+in+rats&doi=10.1111%2Fbph.13188"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Prolyl hydroxylase inhibition corrects functional iron deficiency and inflammation-induced anaemia in rats</span></div><div class="casAuthors">Barrett, Terrance D.; Palomino, Heather L.; Brondstetter, Theresa I.; Kanelakis, Kimon C.; Wu, Xiaodong; Yan, Wen; Merton, Katherine P.; Schoetens, Freddy; Ma, Jing Ying; Skaptason, Judy; Gao, Jingjin; Tran, Da-Thao; Venkatesan, Hariharan; Rosen, Mark D.; Shankley, Nigel P.; Rabinowitz, Michael H.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">172</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">4078-4088</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose : Small-mol. inhibitors of prolyl hydroxylase (PHD) enzymes are a novel target for the treatment of anemia and functional iron deficiency (FID).  Other than being orally bioavailable, the differentiation of PHD inhibitors from recombinant human erythropoietin (rhEPO) has not been demonstrated.  Exptl. Approach : JNJ-42905343 was identified and characterized as a novel inhibitor of PHD and its action was compared with rhEPO in healthy rats and in a rat model of inflammation-induced anemia and FID [peptidoglycan-polysaccharide (PGPS) model].  Key Results : Oral administration of JNJ-42905343 to healthy rats increased the gene expression of cytochrome b (DcytB) and divalent metal-ion transporter 1 (DMT1) in the duodenum, and increased plasma EPO.  Repeated administration of JNJ-42905343 for 28 days increased blood Hb, mean corpuscular Hb (MCH) and mean corpuscular vol. (MCV).  The serum iron concn. was increased with low doses (0.3 mg·kg-1) but reduced at high doses (6 mg·kg-1).  In PGPS-treated rats, administration of JNJ-42905343 for 28 days cor. FID and anemia, as reflected by increased blood Hb, MCH and MCV.  Increased expression of DcytB and DMT1 genes in the duodenum resulting in increased iron availability was defined as the mechanism for these effects. rhEPO did not affect DcytB and DMT1 and was not effective in PGPS-treated rats.  Conclusions and Implications : PHD inhibition has a beneficial effect on iron metab. in addn. to stimulating the release of EPO.  Small-mol. inhibitors of PHD such as JNJ-42905343 represent a mechanism distinct from rhEPO to treat anemia and FID.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDLib9Ge_SCLVg90H21EOLACvtfcHk0lj0fmvsdNqqAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVOhurnM&md5=a6174cd68a11e9240f4e1a879e571819</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1111%2Fbph.13188&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.13188%26sid%3Dliteratum%253Aachs%26aulast%3DBarrett%26aufirst%3DT.%2BD.%26aulast%3DPalomino%26aufirst%3DH.%2BL.%26aulast%3DBrondstetter%26aufirst%3DT.%2BI.%26aulast%3DKanelakis%26aufirst%3DK.%2BC.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DYan%26aufirst%3DW.%26aulast%3DMerton%26aufirst%3DK.%2BP.%26aulast%3DSchoetens%26aufirst%3DF.%26aulast%3DMa%26aufirst%3DJ.%2BY.%26aulast%3DSkaptason%26aufirst%3DJ.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DTran%26aufirst%3DD.-T.%26aulast%3DVenkatesan%26aufirst%3DH.%26aulast%3DRosen%26aufirst%3DM.%2BD.%26aulast%3DShankley%26aufirst%3DN.%2BP.%26aulast%3DRabinowitz%26aufirst%3DM.%2BH.%26atitle%3DProlyl%2520hydroxylase%2520inhibition%2520corrects%2520functional%2520iron%2520deficiency%2520and%2520inflammation-induced%2520anaemia%2520in%2520rats%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2015%26volume%3D172%26issue%3D16%26spage%3D4078%26epage%3D4088%26doi%3D10.1111%2Fbph.13188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rabinowitz, M. H.</span>; <span class="NLM_string-name">Rosen, M. D.</span>; <span class="NLM_string-name">Tarantino, K. T.</span>; <span class="NLM_string-name">Venkatesan, H.</span></span> <span> </span><span class="NLM_article-title">1-(4-Aminoquinazolin-2-yl)-1<i>H</i>-pyrazole-4-carboxylic Acid Compound as Prolyl Hydroxylase Inhibitors</span>. <span class="NLM_patent">WO2012021830A1</span>, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=M.+H.+Rabinowitz&author=M.+D.+Rosen&author=K.+T.+Tarantino&author=H.+Venkatesan&title=1-%284-Aminoquinazolin-2-yl%29-1H-pyrazole-4-carboxylic+Acid+Compound+as+Prolyl+Hydroxylase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DRabinowitz%26aufirst%3DM.%2BH.%26atitle%3D1-%25284-Aminoquinazolin-2-yl%2529-1H-pyrazole-4-carboxylic%2520Acid%2520Compound%2520as%2520Prolyl%2520Hydroxylase%2520Inhibitors%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Seeley, T. W.</span></span> <span> </span><span class="NLM_article-title">Novel and beneficial pharmacodynamic properties of endogenous EPO and ‘complete erythropoiesis’ induced by selective HIF prolyl hydroxylase inhibitors</span>. <i>J. Am. Soc. Nephrol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">761A</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2005&pages=761A&author=T.+W.+Seeley&title=Novel+and+beneficial+pharmacodynamic+properties+of+endogenous+EPO+and+%E2%80%98complete+erythropoiesis%E2%80%99+induced+by+selective+HIF+prolyl+hydroxylase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSeeley%26aufirst%3DT.%2BW.%26atitle%3DNovel%2520and%2520beneficial%2520pharmacodynamic%2520properties%2520of%2520endogenous%2520EPO%2520and%2520%25E2%2580%2598complete%2520erythropoiesis%25E2%2580%2599%2520induced%2520by%2520selective%2520HIF%2520prolyl%2520hydroxylase%2520inhibitors%26jtitle%3DJ.%2520Am.%2520Soc.%2520Nephrol.%26date%3D2005%26volume%3D16%26spage%3D761A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Macdougall, I. C.</span></span> <span> </span><span class="NLM_article-title">New anemia therapies: translating novel strategies from bench to bedside</span>. <i>Am. J. Kidney Dis.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">444</span>– <span class="NLM_lpage">451</span>, <span class="refDoi"> DOI: 10.1053/j.ajkd.2011.11.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1053%2Fj.ajkd.2011.11.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=22192713" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=1%3ACAS%3A280%3ADC%252BC383jsl2gtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2012&pages=444-451&author=I.+C.+Macdougall&title=New+anemia+therapies%3A+translating+novel+strategies+from+bench+to+bedside&doi=10.1053%2Fj.ajkd.2011.11.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">New anemia therapies: translating novel strategies from bench to bedside</span></div><div class="casAuthors">Macdougall Iain C</div><div class="citationInfo"><span class="NLM_cas:title">American journal of kidney diseases : the official journal of the National Kidney Foundation</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">444-51</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Recombinant human erythropoietin (epoetin) has been available for the treatment of renal anemia for more than 20 years, and within the last decade two molecularly engineered analogues darbepoetin alfa and pegylated epoetin beta were introduced as longer-acting erythropoiesis-stimulating agents.  Recently, newer strategies for correcting anemia have been explored, some of which remain in the laboratory while others are translating across into clinical trials.  Peginesatide has completed phase 3 clinical trials for the treatment of anemia associated with chronic kidney disease; this molecule is immunologically distinct from the erythropoietic proteins, with no cross-reactivity with anti-erythropoietin antibodies.  HIF (hypoxia inducible factor) stabilization involves the pharmacologic inhibition of prolyl hydroxylation of HIF-α (the major transcription factor controlling erythropoietin gene expression), thereby preventing its degradation in the proteasome.  Hepcidin is the master regulator of iron metabolism, and this peptide is upregulated in inflammatory conditions, including uremia; its antagonism has been shown to cause amelioration of inflammatory anemia in animal models.  For the time being, erythropoiesis-stimulating agent therapy remains the mainstay of anemia management in chronic kidney disease, but it is possible that one or more of the strategies discussed in this review may have a future role in the treatment of this condition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSUtCOJzerupCEJCPKhJPuqfW6udTcc2eaSg5W94fxwHLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC383jsl2gtQ%253D%253D&md5=066b3c9437dc448d2f96a5fd552a2ef5</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1053%2Fj.ajkd.2011.11.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1053%252Fj.ajkd.2011.11.013%26sid%3Dliteratum%253Aachs%26aulast%3DMacdougall%26aufirst%3DI.%2BC.%26atitle%3DNew%2520anemia%2520therapies%253A%2520translating%2520novel%2520strategies%2520from%2520bench%2520to%2520bedside%26jtitle%3DAm.%2520J.%2520Kidney%2520Dis.%26date%3D2012%26volume%3D59%26spage%3D444%26epage%3D451%26doi%3D10.1053%2Fj.ajkd.2011.11.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guenzler-Pukall, V.</span>; <span class="NLM_string-name">Wang, Q.</span>; <span class="NLM_string-name">Langsetmo, P. I.</span>; <span class="NLM_string-name">Guo, G.</span></span> <span> </span><span class="NLM_article-title">Methods for Reducing Blood Pressure</span>. <span class="NLM_patent">WO2009058403A1</span>, <span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=V.+Guenzler-Pukall&author=Q.+Wang&author=P.+I.+Langsetmo&author=G.+Guo&title=Methods+for+Reducing+Blood+Pressure"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGuenzler-Pukall%26aufirst%3DV.%26atitle%3DMethods%2520for%2520Reducing%2520Blood%2520Pressure%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Long, W.</span>; <span class="NLM_string-name">Zhang, J.</span>; <span class="NLM_string-name">Hu, Y.</span>; <span class="NLM_string-name">Wang, Y.</span></span> <span> </span><span class="NLM_article-title">Polymorphic Forms of Compounds as Prolyl Hydroxylase Inhibitor, and Uses Thereof</span>. <span class="NLM_patent">WO2013013609A1</span>, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=W.+Long&author=J.+Zhang&author=Y.+Hu&author=Y.+Wang&title=Polymorphic+Forms+of+Compounds+as+Prolyl+Hydroxylase+Inhibitor%2C+and+Uses+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLong%26aufirst%3DW.%26atitle%3DPolymorphic%2520Forms%2520of%2520Compounds%2520as%2520Prolyl%2520Hydroxylase%2520Inhibitor%252C%2520and%2520Uses%2520Thereof%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ho, W. B.</span>; <span class="NLM_string-name">Zhao, H.</span>; <span class="NLM_string-name">Deng, S.</span>; <span class="NLM_string-name">NG, D.</span>; <span class="NLM_string-name">Wright, L. R.</span>; <span class="NLM_string-name">Wu, M.</span>; <span class="NLM_string-name">Xiaoti, Z.</span>; <span class="NLM_string-name">Arend, M. P.</span>; <span class="NLM_string-name">Flippin, L. A.</span></span> <span> </span><span class="NLM_article-title">4-Hydroxy-isoquinoline Compounds as HIF Hydroxylase Inhibitors</span>. <span class="NLM_patent">US 20150038528</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=W.+B.+Ho&author=H.+Zhao&author=S.+Deng&author=D.+NG&author=L.+R.+Wright&author=M.+Wu&author=Z.+Xiaoti&author=M.+P.+Arend&author=L.+A.+Flippin&title=4-Hydroxy-isoquinoline+Compounds+as+HIF+Hydroxylase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHo%26aufirst%3DW.%2BB.%26atitle%3D4-Hydroxy-isoquinoline%2520Compounds%2520as%2520HIF%2520Hydroxylase%2520Inhibitors%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span>; <span class="NLM_string-name">Cai, S.</span>; <span class="NLM_string-name">Wang, G.</span>; <span class="NLM_string-name">Jiao, L.</span>; <span class="NLM_string-name">Min, P.</span>; <span class="NLM_string-name">Jing, Y.</span>; <span class="NLM_string-name">Guo, M.</span></span> <span> </span><span class="NLM_article-title">Compound of 5-Hydroxyl-1,7-naphthyridine Substituted by Aryl or Heteroaryl, Preparation Method Thereof and Pharmaceutical Use Thereof</span>. <span class="NLM_patent">WO2016155358A1</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=Y.+Zhou&author=S.+Cai&author=G.+Wang&author=L.+Jiao&author=P.+Min&author=Y.+Jing&author=M.+Guo&title=Compound+of+5-Hydroxyl-1%2C7-naphthyridine+Substituted+by+Aryl+or+Heteroaryl%2C+Preparation+Method+Thereof+and+Pharmaceutical+Use+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DY.%26atitle%3DCompound%2520of%25205-Hydroxyl-1%252C7-naphthyridine%2520Substituted%2520by%2520Aryl%2520or%2520Heteroaryl%252C%2520Preparation%2520Method%2520Thereof%2520and%2520Pharmaceutical%2520Use%2520Thereof%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span>; <span class="NLM_string-name">Cai, S.</span>; <span class="NLM_string-name">Wang, G.</span>; <span class="NLM_string-name">Jiao, L.</span>; <span class="NLM_string-name">Min, P.</span>; <span class="NLM_string-name">Jing, Y.</span>; <span class="NLM_string-name">Guo, M.</span></span> <span> </span><span class="NLM_article-title">Compound of 5-Hydroxyl-1,7-naphthyridine Substituted by Aryloxy or Heteroaryloxy, Preparation Method Thereof and Pharmaceutical Use Thereof</span>. <span class="NLM_patent">WO2016155357A1</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=Y.+Zhou&author=S.+Cai&author=G.+Wang&author=L.+Jiao&author=P.+Min&author=Y.+Jing&author=M.+Guo&title=Compound+of+5-Hydroxyl-1%2C7-naphthyridine+Substituted+by+Aryloxy+or+Heteroaryloxy%2C+Preparation+Method+Thereof+and+Pharmaceutical+Use+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DY.%26atitle%3DCompound%2520of%25205-Hydroxyl-1%252C7-naphthyridine%2520Substituted%2520by%2520Aryloxy%2520or%2520Heteroaryloxy%252C%2520Preparation%2520Method%2520Thereof%2520and%2520Pharmaceutical%2520Use%2520Thereof%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kawamoto, R. M.</span></span> <span> </span><span class="NLM_article-title">Prolyl Hydroxylase Inhibitors and Method of Use</span>. <span class="NLM_patent">WO2008002576A2</span>, <span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=R.+M.+Kawamoto&title=Prolyl+Hydroxylase+Inhibitors+and+Method+of+Use"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKawamoto%26aufirst%3DR.%2BM.%26atitle%3DProlyl%2520Hydroxylase%2520Inhibitors%2520and%2520Method%2520of%2520Use%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shalwitz, R.</span>; <span class="NLM_string-name">Gardner, J. H.</span>; <span class="NLM_string-name">Janusz, J. M.</span></span> <span> </span><span class="NLM_article-title">Compounds and Compositions for Stabilizing Hypoxia Inducible Factor-2 alpha as a Method for Treating Cancer</span>. <span class="NLM_patent">WO2012170442A1</span>, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=R.+Shalwitz&author=J.+H.+Gardner&author=J.+M.+Janusz&title=Compounds+and+Compositions+for+Stabilizing+Hypoxia+Inducible+Factor-2+alpha+as+a+Method+for+Treating+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DShalwitz%26aufirst%3DR.%26atitle%3DCompounds%2520and%2520Compositions%2520for%2520Stabilizing%2520Hypoxia%2520Inducible%2520Factor-2%2520alpha%2520as%2520a%2520Method%2520for%2520Treating%2520Cancer%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Copp, J. D.</span>; <span class="NLM_string-name">Newman, A. W.</span>; <span class="NLM_string-name">Luong, A.</span></span> <span> </span><span class="NLM_article-title">Solid Forms of {[5-(3-Chlorophenyl)-3-Hydroxypyridine-2-carbonyl]amino}acetic acid, Compositions, and Uses Thereof</span>. <span class="NLM_patent">WO2015073779A1</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=J.+D.+Copp&author=A.+W.+Newman&author=A.+Luong&title=Solid+Forms+of+%7B%5B5-%283-Chlorophenyl%29-3-Hydroxypyridine-2-carbonyl%5Damino%7Dacetic+acid%2C+Compositions%2C+and+Uses+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCopp%26aufirst%3DJ.%2BD.%26atitle%3DSolid%2520Forms%2520of%2520%257B%255B5-%25283-Chlorophenyl%2529-3-Hydroxypyridine-2-carbonyl%255Damino%257Dacetic%2520acid%252C%2520Compositions%252C%2520and%2520Uses%2520Thereof%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lanthier, C. M.</span>; <span class="NLM_string-name">Boris, G.</span>; <span class="NLM_string-name">Jan, O.</span>; <span class="NLM_string-name">Edward, D. C.</span>; <span class="NLM_string-name">Quigbo, L. A.</span>; <span class="NLM_string-name">Densmore, C. J.</span>; <span class="NLM_string-name">Michael, J. J.</span></span> <span> </span><span class="NLM_article-title">Process for Preparing [(3-Hydroxypyridine-2-carbonyl)amino]alkanoic Acids, Esters and Amides</span>. <span class="NLM_patent">WO2012170377A1</span>, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=C.+M.+Lanthier&author=G.+Boris&author=O.+Jan&author=D.+C.+Edward&author=L.+A.+Quigbo&author=C.+J.+Densmore&author=J.+J.+Michael&title=Process+for+Preparing+%5B%283-Hydroxypyridine-2-carbonyl%29amino%5Dalkanoic+Acids%2C+Esters+and+Amides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLanthier%26aufirst%3DC.%2BM.%26atitle%3DProcess%2520for%2520Preparing%2520%255B%25283-Hydroxypyridine-2-carbonyl%2529amino%255Dalkanoic%2520Acids%252C%2520Esters%2520and%2520Amides%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Daly, W.</span>; <span class="NLM_string-name">Shalwitz, R.</span></span> <span> </span><span class="NLM_article-title">Compositions and Method for Treating Ocular Diseases</span>. <span class="NLM_patent">WO2015112831A1</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=W.+Daly&author=R.+Shalwitz&title=Compositions+and+Method+for+Treating+Ocular+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDaly%26aufirst%3DW.%26atitle%3DCompositions%2520and%2520Method%2520for%2520Treating%2520Ocular%2520Diseases%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A.</span>; <span class="NLM_string-name">Chandorkar, G. A.</span>; <span class="NLM_string-name">Ette, E. I.</span>; <span class="NLM_string-name">Maroni, B. J.</span>; <span class="NLM_string-name">Hartman, C. S.</span>; <span class="NLM_string-name">Farzaneh-Far, R.</span>; <span class="NLM_string-name">Inrig, J.
K.</span></span> <span> </span><span class="NLM_article-title">Compositions and Method for Treating Anemia</span>. <span class="NLM_patent">WO2016161094A1</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=A.+Smith&author=G.+A.+Chandorkar&author=E.+I.+Ette&author=B.+J.+Maroni&author=C.+S.+Hartman&author=R.+Farzaneh-Far&author=J.%0AK.+Inrig&title=Compositions+and+Method+for+Treating+Anemia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DA.%26atitle%3DCompositions%2520and%2520Method%2520for%2520Treating%2520Anemia%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hanselmann, R.</span></span> <span> </span><span class="NLM_article-title">Deuterium-Enriched Hypoxia-Inducible Factor Prolyl Hydroxylase Enzyme Inhibitors</span>. <span class="NLM_patent">WO2016153996A1</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=R.+Hanselmann&title=Deuterium-Enriched+Hypoxia-Inducible+Factor+Prolyl+Hydroxylase+Enzyme+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHanselmann%26aufirst%3DR.%26atitle%3DDeuterium-Enriched%2520Hypoxia-Inducible%2520Factor%2520Prolyl%2520Hydroxylase%2520Enzyme%2520Inhibitors%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span>; <span class="NLM_string-name">You, Q.</span>; <span class="NLM_string-name">Lei, Y.</span>; <span class="NLM_string-name">Hu, T.</span>; <span class="NLM_string-name">Wu, X.</span>; <span class="NLM_string-name">Sun, H.</span>; <span class="NLM_string-name">Guo, X.</span>; <span class="NLM_string-name">Xu, X.</span></span> <span> </span><span class="NLM_article-title">Alkynyl Pyridine Prolyl Hydroxylase Inhibitor, and Preparation Method and Medical Use Thereof</span>. <span class="NLM_patent">WO2017059623A1</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=X.+Zhang&author=Q.+You&author=Y.+Lei&author=T.+Hu&author=X.+Wu&author=H.+Sun&author=X.+Guo&author=X.+Xu&title=Alkynyl+Pyridine+Prolyl+Hydroxylase+Inhibitor%2C+and+Preparation+Method+and+Medical+Use+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26atitle%3DAlkynyl%2520Pyridine%2520Prolyl%2520Hydroxylase%2520Inhibitor%252C%2520and%2520Preparation%2520Method%2520and%2520Medical%2520Use%2520Thereof%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nakajima, T.</span>; <span class="NLM_string-name">Goi, T.</span>; <span class="NLM_string-name">Kawata, A.</span>; <span class="NLM_string-name">Sugahara, M.</span>; <span class="NLM_string-name">Yamakoshi, S.</span></span> <span> </span><span class="NLM_article-title">Pyrazolopyrimidine Compound</span>. <span class="NLM_patent">WO2014030716A1</span>, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=T.+Nakajima&author=T.+Goi&author=A.+Kawata&author=M.+Sugahara&author=S.+Yamakoshi&title=Pyrazolopyrimidine+Compound"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DNakajima%26aufirst%3DT.%26atitle%3DPyrazolopyrimidine%2520Compound%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, C.</span>; <span class="NLM_string-name">Zou, W.</span>; <span class="NLM_string-name">Hua, Y.</span>; <span class="NLM_string-name">Dang, Q.</span></span> <span> </span><span class="NLM_article-title">Substituted Pyrimidines</span>. <span class="NLM_patent">WO2013040789A1</span>, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=C.+Zhou&author=W.+Zou&author=Y.+Hua&author=Q.+Dang&title=Substituted+Pyrimidines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DC.%26atitle%3DSubstituted%2520Pyrimidines%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dang, Q.</span>; <span class="NLM_string-name">Zhou, C.</span>; <span class="NLM_string-name">Zou, W.</span>; <span class="NLM_string-name">Hua, Y.</span></span> <span> </span><span class="NLM_article-title">Substituted Pyrimidines</span>. <span class="NLM_patent">WO2013043621A1</span>, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=Q.+Dang&author=C.+Zhou&author=W.+Zou&author=Y.+Hua&title=Substituted+Pyrimidines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDang%26aufirst%3DQ.%26atitle%3DSubstituted%2520Pyrimidines%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ujjainwalla, F.</span>; <span class="NLM_string-name">Tan, J. Q.</span>; <span class="NLM_string-name">Dang, Q.</span>; <span class="NLM_string-name">Sinz, C.
J.</span>; <span class="NLM_string-name">Wang, M.</span>; <span class="NLM_string-name">Chen, Y.</span>; <span class="NLM_string-name">Cai, J.</span>; <span class="NLM_string-name">Du, X.</span></span> <span> </span><span class="NLM_article-title">Substituted Pyridine Inhibitors of HIF Prolyl Hydroxylase</span>. <span class="NLM_patent">WO2016054806A1</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=F.+Ujjainwalla&author=J.+Q.+Tan&author=Q.+Dang&author=C.%0AJ.+Sinz&author=M.+Wang&author=Y.+Chen&author=J.+Cai&author=X.+Du&title=Substituted+Pyridine+Inhibitors+of+HIF+Prolyl+Hydroxylase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DUjjainwalla%26aufirst%3DF.%26atitle%3DSubstituted%2520Pyridine%2520Inhibitors%2520of%2520HIF%2520Prolyl%2520Hydroxylase%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ujjainwalla, F.</span>; <span class="NLM_string-name">Tan, J. Q.</span>; <span class="NLM_string-name">Dang, Q.</span>; <span class="NLM_string-name">Sinz, C.
J.</span>; <span class="NLM_string-name">Wang, M.</span>; <span class="NLM_string-name">Cai, J.</span>; <span class="NLM_string-name">Du, X.</span>; <span class="NLM_string-name">Chen, Y.</span></span> <span> </span><span class="NLM_article-title">Substituted Pyridine Inhibitors of HIF Prolyl Hydroxylase</span>. <span class="NLM_patent">WO2016057743A1</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=F.+Ujjainwalla&author=J.+Q.+Tan&author=Q.+Dang&author=C.%0AJ.+Sinz&author=M.+Wang&author=J.+Cai&author=X.+Du&author=Y.+Chen&title=Substituted+Pyridine+Inhibitors+of+HIF+Prolyl+Hydroxylase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DUjjainwalla%26aufirst%3DF.%26atitle%3DSubstituted%2520Pyridine%2520Inhibitors%2520of%2520HIF%2520Prolyl%2520Hydroxylase%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ujjainwalla, F.</span>; <span class="NLM_string-name">Tan, J. Q.</span>; <span class="NLM_string-name">Dang, Q.</span>; <span class="NLM_string-name">Sinz, C.
J.</span>; <span class="NLM_string-name">Crespo, A.</span>; <span class="NLM_string-name">Wang, M.</span>; <span class="NLM_string-name">Chen, Y.</span>; <span class="NLM_string-name">Cai, J.</span>; <span class="NLM_string-name">Wu, F.</span>; <span class="NLM_string-name">Du, X.</span></span> <span> </span><span class="NLM_article-title">Substituted Pyrimidine as Inhibitors of HIF Prolyl Hydroxylase</span>. <span class="NLM_patent">WO2016057762A1</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=F.+Ujjainwalla&author=J.+Q.+Tan&author=Q.+Dang&author=C.%0AJ.+Sinz&author=A.+Crespo&author=M.+Wang&author=Y.+Chen&author=J.+Cai&author=F.+Wu&author=X.+Du&title=Substituted+Pyrimidine+as+Inhibitors+of+HIF+Prolyl+Hydroxylase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DUjjainwalla%26aufirst%3DF.%26atitle%3DSubstituted%2520Pyrimidine%2520as%2520Inhibitors%2520of%2520HIF%2520Prolyl%2520Hydroxylase%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ujjainwalla, F.</span>; <span class="NLM_string-name">Tan, J. Q.</span>; <span class="NLM_string-name">Dang, Q.</span>; <span class="NLM_string-name">Sinz, C.
J.</span>; <span class="NLM_string-name">Crespo, A.</span>; <span class="NLM_string-name">Wang, M.</span>; <span class="NLM_string-name">Chen, Y.</span>; <span class="NLM_string-name">Cai, J.</span>; <span class="NLM_string-name">Wu, F.</span>; <span class="NLM_string-name">Du, X.</span></span> <span> </span><span class="NLM_article-title">Substituted Pyrimidine as Inhibitors of HIF Prolyl Hydroxylase</span>. <span class="NLM_patent">WO2016054804A1</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=F.+Ujjainwalla&author=J.+Q.+Tan&author=Q.+Dang&author=C.%0AJ.+Sinz&author=A.+Crespo&author=M.+Wang&author=Y.+Chen&author=J.+Cai&author=F.+Wu&author=X.+Du&title=Substituted+Pyrimidine+as+Inhibitors+of+HIF+Prolyl+Hydroxylase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DUjjainwalla%26aufirst%3DF.%26atitle%3DSubstituted%2520Pyrimidine%2520as%2520Inhibitors%2520of%2520HIF%2520Prolyl%2520Hydroxylase%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ujjainwalla, F.</span>; <span class="NLM_string-name">Tan, J. Q.</span>; <span class="NLM_string-name">Dang, Q.</span>; <span class="NLM_string-name">Sinz, C.
J.</span>; <span class="NLM_string-name">Wang, M.</span>; <span class="NLM_string-name">Chen, Y.</span>; <span class="NLM_string-name">Cai, J.</span></span> <span> </span><span class="NLM_article-title">Substituted Pyrimidine as Inhibitors of HIF Prolyl Hydroxylase</span>. <span class="NLM_patent">WO2016057753A1</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=F.+Ujjainwalla&author=J.+Q.+Tan&author=Q.+Dang&author=C.%0AJ.+Sinz&author=M.+Wang&author=Y.+Chen&author=J.+Cai&title=Substituted+Pyrimidine+as+Inhibitors+of+HIF+Prolyl+Hydroxylase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DUjjainwalla%26aufirst%3DF.%26atitle%3DSubstituted%2520Pyrimidine%2520as%2520Inhibitors%2520of%2520HIF%2520Prolyl%2520Hydroxylase%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ariazi, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duffy, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fitch, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pappalardi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biju, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Difilippo, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiggall, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erickson-Miller, C.</span></span> <span> </span><span class="NLM_article-title">Discovery and preclinical characterization of GSK1278863 (Daprodustat), a small molecule hypoxia inducible factor-prolyl hydroxylase inhibitor for anemia</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">336</span>– <span class="NLM_lpage">347</span>, <span class="refDoi"> DOI: 10.1124/jpet.117.242503</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1124%2Fjpet.117.242503" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2017&pages=336-347&author=J.+L.+Ariaziauthor=K.+J.+Duffyauthor=D.+F.+Adamsauthor=D.+Fitchauthor=L.+Luoauthor=M.+Pappalardiauthor=M.+Bijuauthor=E.+H.+Difilippoauthor=T.+Shawauthor=K.+Wiggallauthor=C.+Erickson-Miller&title=Discovery+and+preclinical+characterization+of+GSK1278863+%28Daprodustat%29%2C+a+small+molecule+hypoxia+inducible+factor-prolyl+hydroxylase+inhibitor+for+anemia&doi=10.1124%2Fjpet.117.242503"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1124%2Fjpet.117.242503&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.117.242503%26sid%3Dliteratum%253Aachs%26aulast%3DAriazi%26aufirst%3DJ.%2BL.%26aulast%3DDuffy%26aufirst%3DK.%2BJ.%26aulast%3DAdams%26aufirst%3DD.%2BF.%26aulast%3DFitch%26aufirst%3DD.%26aulast%3DLuo%26aufirst%3DL.%26aulast%3DPappalardi%26aufirst%3DM.%26aulast%3DBiju%26aufirst%3DM.%26aulast%3DDifilippo%26aufirst%3DE.%2BH.%26aulast%3DShaw%26aufirst%3DT.%26aulast%3DWiggall%26aufirst%3DK.%26aulast%3DErickson-Miller%26aufirst%3DC.%26atitle%3DDiscovery%2520and%2520preclinical%2520characterization%2520of%2520GSK1278863%2520%2528Daprodustat%2529%252C%2520a%2520small%2520molecule%2520hypoxia%2520inducible%2520factor-prolyl%2520hydroxylase%2520inhibitor%2520for%2520anemia%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2017%26volume%3D36%26spage%3D336%26epage%3D347%26doi%3D10.1124%2Fjpet.117.242503" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takayama, T.</span>; <span class="NLM_string-name">Shibata, T.</span>; <span class="NLM_string-name">Shiozawa, F.</span>; <span class="NLM_string-name">Kawabe, K.</span>; <span class="NLM_string-name">Shimizu, Y.</span>; <span class="NLM_string-name">Hamada, M.</span>; <span class="NLM_string-name">Hiratate, A.</span>; <span class="NLM_string-name">Takahashi, M.</span>; <span class="NLM_string-name">Ushiyama, F.</span>; <span class="NLM_string-name">Takahiro, O. I.</span>; <span class="NLM_string-name">Shirasaki, Y.</span>; <span class="NLM_string-name">Matsuda, D.</span>; <span class="NLM_string-name">Koizumi, C.</span>; <span class="NLM_string-name">Kato, S.</span></span> <span> </span><span class="NLM_article-title">Partially Saturated Nitrogen-Containing Heterocyclic Compound</span>. <span class="NLM_patent">WO2014021281A1</span>, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=T.+Takayama&author=T.+Shibata&author=F.+Shiozawa&author=K.+Kawabe&author=Y.+Shimizu&author=M.+Hamada&author=A.+Hiratate&author=M.+Takahashi&author=F.+Ushiyama&author=O.+I.+Takahiro&author=Y.+Shirasaki&author=D.+Matsuda&author=C.+Koizumi&author=S.+Kato&title=Partially+Saturated+Nitrogen-Containing+Heterocyclic+Compound"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DTakayama%26aufirst%3DT.%26atitle%3DPartially%2520Saturated%2520Nitrogen-Containing%2520Heterocyclic%2520Compound%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Desai, R. C.</span>; <span class="NLM_string-name">Pandya, V.</span>; <span class="NLM_string-name">Patel, P.
R.</span></span> <span> </span><span class="NLM_article-title">Novel Quinolone Derivatives</span>. <span class="NLM_patent">WO2014102818A1</span>. <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=R.+C.+Desai&author=V.+Pandya&author=P.%0AR.+Patel&title=Novel+Quinolone+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDesai%26aufirst%3DR.%2BC.%26atitle%3DNovel%2520Quinolone%2520Derivatives%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kansagra, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parmar, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jani, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srinivas, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lickliter, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, H. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parikh, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heading, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dholakia, V. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sukhadiya, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parmar, K. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barot, K.</span></span> <span> </span><span class="NLM_article-title">Phase I clinical study of ZYAN1, a novel prolyl-hydroxylase (PHD) inhibitor to evaluate the safety, tolerability, and pharmacokinetics following oral administration in healthy volunteers</span>. <i>Clin. Pharmacokinet.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">87</span>– <span class="NLM_lpage">102</span>, <span class="refDoi"> DOI: 10.1007/s40262-017-0551-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1007%2Fs40262-017-0551-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=28508936" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=1%3ACAS%3A528%3ADC%252BC2sXnvVGjtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2018&pages=87-102&issue=1&author=K.+A.+Kansagraauthor=D.+Parmarauthor=R.+H.+Janiauthor=N.+R.+Srinivasauthor=J.+Lickliterauthor=H.+V.+Patelauthor=D.+P.+Parikhauthor=H.+Headingauthor=H.+B.+Patelauthor=R.+J.+Guptaauthor=C.+Y.+Shahauthor=M.+R.+Patelauthor=V.+N.+Dholakiaauthor=R.+Sukhadiyaauthor=M.+R.+Jainauthor=K.+V.+Parmarauthor=K.+Barot&title=Phase+I+clinical+study+of+ZYAN1%2C+a+novel+prolyl-hydroxylase+%28PHD%29+inhibitor+to+evaluate+the+safety%2C+tolerability%2C+and+pharmacokinetics+following+oral+administration+in+healthy+volunteers&doi=10.1007%2Fs40262-017-0551-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I Clinical Study of ZYAN1, A Novel Prolyl-Hydroxylase (PHD) Inhibitor to Evaluate the Safety, Tolerability, and Pharmacokinetics Following Oral Administration in Healthy Volunteers</span></div><div class="casAuthors">Kansagra, Kevinkumar A.; Parmar, Deven; Jani, Rajendra H.; Srinivas, Nuggehally R.; Lickliter, Jason; Patel, Harilal V.; Parikh, Devang P.; Heading, Heather; Patel, Hardik B.; Gupta, Rahul J.; Shah, Chintan Y.; Patel, Maulik R.; Dholakia, Vyom N.; Sukhadiya, Raghav; Jain, Mukul R.; Parmar, Krupi V.; Barot, Kinjal</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacokinetics</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">87-102</span>CODEN:
                <span class="NLM_cas:coden">CPKNDH</span>;
        ISSN:<span class="NLM_cas:issn">0312-5963</span>.
    
            (<span class="NLM_cas:orgname">Springer International Publishing AG</span>)
        </div><div class="casAbstract">Objective: This phase I study of ZYAN1 was conducted to evaluate the safety, tolerability, and pharmacokinetics following oral administration in healthy volunteers.  Methods: The study was a randomized, double-blind, placebo-controlled phase I study carried out in two parts in addn. to a third part involving an open-label study to evaluate the food/sex effect.  A total of 100 subjects were enrolled into the study as follows: part I-single-dose study with ZYAN1 10, 25, 50, 100, 150, 200, and 300 mg (n = 56); part II-multiple-dose study with every other day dosing of ZYAN1 100, 150, 200, and 300 mg (n = 32); and part III-sex and food effect study with ZYAN1 150 mg (n = 12; open-label).  Results: ZYAN1 was well-tolerated after single and multiple oral ascending doses.  No drug-related serious adverse events were reported.  Following a single ascending dose of ZYAN1, the max. concn. (Cmax) ranged from 566.47 ± 163.03 to 17,858.33 ± 2899.19 ng/mL and the median time to Cmax (tmax) was approx. 2.5 h for the studied 30-fold oral doses of ZYAN1.  Regardless of single or multiple doses, mean Cmax and area under the concn.-time curve from time zero to time t (AUCt) values generally showed a dose-proportional increase.  The mean elimination half-life (t1/2) of ZYAN1 ranged from 6.9 to 13 h with negligible accumulation.  Following a single dose of ZYAN1, the mean serum erythropoietin (EPO) Cmax values showed dose response (i.e., 6.6 and 79.9 mIU/L for 10 and 300 mg ZYAN1 doses, resp.), while the time to mean maximal serum EPO concns. ranged from 10 to 72 h.  Conclusion: Oral single (10-300 mg) and multiple dosing (100-300 mg) of ZYAN1 in healthy subjects was found to be safe and well-tolerated.  With increasing ZYAN1 dose, there was almost a proportional increase in mean Cmax and AUCt.  The mean serum EPO concns. showed a trend of dose response.  Based on the t1/2, pharmacodynamic activity, and lack of drug accumulation, a once every 2 days dosing regimen of ZYAN1 was appropriate for phase II study.  Trial Registration: Australian New Zealand Clin. Trials Registry trial ID ACTRN12614001240639.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBByFCzbT49rVg90H21EOLACvtfcHk0lid3Kb3P-wkCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXnvVGjtrk%253D&md5=17a24e21816ac53a13c987b8cd2abf0c</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1007%2Fs40262-017-0551-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40262-017-0551-3%26sid%3Dliteratum%253Aachs%26aulast%3DKansagra%26aufirst%3DK.%2BA.%26aulast%3DParmar%26aufirst%3DD.%26aulast%3DJani%26aufirst%3DR.%2BH.%26aulast%3DSrinivas%26aufirst%3DN.%2BR.%26aulast%3DLickliter%26aufirst%3DJ.%26aulast%3DPatel%26aufirst%3DH.%2BV.%26aulast%3DParikh%26aufirst%3DD.%2BP.%26aulast%3DHeading%26aufirst%3DH.%26aulast%3DPatel%26aufirst%3DH.%2BB.%26aulast%3DGupta%26aufirst%3DR.%2BJ.%26aulast%3DShah%26aufirst%3DC.%2BY.%26aulast%3DPatel%26aufirst%3DM.%2BR.%26aulast%3DDholakia%26aufirst%3DV.%2BN.%26aulast%3DSukhadiya%26aufirst%3DR.%26aulast%3DJain%26aufirst%3DM.%2BR.%26aulast%3DParmar%26aufirst%3DK.%2BV.%26aulast%3DBarot%26aufirst%3DK.%26atitle%3DPhase%2520I%2520clinical%2520study%2520of%2520ZYAN1%252C%2520a%2520novel%2520prolyl-hydroxylase%2520%2528PHD%2529%2520inhibitor%2520to%2520evaluate%2520the%2520safety%252C%2520tolerability%252C%2520and%2520pharmacokinetics%2520following%2520oral%2520administration%2520in%2520healthy%2520volunteers%26jtitle%3DClin.%2520Pharmacokinet.%26date%3D2018%26volume%3D57%26issue%3D1%26spage%3D87%26epage%3D102%26doi%3D10.1007%2Fs40262-017-0551-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cai, J.</span>; <span class="NLM_string-name">Colandrea, V.</span>; <span class="NLM_string-name">Crespo, A.</span>; <span class="NLM_string-name">Debenham, J.</span>; <span class="NLM_string-name">Du, X.</span>; <span class="NLM_string-name">Guiadeen, D.</span>; <span class="NLM_string-name">Liu, P.</span>; <span class="NLM_string-name">Liu, R.</span>; <span class="NLM_string-name">Madsen-Duggan, C. B.</span>; <span class="NLM_string-name">Mccoy, J. G.</span>; <span class="NLM_string-name">Quan, W.</span>; <span class="NLM_string-name">Sinz, C.</span>; <span class="NLM_string-name">Wang, L.</span></span> <span> </span><span class="NLM_article-title">Inhibitors of HIF Prolyl Hydroxylase</span>. <span class="NLM_patent">WO2016049097A1</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=J.+Cai&author=V.+Colandrea&author=A.+Crespo&author=J.+Debenham&author=X.+Du&author=D.+Guiadeen&author=P.+Liu&author=R.+Liu&author=C.+B.+Madsen-Duggan&author=J.+G.+Mccoy&author=W.+Quan&author=C.+Sinz&author=L.+Wang&title=Inhibitors+of+HIF+Prolyl+Hydroxylase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DJ.%26atitle%3DInhibitors%2520of%2520HIF%2520Prolyl%2520Hydroxylase%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cai, J.</span>; <span class="NLM_string-name">Colandrea, V.</span>; <span class="NLM_string-name">Crespo, A.</span>; <span class="NLM_string-name">Du, X.</span>; <span class="NLM_string-name">Dubois, B. G.</span>; <span class="NLM_string-name">Guiadeen, D.</span>; <span class="NLM_string-name">Kothandaraman, S.</span>; <span class="NLM_string-name">Liu, P.</span>; <span class="NLM_string-name">Liu, R.</span>; <span class="NLM_string-name">Quan, W.</span>; <span class="NLM_string-name">Sinz, C.</span>; <span class="NLM_string-name">Wang, L.</span></span> <span> </span><span class="NLM_article-title">Inhibitors of HIF Prolyl Hydroxylase</span>. <span class="NLM_patent">WO2016049099A1</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=J.+Cai&author=V.+Colandrea&author=A.+Crespo&author=X.+Du&author=B.+G.+Dubois&author=D.+Guiadeen&author=S.+Kothandaraman&author=P.+Liu&author=R.+Liu&author=W.+Quan&author=C.+Sinz&author=L.+Wang&title=Inhibitors+of+HIF+Prolyl+Hydroxylase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DJ.%26atitle%3DInhibitors%2520of%2520HIF%2520Prolyl%2520Hydroxylase%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cai, J.</span>; <span class="NLM_string-name">Crespo, A.</span>; <span class="NLM_string-name">Debenham, J.</span>; <span class="NLM_string-name">Du, X.</span>; <span class="NLM_string-name">Liu, P.</span>; <span class="NLM_string-name">Liu, R.</span>; <span class="NLM_string-name">Madsen-Duggan, C. B.</span>; <span class="NLM_string-name">Quan, W.</span>; <span class="NLM_string-name">Sinz, C.</span>; <span class="NLM_string-name">Wang, L.</span></span> <span> </span><span class="NLM_article-title">Inhibitors of HIF Prolyl Hydroxylase</span>. <span class="NLM_patent">WO2016049098A1</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=J.+Cai&author=A.+Crespo&author=J.+Debenham&author=X.+Du&author=P.+Liu&author=R.+Liu&author=C.+B.+Madsen-Duggan&author=W.+Quan&author=C.+Sinz&author=L.+Wang&title=Inhibitors+of+HIF+Prolyl+Hydroxylase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DJ.%26atitle%3DInhibitors%2520of%2520HIF%2520Prolyl%2520Hydroxylase%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cai, J.</span>; <span class="NLM_string-name">Crespo, A.</span>; <span class="NLM_string-name">Du, X.</span>; <span class="NLM_string-name">Dubois, B. G.</span>; <span class="NLM_string-name">Liu, P.</span>; <span class="NLM_string-name">Liu, R.</span>; <span class="NLM_string-name">Quan, W.</span>; <span class="NLM_string-name">Sinz, C.</span>; <span class="NLM_string-name">Wang, L.</span></span> <span> </span><span class="NLM_article-title">Inhibitors of HIF Prolyl Hydroxylase</span>. <span class="NLM_patent">WO2016049100A1</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=J.+Cai&author=A.+Crespo&author=X.+Du&author=B.+G.+Dubois&author=P.+Liu&author=R.+Liu&author=W.+Quan&author=C.+Sinz&author=L.+Wang&title=Inhibitors+of+HIF+Prolyl+Hydroxylase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DJ.%26atitle%3DInhibitors%2520of%2520HIF%2520Prolyl%2520Hydroxylase%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ogoshi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsui, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitani, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokota, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terashita, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Motoda, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueyama, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hotta, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hase, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukui, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshiuchi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abe, H.</span></span> <span> </span><span class="NLM_article-title">Discovery of JTZ-951: a HIF prolyl hydroxylase inhibitor for the treatment of renal anemia</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">1320</span>– <span class="NLM_lpage">1325</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.7b00404</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.7b00404" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVCksrbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=1320-1325&issue=12&author=Y.+Ogoshiauthor=T.+Matsuiauthor=I.+Mitaniauthor=M.+Yokotaauthor=M.+Terashitaauthor=D.+Motodaauthor=K.+Ueyamaauthor=T.+Hottaauthor=T.+Itoauthor=Y.+Haseauthor=K.+Fukuiauthor=K.+Deaiauthor=H.+Yoshiuchiauthor=S.+Itoauthor=H.+Abe&title=Discovery+of+JTZ-951%3A+a+HIF+prolyl+hydroxylase+inhibitor+for+the+treatment+of+renal+anemia&doi=10.1021%2Facsmedchemlett.7b00404"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of JTZ-951: A HIF Prolyl Hydroxylase Inhibitor for the Treatment of Renal Anemia</span></div><div class="casAuthors">Ogoshi, Yosuke; Matsui, Takuya; Mitani, Ikuo; Yokota, Masahiro; Terashita, Masakazu; Motoda, Dai; Ueyama, Kazuhito; Hotta, Takahiro; Ito, Takashi; Hase, Yasunori; Fukui, Kenji; Deai, Katsuya; Yoshiuchi, Hiromi; Ito, Soichiro; Abe, Hiroyuki</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1320-1325</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibition of hypoxia inducible factor prolyl hydroxylase (PHD) represents a promising strategy for the discovery of a next generation treatment for renal anemia.  We identified several 5,6-fused ring systems as novel scaffolds of the PHD inhibitor on the basis of pharmacophore anal.  In particular, triazolopyridine derivs. showed potent PHD2 inhibitory activities.  Examn. of the predominance of the triazolopyridines in potency by electrostatic calcns. suggested favorable π-π stacking interactions with Tyr310.  Lead optimization to improve the efficacy of erythropoietin release in cells and in vivo by improving cell permeability led to the discovery of JTZ-951 (compd. 14), with a 5-phenethyl substituent on the triazolopyridine group, which increased Hb levels with daily oral dosing in rats.  Compd. 14 was rapidly absorbed after oral administration and disappeared shortly thereafter, which could be advantageous in terms of safety.  Compd. 14 was selected as a clin. candidate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyv_5DiDhDq7Vg90H21EOLACvtfcHk0lgvPgC2ZZXtJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVCksrbM&md5=f1fb9366a5c92eafabb512f2e2fecc23</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.7b00404&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.7b00404%26sid%3Dliteratum%253Aachs%26aulast%3DOgoshi%26aufirst%3DY.%26aulast%3DMatsui%26aufirst%3DT.%26aulast%3DMitani%26aufirst%3DI.%26aulast%3DYokota%26aufirst%3DM.%26aulast%3DTerashita%26aufirst%3DM.%26aulast%3DMotoda%26aufirst%3DD.%26aulast%3DUeyama%26aufirst%3DK.%26aulast%3DHotta%26aufirst%3DT.%26aulast%3DIto%26aufirst%3DT.%26aulast%3DHase%26aufirst%3DY.%26aulast%3DFukui%26aufirst%3DK.%26aulast%3DDeai%26aufirst%3DK.%26aulast%3DYoshiuchi%26aufirst%3DH.%26aulast%3DIto%26aufirst%3DS.%26aulast%3DAbe%26aufirst%3DH.%26atitle%3DDiscovery%2520of%2520JTZ-951%253A%2520a%2520HIF%2520prolyl%2520hydroxylase%2520inhibitor%2520for%2520the%2520treatment%2520of%2520renal%2520anemia%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D8%26issue%3D12%26spage%3D1320%26epage%3D1325%26doi%3D10.1021%2Facsmedchemlett.7b00404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schulz, M. J.</span>; <span class="NLM_string-name">Wang, Y.</span></span> <span> </span><span class="NLM_article-title">Prolyl Hydroxylase Inhibitors</span>. <span class="NLM_patent">WO2010059549A1</span>, <span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=M.+J.+Schulz&author=Y.+Wang&title=Prolyl+Hydroxylase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSchulz%26aufirst%3DM.%2BJ.%26atitle%3DProlyl%2520Hydroxylase%2520Inhibitors%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gotchev, D. B.</span>; <span class="NLM_string-name">Jin, J.</span>; <span class="NLM_string-name">Wang, Y.</span></span> <span> </span><span class="NLM_article-title">Prolyl Hydroxylase Inhibitors</span>. <span class="NLM_patent">WO2009086044A1</span>, <span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=D.+B.+Gotchev&author=J.+Jin&author=Y.+Wang&title=Prolyl+Hydroxylase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGotchev%26aufirst%3DD.%2BB.%26atitle%3DProlyl%2520Hydroxylase%2520Inhibitors%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span>; <span class="NLM_string-name">Yu, H.</span></span> <span> </span><span class="NLM_article-title">Prolyl Hydroxylase Inhibitors</span>. <span class="NLM_patent">WO2010059552A1</span>, <span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=Y.+Wang&author=H.+Yu&title=Prolyl+Hydroxylase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26atitle%3DProlyl%2520Hydroxylase%2520Inhibitors%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jin, J.</span>; <span class="NLM_string-name">Schulz, M. J.</span>; <span class="NLM_string-name">Wang, Y.</span></span> <span> </span><span class="NLM_article-title">Prolyl Hydroxylase Inhibitors</span>. <span class="NLM_patent">WO2010022308A1</span>, <span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=J.+Jin&author=M.+J.+Schulz&author=Y.+Wang&title=Prolyl+Hydroxylase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DJin%26aufirst%3DJ.%26atitle%3DProlyl%2520Hydroxylase%2520Inhibitors%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schulz, M. J.</span>; <span class="NLM_string-name">Wang, Y.</span>; <span class="NLM_string-name">Ghergurovich, J. M.</span></span> <span> </span><span class="NLM_article-title">Prolyl Hydroxylase Inhibitors</span>. <span class="NLM_patent">WO2010059555A1</span>, <span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=M.+J.+Schulz&author=Y.+Wang&author=J.+M.+Ghergurovich&title=Prolyl+Hydroxylase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSchulz%26aufirst%3DM.%2BJ.%26atitle%3DProlyl%2520Hydroxylase%2520Inhibitors%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gardner, J. H.</span>; <span class="NLM_string-name">Shalwitz, R.</span></span> <span> </span><span class="NLM_article-title">Prolyl Hydroxylase Inhibitors</span>. <span class="NLM_patent">WO2011057115A1</span>, <span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=J.+H.+Gardner&author=R.+Shalwitz&title=Prolyl+Hydroxylase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGardner%26aufirst%3DJ.%2BH.%26atitle%3DProlyl%2520Hydroxylase%2520Inhibitors%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shalwitz, R.</span>; <span class="NLM_string-name">Gardner, J. H.</span></span> <span> </span><span class="NLM_article-title">Methods for Increasing the Stabilization of Hypoxia Inducible Factor-1 Alpha</span>. <span class="NLM_patent">WO2011057112A1</span>, <span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=R.+Shalwitz&author=J.+H.+Gardner&title=Methods+for+Increasing+the+Stabilization+of+Hypoxia+Inducible+Factor-1+Alpha"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DShalwitz%26aufirst%3DR.%26atitle%3DMethods%2520for%2520Increasing%2520the%2520Stabilization%2520of%2520Hypoxia%2520Inducible%2520Factor-1%2520Alpha%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clements, M. J.</span>; <span class="NLM_string-name">Debenham, J. S.</span>; <span class="NLM_string-name">Hale, J. J.</span>; <span class="NLM_string-name">Madsen-Duggan, C. B.</span>; <span class="NLM_string-name">Walsh, T. F.</span></span> <span> </span><span class="NLM_article-title">Preparation of Substituted 4-Hydroxypyrimidine-5- Carboxamides</span>. <span class="NLM_patent">WO2009117269A1</span>, <span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=M.+J.+Clements&author=J.+S.+Debenham&author=J.+J.+Hale&author=C.+B.+Madsen-Duggan&author=T.+F.+Walsh&title=Preparation+of+Substituted+4-Hydroxypyrimidine-5-+Carboxamides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DClements%26aufirst%3DM.%2BJ.%26atitle%3DPreparation%2520of%2520Substituted%25204-Hydroxypyrimidine-5-%2520Carboxamides%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, C.</span>; <span class="NLM_string-name">Zou, W.</span>; <span class="NLM_string-name">Hua, Y.</span>; <span class="NLM_string-name">Dang, Q.</span></span> <span> </span><span class="NLM_article-title">Substituted Pyrimidines</span>. <span class="NLM_patent">WO2011130908A1</span>, <span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=C.+Zhou&author=W.+Zou&author=Y.+Hua&author=Q.+Dang&title=Substituted+Pyrimidines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DC.%26atitle%3DSubstituted%2520Pyrimidines%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Debenham, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madsen-Duggan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clements, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, T. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuethe, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reibarkh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salowe, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sonatore, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hajdu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milligan, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Visco, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lingham, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stickens, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeMartino, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolff, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherer, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hale, J.</span></span> <span> </span><span class="NLM_article-title">Discovery of N-[bis(4-methoxyphenyl)methyl]-4-hydroxy-2-(pyridazin-3-yl)pyrimidine-5-carboxamide (MK-8617), an orally active pan-inhibitor of hypoxia-inducible factor prolyl hydroxylase 1–3 (HIF PHD1–3) for the treatment of anemia</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">11039</span>– <span class="NLM_lpage">11049</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01242</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01242" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVaiurnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=11039-11049&author=J.+S.+Debenhamauthor=C.+Madsen-Dugganauthor=M.+J.+Clementsauthor=T.+F.+Walshauthor=J.+T.+Kuetheauthor=M.+Reibarkhauthor=S.+P.+Saloweauthor=L.+M.+Sonatoreauthor=R.+Hajduauthor=J.+A.+Milliganauthor=D.+M.+Viscoauthor=D.+Zhouauthor=R.+B.+Linghamauthor=D.+Stickensauthor=J.+A.+DeMartinoauthor=X.+Tongauthor=M.+Wolffauthor=J.+Pangauthor=R.+R.+Millerauthor=E.+C.+Shererauthor=J.+Hale&title=Discovery+of+N-%5Bbis%284-methoxyphenyl%29methyl%5D-4-hydroxy-2-%28pyridazin-3-yl%29pyrimidine-5-carboxamide+%28MK-8617%29%2C+an+orally+active+pan-inhibitor+of+hypoxia-inducible+factor+prolyl+hydroxylase+1%E2%80%933+%28HIF+PHD1%E2%80%933%29+for+the+treatment+of+anemia&doi=10.1021%2Facs.jmedchem.6b01242"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of N-[Bis(4-methoxyphenyl)methyl]-4-hydroxy-2-(pyridazin-3-yl)pyrimidine-5-carboxamide (MK-8617), an Orally Active Pan-Inhibitor of Hypoxia-Inducible Factor Prolyl Hydroxylase 1-3 (HIF PHD1-3) for the Treatment of Anemia</span></div><div class="casAuthors">Debenham, John S.; Madsen-Duggan, Christina; Clements, Matthew J.; Walsh, Thomas F.; Kuethe, Jeffrey T.; Reibarkh, Mikhail; Salowe, Scott P.; Sonatore, Lisa M.; Hajdu, Richard; Milligan, James A.; Visco, Denise M.; Zhou, Dan; Lingham, Russell B.; Stickens, Dominique; DeMartino, Julie A.; Tong, Xinchun; Wolff, Michael; Pang, Jianmei; Miller, Randy R.; Sherer, Edward C.; Hale, Jeffrey J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">11039-11049</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The discovery of novel 4-hydroxy-2-(heterocyclic)pyrimidine-5-carboxamide inhibitors of hypoxia-inducible factor (HIF) prolyl hydroxylases (PHD) are described.  These are potent, selective, orally bioavailable across several species and are active in stimulating erythropoiesis.  Mouse and rat studies showed hematol. changes with elevations of plasma EPO and circulating reticulocytes following single oral dose administration while 4 wk QD po administration in rat elevated Hb levels.  A major focus of the optimization process was to decrease the long half-life obsd. in higher species with early compds.  These efforts led to the identification of 28 (MK-8617) which has advanced to human clin. trials for anemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhs63u66yCX7Vg90H21EOLACvtfcHk0lhIaNqK4AApBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVaiurnN&md5=7acb236af3ca035b010a203f7234a5b7</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01242&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01242%26sid%3Dliteratum%253Aachs%26aulast%3DDebenham%26aufirst%3DJ.%2BS.%26aulast%3DMadsen-Duggan%26aufirst%3DC.%26aulast%3DClements%26aufirst%3DM.%2BJ.%26aulast%3DWalsh%26aufirst%3DT.%2BF.%26aulast%3DKuethe%26aufirst%3DJ.%2BT.%26aulast%3DReibarkh%26aufirst%3DM.%26aulast%3DSalowe%26aufirst%3DS.%2BP.%26aulast%3DSonatore%26aufirst%3DL.%2BM.%26aulast%3DHajdu%26aufirst%3DR.%26aulast%3DMilligan%26aufirst%3DJ.%2BA.%26aulast%3DVisco%26aufirst%3DD.%2BM.%26aulast%3DZhou%26aufirst%3DD.%26aulast%3DLingham%26aufirst%3DR.%2BB.%26aulast%3DStickens%26aufirst%3DD.%26aulast%3DDeMartino%26aufirst%3DJ.%2BA.%26aulast%3DTong%26aufirst%3DX.%26aulast%3DWolff%26aufirst%3DM.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DMiller%26aufirst%3DR.%2BR.%26aulast%3DSherer%26aufirst%3DE.%2BC.%26aulast%3DHale%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520N-%255Bbis%25284-methoxyphenyl%2529methyl%255D-4-hydroxy-2-%2528pyridazin-3-yl%2529pyrimidine-5-carboxamide%2520%2528MK-8617%2529%252C%2520an%2520orally%2520active%2520pan-inhibitor%2520of%2520hypoxia-inducible%2520factor%2520prolyl%2520hydroxylase%25201%25E2%2580%25933%2520%2528HIF%2520PHD1%25E2%2580%25933%2529%2520for%2520the%2520treatment%2520of%2520anemia%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D11039%26epage%3D11049%26doi%3D10.1021%2Facs.jmedchem.6b01242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, C.</span>; <span class="NLM_string-name">Zou, W.</span>; <span class="NLM_string-name">Hua, Y.</span>; <span class="NLM_string-name">Dang, Q.</span></span> <span> </span><span class="NLM_article-title">Substituted Pyrimidines</span>. <span class="NLM_patent">WO2013040790A1</span>, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=C.+Zhou&author=W.+Zou&author=Y.+Hua&author=Q.+Dang&title=Substituted+Pyrimidines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DC.%26atitle%3DSubstituted%2520Pyrimidines%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dang, Q.</span>; <span class="NLM_string-name">Zhou, C.</span>; <span class="NLM_string-name">Zou, W.</span>; <span class="NLM_string-name">Hua, Y.</span></span> <span> </span><span class="NLM_article-title">Substituted Pyrimidines</span>. <span class="NLM_patent">WO2013043624A1</span>, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=Q.+Dang&author=C.+Zhou&author=W.+Zou&author=Y.+Hua&title=Substituted+Pyrimidines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDang%26aufirst%3DQ.%26atitle%3DSubstituted%2520Pyrimidines%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fletcher, J. M.</span>; <span class="NLM_string-name">Hale, J. J.</span>; <span class="NLM_string-name">Miao, S.</span>; <span class="NLM_string-name">Vachal, P.</span></span> <span> </span><span class="NLM_article-title">Spiroindalones</span>. <span class="NLM_patent">WO2008144266A1</span>, <span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=J.+M.+Fletcher&author=J.+J.+Hale&author=S.+Miao&author=P.+Vachal&title=Spiroindalones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DFletcher%26aufirst%3DJ.%2BM.%26atitle%3DSpiroindalones%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fletcher, J. M.</span>; <span class="NLM_string-name">Hale, J. J.</span>; <span class="NLM_string-name">Miao, S.</span>; <span class="NLM_string-name">Vachal, P.</span></span> <span> </span><span class="NLM_article-title">Spiroazaindoles</span>. <span class="NLM_patent">WO2009137291A2</span>, <span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=J.+M.+Fletcher&author=J.+J.+Hale&author=S.+Miao&author=P.+Vachal&title=Spiroazaindoles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DFletcher%26aufirst%3DJ.%2BM.%26atitle%3DSpiroazaindoles%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vachal, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierce, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guiadeen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colandrea, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyvratt, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salowe, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sonatore, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milligan, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hajdu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gollapudi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keohane, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lingham, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandala, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeMartino, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolff, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinhuebel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kieczykowski, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleitz, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Athanasopoulos, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adam, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akyuz, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jena, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lusen, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stein, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherer, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hale, J. J.</span></span> <span> </span><span class="NLM_article-title">1,3,8-Triazaspiro[4.5]decane-2,4-diones as efficacious pan-inhibitors of hypoxia-inducible factor prolyl hydroxylase 1–3 (HIF PHD1–3) for the treatment of anemia</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">2945</span>– <span class="NLM_lpage">2959</span>, <span class="refDoi"> DOI: 10.1021/jm201542d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201542d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=1%3ACAS%3A528%3ADC%252BC38XivVOhtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=2945-2959&author=P.+Vachalauthor=S.+Miaoauthor=J.+M.+Pierceauthor=D.+Guiadeenauthor=V.+J.+Colandreaauthor=M.+J.+Wyvrattauthor=S.+P.+Saloweauthor=L.+M.+Sonatoreauthor=J.+A.+Milliganauthor=R.+Hajduauthor=A.+Gollapudiauthor=C.+A.+Keohaneauthor=R.+B.+Linghamauthor=S.+M.+Mandalaauthor=J.+A.+DeMartinoauthor=X.+Tongauthor=M.+Wolffauthor=D.+Steinhuebelauthor=G.+R.+Kieczykowskiauthor=F.+J.+Fleitzauthor=K.+Chapmanauthor=J.+Athanasopoulosauthor=G.+Adamauthor=C.+D.+Akyuzauthor=D.+K.+Jenaauthor=J.+W.+Lusenauthor=J.+Mengauthor=B.+D.+Steinauthor=L.+Xiaauthor=E.+C.+Shererauthor=J.+J.+Hale&title=1%2C3%2C8-Triazaspiro%5B4.5%5Ddecane-2%2C4-diones+as+efficacious+pan-inhibitors+of+hypoxia-inducible+factor+prolyl+hydroxylase+1%E2%80%933+%28HIF+PHD1%E2%80%933%29+for+the+treatment+of+anemia&doi=10.1021%2Fjm201542d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">1,3,8-Triazaspiro[4.5]decane-2,4-diones as Efficacious Pan-Inhibitors of Hypoxia-Inducible Factor Prolyl Hydroxylase 1-3 (HIF PHD1-3) for the Treatment of Anemia</span></div><div class="casAuthors">Vachal, Petr; Miao, Shouwu; Pierce, Joan M.; Guiadeen, Deodial; Colandrea, Vincent J.; Wyvratt, Matthew J.; Salowe, Scott P.; Sonatore, Lisa M.; Milligan, James A.; Hajdu, Richard; Gollapudi, Anantha; Keohane, Carol A.; Lingham, Russell B.; Mandala, Suzanne M.; DeMartino, Julie A.; Tong, Xinchun; Wolff, Michael; Steinhuebel, Dietrich; Kieczykowski, Gerard R.; Fleitz, Fred J.; Chapman, Kevin; Athanasopoulos, John; Adam, Gregory; Akyuz, Can D.; Jena, Dhirendra K.; Lusen, Jeffrey W.; Meng, Juncai; Stein, Benjamin D.; Xia, Lei; Sherer, Edward C.; Hale, Jeffrey J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2945-2959</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The discovery of 1,3,8-triazaspiro[4.5]decane-2,4-diones (spirohydantoins) as a structural class of pan-inhibitors of the prolyl hydroxylase (PHD) family of enzymes for the treatment of anemia is described.  The initial hit class, spirooxindoles, was identified through affinity selection mass spectrometry (AS-MS) and optimized for PHD2 inhibition and optimal PK/PD profile (short-acting PHDi inhibitors). 1,3,8-Triazaspiro[4.5]decane-2,4-diones (spirohydantoins) were optimized as an advanced lead class derived from the original spiroindole hit.  A new set of general conditions for C-N coupling, developed using a high-throughput experimentation (HTE) technique, enabled a full SAR anal. of the spirohydantoins.  This rapid and directed SAR exploration has resulted in the first reported examples of hydantoin derivs. with good PK in preclin. species.  Potassium channel off-target activity (hERG) was successfully eliminated through the systematic introduction of acidic functionality to the mol. structure.  Undesired upregulation of alanine aminotransferase (ALT) liver enzymes was mitigated and a robust on-/off-target margin was achieved.  Spirohydantoins represent a class of highly efficacious, short-acting PHD1-3 inhibitors causing a robust erythropoietin (EPO) upregulation in vivo in multiple preclin. species.  This profile deems spirohydantoins as attractive short-acting PHDi inhibitors with the potential for treatment of anemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMoX0fQFHBsLVg90H21EOLACvtfcHk0lg-Ucj1LAFg7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XivVOhtLs%253D&md5=3d23fd3c5379c259eb556d1fac6133de</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1021%2Fjm201542d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201542d%26sid%3Dliteratum%253Aachs%26aulast%3DVachal%26aufirst%3DP.%26aulast%3DMiao%26aufirst%3DS.%26aulast%3DPierce%26aufirst%3DJ.%2BM.%26aulast%3DGuiadeen%26aufirst%3DD.%26aulast%3DColandrea%26aufirst%3DV.%2BJ.%26aulast%3DWyvratt%26aufirst%3DM.%2BJ.%26aulast%3DSalowe%26aufirst%3DS.%2BP.%26aulast%3DSonatore%26aufirst%3DL.%2BM.%26aulast%3DMilligan%26aufirst%3DJ.%2BA.%26aulast%3DHajdu%26aufirst%3DR.%26aulast%3DGollapudi%26aufirst%3DA.%26aulast%3DKeohane%26aufirst%3DC.%2BA.%26aulast%3DLingham%26aufirst%3DR.%2BB.%26aulast%3DMandala%26aufirst%3DS.%2BM.%26aulast%3DDeMartino%26aufirst%3DJ.%2BA.%26aulast%3DTong%26aufirst%3DX.%26aulast%3DWolff%26aufirst%3DM.%26aulast%3DSteinhuebel%26aufirst%3DD.%26aulast%3DKieczykowski%26aufirst%3DG.%2BR.%26aulast%3DFleitz%26aufirst%3DF.%2BJ.%26aulast%3DChapman%26aufirst%3DK.%26aulast%3DAthanasopoulos%26aufirst%3DJ.%26aulast%3DAdam%26aufirst%3DG.%26aulast%3DAkyuz%26aufirst%3DC.%2BD.%26aulast%3DJena%26aufirst%3DD.%2BK.%26aulast%3DLusen%26aufirst%3DJ.%2BW.%26aulast%3DMeng%26aufirst%3DJ.%26aulast%3DStein%26aufirst%3DB.%2BD.%26aulast%3DXia%26aufirst%3DL.%26aulast%3DSherer%26aufirst%3DE.%2BC.%26aulast%3DHale%26aufirst%3DJ.%2BJ.%26atitle%3D1%252C3%252C8-Triazaspiro%255B4.5%255Ddecane-2%252C4-diones%2520as%2520efficacious%2520pan-inhibitors%2520of%2520hypoxia-inducible%2520factor%2520prolyl%2520hydroxylase%25201%25E2%2580%25933%2520%2528HIF%2520PHD1%25E2%2580%25933%2529%2520for%2520the%2520treatment%2520of%2520anemia%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D2945%26epage%3D2959%26doi%3D10.1021%2Fjm201542d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref114"><div class="reference"><strong class="refLabel"><a href="#ref114" class="rightTabRefNumLink">114</a></strong><div class="NLM_citation" id="rightTab-cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pierce, J. M.</span>; <span class="NLM_string-name">Hale, J. J.</span>; <span class="NLM_string-name">Miao, S.</span>; <span class="NLM_string-name">Vachal, P.</span></span> <span> </span><span class="NLM_article-title">Substituted 1,3,8-Triazaspiro[4,5]decane-2,4-diones</span>. <span class="NLM_patent">WO2010147776A1</span>, <span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=J.+M.+Pierce&author=J.+J.+Hale&author=S.+Miao&author=P.+Vachal&title=Substituted+1%2C3%2C8-Triazaspiro%5B4%2C5%5Ddecane-2%2C4-diones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DPierce%26aufirst%3DJ.%2BM.%26atitle%3DSubstituted%25201%252C3%252C8-Triazaspiro%255B4%252C5%255Ddecane-2%252C4-diones%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref115"><div class="reference"><strong class="refLabel"><a href="#ref115" class="rightTabRefNumLink">115</a></strong><div class="NLM_citation" id="rightTab-cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Deng, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, T. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, F.</span></span> <span> </span><span class="NLM_article-title">Novel complex crystal structure of prolyl hydroxylase domain-containing protein 2 (PHD2): 2,8-Diazaspiro[4.5]decan-1-ones as potent, orally bioavailable PHD2 inhibitors</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">6349</span>– <span class="NLM_lpage">6358</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2013.08.046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1016%2Fj.bmc.2013.08.046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=24055079" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVOktL%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=6349-6358&author=G.+Dengauthor=B.+Zhaoauthor=Y.+Maauthor=Q.+Xuauthor=H.+Wangauthor=L.+Yangauthor=Q.+Zhangauthor=T.+B.+Guoauthor=W.+Zhangauthor=Y.+Jiaoauthor=X.+Caiauthor=J.+Zhangauthor=H.+Liuauthor=X.+Guanauthor=H.+Luauthor=J.+Xiangauthor=J.+D.+Elliottauthor=X.+Linauthor=F.+Ren&title=Novel+complex+crystal+structure+of+prolyl+hydroxylase+domain-containing+protein+2+%28PHD2%29%3A+2%2C8-Diazaspiro%5B4.5%5Ddecan-1-ones+as+potent%2C+orally+bioavailable+PHD2+inhibitors&doi=10.1016%2Fj.bmc.2013.08.046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Novel complex crystal structure of prolyl hydroxylase domain-containing protein 2 (PHD2): 2,8-Diazaspiro[4.5]decan-1-ones as potent, orally bioavailable PHD2 inhibitors</span></div><div class="casAuthors">Deng, Guanghui; Zhao, Baowei; Ma, Yingli; Xu, Qiongfeng; Wang, Hailong; Yang, Liuqing; Zhang, Qing; Guo, Taylor B.; Zhang, Wei; Jiao, Yang; Cai, Xin; Zhang, Jinqiang; Liu, Houfu; Guan, Xiaoming; Lu, Hongtao; Xiang, Jianing; Elliott, John D.; Lin, Xichen; Ren, Feng</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6349-6358</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We have discovered a novel complex crystal structure of the PHD2 enzyme with its inhibitor, the 2,8-diazaspiro[4.5]decan-1-one analog 4b.  The widely reported salt bridge between Arg383 of the enzyme and its inhibitors in all complex structures published thus far was not obsd. in our case.  In our complex structure compd. 4b forms several novel interactions with the enzyme, which include a hydrogen bond with Arg322, a π-cation interaction with Arg322, a π-π stacking with Trp389, and a π-π stacking with His313.  Guided by the structural information, SAR studies were performed on the 2,8-diazaspiro[4.5]decan-1-one series leading to the discovery of compd. 9p with high potency and good oral pharmacokinetic profile in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqNWYl7HPN17Vg90H21EOLACvtfcHk0lh81lLKoKFmzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVOktL%252FE&md5=0031299974826f02e70f62914fa48e49</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2013.08.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2013.08.046%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DG.%26aulast%3DZhao%26aufirst%3DB.%26aulast%3DMa%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DGuo%26aufirst%3DT.%2BB.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DJiao%26aufirst%3DY.%26aulast%3DCai%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DGuan%26aufirst%3DX.%26aulast%3DLu%26aufirst%3DH.%26aulast%3DXiang%26aufirst%3DJ.%26aulast%3DElliott%26aufirst%3DJ.%2BD.%26aulast%3DLin%26aufirst%3DX.%26aulast%3DRen%26aufirst%3DF.%26atitle%3DNovel%2520complex%2520crystal%2520structure%2520of%2520prolyl%2520hydroxylase%2520domain-containing%2520protein%25202%2520%2528PHD2%2529%253A%25202%252C8-Diazaspiro%255B4.5%255Ddecan-1-ones%2520as%2520potent%252C%2520orally%2520bioavailable%2520PHD2%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26spage%3D6349%26epage%3D6358%26doi%3D10.1016%2Fj.bmc.2013.08.046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref116"><div class="reference"><strong class="refLabel"><a href="#ref116" class="rightTabRefNumLink">116</a></strong><div class="NLM_citation" id="rightTab-cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Flamme, I.</span>; <span class="NLM_string-name">Ergueden, J.-K.</span>; <span class="NLM_string-name">Oehme, F.</span>; <span class="NLM_string-name">Thede, K.</span>; <span class="NLM_string-name">Karig, G.</span>; <span class="NLM_string-name">Kuhl, A.</span>; <span class="NLM_string-name">Wild, H.</span>; <span class="NLM_string-name">Schuhmacher, J.</span>; <span class="NLM_string-name">Kolkhof, P.</span>; <span class="NLM_string-name">Baerfacker, L.</span>; <span class="NLM_string-name">Huetter, J.</span></span> <span> </span><span class="NLM_article-title">Dipyridyl-Dihydropyrazolones and Their Use</span>. <span class="NLM_patent">US2010035906A1</span>, <span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=I.+Flamme&author=J.-K.+Ergueden&author=F.+Oehme&author=K.+Thede&author=G.+Karig&author=A.+Kuhl&author=H.+Wild&author=J.+Schuhmacher&author=P.+Kolkhof&author=L.+Baerfacker&author=J.+Huetter&title=Dipyridyl-Dihydropyrazolones+and+Their+Use"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DFlamme%26aufirst%3DI.%26atitle%3DDipyridyl-Dihydropyrazolones%2520and%2520Their%2520Use%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref117"><div class="reference"><strong class="refLabel"><a href="#ref117" class="rightTabRefNumLink">117</a></strong><div class="NLM_citation" id="rightTab-cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thede, K.</span>; <span class="NLM_string-name">Flamme, I.</span>; <span class="NLM_string-name">Oehme, F.</span>; <span class="NLM_string-name">Ergueden, J. K.</span>; <span class="NLM_string-name">Stoll, F.</span>; <span class="NLM_string-name">Schuhmacher, J.</span>; <span class="NLM_string-name">Wild, H.</span>; <span class="NLM_string-name">Kolkhof, P.</span>; <span class="NLM_string-name">Beck, H.</span>; <span class="NLM_string-name">Keldenich, J.</span>; <span class="NLM_string-name">Akbaba, M.</span>; <span class="NLM_string-name">Jeske, M.</span></span> <span> </span><span class="NLM_article-title">Substituted Dihydropyrazolones for Treating Cardiovascular and Hematological Diseases</span>. <span class="NLM_patent">US20100305085A1</span>, <span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=K.+Thede&author=I.+Flamme&author=F.+Oehme&author=J.+K.+Ergueden&author=F.+Stoll&author=J.+Schuhmacher&author=H.+Wild&author=P.+Kolkhof&author=H.+Beck&author=J.+Keldenich&author=M.+Akbaba&author=M.+Jeske&title=Substituted+Dihydropyrazolones+for+Treating+Cardiovascular+and+Hematological+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DThede%26aufirst%3DK.%26atitle%3DSubstituted%2520Dihydropyrazolones%2520for%2520Treating%2520Cardiovascular%2520and%2520Hematological%2520Diseases%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref118"><div class="reference"><strong class="refLabel"><a href="#ref118" class="rightTabRefNumLink">118</a></strong><div class="NLM_citation" id="rightTab-cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jeske, M.</span>; <span class="NLM_string-name">Flamme, I.</span>; <span class="NLM_string-name">Stoll, F.</span>; <span class="NLM_string-name">Oehme, F.</span></span> <span> </span><span class="NLM_article-title">Dihydropyrazolthiones as HIF Prolylhydroxylase Inhibitors</span>. <span class="NLM_patent">DE102007048447A1</span>, <span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=M.+Jeske&author=I.+Flamme&author=F.+Stoll&author=F.+Oehme&title=Dihydropyrazolthiones+as+HIF+Prolylhydroxylase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DJeske%26aufirst%3DM.%26atitle%3DDihydropyrazolthiones%2520as%2520HIF%2520Prolylhydroxylase%2520Inhibitors%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref119"><div class="reference"><strong class="refLabel"><a href="#ref119" class="rightTabRefNumLink">119</a></strong><div class="NLM_citation" id="rightTab-cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jeske, M.</span>; <span class="NLM_string-name">Flamme, I.</span>; <span class="NLM_string-name">Stoll, F.</span>; <span class="NLM_string-name">Oehme, F.</span>; <span class="NLM_string-name">Akbaba, M.</span></span> <span> </span><span class="NLM_article-title">Dihydrotriazolones as HIF Prolylhydroxylase Inhibitors</span>. <span class="NLM_patent">DE102007049157A1</span>, <span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=M.+Jeske&author=I.+Flamme&author=F.+Stoll&author=F.+Oehme&author=M.+Akbaba&title=Dihydrotriazolones+as+HIF+Prolylhydroxylase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DJeske%26aufirst%3DM.%26atitle%3DDihydrotriazolones%2520as%2520HIF%2520Prolylhydroxylase%2520Inhibitors%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref120"><div class="reference"><strong class="refLabel"><a href="#ref120" class="rightTabRefNumLink">120</a></strong><div class="NLM_citation" id="rightTab-cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beck, H.</span>; <span class="NLM_string-name">Jeske, M.</span>; <span class="NLM_string-name">Thede, K.</span>; <span class="NLM_string-name">Stoll, F.</span>; <span class="NLM_string-name">Flamme, I.</span>; <span class="NLM_string-name">Akbaba, M.</span>; <span class="NLM_string-name">Ergüden, J. K.</span>; <span class="NLM_string-name">Karig, G.</span>; <span class="NLM_string-name">Keldenich, J.</span>; <span class="NLM_string-name">Oehme, F.</span>; <span class="NLM_string-name">Militzer, H. C.</span>; <span class="NLM_string-name">Hartung, I. V.</span>; <span class="NLM_string-name">Thuss, U.</span></span> <span> </span><span class="NLM_article-title">Discovery of Molidustat (BAY 85-3934): A small-molecule oral HIF-prolyl hydroxylase (HIF-PH) inhibitor for the treatment of renal anemia</span>.  <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2018</span>, DOI: <span class="refDoi"> DOI: 10.1002/cmdc.201700783</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1002%2Fcmdc.201700783" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=H.+Beck&author=M.+Jeske&author=K.+Thede&author=F.+Stoll&author=I.+Flamme&author=M.+Akbaba&author=J.+K.+Erg%C3%BCden&author=G.+Karig&author=J.+Keldenich&author=F.+Oehme&author=H.+C.+Militzer&author=I.+V.+Hartung&author=U.+Thuss&title=Discovery+of+Molidustat+%28BAY+85-3934%29%3A+A+small-molecule+oral+HIF-prolyl+hydroxylase+%28HIF-PH%29+inhibitor+for+the+treatment+of+renal+anemia&doi=10.1002%2Fcmdc.201700783"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201700783&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201700783%26sid%3Dliteratum%253Aachs%26aulast%3DBeck%26aufirst%3DH.%26atitle%3DDiscovery%2520of%2520Molidustat%2520%2528BAY%252085-3934%2529%253A%2520A%2520small-molecule%2520oral%2520HIF-prolyl%2520hydroxylase%2520%2528HIF-PH%2529%2520inhibitor%2520for%2520the%2520treatment%2520of%2520renal%2520anemia%26jtitle%3DChemMedChem%26date%3D2018%26doi%3D10.1002%2Fcmdc.201700783" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref121"><div class="reference"><strong class="refLabel"><a href="#ref121" class="rightTabRefNumLink">121</a></strong><div class="NLM_citation" id="rightTab-cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Flamme, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oehme, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellinghaus, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeske, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keldenich, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thuss, U.</span></span> <span> </span><span class="NLM_article-title">Mimicking hypoxia to treat anemia: HIF-stabilizer BAY 85–3934 (Molidustat) stimulates erythropoietin production without hypertensive effects</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">e111838</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0111838</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1371%2Fjournal.pone.0111838" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=e111838&author=I.+Flammeauthor=F.+Oehmeauthor=P.+Ellinghausauthor=M.+Jeskeauthor=J.+Keldenichauthor=U.+Thuss&title=Mimicking+hypoxia+to+treat+anemia%3A+HIF-stabilizer+BAY+85%E2%80%933934+%28Molidustat%29+stimulates+erythropoietin+production+without+hypertensive+effects&doi=10.1371%2Fjournal.pone.0111838"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0111838&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0111838%26sid%3Dliteratum%253Aachs%26aulast%3DFlamme%26aufirst%3DI.%26aulast%3DOehme%26aufirst%3DF.%26aulast%3DEllinghaus%26aufirst%3DP.%26aulast%3DJeske%26aufirst%3DM.%26aulast%3DKeldenich%26aufirst%3DJ.%26aulast%3DThuss%26aufirst%3DU.%26atitle%3DMimicking%2520hypoxia%2520to%2520treat%2520anemia%253A%2520HIF-stabilizer%2520BAY%252085%25E2%2580%25933934%2520%2528Molidustat%2529%2520stimulates%2520erythropoietin%2520production%2520without%2520hypertensive%2520effects%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26spage%3De111838%26doi%3D10.1371%2Fjournal.pone.0111838" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref122"><div class="reference"><strong class="refLabel"><a href="#ref122" class="rightTabRefNumLink">122</a></strong><div class="NLM_citation" id="rightTab-cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brown, J. W.</span>; <span class="NLM_string-name">Davis, M.</span>; <span class="NLM_string-name">Ivetac, A.</span>; <span class="NLM_string-name">Jones, B.</span>; <span class="NLM_string-name">Kiryanov, A. A.</span>; <span class="NLM_string-name">Kuehler, J.</span>; <span class="NLM_string-name">Lanier, M.</span>; <span class="NLM_string-name">Miura, J.</span>; <span class="NLM_string-name">Murphy, S.</span>; <span class="NLM_string-name">Wang, X.</span></span> <span> </span><span class="NLM_article-title">6-(5-Hydroxy-1<i>H</i>-pyrazol-1-yl)nicotinamide Derivatives and Their Use as PHD Inhibitors</span>. <span class="NLM_patent">WO2014160810A1</span>, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=J.+W.+Brown&author=M.+Davis&author=A.+Ivetac&author=B.+Jones&author=A.+A.+Kiryanov&author=J.+Kuehler&author=M.+Lanier&author=J.+Miura&author=S.+Murphy&author=X.+Wang&title=6-%285-Hydroxy-1H-pyrazol-1-yl%29nicotinamide+Derivatives+and+Their+Use+as+PHD+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DJ.%2BW.%26atitle%3D6-%25285-Hydroxy-1H-pyrazol-1-yl%2529nicotinamide%2520Derivatives%2520and%2520Their%2520Use%2520as%2520PHD%2520Inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref123"><div class="reference"><strong class="refLabel"><a href="#ref123" class="rightTabRefNumLink">123</a></strong><div class="NLM_citation" id="rightTab-cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carmeliet, P.</span></span> <span> </span><span class="NLM_article-title">Angiogenesis in health and disease</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">653</span>– <span class="NLM_lpage">660</span>, <span class="refDoi"> DOI: 10.1038/nm0603-653</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1038%2Fnm0603-653" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=12778163" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=1%3ACAS%3A528%3ADC%252BD3sXktFOntbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2003&pages=653-660&author=P.+Carmeliet&title=Angiogenesis+in+health+and+disease&doi=10.1038%2Fnm0603-653"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">Angiogenesis in health and disease</span></div><div class="casAuthors">Carmeliet, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">653-660</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Blood vessels constitute the first organ in the embryo and form the largest network in our body but, sadly, are also often deadly.  When dysregulated, the formation of new blood vessels contributes to numerous malignant, ischemic, inflammatory, infectious and immune disorders.  Mol. insights into these processes are being generated at a rapidly increasing pace, offering new therapeutic opportunities that are currently being evaluated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVe6HXO3QPLbVg90H21EOLACvtfcHk0lip0S2B7cSIfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXktFOntbY%253D&md5=501ed35c48dbcc7c9d18b804c996284a</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1038%2Fnm0603-653&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm0603-653%26sid%3Dliteratum%253Aachs%26aulast%3DCarmeliet%26aufirst%3DP.%26atitle%3DAngiogenesis%2520in%2520health%2520and%2520disease%26jtitle%3DNat.%2520Med.%26date%3D2003%26volume%3D9%26spage%3D653%26epage%3D660%26doi%3D10.1038%2Fnm0603-653" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref124"><div class="reference"><strong class="refLabel"><a href="#ref124" class="rightTabRefNumLink">124</a></strong><div class="NLM_citation" id="rightTab-cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sakamoto, A.</span>; <span class="NLM_string-name">Tanaka, N.</span>; <span class="NLM_string-name">Fukuda, T.</span></span> <span> </span><span class="NLM_article-title">4-Alkanoylamino-3-pyrazolone Derivative</span>. <span class="NLM_patent">US2015011552A1</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=A.+Sakamoto&author=N.+Tanaka&author=T.+Fukuda&title=4-Alkanoylamino-3-pyrazolone+Derivative"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSakamoto%26aufirst%3DA.%26atitle%3D4-Alkanoylamino-3-pyrazolone%2520Derivative%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref125"><div class="reference"><strong class="refLabel"><a href="#ref125" class="rightTabRefNumLink">125</a></strong><div class="NLM_citation" id="rightTab-cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Suga, Y.</span>; <span class="NLM_string-name">Shimizu, Y.</span>; <span class="NLM_string-name">Kawabe, K.</span>; <span class="NLM_string-name">Bohno, A.</span>; <span class="NLM_string-name">Hamada, M.</span>; <span class="NLM_string-name">Takahashi, M.</span></span> <span> </span><span class="NLM_article-title">Heteroaryl Compound Substituted by Triazolyl</span>. <span class="NLM_patent">WO2015163472A1</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=Y.+Suga&author=Y.+Shimizu&author=K.+Kawabe&author=A.+Bohno&author=M.+Hamada&author=M.+Takahashi&title=Heteroaryl+Compound+Substituted+by+Triazolyl"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSuga%26aufirst%3DY.%26atitle%3DHeteroaryl%2520Compound%2520Substituted%2520by%2520Triazolyl%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref126"><div class="reference"><strong class="refLabel"><a href="#ref126" class="rightTabRefNumLink">126</a></strong><div class="NLM_citation" id="rightTab-cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hong, Y. R.</span>; <span class="NLM_string-name">Shin, D.</span>; <span class="NLM_string-name">Ro, S.</span>; <span class="NLM_string-name">Cho, J.
M.</span>; <span class="NLM_string-name">Kim, H. T.</span>; <span class="NLM_string-name">Lee, J. H.</span>; <span class="NLM_string-name">Kim, J. M.</span>; <span class="NLM_string-name">Lee, W. S.</span>; <span class="NLM_string-name">Choi, J. R.</span></span> <span> </span><span class="NLM_article-title">Phenol Derivatives and Methods of Use Thereof</span>. <span class="NLM_patent">WO2010018458A2</span>, <span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=Y.+R.+Hong&author=D.+Shin&author=S.+Ro&author=J.%0AM.+Cho&author=H.+T.+Kim&author=J.+H.+Lee&author=J.+M.+Kim&author=W.+S.+Lee&author=J.+R.+Choi&title=Phenol+Derivatives+and+Methods+of+Use+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHong%26aufirst%3DY.%2BR.%26atitle%3DPhenol%2520Derivatives%2520and%2520Methods%2520of%2520Use%2520Thereof%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref127"><div class="reference"><strong class="refLabel"><a href="#ref127" class="rightTabRefNumLink">127</a></strong><div class="NLM_citation" id="rightTab-cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hong, Y. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, I. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, Y. H.</span></span> <span> </span><span class="NLM_article-title">Discovery of novel 2-[2-(3-hydroxy-pyridin-2-yl)-thiazol-4-yl]-acetamide derivatives as HIF prolyl 4-hydroxylase inhibitors; SAR, synthesis and modeling evaluation</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">3142</span>– <span class="NLM_lpage">3145</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2014.05.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1016%2Fj.bmcl.2014.05.003" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=3142-3145&author=Y.+R.+Hongauthor=H.+T.+Kimauthor=S.+Roauthor=J.+M.+Choauthor=S.+H.+Leeauthor=I.+S.+Kimauthor=Y.+H.+Jung&title=Discovery+of+novel+2-%5B2-%283-hydroxy-pyridin-2-yl%29-thiazol-4-yl%5D-acetamide+derivatives+as+HIF+prolyl+4-hydroxylase+inhibitors%3B+SAR%2C+synthesis+and+modeling+evaluation&doi=10.1016%2Fj.bmcl.2014.05.003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.05.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.05.003%26sid%3Dliteratum%253Aachs%26aulast%3DHong%26aufirst%3DY.%2BR.%26aulast%3DKim%26aufirst%3DH.%2BT.%26aulast%3DRo%26aufirst%3DS.%26aulast%3DCho%26aufirst%3DJ.%2BM.%26aulast%3DLee%26aufirst%3DS.%2BH.%26aulast%3DKim%26aufirst%3DI.%2BS.%26aulast%3DJung%26aufirst%3DY.%2BH.%26atitle%3DDiscovery%2520of%2520novel%25202-%255B2-%25283-hydroxy-pyridin-2-yl%2529-thiazol-4-yl%255D-acetamide%2520derivatives%2520as%2520HIF%2520prolyl%25204-hydroxylase%2520inhibitors%253B%2520SAR%252C%2520synthesis%2520and%2520modeling%2520evaluation%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D3142%26epage%3D3145%26doi%3D10.1016%2Fj.bmcl.2014.05.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref128"><div class="reference"><strong class="refLabel"><a href="#ref128" class="rightTabRefNumLink">128</a></strong><div class="NLM_citation" id="rightTab-cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, S.</span>; <span class="NLM_string-name">Barker, G.</span>; <span class="NLM_string-name">Canning, H.</span>; <span class="NLM_string-name">Davenport, R.</span>; <span class="NLM_string-name">Harrison, D.</span>; <span class="NLM_string-name">Jenkins, K.</span>; <span class="NLM_string-name">Livermore, D.</span>; <span class="NLM_string-name">Wright, S.</span>; <span class="NLM_string-name">Kinsella, N.</span></span> <span> </span><span class="NLM_article-title">Fused Bicyclic Heteroaryl Derivatives having Activity as PHD Inhibitors</span>. <span class="NLM_patent">WO2016148306A1</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=S.+Ahmed&author=G.+Barker&author=H.+Canning&author=R.+Davenport&author=D.+Harrison&author=K.+Jenkins&author=D.+Livermore&author=S.+Wright&author=N.+Kinsella&title=Fused+Bicyclic+Heteroaryl+Derivatives+having+Activity+as+PHD+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAhmed%26aufirst%3DS.%26atitle%3DFused%2520Bicyclic%2520Heteroaryl%2520Derivatives%2520having%2520Activity%2520as%2520PHD%2520Inhibitors%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref129"><div class="reference"><strong class="refLabel"><a href="#ref129" class="rightTabRefNumLink">129</a></strong><div class="NLM_citation" id="rightTab-cit129"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ayscough, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barker, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canning, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davenport, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Downham, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenkins, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinsella, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Livermore, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ivetac, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skene, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkens, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webster, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hendrick, A. G.</span></span> <span> </span><span class="NLM_article-title">1,2,4-Triazolo-[1,5-a]pyridine HIF prolyl hydroxylase domain-1 (PHD-1) inhibitors with a novel monodentate binding interaction</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">5663</span>– <span class="NLM_lpage">5672</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00352</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00352" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=5663-5672&author=S.+Ahmedauthor=A.+Ayscoughauthor=G.+R.+Barkerauthor=H.+E.+Canningauthor=R.+Davenportauthor=R.+Downhamauthor=D.+Harrisonauthor=K.+Jenkinsauthor=N.+Kinsellaauthor=D.+G.+Livermoreauthor=S.+Wrightauthor=A.+D.+Ivetacauthor=R.+Skeneauthor=S.+J.+Wilkensauthor=N.+A.+Websterauthor=A.+G.+Hendrick&title=1%2C2%2C4-Triazolo-%5B1%2C5-a%5Dpyridine+HIF+prolyl+hydroxylase+domain-1+%28PHD-1%29+inhibitors+with+a+novel+monodentate+binding+interaction&doi=10.1021%2Facs.jmedchem.7b00352"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00352&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00352%26sid%3Dliteratum%253Aachs%26aulast%3DAhmed%26aufirst%3DS.%26aulast%3DAyscough%26aufirst%3DA.%26aulast%3DBarker%26aufirst%3DG.%2BR.%26aulast%3DCanning%26aufirst%3DH.%2BE.%26aulast%3DDavenport%26aufirst%3DR.%26aulast%3DDownham%26aufirst%3DR.%26aulast%3DHarrison%26aufirst%3DD.%26aulast%3DJenkins%26aufirst%3DK.%26aulast%3DKinsella%26aufirst%3DN.%26aulast%3DLivermore%26aufirst%3DD.%2BG.%26aulast%3DWright%26aufirst%3DS.%26aulast%3DIvetac%26aufirst%3DA.%2BD.%26aulast%3DSkene%26aufirst%3DR.%26aulast%3DWilkens%26aufirst%3DS.%2BJ.%26aulast%3DWebster%26aufirst%3DN.%2BA.%26aulast%3DHendrick%26aufirst%3DA.%2BG.%26atitle%3D1%252C2%252C4-Triazolo-%255B1%252C5-a%255Dpyridine%2520HIF%2520prolyl%2520hydroxylase%2520domain-1%2520%2528PHD-1%2529%2520inhibitors%2520with%2520a%2520novel%2520monodentate%2520binding%2520interaction%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D5663%26epage%3D5672%26doi%3D10.1021%2Facs.jmedchem.7b00352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref130"><div class="reference"><strong class="refLabel"><a href="#ref130" class="rightTabRefNumLink">130</a></strong><div class="NLM_citation" id="rightTab-cit130"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yeoh, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thalhammer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demetriades, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chowdhury, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stolze, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNeill, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woon, E. C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackeen, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawamura, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ratcliffe, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mecinović, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, C.</span></span> <span> </span><span class="NLM_article-title">Dual-action inhibitors of HIF prolyl hydroxylases that induce binding of a second iron ion</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">732</span>– <span class="NLM_lpage">745</span>, <span class="refDoi"> DOI: 10.1039/C2OB26648B</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1039%2FC2OB26648B" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=23151668" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjtlGitA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2013&pages=732-745&author=K.+K.+Yeohauthor=M.+C.+Chanauthor=A.+Thalhammerauthor=M.+Demetriadesauthor=R.+Chowdhuryauthor=Y.+M.+Tianauthor=I.+Stolzeauthor=L.+A.+McNeillauthor=M.+K.+Leeauthor=E.+C.+Y.+Woonauthor=M.+M.+Mackeenauthor=A.+Kawamuraauthor=P.+J.+Ratcliffeauthor=J.+Mecinovi%C4%87author=C.+Schofield&title=Dual-action+inhibitors+of+HIF+prolyl+hydroxylases+that+induce+binding+of+a+second+iron+ion&doi=10.1039%2FC2OB26648B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">Dual-action inhibitors of HIF prolyl hydroxylases that induce binding of a second iron ion</span></div><div class="casAuthors">Yeoh, Kar Kheng; Chan, Mun Chiang; Thalhammer, Armin; Demetriades, Marina; Chowdhury, Rasheduzzaman; Tian, Ya-Min; Stolze, Ineke; McNeill, Luke A.; Lee, Myung Kyu; Woon, Esther C. Y.; Mackeen, Mukram M.; Kawamura, Akane; Ratcliffe, Peter J.; Mecinovic, Jasmin; Schofield, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">732-745</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Inhibition of the hypoxia-inducible factor (HIF) prolyl hydroxylases (PHD or EGLN enzymes) is of interest for the treatment of anemia and ischemia-related diseases.  Most PHD inhibitors work by binding to the single ferrous ion and competing with 2-oxoglutarate (2OG) co-substrate for binding at the PHD active site.  Non-specific iron chelators also inhibit the PHDs, both in vitro and in cells.  The authors report the identification of dual action PHD inhibitors, which bind to the active site iron and also induce the binding of a second iron ion at the active site.  Following anal. of small-mol. iron complexes and application of non-denaturing protein mass spectrometry to assess PHD2·iron·inhibitor stoichiometry, selected diacylhydrazines were identified as PHD2 inhibitors that induce the binding of a second iron ion.  Some compds. were shown to inhibit the HIF hydroxylases in human hepatoma and renal carcinoma cell lines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGph9TkImzYXwLVg90H21EOLACvtfcHk0lhEecBrU-lxRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjtlGitA%253D%253D&md5=797d732fe07a58d6e1f1c82ebb507b1e</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1039%2FC2OB26648B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC2OB26648B%26sid%3Dliteratum%253Aachs%26aulast%3DYeoh%26aufirst%3DK.%2BK.%26aulast%3DChan%26aufirst%3DM.%2BC.%26aulast%3DThalhammer%26aufirst%3DA.%26aulast%3DDemetriades%26aufirst%3DM.%26aulast%3DChowdhury%26aufirst%3DR.%26aulast%3DTian%26aufirst%3DY.%2BM.%26aulast%3DStolze%26aufirst%3DI.%26aulast%3DMcNeill%26aufirst%3DL.%2BA.%26aulast%3DLee%26aufirst%3DM.%2BK.%26aulast%3DWoon%26aufirst%3DE.%2BC.%2BY.%26aulast%3DMackeen%26aufirst%3DM.%2BM.%26aulast%3DKawamura%26aufirst%3DA.%26aulast%3DRatcliffe%26aufirst%3DP.%2BJ.%26aulast%3DMecinovi%25C4%2587%26aufirst%3DJ.%26aulast%3DSchofield%26aufirst%3DC.%26atitle%3DDual-action%2520inhibitors%2520of%2520HIF%2520prolyl%2520hydroxylases%2520that%2520induce%2520binding%2520of%2520a%2520second%2520iron%2520ion%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2013%26volume%3D11%26spage%3D732%26epage%3D745%26doi%3D10.1039%2FC2OB26648B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref131"><div class="reference"><strong class="refLabel"><a href="#ref131" class="rightTabRefNumLink">131</a></strong><div class="NLM_citation" id="rightTab-cit131"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Na, Y. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woo, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, E. G.</span></span> <span> </span><span class="NLM_article-title">Pyrithione Zn selectively inhibits hypoxia-inducible factor prolyl hydroxylase PHD3</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>472</i></span>,  <span class="NLM_fpage">313</span>– <span class="NLM_lpage">318</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2016.02.115</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1016%2Fj.bbrc.2016.02.115" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=472&publication_year=2016&pages=313-318&author=Y.+R.+Naauthor=D.+J.+Wooauthor=S.+Y.+Kimauthor=E.+G.+Yang&title=Pyrithione+Zn+selectively+inhibits+hypoxia-inducible+factor+prolyl+hydroxylase+PHD3&doi=10.1016%2Fj.bbrc.2016.02.115"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2016.02.115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2016.02.115%26sid%3Dliteratum%253Aachs%26aulast%3DNa%26aufirst%3DY.%2BR.%26aulast%3DWoo%26aufirst%3DD.%2BJ.%26aulast%3DKim%26aufirst%3DS.%2BY.%26aulast%3DYang%26aufirst%3DE.%2BG.%26atitle%3DPyrithione%2520Zn%2520selectively%2520inhibits%2520hypoxia-inducible%2520factor%2520prolyl%2520hydroxylase%2520PHD3%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2016%26volume%3D472%26spage%3D313%26epage%3D318%26doi%3D10.1016%2Fj.bbrc.2016.02.115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref132"><div class="reference"><strong class="refLabel"><a href="#ref132" class="rightTabRefNumLink">132</a></strong><div class="NLM_citation" id="rightTab-cit132"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Seeley, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sternlicht, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klaus, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neff, T. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D. Y.</span></span> <span> </span><span class="NLM_article-title">Induction of erythropoiesis by hypoxia-inducible factor prolyl hydroxylase inhibitors without promotion of tumor initiation, progression, or metastasis in a VEGF-sensitive model of spontaneous breast cancer</span>. <i>Hypoxia</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">9</span>, <span class="refDoi"> DOI: 10.2147/HP.S130526</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.2147%2FHP.S130526" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2017&pages=1-9&author=T.+W.+Seeleyauthor=M.+D.+Sternlichtauthor=S.+J.+Klausauthor=T.+B.+Neffauthor=D.+Y.+Liu&title=Induction+of+erythropoiesis+by+hypoxia-inducible+factor+prolyl+hydroxylase+inhibitors+without+promotion+of+tumor+initiation%2C+progression%2C+or+metastasis+in+a+VEGF-sensitive+model+of+spontaneous+breast+cancer&doi=10.2147%2FHP.S130526"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.2147%2FHP.S130526&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FHP.S130526%26sid%3Dliteratum%253Aachs%26aulast%3DSeeley%26aufirst%3DT.%2BW.%26aulast%3DSternlicht%26aufirst%3DM.%2BD.%26aulast%3DKlaus%26aufirst%3DS.%2BJ.%26aulast%3DNeff%26aufirst%3DT.%2BB.%26aulast%3DLiu%26aufirst%3DD.%2BY.%26atitle%3DInduction%2520of%2520erythropoiesis%2520by%2520hypoxia-inducible%2520factor%2520prolyl%2520hydroxylase%2520inhibitors%2520without%2520promotion%2520of%2520tumor%2520initiation%252C%2520progression%252C%2520or%2520metastasis%2520in%2520a%2520VEGF-sensitive%2520model%2520of%2520spontaneous%2520breast%2520cancer%26jtitle%3DHypoxia%26date%3D2017%26volume%3D5%26spage%3D1%26epage%3D9%26doi%3D10.2147%2FHP.S130526" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref133"><div class="reference"><strong class="refLabel"><a href="#ref133" class="rightTabRefNumLink">133</a></strong><div class="NLM_citation" id="rightTab-cit133"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Akizawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsubakihara, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nangaku, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Endo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakajima, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohno, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawase, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lepore, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cobitz, A.</span></span> <span> </span><span class="NLM_article-title">Effects of Daprodustat, a novel hypoxia-inducible factor prolyl hydroxylase inhibitor on anemia management in Japanese hemodialysis subjects</span>. <i>Am. J. Nephrol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">127</span>– <span class="NLM_lpage">135</span>, <span class="refDoi"> DOI: 10.1159/000454818</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1159%2F000454818" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=27978511" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjtVGqu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2017&pages=127-135&author=T.+Akizawaauthor=Y.+Tsubakiharaauthor=M.+Nangakuauthor=Y.+Endoauthor=H.+Nakajimaauthor=T.+Kohnoauthor=Y.+Imaiauthor=N.+Kawaseauthor=K.+Haraauthor=J.+Leporeauthor=A.+Cobitz&title=Effects+of+Daprodustat%2C+a+novel+hypoxia-inducible+factor+prolyl+hydroxylase+inhibitor+on+anemia+management+in+Japanese+hemodialysis+subjects&doi=10.1159%2F000454818"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of Daprodustat, a Novel Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor on Anemia Management in Japanese Hemodialysis Subjects</span></div><div class="casAuthors">Akizawa, Tadao; Tsubakihara, Yoshiharu; Nangaku, Masaomi; Endo, Yukihiro; Nakajima, Hiromu; Kohno, Tomoko; Imai, Yukiko; Kawase, Natsumi; Hara, Katsutoshi; Lepore, John; Cobitz, Alexander</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Nephrology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">127-135</span>CODEN:
                <span class="NLM_cas:coden">AJNED9</span>;
        ISSN:<span class="NLM_cas:issn">0250-8095</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">Background: Daprodustat (GSK1278863) is an oral hypoxia-inducible factor prolyl hydroxylase inhibitor being developed for treatment of anemia assocd. with chronic kidney disease (CKD).  The effect of daprodustat in Japanese CKD patients with anemia has not been previously investigated.  Methods: We evaluated the relationship between daprodustat dose and Hb response in Japanese patients on hemodialysis (HD) with anemia in a 4-wk, phase II, double-blind, placebo-controlled study.  After interrupting their erythropoiesis-stimulating agent for between 2 and 8 wk, subjects with Hb 8.5-10.5 g/dL were randomized to placebo or daprodustat 4, 6, 8, or 10 mg orally once daily.  Hb, erythropoietin (EPO), and vascular endothelial growth factor (VEGF) levels during therapy were evaluated.  Results: Eighty-six of 97 randomized subjects completed the study.  Mean baseline Hb ranged from 9.68 to 9.92 g/dL across groups.  After 4-wk administration, mean Hb changes were -0.28, -0.01, 0.54, and 0.97 g/dL in the 4, 6, 8, and 10 mg groups, resp., as compared to -1.41 g/dL for placebo.  Dose-dependent increase in plasma EPO concn. were obsd. up to 8 mg, with the 10 mg dose responses being similar to 8 mg.  Plasma VEGF concns. were minimally changed, even though 5 subjects treated with 6-10 mg reached EPO >500 mIU/mL.  Conclusion: Daprodustat 4-10 mg once-daily produced dose-dependent increase in Hb relative to placebo in Japanese HD subjects.  The doses evaluated in the study have moderately increased endogenous EPO without changes in circulating VEGF levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyY5upHTQiSLVg90H21EOLACvtfcHk0lhEecBrU-lxRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjtVGqu7c%253D&md5=58ea3d73ec47776ca16ffe46dea7c56c</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1159%2F000454818&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000454818%26sid%3Dliteratum%253Aachs%26aulast%3DAkizawa%26aufirst%3DT.%26aulast%3DTsubakihara%26aufirst%3DY.%26aulast%3DNangaku%26aufirst%3DM.%26aulast%3DEndo%26aufirst%3DY.%26aulast%3DNakajima%26aufirst%3DH.%26aulast%3DKohno%26aufirst%3DT.%26aulast%3DImai%26aufirst%3DY.%26aulast%3DKawase%26aufirst%3DN.%26aulast%3DHara%26aufirst%3DK.%26aulast%3DLepore%26aufirst%3DJ.%26aulast%3DCobitz%26aufirst%3DA.%26atitle%3DEffects%2520of%2520Daprodustat%252C%2520a%2520novel%2520hypoxia-inducible%2520factor%2520prolyl%2520hydroxylase%2520inhibitor%2520on%2520anemia%2520management%2520in%2520Japanese%2520hemodialysis%2520subjects%26jtitle%3DAm.%2520J.%2520Nephrol.%26date%3D2017%26volume%3D45%26spage%3D127%26epage%3D135%26doi%3D10.1159%2F000454818" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref134"><div class="reference"><strong class="refLabel"><a href="#ref134" class="rightTabRefNumLink">134</a></strong><div class="NLM_citation" id="rightTab-cit134"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Caltabiano, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serbest, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravindranath, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cobitz, A. R.</span></span> <span> </span><span class="NLM_article-title">A randomized, placebo- and positive-controlled, single-dose, crossover thorough QT/QTc study assessing the effect of Daprodustat on cardiac repolarization in healthy subjects. Clin</span>. <i>Pharmacol. Drug. Dev.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">627</span>– <span class="NLM_lpage">640</span>, <span class="refDoi"> DOI: 10.1002/cpdd.342</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1002%2Fcpdd.342" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=28419747" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslymsLvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2017&pages=627-640&author=S.+Caltabianoauthor=J.+Collinsauthor=G.+Serbestauthor=L.+Morganauthor=D.+A.+Smithauthor=R.+Ravindranathauthor=A.+R.+Cobitz&title=A+randomized%2C+placebo-+and+positive-controlled%2C+single-dose%2C+crossover+thorough+QT%2FQTc+study+assessing+the+effect+of+Daprodustat+on+cardiac+repolarization+in+healthy+subjects.+Clin&doi=10.1002%2Fcpdd.342"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">A Randomized, Placebo- and Positive-Controlled, Single-Dose, Crossover Thorough QT/QTc Study Assessing the Effect of Daprodustat on Cardiac Repolarization in Healthy Subjects</span></div><div class="casAuthors">Caltabiano, Stephen; Collins, Jon; Serbest, Gul; Morgan, Lisa; Smith, Deborah A.; Ravindranath, Ramiya; Cobitz, Alexander R.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacology in Drug Development</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">627-640</span>CODEN:
                <span class="NLM_cas:coden">CPDDAH</span>;
        ISSN:<span class="NLM_cas:issn">2160-7648</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Daprodustat (GSK1278863) is a prolyl hydroxylase inhibitor in phase 3 clin. studies for the treatment of anemia assocd. with chronic kidney disease.  This study was conducted to evaluate the effect of daprodustat on cardiac repolarization and enrolled 55 healthy adult male (29) and female (26) subjects who received single-dose 75 and 500 mg daprodustat, 400 mg moxifloxacin, and placebo.  Mean placebo-cor. change from baseline QT interval for daprodustat showed no statistically significant increase.  However, statistically significant decreases in the ΔΔQTcF were obsd. for both doses of daprodustat, reaching a lowest value of -2.74 ms for 75 mg and -5.93 ms for 500 mg daprodustat; this minor shortening effect is not considered clin. significant.  The moxifloxacin group showed a statistically significant increase in the ΔΔQTcF value, reaching a maximal increase of 11.47 ms at 4 h.  Forty subjects (73%) reported at least 1 adverse event, with the highest incidence with 500 mg daprodustat.  This group had a higher incidence of gastrointestinal adverse events compared to the other treatment groups.  These results suggest that 500 mg daprodustat was not well tolerated; however, daprodustat at 75 mg was generally well tolerated.  No new safety concerns were identified in subjects who received 500 mg daprodustat.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvUSuZnIyGm7Vg90H21EOLACvtfcHk0lgYFvZx2qRixQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslymsLvO&md5=dae5a9b0d2700402da22e5f25d6680c3</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1002%2Fcpdd.342&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcpdd.342%26sid%3Dliteratum%253Aachs%26aulast%3DCaltabiano%26aufirst%3DS.%26aulast%3DCollins%26aufirst%3DJ.%26aulast%3DSerbest%26aufirst%3DG.%26aulast%3DMorgan%26aufirst%3DL.%26aulast%3DSmith%26aufirst%3DD.%2BA.%26aulast%3DRavindranath%26aufirst%3DR.%26aulast%3DCobitz%26aufirst%3DA.%2BR.%26atitle%3DA%2520randomized%252C%2520placebo-%2520and%2520positive-controlled%252C%2520single-dose%252C%2520crossover%2520thorough%2520QT%252FQTc%2520study%2520assessing%2520the%2520effect%2520of%2520Daprodustat%2520on%2520cardiac%2520repolarization%2520in%2520healthy%2520subjects.%2520Clin%26jtitle%3DPharmacol.%2520Drug.%2520Dev.%26date%3D2017%26volume%3D6%26spage%3D627%26epage%3D640%26doi%3D10.1002%2Fcpdd.342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref135"><div class="reference"><strong class="refLabel"><a href="#ref135" class="rightTabRefNumLink">135</a></strong><div class="NLM_citation" id="rightTab-cit135"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pergola, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spinowitz, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartman, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maroni, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haase, V. H.</span></span> <span> </span><span class="NLM_article-title">Vadadustat, a novel oral HIF stabilizer, provides effective anemia treatment in nondialysis-dependent chronic kidney disease</span>. <i>Kidney Int.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>90</i></span>,  <span class="NLM_fpage">1115</span>– <span class="NLM_lpage">1122</span>, <span class="refDoi"> DOI: 10.1016/j.kint.2016.07.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1016%2Fj.kint.2016.07.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=27650732" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFenur7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2016&pages=1115-1122&author=P.+E.+Pergolaauthor=B.+S.+Spinowitzauthor=C.+S.+Hartmanauthor=B.+J.+Maroniauthor=V.+H.+Haase&title=Vadadustat%2C+a+novel+oral+HIF+stabilizer%2C+provides+effective+anemia+treatment+in+nondialysis-dependent+chronic+kidney+disease&doi=10.1016%2Fj.kint.2016.07.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">Vadadustat, a novel oral HIF stabilizer, provides effective anemia treatment in nondialysis-dependent chronic kidney disease</span></div><div class="casAuthors">Pergola, Pablo E.; Spinowitz, Bruce S.; Hartman, Charlotte S.; Maroni, Bradley J.; Haase, Volker H.</div><div class="citationInfo"><span class="NLM_cas:title">Kidney International</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1115-1122</span>CODEN:
                <span class="NLM_cas:coden">KDYIA5</span>;
        ISSN:<span class="NLM_cas:issn">0085-2538</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Current treatment of anemia in chronic kidney disease (CKD) with erythropoiesis-stimulating agents can lead to substantial Hb oscillations above target range and high levels of circulating erythropoietin.  Vadadustat (AKB-6548), a novel, titratable, oral hypoxia-inducible factor prolyl hydroxylase inhibitor induces endogenous erythropoietin synthesis and enhances iron mobilization.  In this 20-wk, double-blind, randomized, placebo-controlled, phase 2b study, we evaluated the efficacy and safety of once-daily vadadustat in patients with stages 3a to 5 non-dialysis-dependent CKD.  The primary endpoint was the percentage of patients who, during the last 2 wk of treatment, achieved or maintained either a mean Hb level of 11.0 g/dL or more or a mean increase in Hb of 1.2 g/dL or more over the predose av.  Significantly, the primary endpoint was met in 54.9% of patients on vadadustat and 10.3% of patients on placebo.  Significant increases in both reticulocytes and total iron-binding capacity and significant decreases in both serum hepcidin and ferritin levels were obsd. in patients on vadadustat compared with placebo.  The overall incidence of adverse events was comparable between the 2 groups.  Serious adverse events occurred in 23.9% and 15.3% of the vadadustat- and placebo-treated patients, resp.  Three deaths occurred in the vadadustat arm.  Thus, this phase 2b study demonstrated that vadadustat raised and maintained Hb levels in a predictable and controlled manner while enhancing iron mobilization in patients with nondialysis-dependent CKD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAqp2IOl9lT7Vg90H21EOLACvtfcHk0lgYFvZx2qRixQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFenur7M&md5=4e4f226a11b371b8bc7de145a1d0c2e1</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1016%2Fj.kint.2016.07.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.kint.2016.07.019%26sid%3Dliteratum%253Aachs%26aulast%3DPergola%26aufirst%3DP.%2BE.%26aulast%3DSpinowitz%26aufirst%3DB.%2BS.%26aulast%3DHartman%26aufirst%3DC.%2BS.%26aulast%3DMaroni%26aufirst%3DB.%2BJ.%26aulast%3DHaase%26aufirst%3DV.%2BH.%26atitle%3DVadadustat%252C%2520a%2520novel%2520oral%2520HIF%2520stabilizer%252C%2520provides%2520effective%2520anemia%2520treatment%2520in%2520nondialysis-dependent%2520chronic%2520kidney%2520disease%26jtitle%3DKidney%2520Int.%26date%3D2016%26volume%3D90%26spage%3D1115%26epage%3D1122%26doi%3D10.1016%2Fj.kint.2016.07.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref136"><div class="reference"><strong class="refLabel"><a href="#ref136" class="rightTabRefNumLink">136</a></strong><div class="NLM_citation" id="rightTab-cit136"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martin, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maroni, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuraw, Q. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">deGoma, E. M.</span></span> <span> </span><span class="NLM_article-title">Clinical trial of Vadadustat in patients with anemia secondary to Stage 3 or 4 chronic kidney disease</span>. <i>Am. J. Nephrol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">380</span>– <span class="NLM_lpage">388</span>, <span class="refDoi"> DOI: 10.1159/000464476</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1159%2F000464476" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=28343225" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=1%3ACAS%3A528%3ADC%252BC2sXotVOisrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2017&pages=380-388&author=E.+R.+Martinauthor=M.+T.+Smithauthor=B.+J.+Maroniauthor=Q.+C.+Zurawauthor=E.+M.+deGoma&title=Clinical+trial+of+Vadadustat+in+patients+with+anemia+secondary+to+Stage+3+or+4+chronic+kidney+disease&doi=10.1159%2F000464476"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical Trial of Vadadustat in Patients with Anemia Secondary to Stage 3 or 4 Chronic Kidney Disease</span></div><div class="casAuthors">Martin, Edouard R.; Smith, Mark T.; Maroni, Bradley J.; Zuraw, Qing C.; de Goma, Emil M.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Nephrology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">380-388</span>CODEN:
                <span class="NLM_cas:coden">AJNED9</span>;
        ISSN:<span class="NLM_cas:issn">0250-8095</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">Background: Therapeutic options for the treatment of anemia secondary to chronic kidney disease (CKD) remain limited.  Vadadustat (AKB-6548) is an oral hypoxia-inducible factor prolyl-hydroxylase domain (HIF-PHD) inhibitor that is being investigated for the treatment of anemia secondary to CKD.  Methods: A phase 2a, multicenter, randomized, double-blind, placebo-controlled, dose-ranging trial (NCT01381094) was undertaken in adults with anemia secondary to CKD stage 3 or 4.  Eligible subjects were evenly randomized to 5 groups: 240, 370, 500, or 630 mg of once-daily oral vadadustat or placebo for 6 wk.  All subjects received low-dose supplemental oral iron (50 mg daily).  The primary endpoint was the mean abs. change in Hb (Hb) from baseline to the end of treatment.  Secondary endpoints included iron indexes, safety, and tolerability.  Results: Ninety-three subjects were randomized.  Compared with placebo, vadadustat significantly increased Hb after 6 wk in a dose-dependent manner (anal. of variance; p < 0.0001).  Vadadustat increased the total iron-binding capacity and decreased concns. of ferritin and hepcidin.  The proportion of subjects with at least 1 treatment-emergent adverse event was similar between vadadustat- and placebo-treated groups.  No significant changes in blood pressure, vascular endothelial growth factor, C-reactive protein, or total cholesterol were obsd.  Limitations of this study included its small sample size and short treatment duration.  Conclusions: Vadadustat increased Hb levels and improved biomarkers of iron mobilization and utilization in patients with anemia secondary to stage 3 or 4 CKD.  Global multicenter, randomized phase 3 trials are ongoing in non-dialysis-dependent and dialysis-dependent patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgKvwpkpLVLrVg90H21EOLACvtfcHk0lhxRlEVx0shJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXotVOisrg%253D&md5=c8966ae7f2b5e59f0b031da132c3d26a</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1159%2F000464476&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000464476%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DE.%2BR.%26aulast%3DSmith%26aufirst%3DM.%2BT.%26aulast%3DMaroni%26aufirst%3DB.%2BJ.%26aulast%3DZuraw%26aufirst%3DQ.%2BC.%26aulast%3DdeGoma%26aufirst%3DE.%2BM.%26atitle%3DClinical%2520trial%2520of%2520Vadadustat%2520in%2520patients%2520with%2520anemia%2520secondary%2520to%2520Stage%25203%2520or%25204%2520chronic%2520kidney%2520disease%26jtitle%3DAm.%2520J.%2520Nephrol.%26date%3D2017%26volume%3D45%26spage%3D380%26epage%3D388%26doi%3D10.1159%2F000464476" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref137"><div class="reference"><strong class="refLabel"><a href="#ref137" class="rightTabRefNumLink">137</a></strong><div class="NLM_citation" id="rightTab-cit137"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boettcher, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lentini, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flamme, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kubitza, D.</span></span> <span> </span><span class="NLM_article-title">First-in-man study with BAY 85-3934—a new oral selective HIF-PH inhibitor for the treatment of renal anemia</span>. <i>J. Am. Soc. Nephrol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">347A</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2013&pages=347A&author=M.+Boettcherauthor=S.+Lentiniauthor=A.+Kaiserauthor=I.+Flammeauthor=D.+Kubitza&title=First-in-man+study+with+BAY+85-3934%E2%80%94a+new+oral+selective+HIF-PH+inhibitor+for+the+treatment+of+renal+anemia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBoettcher%26aufirst%3DM.%26aulast%3DLentini%26aufirst%3DS.%26aulast%3DKaiser%26aufirst%3DA.%26aulast%3DFlamme%26aufirst%3DI.%26aulast%3DKubitza%26aufirst%3DD.%26atitle%3DFirst-in-man%2520study%2520with%2520BAY%252085-3934%25E2%2580%2594a%2520new%2520oral%2520selective%2520HIF-PH%2520inhibitor%2520for%2520the%2520treatment%2520of%2520renal%2520anemia%26jtitle%3DJ.%2520Am.%2520Soc.%2520Nephrol.%26date%3D2013%26volume%3D24%26spage%3D347A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref138"><div class="reference"><strong class="refLabel"><a href="#ref138" class="rightTabRefNumLink">138</a></strong><div class="NLM_citation" id="rightTab-cit138"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jain, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joharapurkar, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandya, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joshi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kshirsagar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desai, R. C.</span></span> <span> </span><span class="NLM_article-title">Pharmacological characterization of ZYAN1, a novel prolyl hydroxylase inhibitor for the treatment of anemia</span>. <i>Drug Res. (Stuttgart, Ger.)</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">107</span>– <span class="NLM_lpage">112</span>, <span class="refDoi"> DOI: 10.1055/s-0035-1554630</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1055%2Fs-0035-1554630" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=26367279" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=1%3ACAS%3A528%3ADC%252BC28XitlGhtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2016&pages=107-112&author=M.+R.+Jainauthor=A.+A.+Joharapurkarauthor=V.+Pandyaauthor=V.+Patelauthor=J.+Joshiauthor=S.+Kshirsagarauthor=K.+Patelauthor=P.+R.+Patelauthor=R.+C.+Desai&title=Pharmacological+characterization+of+ZYAN1%2C+a+novel+prolyl+hydroxylase+inhibitor+for+the+treatment+of+anemia&doi=10.1055%2Fs-0035-1554630"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological Characterization of ZYAN1, a Novel Prolyl Hydroxylase Inhibitor for the Treatment of Anemia</span></div><div class="casAuthors">Jain, M. R.; Joharapurkar, A. A.; Pandya, V.; Patel, V.; Joshi, J.; Kshirsagar, S.; Patel, K.; Patel, P. R.; Desai, R. C.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Research (Stuttgart, Germany)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">107-112</span>CODEN:
                <span class="NLM_cas:coden">DRSGAO</span>;
        ISSN:<span class="NLM_cas:issn">2194-9379</span>.
    
            (<span class="NLM_cas:orgname">Georg Thieme Verlag</span>)
        </div><div class="casAbstract">Prolyl hydroxylase (PHD) inhibitors stabilize hypoxia inducible factor (HIF), and exert antianemic effect by potentiating erythropoietin (EPO) expression and down-regulation of hepcidin.  ZYAN1 is a novel PHD inhibitor under clin. development for the treatment of anemia.  The pharmacodynamic effects of acute and chronic dosing of ZYAN1 were assessed in normal and 5/6 nephrectomized Wistar rats.  The effect of ZYAN1 was also investigated in cisplatin-induced anemia using C57 mice.  Acute treatment with ZYAN1 increased circulating EPO levels (10.3±3.7 and 40.0±8.5 fold rise at 15 and 30 mg/kg, resp.), reticulocyte count (4.2±0.5 and 6.0±0.2 fold rise at 15 and 30 mg/kg, resp.) and stabilized HIF (28% increase at 45 mg/kg) in normal rats.  Nephrectomized rats showed similar dose-related pharmacodynamic effects.  In a 28-day study in nephrectomized rats, ZYAN1 administered every alternate day, caused increase in Hb (1.9±0.3 and 2.5±0.4 g/dL) and RBC count (10.7±4.0 and 14.0±4.1%) at 15 and 30 mg/kg resp.  In cisplatin-treated mice also an increase in Hb (3.4±0.2 and 5.9±0.2 g/dL) and RBC count (22.5±2.2 and 37.3±1.7%) at 15 and 30 mg/kg resp. was obsd.  ZYAN1's effects on Hb and RBC count were distinct from darbepoietin.  ZYAN1 demonstrated hematinic potential by combined effects on EPO release and efficient iron utilization.  The efficacy of ZYAN1 in disease models of different etiologies suggests that it will be useful in treating wide spectrum of anemia patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsV4aoOEPUh7Vg90H21EOLACvtfcHk0lhxRlEVx0shJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitlGhtbw%253D&md5=7e208ae1360c3835387bea38f355e671</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1055%2Fs-0035-1554630&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-0035-1554630%26sid%3Dliteratum%253Aachs%26aulast%3DJain%26aufirst%3DM.%2BR.%26aulast%3DJoharapurkar%26aufirst%3DA.%2BA.%26aulast%3DPandya%26aufirst%3DV.%26aulast%3DPatel%26aufirst%3DV.%26aulast%3DJoshi%26aufirst%3DJ.%26aulast%3DKshirsagar%26aufirst%3DS.%26aulast%3DPatel%26aufirst%3DK.%26aulast%3DPatel%26aufirst%3DP.%2BR.%26aulast%3DDesai%26aufirst%3DR.%2BC.%26atitle%3DPharmacological%2520characterization%2520of%2520ZYAN1%252C%2520a%2520novel%2520prolyl%2520hydroxylase%2520inhibitor%2520for%2520the%2520treatment%2520of%2520anemia%26jtitle%3DDrug%2520Res.%2520%2528Stuttgart%252C%2520Ger.%2529%26date%3D2016%26volume%3D66%26spage%3D107%26epage%3D112%26doi%3D10.1055%2Fs-0035-1554630" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref139"><div class="reference"><strong class="refLabel"><a href="#ref139" class="rightTabRefNumLink">139</a></strong><div class="NLM_citation" id="rightTab-cit139"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patel, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joharapurkar, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandya, V. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kshirsagar, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gevriya, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srinivas, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desai, R. C.</span></span> <span> </span><span class="NLM_article-title">Influence of acute and chronic kidney failure in rats on the disposition and pharmacokinetics of ZYAN1, a novel prolyl hydroxylase inhibitor, for the treatment of chronic kidney disease-induced anemia</span>. <i>Xenobiotica</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">37</span>– <span class="NLM_lpage">44</span>, <span class="refDoi"> DOI: 10.1080/00498254.2016.1278287</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;key=10.1080%2F00498254.2016.1278287" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2017&pages=37-44&author=H.+Patelauthor=A.+A.+Joharapurkarauthor=V.+B.+Pandyaauthor=V.+J.+Patelauthor=S.+G.+Kshirsagarauthor=P.+Patelauthor=B.+Gevriyaauthor=M.+R.+Jainauthor=N.+R.+Srinivasauthor=P.+R.+Patelauthor=R.+C.+Desai&title=Influence+of+acute+and+chronic+kidney+failure+in+rats+on+the+disposition+and+pharmacokinetics+of+ZYAN1%2C+a+novel+prolyl+hydroxylase+inhibitor%2C+for+the+treatment+of+chronic+kidney+disease-induced+anemia&doi=10.1080%2F00498254.2016.1278287"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1080%2F00498254.2016.1278287&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00498254.2016.1278287%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DH.%26aulast%3DJoharapurkar%26aufirst%3DA.%2BA.%26aulast%3DPandya%26aufirst%3DV.%2BB.%26aulast%3DPatel%26aufirst%3DV.%2BJ.%26aulast%3DKshirsagar%26aufirst%3DS.%2BG.%26aulast%3DPatel%26aufirst%3DP.%26aulast%3DGevriya%26aufirst%3DB.%26aulast%3DJain%26aufirst%3DM.%2BR.%26aulast%3DSrinivas%26aufirst%3DN.%2BR.%26aulast%3DPatel%26aufirst%3DP.%2BR.%26aulast%3DDesai%26aufirst%3DR.%2BC.%26atitle%3DInfluence%2520of%2520acute%2520and%2520chronic%2520kidney%2520failure%2520in%2520rats%2520on%2520the%2520disposition%2520and%2520pharmacokinetics%2520of%2520ZYAN1%252C%2520a%2520novel%2520prolyl%2520hydroxylase%2520inhibitor%252C%2520for%2520the%2520treatment%2520of%2520chronic%2520kidney%2520disease-induced%2520anemia%26jtitle%3DXenobiotica%26date%3D2017%26volume%3D48%26spage%3D37%26epage%3D44%26doi%3D10.1080%2F00498254.2016.1278287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3OUJ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3OUJ','PDB','3OUJ'); return false;">PDB: 3OUJ</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3HQR" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3HQR','PDB','3HQR'); return false;">PDB: 3HQR</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2HBT" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2HBT','PDB','2HBT'); return false;">PDB: 2HBT</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2G1M" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2G1M','PDB','2G1M'); return false;">PDB: 2G1M</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3HQU" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3HQU','PDB','3HQU'); return false;">PDB: 3HQU</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3OUI" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3OUI','PDB','3OUI'); return false;">PDB: 3OUI</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2G19" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2G19','PDB','2G19'); return false;">PDB: 2G19</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4KBZ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4KBZ','PDB','4KBZ'); return false;">PDB: 4KBZ</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5V1B" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5V1B','PDB','5V1B'); return false;">PDB: 5V1B</a></li></ul></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-16%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b01686%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b01686" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-b425991822a79ada59b3.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-fb88834b824b41b135ad.js"></script>

<script type="text/javascript" src="/wro/ke1q~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"667985721d95d932","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.6.0","si":10}'></script>
</body>
</html>
